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Abstract 
 
Enteropathogenic E. coli (EPEC), Enterohaemorhagic E. coli (EHEC) and Citrobacter rodentium 
are constituent members of the attaching and effacing (A/E) pathogens. The A/E group of 
bacteria are considered to be extracellular pathogens which form characteristic lesions by 
intimately adhering to host enterocytes and directing the effacement intestinal brush border. 
EPEC and EHEC are diarrhoeal pathogens, which are a global health burden in developing and 
industrialised countries respectively. Citrobacter rodentium is a murine pathogen which is an 
excellent animal model for EPEC and EHEC infection. 
EPEC, EHEC and C. rodentium conserve a genomic region termed the locus of enterocyte 
effacement (LEE) which encodes a type 3 secretion system (T3SS), a core set of type 3 secreted 
effector proteins and the outer membrane adhesin intimin, which are essential for A/E lesion 
formation. A/E pathogens utilise their T3SSs to translocate dozens of effector proteins directly 
from the bacteria into host cells. Once translocated these effector proteins modulate a range of 
eukaryotic signalling pathways including those which regulate the host cell cytoskeleton. An 
example of this is the T3SS effector Tir which localises to the mammalian plasma membrane, 
acts as a receptor for intimin and subsequently directs the polymerisation of actin rich pedestals 
beneath adherent bacteria.  
Subversion of the eukaryotic cytoskeleton is a strategy employed by a range of bacterial 
pathogens. Due to the pivotal role of Rho GTPases in regulating actin dynamics they are 
commonly targeted by bacterial virulence factors. Recently a family of type 3 secreted effector 
proteins has been defined based on their homology around an invariant tryptophan and glutamic 
acid residue separated by three variable amino acids (WxxxE).  
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In this study we have identified the EspM family of proteins and EspT as novel WxxxE effectors 
in the A/E pathogens. We demonstrate that the EspM proteins and EspT are translocated into 
host cells in a T3SS dependent manner. Once translocated, EspM proteins direct the nucleation 
of actin stress fibres, while EspT drives the formation of lamellipodia and membrane ruffles. 
Furthermore, we found that the cytoskeletal re-arrangements associated with the WxxxE proteins 
are dependent on the activation of the small Rho GTPases. EspM proteins activate RhoA while 
EspT induces the activity of both Rac1 and Cdc42.  
A more detailed structural and function analysis of the mechanism by which EspM2 activates 
RhoA revealed that EspM2 binds RhoA in a concentration dependent manner and subsequently 
promotes RhoA nucleotide exchange from a GDP to GTP bound form. We also show that 
EspM2 adopts a structure similar to that of the previously reported Salmonella T3SS Rho GEF 
SopE despite their limited sequence homology. Although the catalytic domain of SopE was not 
conserved in EspM2 we identified a novel loop which is essential for EspM2 RhoA GEF 
activity.   
As expression of EspT resulted in the formation of membrane ruffles which are often associated 
with the invasion of bacterial pathogens we investigated whether EspT dependent cytoskeletal 
remodelling could facilitate the internalisation of the canonically non-invasive A/E pathogens. 
Interestingly, we found that EPEC strains expressing EspT were significantly more invasive than 
those which did not and furthermore that this invasion was dependent upon the activity of Rac1 
and Wave2. Additionally, we demonstrate that once internalised EPEC is maintained within a 
vacuole (ECV) and is capable of surviving and replicating intracellularly. We also report that 
EPEC translocates Tir into the vacuolar membrane where it can nucleate actin in an analogous 
manner to the formation of pedestals by extracellular bacteria. This is the first time an 
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intracellular bacterial pathogen has been shown to polymerise actin tails across a vacuolar 
membrane. 
Together the results presented in this study demonstrate that the EspM and EspT families of 
WxxxE effector proteins are potent modulators of eukaryotic GTPase signalling cascades and as 
a result convey novel virulence attributes to the A/E pathogen group.  
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1.0 Escherichia coli 
 
Escherichia coli is the most abundant facultative anaerobic Gram negative bacterial commensal 
of the intestinal microflora. For more than half a century after its discovery, in 1885, E. coli was 
considered to be avirulent. However, accumulating evidence linking the bacterium with 
infection, particularly of the gastro-intestinal tract, led to the realisation that E. coli can cause 
disease. As well as diarrhoeal disease caused by Intestinal Pathogenic E.coli (InPEC) other 
pathogenic E. coli strains categorised as Extraintestinal Pathogenic E.coli (ExPEC) are 
associated with other conditions including urinary tract infections, neonatal meningitis and 
septicaemia (Kaper et al., 2004; Smith et al., 2007). Currently, InPEC are recognised as a major 
cause of diarrhoeal infections worldwide and is considered to be a serious public health problem 
particularly in developing nations (Chen and Frankel 2005). Pathogenic E. coli were first 
grouped according to the serology of their surface characteristics in a method described by 
Kauffmann in 1947 (Kauffmann, 1947). A modified version of the Kauffmann’s serological 
approach is still used today to classify E. coli isolates based on their somatic (O), flagellar (H) 
and Capsular (K) antigens (Orskov et al., 1984). InPEC  isolates are not normally encapsulated 
and are therefore grouped based on their somatic and flagellar antigens (Nataro and Kaper, 
1998). 
1.1. Intestinal Pathogenic E.coli (InPEC)  
 
At present there are six pathotypes of diarrhoeagenic InPEC which are recognised and grouped 
based on their virulence attributes and genetic features (Figure 1). Currently accepted groups are: 
enteroinvasive E.coli (EIEC), enteroaggregative E.coli (EAEC), diffuse adherent E. coli 
(DAEC), enterotoxigenic E.coli (ETEC) and enteropathogenic E.coli (EPEC), enterohemorrhagic 
E.coli (EHEC).  
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1.1.1 Enteroinvasive E.coli (EIEC) 
 
The EIEC pathovar is currently comprised of fourteen distinct O antigens including O112ac, 
O124, and O152 which are identical to Shigella boydii and Shigella dysenteriae (Reviewed in 
(Parsot, 2005)). EIEC infection is most commonly associated with the onset of dysentery in a 
very similar manner to Shigella species (Kotloff et al., 1999).  Both EIEC and Shigella harbour a 
220 kb plasmid referred to generally as pINV which is the primary locus required to bring about 
bacterial invasion of non-phagocytic cells. The pINV plasmid encodes a type 3 secretion system 
(T3SS), gene regulators, chaperones and around twenty four effectors proteins which are 
translocated into host cells. pINV also encodes the outer membrane protein IcsA which is 
involved in actin based intracellular movement (Reviewed in (Parsot, 2005)). EIEC and Shigella 
species share an almost identical virulence strategy centred on the invasion of host cells and 
subsequent cell to cell spread resulting in severe watery diarrhoea. Colonisation of the gut by 
Shigella and EIEC species is characterised by destruction of the host colonic epithelium and a 
subsequent inflammatory response (Schroeder and Hilbi, 2008). Until now, EIEC is the only 
InPEC pathovar for which invasion of the host cell is the main virulence strategy; the rest of the 
pathovars are considered as extracellular. 
1.1.2 Enteroaggregative E.coli (EAEC) and Diffusely Adhering E.coli (DAEC) 
 
The EAEC and DAEC pathotypes are defined on the basis of their adherence patterns. EAEC 
serogroups commonly include O3, O7, O15, O44, O77, O86, O111, O126 and O127 (Stenutz et 
al., 2006). EAEC is most commonly associated with infantile diarrhoea and is one of the most 
prevalent pathogens associated with adult traveller’s diarrhoea (Araujo et al., 2007; Huang et al., 
2008) . EAEC pathogenesis is resultant from the formation of a mucoid biofilm on the intestinal 
epithelium and the delivery of bacterial toxins into host cells. EAEC aggregation and biofilm 
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formation is dependent on the aggregative adherence fimbriae (AAF) or the hdaA pilin which are 
both regulated by the AggR regulatory protein (Boisen et al., 2008; Farfan et al., 2008). Another 
secreted protein called dispersin is associated with a relief of the aggregative phenotype and is 
thought to allow dispersal of the EAEC aggregates and infection of new intestinal sites (Velarde 
et al., 2007).  So far three toxins have been identified in EAEC; Shigella enterotoxin 1 (shET1), a 
serine protease plasmid encoded toxin (pet) and the heat stable toxin EAST (reviewed in (Flores 
and Okhuysen, 2009))    
The DAEC pathotype is defined by a diffuse pattern of  bacteria adherence on cultured epithelial 
cells (Nataro and Kaper, 1998). The DAEC are a heterogeneous group and are divided into two 
sub groups; the first class of DAEC strains harbour Afa/Dr adhesins (Afa/DrDAEC) and are 
primarily associated with urinary tract infections and sometimes with gastrointestinal disease (Le 
Bouguenec and Servin, 2006). The second class of DAEC express adhesins involved in diffuse 
adherence (AIDA) and share a variety of virulence factors with the intestinal pathogens EPEC 
and EHEC (Le Bouguenec and Servin, 2006). 
1.1.4 Enterotoxigenic E.coli (ETEC) 
 
ETEC is associated with infantile and traveller’s diarrhoea particularly in regions associated with 
poor sanitation (Okoh and Osode, 2008). In a similar manner to EAEC and DAEC, ETEC 
colonises the gut via adhering to enterocytes using specialised outer membrane colonisation 
factors. To date more than 20 ETEC colonisation factors have been identified (reviewed in 
(Turner et al., 2006)). Once ETEC has established a tight adherence to host cells it secretes one 
or more toxins which have a cytopathic effect on host cells. These toxins include heat stable STa 
and STb enterotoxins which bind host receptors and synergistically mediate the influx of fluid 
into the gut by modifying host cell calcium homeostasis (Turner et al., 2006). ETEC also 
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elaborates heat liable toxins which are members of the A1B5 family of toxins, once secreted the 
B subunits bind the host cell membrane to direct the internalisation of the A subunit. Once in the 
cytoplasm the A subunit modifies host cell adenylate cyclase signalling (Nataro and Kaper, 
1998). ETEC also secretes various other toxigenic factors including the EatA serine protease 
autotransporter, the CylA pore forming toxin and EAST (reviewed in (Turner et al., 2006)).  
1.1.5 Enteropathogenic E.coli (EPEC), Enterohemorrhagic E.coli (EHEC): Attaching 
and Effacing Pathogens 
 
EPEC, EHEC and the mouse pathogen Citrobacter rodentium comprise a group of closely 
related extracellular diarrhoeal pathogens which are characterised by their ability to colonise the 
gut epithelium by intimately adhering to enterocytes and producing distinctive attaching and 
effacing (A/E) lesions (Knutton et al., 1987). A/E lesions are characterised by disruption of the 
local intestinal brush border and distension of the microvili (Figure 1.3). A pathogenicity island 
referred to as the Locus of Enterocyte Effacement (LEE) is the genetic determinant required in 
order to induce the formation of A/E lesions (McDaniel et al., 1995). The LEE island encodes 
the functional and structural components of a type 3 secretion system (T3SS), associated 
chaperones and seven T3SS effector proteins which are translocated into host cells (McDaniel et 
al., 1995).  
EHEC is comprised of a range of serogroups including O26, O55, O111 and O145, however the 
most prevalent and virulent EHEC serotype is O157. EHEC O157s are often segregated based on 
their ability to ferment sorbitol, conventionally non sorbitol fermenting (nsf) O157 EHEC were 
associated with severe disease however in recent times there has been an increase in the 
prevalence of infections attributed to sorbitol fermenting (sf) O157 serovars (Eklund et al., 
2006). EHEC strains carry two isoforms of a potent phage encoded Shiga toxin (Stx1 and Stx2) 
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similar to that of Shigella dysenteriae (Herold et al., 2004).  EHEC is associated with acute 
gastroenteritis which can progress to more serious conditions such as haemorrhagic colitis (HC) 
and Haemolytic Uremic Syndrome (HUS), a common cause of acute renal failure in children and 
the elderly in the developed world (Thorpe, 2004). EHEC is considered to be an important 
pathogen in developed countries and in 2006 there were 1003 cases of O157:H7 related 
infections in England and Wales (HPA). Sporadic outbreaks of EHEC are reported worldwide 
and are normally linked to contaminated bovine products, salads or drinks. The largest outbreak 
reported to date occurred in Osaka, Japan in 1996 causing 9000 cases and 11 deaths (WHO). 
EPEC is also comprised of a variety of serogroups, most commonly, O26, O55, O111, O119, 
O127 and O142. EPEC strains can be classified as typical EPEC (tEPEC) and atypical EPEC 
(aEPEC) based on the presence or absence of a large virulence plasmid called EPEC adherence 
factor (EAF), respectively (Kaper et al., 2004). The EAF plasmid encodes the components 
necessary for the assembly of long bundle forming pili (BFP) which promote the aggregation of 
EPEC bacteria into tight microcolonies (Giron et al., 1991). tEPEC are divided in to two distinct 
evolutionary lineages: EPEC1 and EPEC2. EPEC1 is characterised by expression of the flagellar 
antigens H6 or H34 (Whittmen et al 1993) and encodes intimin subtype α (Adu-Bobie 1998). 
EPEC2 has the H2 or H- flagellar antigens (Whittmen et al 1993) and the β subtype of intimin 
(Adu-Bobie 1998). The archetypal stain of EPEC1 is E2348/69 an O127:H6 strain which has a 
very compact genome only encoding a fraction of the virulence genes associated with EPEC2 
strains such as B171 O111:NM. Infectious diarrhoea is one of the world’s leading causes of 
morbidity and mortality with an estimated 2 million deaths attributed to it annually (WHO). 
EPEC is the single most important bacterial pathogen contributing to infantile mortality in the 
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developing world (Chen and Frankel 2005). EPEC infections are most commonly linked to 
contaminated water supplies and poor sanitation. 
Citrobacter rodentium is naturally occurring mouse pathogen which isgenetically highly similar 
to EPEC and EHEC strains and is the aetiological agent of transmissible murine colonic 
hyperplasia. Citrobacter rodentium shares many of the virulence factors previously described for 
EPEC and EHEC stains including the LEE pathogencity island and associated T3SS alond with an 
extensive repetiore of T3SS effectors (Petty et al 2009). Following ingestion C. rodentium colonizes 
the intestines of mice, residing predominantly in the cecum and colon (Wiles et al 2004) where in 
some inbred strains it can cause serious morbidity and mortality. Infection of the mouse intestinal 
tract with C.rodentium results in the formation of A/E lesions with associated distension of microvili 
and disruption of the host cell actin cytoskeleton indistinguishable from that of EPEC and EHEC 
(Mundy et al 2002). Due to its high degree of similarity to EPEC and EHEC it is used as a model 
in vivo system to study A/E pathogens.  
The pathogenesis of the A/E pathogen group is reliant upon a functional T3SS and the associated 
repertoire of effector proteins. 
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Figure 1.1 Virulence strategies of the Intestinal Pathogenic E.coli Pathovars (InPEC). Each InPEC pathovar 
has unique virulence attributes which contribute to their interaction with host cells. A. EPEC express bundle 
forming pili (BFP) which contribute to initial host association and EPEC microcolony formation (1). EPEC 
mediates the effacement of host cell microvili and utilises the T3SS in conjunction with the outer membrane 
adhesin intimin to establish an intimate adherence to host cells (2). EPEC then continues to secrete effector 
proteins through the T3SS which subvert a variety of host cell processes (3). B. EHEC colonisation of the host 
enterocyte is similar to that of EPEC except that EHEC strains do not posses BFP and so do not form 
microcolonies. In addition to translocating T3SS effector proteins EHEC also secretes a potent Shiga toxin 
which mediates further cytopathic effects. C.  Adhesion of ETEC stains to host enterocytes is mediated by 
outer membrane colonisation factors. Once adhered, ETEC strains elaborate a range of toxins which subvert 
host cell calcium homeostasis as well as other processes. D. EAEC colonise the host gut epithelium by forming 
a mucoid biofilm by virtue of their Aggregative Adherence Factors (AAF). Once a microcolony has been 
established EAEC elaborate a range of enterotoxins including ShET1, Pic, Pet and EAST. E. EIEC unlike the 
other InPEC pathovars does not remain extracellular. EIEC encodes a virulence plasmid known as pINV 
which codes for a T3SS and effector proteins which mediate bacterial invasion of host cells. Once internalised 
EIEC quickly escape from their vacuole, multiply in the cytoplasm and use the specialised outer membrane 
protein IcsA to mediate actin dependent motility and subsequent cell to cell spread. F. DAEC utilise the 
AIDA adhesin factor to adhere to host enterocytes in a diffuse pattern and induce the formation of finger like 
extensions from the host cell membrane which wrap around the adherent bacteria. Reproduced from (Kaper 
et al., 2004). 
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1.2 Bacterial Secretion Systems  
 
Bacteria are often subdivided into the categories Gram positive or negative based on 
characteristics of their cell envelope. Gram positive bacteria posses a single plasma membrane 
which is linked via lipoteichoic acids to a thick peptidoglycan layer. Protein transport in Gram 
positive bacteria is a relatively simple process as the substrates only have to traverse one 
membrane. Gram negative bacteria are comprised of an inner cytosolic membrane and an outer 
membrane enriched with lipopolysaccharides separated by a periplasmic space with a thin 
pedtidoglycan layer. Consequently protein secretion in Gram negative bacteria is a complex 
process as a secreted substrate which is destined to be incorporated into the outer membrane or 
secreted into extracellular milieu must first be translocated across the bacterial inner membrane, 
periplasm and outer membrane. Moreover, some Gram negative bacteria can translocate proteins 
directly into the cytoplasm of the host cell, and in this case the substrate must also traverse the 
eukaryotic plasma membrane. Thus Gram negative bacteria have evolved a plethora of 
specialised transport systems designed to traffic proteins across the inner and outer bacterial 
membranes, to the extracellular milieu or even directly into host cells. Currently six types of 
secretion system have been described in Gram negative bacteria and are designated type 1 to 6 
(Figure 1.2).  
1.2.1 The General Secretory Pathway 
 
The primary system utilised by Gram positive and Gram negative bacteria to translocate proteins 
across the bacterial inner membrane is the general secretory pathway (Sec) (Driessen and 
Nouwen, 2008). The unfolded pre-proteins translated by ribosomes are recognised by trigger 
factor (TF) and or signal recognition particle (SRP) which prevent abberant folding of the pre-
potriens prior to secretion via the Sec system. Trigger factor binds nascent polypedtides at the 
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ribosome independently of an N terminal signal sequence and plays a role in directing the newly 
synthesised polypedtides to the other chaperones which drive their proper folding (Valent et al., 
1995). Proteins which are secereted via the Sec system have an N terminal signal sequences 
which are regognised by the signal recognition particle (SRP). The interaction of SRP with the 
nascent secretory proteins directs them to the membrane in a secretion competent state (reviewed 
in (Luirink et al., 2005)). After  translocation of the prtotein across or into the inner membrane 
the N terminal signal sequence is cleaved to produce the mature protein which is either released 
into the periplasm or incorporated into the inner bacterial membrane. The Sec system consists of 
several key elements including a membrane spanning translocase constructed by three integral 
membrane proteins SecY, SecE and SecG (Brundage et al., 1990) and the multifunctional protein 
SecA (Economou, 1998). SecA recognises and binds substrates of Sec system and subsequently 
guides them to the SecYEG translocase. SecA then acts as an ATPase which performs several 
rounds of ATP binding and hydrolysis associated with conformational shifts which drive the 
translocation of substrate proteins across the bacterial inner membrane (Economou and Wickner, 
1994). In addition to the Sec system, folded proteins can be transported across the bacterial inner 
membrane via the Twin Arginine transport system (Tat) which is powered via the proton motive 
force (reviewed in (Natale et al., 2008)).  
Once a protein has reached the periplasm it can be sorted into any of three distinct routes (i) The 
protein can utilise the chaperone usher pathway which is one of the terminal branches of the Sec 
system. (ii) The protein can be secreted to the extracellular milieu via a complex interaction with 
components of a type 2 secretion system (T2SS) which constitutes the main terminal branch of 
the Sec pathway.  (iii) The protein may have an auto-transporter activity and may facilitate its 
own passage across the bacterial outer membrane this is an example of a type 5 secretion system 
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(T5SS). (reviewed in (Gerlach and Hensel, 2007)). T5SSs can also operate in a two partner 
system where 1 protein encodes the barrel domain whilst the other is the secreted passenger 
(Jacob-Dubuisson et al., 2004).    
1.2.2 The Chaperone Usher Pathway.   
 
Following translocation via the secYEG translocase the secreted pilins are bound by a 
periplasmic chaperone and directed towards an outer membrane usher protein, which allows the 
translocation of folded proteins through a large central pore. The best characterised example of 
this chaperone usher system is the assembly of the Uropathogenic E. coli (UPEC) type 1 pili. In 
this system the periplasmic chaperone FimC binds the prepilins FimA,F,G,H in a one to one ratio 
and prevents premature assembly while directing the immature pilins to the outer membrane 
usher FimD which acts as both an outer membrane translocase and an assembly platform for the 
pili (Saulino et al., 2000). Pilus extension and polymerisation is generated via a cycle of donor 
strand complementation and exchange (Sauer et al., 2004). In donor strand complementation 
FimC interacts with the newly synthesised prepilins to stabilise them via completing an 
Immunoglobulin like fold by donating its G1 strand (Thanassi et al., 1998). The FimC and 
prepilin complex then diffuses to the FimD usher, upon interaction with the exposed N terminus 
of FimD the chaperone then dissociates and the prepilin is incorporated into the nascent pilus 
stand and stabilised via an interaction with the previously incorporated prepilins in a process 
referred to as donor strand exchange (Sauer et al., 1999).     
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1.2.3 Type 2 Secretion System (T2SS) 
 
Proteins which are secreted via the T2SS first utilise the Sec pathway in order to be translocated 
to the periplasm. The T2SS is used by Gram negative bacteria to secrete proteins and toxins into 
the extracellular milieu (reviewed in (Pugsley, 1993)). The T2SS is composed of a complex of 
inner membrane proteins some of which also contain cytoplasmic domains. The inner membrane 
components of the T2SS exhibit homology to Type IV pilins so have been labelled as pseudo-
pilins.  Due to the hydrophobic nature of the T2SS pseudopillins they are often co-translationally 
incorporated into the membrane via in interaction between their N-terminal signal sequences and 
the signal recognition particle (SRP). The signal regonition particle of E. coli is composed of 
4.5S RNA and a polypeptide chain termed Ffh or P48. Upon translation of the psuedopillins the 
nascent poly peptide chain containg the N terminal signal sequence is bound by Ffh while still 
associated with the ribosome and subsequently transported to the membrane bound SRP receptor 
FtsY where it interacts with SecYEG (reviewed in (Luirink et al., 2005)).  Once incorporated in 
or transported across the inner membrane there is speculation that the pseudo-pilins may be able 
to form a pilus like structure in the periplasm but there is no direct evidence for such an 
occurrence. Once a protein is translocated to the periplasm it has to fold to its tertiary or even 
quaternary structure before it is recognised by components of the T2SS (Pugsley, 1993). The 
outer membrane component of the T2SS is typically composed of a ring like structure consisting 
of 12-14 oligomerised monomers of a secretin stabilised in a one to one ratio with an outer 
membrane anchored lipoprotein (Nouwen et al., 1999). Perhaps the best characterised example 
of T2SS is the secretion of the pullulanase (PulA) by Klebsiella oxytoca (Pugsley et al., 1997).   
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1.2.4 Type 4 secretion systems (T4SS) 
 
Type 4 secretion systems (T4SS) are conserved across a wide range of Gram negative pathogens 
including Legionella, Helicobacter, Brucella and Agrobacter. The T4SS is comprised of around 
12 proteins and is capable of transporting proteins as well as DNA (Reviewed in (Li et al., 
2005)). The archetypal T4SS is encoded by Agrobacter tumefaciens and consists of eleven VirB 
proteins (VirB1 to VirB11) and VirD4 (Christie et al., 2005). The T4SS forms a multi protein 
complex which is thought to span both bacterial membranes and the periplasm (Fronzes et al., 
2009). The T4SS has three ATPases (VirB4, VirB11 and VirD4 in Agrobacter) which are 
involved in substrate recognition and secretion as well as assembly of the T4SS apparatus (Krall 
et al., 2002). VirB6, VirB8 and VirB10 are hypothesised to form an inner-membrane pore (Ward 
et al., 2002). The composition of the outer-membrane complex is yet to be established but may 
involve VirB7 and VirB9 components (Fronzes et al., 2009). VirB4, VirB7, VirB9 and VirB10 
form the minimum complex which is still functional (Harris et al., 2001). Some T4SSs also have 
pili like extensions, in the case of Agrobacter these extensions are composed of the VirB2 and 
VirB5 subunits (Li et al., 2005). T4SS can traslocate proteins directly from the bacterial cytosol 
or act as one of the terminal brunches of the Sec system by interacting with substrates in the 
periplasm (Fronzes et al., 2009). 
1.2.5 Type 5 secretion (T5S)  
 
Type 5 secretion is a relatively simple process which is conserved thoughout Gram negative 
bacteria and is often referred to as autotransportation (Dautin and Bernstein, 2007). 
Autotransporters are typically large proteins which consist of N terminal passenger domain 
which is translocated across the bacterial outer membrane by a C terminal transporter domain. 
Initial transport across the inner membrane is directed by the general secretory pathway 
28 
 
(Brandon et al., 2003). Once the autotransporter reaches the periplasm the transporter domain 
inserts in the outer-membrane into a β barrel conformation allowing a threading of the passenger 
domain though the outer-membrane (Reviewed in (Dautin and Bernstein, 2007)). Other type 5 
systems referred to as T5cSS contain a trimeric polypeptide where all of the components are 
involved in constructing the β barrel (Tseng et al., 2009). After translocation through the outer-
membrane the passenger domain might be cleaved from the β barrel (Skillman et al., 2005) the 
mechanism of cleavage is not well conserved between bacterial species. Other T5SSs known as 
two partner systems rely on two independent polypeptides in order to direct secretion, one 
protein forms the β barrel while the other carries the passenger domain and is secreted (Jacob-
Dubuisson et al., 2004). 
 1.2.6 Type 1 Secretion System (T1SS). 
 
Type 1 secretion system (T1SS) is composed of a heterotrimeric complex consisting of a 
cytoplasmic ATPase, a membrane fusion protein and an outer membrane translocator. This 
secretion system is often referred to as an ABC (ATP Binding Cassette) transporter. The 
cytoplasmic ATPase provides substrate specificity and hydrolyses ATP in order to power protein 
translocation, the membrane fusion protein spans the periplasmic space to nullify the 
requirement for a periplasmic chaperone and the outer membrane protein creates a pore which 
allows protein secretion (reviewed in (Gerlach and Hensel, 2007)).  Perhaps the best 
characterised example of a T1SS is the secretion of haemolysin by some UPEC strain. The HlyD 
membrane fusion protein has a large periplasmic domain and a short cytoslolic region linked by 
one transmembrane helix. Using various truncations of HlyD it was demonstrated that its 
cytoplasmic region is specifically required to bind the substrate and that this interaction directs 
the formation of a complex which recruits the outer membrane TolC to induce pore formation 
29 
 
(Balakrishnan et al., 2001). The structure of homotrimeric TolC demonstrated that the outer 
membrane pore consists of twelve tunnel forming helices which in the closed state form tight 
ionic interactions resulting in a closed conformation. Disruption of the ionic interaction leads to a 
relaxation in packing of the helices resulting in an opening of the channel in an iris like manner 
(Andersen et al., 2002).  
1.2.7 Type 6 Secretion Systems (T6SS) 
 
A novel secretion system, known as the type 6 secretion system (T6SS), has recently been 
described in a variety of bacterial species. The T6SS was first defined based on the identification 
of a protein homologous to the Legionella pneumophila T4SS protein IcmF within clusters of 
genes which did not share homology to T4SSs (Das and Chaudhuri, 2003). T6SSs commonly 
consist of between 15 and 25 genes which have been identified based on their contribution to 
virulence or secretion (Pukatzki et al., 2009). The substrates of the T6SS are poorly defined, only 
the Hcp and VgrG components have been demonstrated to be secreted in the majority of 
organisms encoding a T6SS. The remaining proteins encoded within the T6SS clusters are 
thought to be involved in structural aspects of the secretion apparatus (Mougous et al., 2006). A 
definitive model for the secretion system is yet to be elucidated but recent evidence has 
suggested the VgrG component may adopt a phage tail like structure which is capped by Hcp 
monomers which could create a pore through the outer membrane (Leiman et al., 2009). 
1.2.8 Type 3 Secretion Systems (T3SS)       
 
Type 3 secretions systems are complex macromolecular machines which are capable of 
translocating effector proteins directly from the bacteria into the host cell cytoplasm.  A wide 
range of Gram negative pathogens encode a T3SS apparatus including EPEC, EHEC, C. 
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rodentium, Shigella, Yersinia and Pseudomonas (Reviewed in (Moraes et al., 2008)). Salmonella 
species encode two independent T3SS, Spi1 and Spi2, which are expressed at different stages 
during infection and have distinct substrate repertoires (Gerlach and Hensel, 2007). The T3SS 
apparatus is composed of approximately 20-25 distinct proteins which form a basal body, a 
needle complex and a translocation pore (Reviewed in (Cornelis, 2006)). The basal body spans 
both the bacterial inner and outer membranes and is composed of two ring like structures. The 
inner-membrane ring is anchored in the membrane and is associated with a cytoplasmic ATPase 
which provided the energy required for protein translocation (Yip et al., 2005). The outer-
membrane secretin is first exported to the periplasm where it required the assistance of a 
lipoprotein for proper assembly and orientation (Crago and Koronakis, 1998). The assembled 
basal body is then involved in the secretion and assembly of a stiff needle extension composed of 
several hundred YscF family monomers linked via their coiled coil domains (Cordes et al., 
2003). The needle is tipped with a hollow extension which extends towards the eukaryotic 
membrane and directs the proper insertion of translocator proteins. The final component of the 
T3SS secretion is system is a pair of translocator proteins which direct the formation of a pore in 
the eukaryotic plasma membrane to allow injection of T3SS effector proteins directly into the 
host cell (Moraes et al., 2008). The correct assembly of the T3SS apparatus is orchestrated by a 
series of bacterial cytoplasmic chaperones. Class III chaperones bind to the structural 
components of the T3SS and maintain them in secretion competent state whilst masking their 
oligomerisation domains to prevent premature assembly (Yip et al., 2005). Class II chaperones 
are involved in maintaining the translocator proteins in a partially unfolded state to prevent toxic 
effects to bacterial cell (Creasey et al., 2003b). The substrates of the T3SS, called effectors, have 
an un-cleaved N-terminal chaperone recognition sequences which are not yet full defined and do 
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not appear well conserved from genus to genus (Galan and Wolf-Watz, 2006). Class I chaperone 
bind to substrates of the T3SS maintaining them in a secretion competent state whilst directing 
them to the injectisome where they dissociate (Creasey et al., 2003a). 
 
Figure 1.2 Gram Negative Bacterial secretion systems (T1SS-T6SS). TISSs are also referred to as ABC 
transporters and protein translocation across both bacterial membranes is powered by ATP hydrolysis. T3SS 
and T4SS are more complex multi component protein translocation machines which are also powered by 
ATP hydrolysis and can translocate effector proteins across both bacterial membranes and also directly into 
host cells. The T2SS and T5SS require a two step process in order to secrete proteins to the extracellular 
milieu. T2SS requires periplasmic chaperones and an outer membrane usher protein to export proteins 
whereas T5S is mediated by the formation of a translocation pore in the outermembrane by the C terminus of 
its autotransporter substrates. The mechanism of T6SS is yet to be fully understood but the structure 
resembles a phage tail spike composed of its VgrG and Hcp components and secretion is powered by an 
ATPase. Adapted from (Tseng et al., 2009).  
 
 
1.3 The A/E pathogen T3SS and LEE Pathogenicity Island.  
 
Central to their virulence strategies, EPEC, EHEC and Citrobacter rodentium encode a T3SS in 
order to translocate effector proteins directly from the bacterial cell in to the host cell cytoplasm. 
The T3SS of EPEC, EHEC and Citrobacter rodentium is encoded on a region of the genome 
referred to as the Locus of Enterocyte Effacement (LEE) which is required for A/E lesion 
formation (McDaniel et al., 1995) (Figure 1.3). The 5´ end of the LEE island encodes the 
structural components of the T3SS. The central region encodes the outer-membrane adhesin 
intimin (Jerse et al., 1990) and the translocated intimin receptor (Tir) (Kenny et al., 1997). The 3´ 
32 
 
end of the Lee locus codes for additional T3SS structural, translocator and effector proteins 
(Figure 1.3). In EPEC, EHEC and Citrobacter rodentium the fundamental components resemble 
other bacterial T3SS’s with EscC, EscR, EscS, EscT, EscU and EscV forming the basal body, 
and EscJ linking the inner and outer membrane complexes. EscF forms the needle structure with 
EspD and EspB forming the translocation pore (Figure 1.3). The unique feature of the 
EPEC/EHEC and Citrobacter rodentium T3SS is the presence of the filamentous extension to 
the needle complex provided by polymerisation of EspA monomers. This forms a hollow conduit 
between the bacterial cell and the host membrane and constitutes a novel class of filamentous 
T3SS (FT3SS) (Daniell et al., 2001). There are several elements of the type 3 secretion apparatus 
which can be used to manipulate the T3SS to enhance or null secretion for the characterisation of 
putative effectors. One such example of this is EscN, the ATPase essential for powering type 3 
secretion which when deleted renders the T3SS inactive (Gauthier et al., 2003). 
Pathogenic E. coli and Citrobacter rodentium use the T3SS to translocate a range of effector 
proteins which allow them to subvert the host cell cytoskeleton in order to induce A/E lesion 
formation and to hijack several other key eukaryotic signalling pathways.  
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Figure 1.3 A. The LEE operon of A/E pathogens. The 5’ region of LEE encodes the outer membrane adhesion 
intimin, its translocated receptor Tir and other T3SS effectors, while the central region encodes the structural 
components of the T3SS and the 3’ region encodes additional effector proteins and translocators. B. The Type 
3 secretion apparatus of the A/E group. Schematic diagram of the EPEC/EHEC and Citrobacter type 3 
secretion apparatus. The basal body of the T3SS is composed of EscC, inner membrane proteins EscR, EscS, 
EscT, EscU and EscV, and the lipoprotein EscJ connect the inner and outer membrane.  EscF makes up the 
needle structure, while EspA subunits polymerise to form the EspA filament. The translocation pore in the 
host plasma membrane is formed by EspB and EspD, connecting the bacteria and host through the EspA 
filaments. EscN, the cytoplasmic ATPase hydrolyzes ATP molecules into ADP, providing energy for the 
system. Reproduced from (Garmendia et al., 2005) 
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1.4 A/E Lesion and Pedestal Formation 
 
The adherence of EPEC, EHEC and C. rodentium to intestinal epithelial cells results in the 
formation of characteristic A/E lesions from which the pathogens derive their name. A/E lesions 
are characterised by the effacement of brush border and distension of microvili at sites proximal 
to bacterial adherence (Figure 1.3). After initial association with host cells A/E pathogens utilise 
their T3SSs to translocate a plethora of effector proteins including the translocated intimin 
receptor (Tir) (Kenny et al., 1997). Tir is transloctaed from the bacterial cytoplasm to the host 
plasma membrane where it acts as a receptor for the bacterial outer membrane adhesion intimin 
(Frankel et al., 2001). The interaction between Tir and intimin results in a clustering of Tir and 
the polymerisation of actin beneath adherent bacteria which during in vitro cell culture results in 
the formation of a raised pedestal upon which the extracellular bacteria rest (Reviewed in 
(Frankel and Phillips, 2008)) (Figure 1.4). EPEC and EHEC employ similar approaches to direct 
actin pedestal formation but with some major differences, this is in part due to variations within 
their respective Tir proteins. During EPEC infection the clustering of Tir into lipid rafts results in 
its phosphorylation on tyrosine Y474 by c-Fyn (Hayward et al., 2009; Phillips et al., 2004). This 
phosphorylation allows the direct recruitment of the mammalian adaptor protein Nck 
(Campellone et al., 2002; Gruenheid et al., 2001), which in turn binds the ubiquitous form of 
Wiskott-Aldrich syndrome protein (N-WASP) resulting in an activation of N-WASP and 
subsequent recruitment of Actin related protein 2/3 (Arp2/3) complex which mediates actin 
polymerisation (Lommel et al., 2001) (Figure 1.5). In contrast, the Tir protein encoded by EHEC 
does not possess a tyrosine at position 474 and instead utilises the non LEE encoded T3SS 
effector TccP/EspFU which is associates with Tir via members of the IRSp53/MIM homology 
domain (IMD) family of adaptor proteins (Vingadassalom et al., 2009; Weiss et al., 2009). 
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TccP/EspFU then binds and activates N-WASP directly (Campellone et al., 2004; Garmendia et 
al., 2004) (Figure 1.5). TccP/EspFU homolog’s have recently been identified in a group of 
atypical EPEC strains which would allow these strains to utilise both the Nck dependent and 
TccP/EspFU mediated pathway to polymerise actin pedestals (Whale et al., 2006) (Figure 1.5). 
Pedestals can be detected by immuno-fluorescence microscopy using the fungal toxin phalliodin 
coupled to a fluorophore. This technique is referred to as Fluorescence Actin Staining (FAS) and 
is utilised as a diagnostic test for EPEC and EHEC infections (Knutton et al., 1991). However, it 
was recently demonstrated using in vivo and ex vivo models of infection that A/E lesion 
formation can occur independently of both Nck and TccP/EspFU mediated actin polymerisation 
(Frankel and Phillips, 2008). This result suggests that pedestal formation and A/E lesion 
formation can be uncoupled from each other (Frankel and Phillips, 2008). 
 
 
 
Figure 1.4 A/E pathogen mediated pedestal and lesion formation. A. Typical pedestal induced by EPEC and 
EHEC bacteria after initial adherence to host epithelial cell in vitro highlighted by the blue arrow. Pedestals 
are actin based membrane protrusions triggers via the interaction of the EPEC T3SS secreted effector tir and 
the bacterial outer membrane protein intimin and subsequent host cell actin polymerisation.   B. 
Transmission electron micrograph of a bovine explant displaying typical A/E lesion formation. Bacteria are 
adhered to a cuplike pedestal structure (blue arrow) on the host enterocyte with disruption of the host brush 
border and distension of microvili in the proximal region highlighted by the red arrow 
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Effector C. rodentium 
O127:H6 
E2348/69 O111:NM B171 O157:H7 Sakai 
O111:H9 
E110019 
      
Cif 0 1 (1) 1 0 0 
EspB 1 1 1 1 1 
EspF 1 1 1 1 2 
EspG 1 2 1 1 1 
EspH 1 1 1 1 1 
EspJ 1 1 0 1 - 
EspK 1 0 0 1 - 
EspL 1 3 (2) 1 4 (1) - 
EspM 3 (1) 0 3 (1) 2 1 
EspN 3 (2) 0 1 1 
 
- 
EspO 1 1 (1) 0 2 1(1) 
EspR 0 0 0 4 (1) - 
EspT 1 0 0 0 1 
EspV 1 0 1 (1) 1 (1) - 
EspW 0 0 1 1 
 
- 
EspX 1 0 0 6 (1) 3(1) 
EspY 0 0 0 5 (1) - 
EspZ 1 1 1 1 1 
 
1 Map 1 1 1 1 
NleA 1 1 1 1 1 
NleB 2 (1) 3 (1) 3 (2) 3 (1) 1 
NleC 1 1 2 (2) 1 0 
NleD 2 1 0 1 0 
NleE 1 2 1 1 - 
NleF 1 1 1 1 
 
1 
NleG 5 (2) 1 6 14 (5) 1(2) 
NleH 1 3 (1) 2 (1) 2 (4) 
Ibe 1 0 2(1) 0 1 
TccP 0 0 1 2 (1) 
 
- 
Tir 1 1 1 1 1 
______  
__________
__ 
_____________
___ ____________ 
______________
__ 
     
 
 35 (6) 27 (6) 40 (12) 62 (12) 
 
25 (8) 
 
Figure 1.6 T3SS effector protein distribution in C. rodentium, EPEC E2348/69 (O127:H6), EPEC B171 
(O111:NM), EHEC Sakai (O157:H7) and EPEC E110019 (O111:H9). The genome of E110019 is not yet 
published so effector number cannot be confrimed.  
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Once translocated these effector proteins subvert a variety of host cell processes including 
vesicle trafficking, apoptosis, the immune response and cytoskeletal signalling. The effector 
EspF is known to localise to the mitochondria triggering cell death (Nougayrede and 
Donnenberg, 2004) and to disrupt tight junctions (McNamara et al., 2001). EspF also perturbs 
host cell vesicle trafficking and induce membrane remodelling by interacting with Snx9 and N-
WASP (Alto et al., 2007). NleA/EspI is a non LEE encoded effector of the A/E pathogens which 
inhibits protein transport from the endoplasmic reticulum via inhibiting the function of CopII 
(Kim et al., 2007). The effector EspJ is known to inhibit the opsono-phagocytosis of EHEC by 
macrophages (Marches et al., 2008). The NleH family of effectors have been demonstrated to 
induce the activation of NF-kappaB and TNF alpha (Hemrajani et al., 2008). More recently NleH 
has been demonstrated to inhibit host cell apoptosis through its interaction with the endoplasmic 
reticulum protein Bax inhibitor-1 (Hemrajani et al., unpublished). One of the major targets of 
A/E pathogen effectors is the eukaryotic cytoskeleton. In addition to Tir and TccP/EspFU 
mediated pedestal formation, the LEE encoded effector Map activates the small GTPase Cdc42 
in order to induce the formation of filopodia at early times during infection (Berger et al., 2009; 
Huang et al., 2009; Kenny and Jepson, 2000). The LEE encoded effector EspG and it non LEE 
encoded homolog EspG2 are known to induce the formation of stress fibres by liberating GEFH1 
via the depolymerisation of microtubules (Matsuzawa et al., 2004). The prophage encoded T3SS 
effector EspL2 has recently been demonstrated to enhance the cross linking of actin filaments via 
an activation of the host cell protein annexin 2 (Miyahara et al., 2009). Annexin 2 is a membrane 
protein which under normal physiological conditions is enriched at actin assembly sites on the 
plasma membrane and vesicles and is involved in coupling membrane and cytoskeletal 
dynamics. 
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1.6 The Actin Cytoskeleton 
 
The eukaryotic cytoskeleton is a dynamic scaffold composed of microtubules, intermediate 
filaments and actin (reviewed in (Desai and Mitchison, 1997; Goldman et al., 2008; Millard et 
al., 2004)). Within the cytoskeleton actin polymerisation and depolymerisation drives the 
formation of dynamic structures which are tailored to respond to a diverse range of cellular and 
environmental cues. The actin cytoskeleton is integral to a plethora of cellular processes 
including maintenance of cell shape, integrity and polarity, cell migration and division (reviewed 
in (Barr and Gruneberg, 2007; Thery and Bornens, 2006)), vesicle trafficking (Girao et al., 
2008), cell death (Franklin-Tong and Gourlay, 2008) and membrane dynamics (Lanzetti, 2007; 
McMahon and Gallop, 2005). Within eukaryotic cells actin is primarily found in its globular 
form (G-actin) which is one of the most abundant cellular proteins. G-actin is a adenosine 
triposphatase (ATPase) which can self associate and assemble into helical filaments which are 
referred to as filamentous actin (F-actin) (Welch and Mullins, 2002). Actin filament assembly is 
characterised by the presence of a slow growing pointed end and a fast growing barbed end 
(reviewed in (Millard et al., 2004)). The assembly of an F-actin filament is driven by association 
of G-actin monomers bound to ATP, as the filament grows in length the ATP is hydrolysed to 
ADP. The barbed end of the filament has an increased affinity for ATP bound G-actin which 
drives growth and extension of the filament. Meanwhile at the pointed end ADP bound G-actin is 
gradually lost creating a treadmilling of free G-actin subunits which can subsequently bind ATP 
to reconstitute to the free ATP-bound G-actin pool (reviewed in (Cooper and Schafer, 2000; 
Pollard et al., 2001)). This treadmilling of G-actin subunits allows the filament to be highly 
dynamic and responsive.  
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The process of self association and filament assembly or disassembly is controlled by a variety 
of other eukaryotic nucleation promoting factors (NPFs), adaptor proteins and actin binding 
proteins (Figure 1.7).  
1.6.1 Actin nucleators 
 
Despite the ability of G-actin monomers to self associate, spontaneous F-actin filament 
nucleation is prohibited by the inherent instability of actin dimers and trimers. This instability is 
no longer inhibitory in larger F-actin polymers which are capable of rapid self association and 
assembly (Millard et al., 2004). This necessitates the activity of actin nucleators which promote 
early actin polymer formation by stabilising actin dimers and trimers and promoting filament 
growth (Chesarone and Goode, 2009). To date there have been 3 classes of actin nucleators 
defined. 
Class 1: WASP superfamily members contain a C-terminal WH2 domain which is used to recruit 
G-actin monomers and it veropolin (V), central (C) and acidic (A) domain to activate the actin 
related proteins 2/3 (Arp2/3) complex (Takenawa and Miki, 2001). The Arp2/3 complex is a 
heptameric arrangement of five Arp2/3 complex components (Arc 1-5) and two actin like 
subunits (Arp2 and Arp3). Arp2/3 does not possess basal actin nucleation activity, however 
when it is bound to NPFs such as WASP family members it is thought that the Arp2/3 complex 
acts a stable dimer or trimer which promotes the association of additional actin monomers in a 
manner similar to GTP loaded G-actin binding to a barbed end on a growing actin filament. It is 
also thought the Arp2/3 complex in association with NPFs can generate branching of existing F-
actin filaments by binding three subunits from the mother filament and nucleating a new branch 
at a 70° angle (reviewed in (Chesarone and Goode, 2009; Goley and Welch, 2006; Takenawa 
and Miki, 2001)). WASP and Arp2/3 generated actin structures such as filopodia and 
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lamellipodia are generated by assembly of highly dynamic branched actin filaments. WASP is 
only encoded within haematopoietic cells but its near identical homolog N-WASP is ubiquitous 
and is particularly enriched in neuronal cells (Ochs and Thrasher, 2006). Other WASP family 
members include the Wave isoforms 1-3, WASH and WHAMM each of these proteins conserve 
the Arp2/3 and actin binding C terminus of WASP but have divergent N terminal domains 
(Campellone et al., 2008; Linardopoulou et al., 2007; Takenawa and Miki, 2001). Wave proteins 
are potent actin nucleation promoting factors involved in the formation of lamellipodia and 
membrane ruffles (Innocenti et al., 2004; Steffen et al., 2004; Suetsugu et al., 2006; Suetsugu et 
al., 1999). WASH, was first identified as a WASP family member encoded in the sub-telomeric 
region of chromosomes (Linardopoulou et al., 2007). More recently WASH has been shown to 
act as a downstream effector of Drosophila Rho where it acts as an actin and microtubule cross-
linking and bundling agent (Liu et al., 2009).  It has also been shown to play a role in a large 
multiprotein complex containing components of the retromer complex, where is has a role in 
endosome fission (Derivery et al., 2009) (Gomez et al., 2009). WHAMM is another WASP 
homolog which has been described to have microtubule binding capacity, and this in conjunction 
with its actin nucleation activity regulates Golgi stability, anterograde vesicle transport and 
membrane tubulation (Campellone et al., 2008) 
Class 2: The second class of actin nucleators, formins, nucleate unbranched linear actin 
filaments. Formins lack any detectable ability to bind actin monomer so it has been postulated 
that they may stabilise spontaneously formed actin dimers and trimers. The FH2 domain of the 
formin binds to the barbed end of nascent actin polymers and remains bound to the barbed end of 
the growing actin filament (Goode and Eck, 2007). 
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Class 3: The most recently identified class of actin nucleator includes Spire, Cordon bleu (Cobl), 
Leiomodin (Lmod) and JMY. Spire proteins have four dual WASP homology domains which are 
capable of binding four actin monomers in a chain which acts as a template for the addition of 
further actin monomers (Quinlan et al., 2005). The post nucleation activity of spire proteins is yet 
to be elucidated. Cobl nucleates actin filaments via a similar mechanism to spire proteins using 
three WASP homology domains to bind actin monomers. The arrangement of the actin 
monomers nucleated by Cobl is hypothesised to be a linear dimer with one perpendicular G-actin 
monomer. Cobl is thought to remain associated with the pointed end of the growing F-actin 
filament (Ahuja et al., 2007). Lmod has a single WASP homology domain and two tropomodulin 
like actin binding sites. Little is known of the mechanism by which Lmod nucleates actin but it is 
thought a nucleation seed of three actin monomers is formed and subsequently stabilised at the 
pointed end (Chereau et al., 2008). JMY was first identified as a cofactor of p53 but has 
subsequently been demonstrated to involved in cell migration and shown to nucleate actin via a 
spire like mechanism (Zuchero et al., 2009).  
 
Regulation of Nucleation promoting factors.      
Nucleation promoting factors are regulated via a plethora of physiological interactions, 
subcellular localisation, autoinhibition, degradation and phosphorylation (reviewed in (Bompard 
and caron 2004)). Inactive N-WASP is present in cells in a closed autoinhibitory conformation in 
which its GTPase binding domain (GBD) and the central (C) region of the VCA module mediate 
a interprotein interaction. This autoinhibitoy conformation is relieved by the binding of Cdc42 to 
the GBD domain of N-WASP resulting resulting in the VCA module being liberated and able to 
bind and activate the Arp2/3 complex (Higgs and Pollard 2001). The Wave family of proteins are 
43 
 
regulated via protein protein interaction. Under resting conditions Wave is complexed with 
PIR121(Sra1), Nap1, Abi1 and HSPC300 (Kunda et al., 2003). This complex has been 
demonstrated to prevent Wave2 degradation and to enhance its membrane localisation (Innocenti 
et al., 2004). Interaction of Rac1 with PIR121 (Sra1) enhances the actin polymerisation activity 
of the wave complex (Steffen et al., 2004). This suggests that unlike N-WASP Wave proteins are 
constitutively active and are regulated via localisation rather than autoinhibition. The interaction 
between the conserved VCA domain of WASP and Wave proteins and Phosphatidylinositol 
(3,4,5)-trisphosphates strongly enhances the actin polymerisation activity of this family of NPFs 
at the membrane (Oikawa et al., 2004). Both WASP and Wave family proteins are also regulated 
through phosphorylation my multiple cellular kinases including MAP Kinases. Abl and Src 
(reviewed in (Bompard and Caron 2004)).  
Similarly to N-WASP the diaphanous related formins (Drf’s) including MDia under resting 
conditions are present in an autoinhibitory conforamtion mediated by an interaction between 
their N terminal GTPase activating domain and their C terminal Diaphanous-autoregulatory 
domain (DAD). This inhibition is relieved via the binding of RhoA and related GTPases 
(Lammers et al., 2005). Formins can also be regulated by phosphorylation mediated by a variety 
of kinases as exemplified by the activation of FHOD1 and MDia via the phosphorylation of Rho 
associated coiled coil kinase (ROCK) (Takeya et al., 2008). Formins can also be regulated via 
homo-oligomerisation which greatly enhances their in vivo actin polymerisation activity 
(Copeland et al., 2004). 
Little is currently understood regarding the regulation of Spire proteins and related actin 
nucleation promoting factors including JMY and LMod.  
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1.6.2 Actin recycling factors 
 
Actin polymerisation and depolymerisation is a dynamic and reciprocal process which allows 
cells to respond to environmental and cellular cues with speed and plasticity. The number of 
actin monomers within a cell is a self limiting factor which governs the number of nascent actin 
filaments which may be nucleated or extended. This necessitates the rapid turnover of existing 
actin filaments to provide monomers to retain the dynamic nature of the actin cytoskeleton via 
the process of treadmilling (reviewed (Carlier et al., 1999b; Pollard et al., 2001)). ADF/cofilin 
has been demonstrated to bind both G and F–actin and in its un-phosphorylated state severs actin 
filaments at the pointed end which leads to a pool of G-actin monomers and also creates free 
barbed ends which can then be re-polymerised (Carlier et al., 1999b). After ADP-bound G-actin 
subunits have dissociated form the pointed end or been severed by ADF/cofilin they must be 
recycled to an ATP bound form to be competent for polymerisation. Profilin binds to ADP bound 
G-actin and catalyses the nucleotide exchange to the ATP-bound form of G-actin (Witke, 2004).       
1.6.3 Elongation factors 
 
Ena/Vasp proteins are recruited to sites of dynamic actin polymerisation but do not themselves 
under physiological conditions nucleate actin filaments (Bear et al., 2000) (reviewed in (Krause 
et al., 2003)). Ena/Vasp proteins have been demonstrated to delay the capping of the barbed end 
of actin filaments and subsequently promoting elongation (Bear et al., 2002). It has also been 
proposed that Ena/Vasp proteins play a role in inhibiting the branching activity of the Arp2/3 
complex and debranching previously nucleated filaments (Krause et al., 2003). Ena/Vasp 
proteins are also known to bind profilin and this sequestration of profilin is postulated to enhance 
the recruitment of newly recycled ATP bound G-actin which can then be added to the uncapped 
barbed ends of growing actin filaments (Jonckheere et al., 1999). 
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Figure 1.7 Factors involved in the assembly and turnover of the actin cytoskeleton. Actin polymerisation and 
depolymerisation drives the formation of dynamic structures able to respond to a range of cellular and 
environmental cues. A. In order to retain its dynamic nature filamentous actin is constantly being treadmilled 
in order to generate free monomers which can be reassembled into new filaments. Actin treadmilling is 
mediated by the slow intrinsic ATP hydrolysis generated by the ATPase activity of actin monomers and the 
depolymerisation and severing activity of actin recycling factors such as ADF cofilin family members. 
Depolymerisation of actin filaments ocurrs at the pointed (-) end of the filament. Actin filament growth is 
mediated by the addition of fresh ATP bound actin monomers at the babrbed end pf the filaments. 
Subsequent to ADP actin dissociating from the pointed end or being severed by coflin it is bound by profilin 
family members which mediate the regeneration of ADP actin monomers to their ATP bound form which can 
then be incorporated at the barbed end of the filament. B. Schematic representation of the mechanism 
utilised by the three classes of actin nucleators which have been identified to date. Adapted from (Baum et al., 
2006). Although actin filaments are capable of rapid self assembly and turnover, the nucleation of nascent 
filaments is an energetically unfavourable process due to the inherent instability of actin dimmers and 
trimers, this necessitates the the role of actin nucleation promoting factors. Currently there are three major 
classes of actin nucleation promoting factors 1. ARP2/3 complex which, when activated in complex with Wasp 
family proteins, mimics a stable actin trimer which promotes rapid filament assembly. 2. Spire proteins 
which contain multiple actin monomer binding sequences which recruit ATP bound actin into chains of 4 to 
act as a templat for subsequent monomer addition. 3. Formins which bind to the barbed end of nascent actin 
filaments and enhance profilin binding and increasing the rate of ATP bound actin monomer addition to the 
filament facilitating their rapid growth.      
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1.7 Rho GTPases 
 
The mammalian cytoskeleton is subject to an intricate and complex regulatory network regulated 
by kinases such as Src (Frame, 2004), Abl (Woodring et al., 2003), LimK (Bernard, 2007) and 
Phosphoinositide 3-kinase (PI3K) (Cain and Ridley, 2009), adaptor proteins including Nck 
(Buday et al., 2002), amphiphysin (Aspenstrom, 2009) and Grb2 (Giubellino et al., 2008), G 
Protein Coupled Receptors (GPCR) (Cotton and Claing, 2009), ezrin-radixin-moesin (ERM) 
proteins (Niggli and Rossy, 2008) and small Rho family GTPases (Etienne-Manneville and Hall, 
2002) to name but a few. 
The Rho GTPases are often referred to as “master regulators of the actin cytoskeleton” due to 
their pivotal role in almost all aspects of actin dynamics. Rho family GTPases are a distinct 
subgroup of within the Ras superfamily of GTPases. Currently 22 Rho Family GTPases were 
indentified in mammalian cells including RhoA, RhoB, RhoC, RhoD, RhoE, RhoG, RhoH, 
RhoBTB1, RhoBTB2, Rac1, Rac2, Rac3, Cdc42, Rnd1, Rnd2, TC10, TCL, Chp, Wrch1, Rif, 
Miro1, Miro2 (reviewed in (Jaffe and Hall, 2005)). The best characterised Rho family GTPases 
are RhoA, Rac1 and Cdc42.  
Rho GTPases are molecular switches which cycle between an inactive GDP bound form and an 
active GTP bound form (Etienne-Manneville and Hall, 2002). As their names suggest Rho 
GTPases have an intrinsic GTPase activity which acts as an internal regulatory system which 
slowly hydrolyses the GTP of the active form to GDP of the inactive form and subsequently 
limiting the longevity of the activation (Jaffe and Hall, 2005). Activation of Rho GTPases 
requires the binding of GTP instead of GDP which results in a subsequent conformational shift 
of the proteins. Rho GTPases contain several key regions including the switch 1 and 2 regions 
and the P-loop which are involved in the activity and regulation of the proteins (Jaffe and Hall, 
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2005). During nucleotide exchange from GDP to GTP the conformation of the switch regions 
change dramatically altering the structure of the GTPases allowing them to interact with 
downstream effector proteins and signalling molecules which mediate the cellular events such as 
actin polymerisation and membrane protrusion (Bishop and Hall, 2000; Etienne-Manneville and 
Hall, 2002). Misregulation of Rho GTPases is associated with a range of developmental 
abnormalities, immunological diseases, physiological conditions. Most importantly aberrant 
GTPases signalling  is linked to almost every aspect of oncogenesis and metastasis (reviewed in  
(Jaffe and Hall, 2002; Li and Lim, 2003; Toksoz and Merdek, 2002). As such, Rho GTPase are 
subjected to tight and elaborate networks of regulation which includes activating Guanine 
Exchange Factors (GEFs), inactivating GTPase Activating Proteins (GAPs) and Inhibitory 
Guanine nucleotide Dissociation Inhibitors (GDIs) as well as numerous kinases, adaptor proteins 
and ubiquitinases (reviewed in (Etienne-Manneville and Hall, 2002; Jaffe and Hall, 2005)) 
(Figure 1.6). Rho family GTPases can also be regulated spatially via the prenylation of C-
terminal motifs which allow then to be anchored in the membrane (Zhang and Casey, 1996). 
1.8 Regulation of Rho GTPases 
1.8.1 GEFs 
 
Rho GTPases have a nucleotide binding groove which can be loaded with GTP or GDP 
depending on the activation status of the GTPase. As well as having the  capacity to bind guanine 
nucleotides Rho GTPases also have a magnesium (Mg2+) binding pocket which acts as a lock to 
stabile the bound nucleotide (Jaffe and Hall, 2005). GEFs binds to GTPases and facilitate the 
switch from a nucleotide and Mg2+ loaded GTPase to an unbound intermediate which remains 
associated with the GEF. Due to the relative abundance of cellular GTP compared to GDP the 
GEF then mediates the binding of GTP to the GTPase nucleotide binding pocket by stabilising 
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the intermediate nucleotide free GTPase. Following the reacquisition of a Mg2+ ion the GEF then 
normally dissociates leaving the GTP bound GTPase to interact with its downstream effectors 
(reviewed in (Schmidt and Hall, 2002)). It has however been reported that some Rho GEFs such 
as Intersectin-1 can form a trimeric complex with GTPases and their downstream effector which 
can enhance the activity of the GEF (Hussain et al., 2001). The majority of Rho GTPases GEFs 
belong to the Dbl superfamily and are characterised by the presence of a Dbl Homology (DH) 
domain. The DH motif comprises 10-15 alpha helices which have 3 conserved regions (CR1-3) 
(Rossman et al., 2005). The  CR1 and CR3 regions along with some additional amino acids at the 
C terminus of the DH domain contribute the majority of the GTPase binding motif (Soisson et 
al., 1998). DH domains interact with the switch regions of Rho GTPase and mediate a significant 
restructuring of the nucleotide binding pocket. The switch 1 region moves along the nucleotide 
binding groove to disturb nucleotide and Mg2+ binding while the switch 2 region rotates to 
occlude the Mg2+ binding site (Rossman et al., 2005). Almost all Rho GEFs also contain 
Pleckstrin Homology (PH) domains which are a one hundred amino acid motif which bind 
phosphoinositols of the plasma membrane and are thought to provide localisation of the GEF and 
or GEF GTPase complex to the membrane (Olson et al., 1997). Some Rho GEFs also contain C 
terminal PSD-95/Sap90, Disc large and Zonal occludin1/ZO1 (PDZ) domains which are thought 
to aid in localising and retaining the GEF in specific cellular localisations (Garcia-Mata and 
Burridge, 2007). Other atypical GEFs such as Dock180 have recently been described which do 
not contain DH domains but rather utilise Dock Homology Region (DHR) domains in order to 
GEF Rho GTPases (Cote and Vuori, 2007). Dock180 has been demonstrated to interact with 
another cellular protein, named Engulfment and Motility protein (ELMO), which by virtue of its 
PH domain stabilises the nucleotide free GTPase and Dock180 complex to enhance the GEF 
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activity of the DHR domains (Lu et al., 2004). Little is known about how GEFs are turned on 
and off, however autoinhibition and localised activation models have been proposed as 
mechanisms for GEF regulation (reviewed in (Schmidt and Hall, 2002)).  
1.8.2 GAPs 
 
Rho family GTPase have a slow intrinsic GTPase activity however this rate is not sufficient to 
provide the tight regulation required when turning off GTPase signalling. GAP proteins are 
required to enhance the intrinsic GTPase activity to provide tight temporal regulation of GTPase 
activity. The repertoire of human GAP proteins is predicted to be around 70 proteins which all 
contain the conserved GAP motif along with various other less well conserved domains (Peck et 
al., 2002). The RhoGAPs can be separated into around 23 sub-families based on different 
structural and physiological variations (reviewed in (Tcherkezian and Lamarche-Vane, 2007).  
GAPs bind GTPases and enhance their intrinsic GTPases activity by inserting an arginine finger 
motif into the nucleotide binding pocket which is essential for the hydrolysis of GTP to GDP 
(Fidyk and Cerione, 2002). The arginine acts as electron acceptor during the hydrolysis reaction 
(Leonard et al., 1998). It has also been proposed that binding of GAPs to Rho family GTPase 
results in a stabilisation of the normally flexible switch regions creating a stable catalytic centre 
for GTP hydrolysis (Scheffzek et al., 1997). After GTP hydrolysis GAPs dissociate from the 
GTPase.  Rho GAPs are regulated through a combination of phosphorylation, localisation, 
protein protein interaction and degradation (reviewed in (Tcherkezian and Lamarche-Vane, 
2007) (Roof et al., 1998). 
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1.8.3 GDIs and GDFs 
 
To date only three human GDI proteins have been identified: RhoGDI which is ubiquitously 
expressed, GDI1β which is present in hematopoietic cell lineages and GDI3 which is only 
expressed in lung, brain and testis (reviewed in (DerMardirossian and Bokoch, 2005)). Rho GDIs 
function by associating with GTPases in their GDP bound form to prevent nucleotide exchange 
by GEFs resulting in the GTPase remaining in an inactive conformation (Olofsson, 1999). GDIs 
are also capable of binding to GTP bound form of Rho GTPase and prevent GTP hydrolysis 
mediated intrinsically or aided by GAPs whilst preventing the active GTPase from interacting 
with its downstream effectors (DerMardirossian and Bokoch, 2005; Scheffzek et al., 2000). Rho 
GDIs are also thought to function by preventing localisation of active Rho GTPases to the 
plasma membrane and removing GTP-bound GTPase from the membrane by burying their 
prenylated membrane anchor thus sequestering them away from activating membrane bound 
GEFs (Olofsson, 1999). Rho GDIs can be dissociated from GTPase by GDI displacement factors 
(GDFs) including the ERM proteins (Takahashi et al., 1997), lipids and the tyrosine kinase Etk 
(Kim et al., 2002). GDIs may also be regulated via direct phosphorylation (DerMardirossian and 
Bokoch, 2005).  
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Figure 1.6 The Regulatory Cycle of Rho GTPases. The Rho family of GTPases are tightly regulated by three 
major classes of protein. Activating Guanine Exchange Factors (GEFs), Inactivating GTPase Activating 
Proteins (GAPs) and Inhibitory Guanine nucleotide Dissociation Inhibitors (GDIs). GEFs interact with Rho 
GTPases and promote the nucleotide exchange of GDP for GTP resulting in an activation of the GTPase. 
GAPs stimulate the intrinsic GTP hydrolysis activity of GTPases resulting in accumulation of the GDP bound 
inactive forms. GDIs bind to GTPases and inhibit their association with their effectors and GEFs. Adapted 
from (Tcherkezian and Lamarche-Vane, 2007) 
 
1.9 RhoA, Rac1 and Cdc42 
 
The best characterised members of the Rho family of small GTPases are RhoA, Rac1 and Cdc42 
which are involved in the formation of stress fibres, lamellipodia and filopodia respectively. 
Studies conducted on these GTPase have clearly defined the mechanisms by RhoA, Rac1 and 
Cdc42 mediate the formation of these three different actin based phenotypes (Jaffe and Hall, 
2005). (Figure 1.7) 
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1.9.1 RhoA 
 
RhoA induces actomyosin contractibility and the subsequent formation of stress fibres in 
fibroblasts (Ridley and Hall, 1992). In addition RhoA induces cell rounding in other cell lines 
which is has been demonstrated also to be due to actomyosin contraction (reviewed in (Ridley, 
2001)) and is essential for retraction of the tail end of cells during cell migration (Ridley et al., 
2003).  
Stress fibres are specific arrangements of actin monomers into long polymers. These fibres are 
involved in structural aspects of the cell architecture. Stress fibres form at focal adhesions which 
link the actin cytoskeleton at the plasma membrane with the extracellular matrix. Contraction of 
these fibres allows the cell to exert tension on the surrounding extracellular matrix, a process 
which is essential for maintaining structural integrity and also in facilitating cell migration 
(reviewed in (Ridley, 1999)). RhoA exerts its effect by interacting with the Rho coiled coil p160 
serine/threonine kinase (ROCK) and the formin mDia. ROCK phosphorylates the Myosin Light 
Chain (MLC) and the Myosin Binding Subunit (MBS) of the MLC phosphatase (Amano et al., 
1996; Kawano et al., 1999). This results in an increase in MLC phosphorylation and formation of 
actomyosin filaments which can exert a mechanical force on the cell (reviewed in (Bishop and 
Hall, 2000)). ROCK also phosphorylates Lim Kinase (LimK) which subsequently 
phosphorylates cofilin,  resulting in an inactivation of cofilin mediated actin filament severing 
(Maekawa et al., 1999). RhoA also interacts with the formin mDia which nucleates and directs 
the polymerisation of linear actin filaments as described previously. The result of RhoA co-
ordination of ROCK and mDia is the formation of actin stress fibres which are coupled to cell 
contraction.  
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1.9.2 Rac1 
 
Ras related C3 substrate 1 (Rac1) was first identified based on its sensitivity to the C3 botulinum 
toxin  (Didsbury et al., 1989). The C3 toxin was identified to transfer a ribosyl moiety to the 
asparagines residue at position 63 leading to its inactivation.  Rac1 activation is coupled with the 
formation of membrane ruffles and lamellipodia which are predominantly associated with cell 
movement (Etienne-Manneville and Hall, 2002; Ridley et al., 1992). Lamellipodia are actin rich 
extensions which project from the leading edge of cells. These structures are thought to provide 
the motor for the crawling movement of cell. The actin at the leading edge of the lamellipodia is 
constantly treadmilling to allow dynamic movement (reviewed in (Fukata et al., 2003)). 
Membrane ruffles are sheet like membrane structures which are induced by mammalian cells in 
order to facilitate crawling movement, macro-pinocitosis and receptor recycling (reviewed in 
(Buccione et al., 2004)). Rac1 activation is also linked to superoxide production, microtubule 
stability, MAP kinase signalling and regulation of transcription factors (reviewed in (Bosco et 
al., 2009)). The major effectors of Rac1 are WASP-like Verprolin-homologous protein 2 
(Wave2, also known as Scar) and the P21 activating kinases (PAK). Wave proteins are members 
of the WASP superfamily of protein and have the conserved C terminal WH2 domain and VCA 
Arp2/3 binding module through which they can nucleate branched actin filaments. Wave 
proteins also have a N terminal Wave homology domain (WHD) and  a central proline rich 
region (PRR) (reviewed in (Takenawa and Miki, 2001)). Wave2 does not bind to Rac1 directly 
but interacts in a complex together with the GTPase in order to induce membrane ruffling and 
lamellipodia formation; there are two different mechanisms which have been proposed to 
describe how a Wave2-Rac1 complex can be formed. Innocenti et al and Steffen et al 
demonstrate that Wave2 binds to Abi1 and two accessory proteins PIR121 and Nap1 which 
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mediate Rac1 binding (Innocenti et al., 2004; Steffen et al., 2004). Another study from Miki et al 
has proposed that IRSp53 is the protein which links Rac1 to Wave2 (Miki et al., 2000). The other 
major effector of Rac1, PAK, has several isoforms which are serine threonine kinases known to 
phosphorylate MLC kinase to decrease actomyosin contractibility (Sanders et al., 1999). PAK 
isoforms have also been demonstrated to inactivate cofilin by the phosphorylation of LimK 
(Edwards et al., 1999). Rac1 has also been shown to signal to growth receptor pathway involved 
in transformation via c-Jun N terminal Kinase (JNK) in a PAK dependent manner (Westwick et 
al., 1997). Recently, Rac1 mediated PAK activation was shown to activate Erk1/2 in order to 
enhance lamellipodial stability (Smith et al., 2008).  PAK has also been linked to an active role 
in the formation of lamellipodia as well as a subsidiary role in transporting the Wave complex to 
the membrane (Machuy et al., 2007) (Takahashi and Suzuki, 2009).   
1.9.3 Cdc42 
 
Cdc42 activation leads to the formation of finger like actin rich membrane protrusions from the 
cell known as filopodia. Filopodia are often found at the leading edge of cells where they contact 
the substratum during migration to generate the resistance required for the lamellipodia to drive 
the cell during migration (Faix and Rottner, 2006). Additionally filopodia are thought to play a 
role in sampling the local environment of the cell and also in contacting neighbouring cells 
(Ridley, 2001). The major effector of Cdc42 is the haematopoietic specific WASP and its 
ubiquitously expressed homolog N-WASP. As previously mention WASP and N-WASP have a 
conserved WH2 domain and VCA module involved in Arp2/3 binding as well as an N terminal 
WH1 motif and a proline rich region (Takenawa and Miki, 2001). WASP/N-WASP differ from 
their Wave homolog’s in that they possess a Cdc42 interacting domain (CRIB). The CRIB motif 
facilitates the direct binding of Cdc42 which subsequently relieves the autoinhibitory 
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conformation of WASP/N-WASP. This allows WASP/N-WASP to promote actin nucleation in 
an Arp2/3 dependent manner. WASP/N-WASP also bind profilin which enhances their actin 
polymerisation activity (Takenawa and Miki, 2001). Cdc42 can also bind to PAK in a similar 
way to that described for Rac1. Cdc42 has also been proposed to play a role in maintaining 
stability of lamellipodia and membrane ruffles which are nucleated in a Rac1 dependent manner 
(Kurokawa et al., 2004).  
 
Figure 1.7 Regulation of the host cell cytoskeleton by RhoA, Rac1 and Cdc42. GTP bound RhoA induces the 
formation of stress fibres via the coordinated activation of Rho coiled coil p160 kinase (ROCK) and the 
formin mDia. Rock and mDia stimulate an increase in actomyosin contractibility and the nucleation of stress 
fibres respectively. Active Rac1 directs the formation of lamellipodia and membrane ruffles via its activation 
of the Wave complex and subsequent recruitment of the actin nucleator Arp2/3. Rac1 also activates the 
effector PAK which is proposed to play a role in maintaining lamellipodia stability as well as localising Wave 
to the membrane. GTP-bound CDc42 induces the formation of finger like extensions in the plasma membrane 
kwon as filopodia. Cdc42 dependent filopodia formation is mediated via the WASP proteins and Arp2/3.  
 
1.10 Bacterial Virulence and Rho GTPases 
 
Rho GTPases are common targets for bacterial toxins and secreted effector proteins due to their 
pivotal role in the control of  cytoskeletal dynamics along with a wide range of other cellular 
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processes including: the NF-κB signalling cascade, progression through G1 of the cellular cycle 
and regulation of JNK and p38 cascades (Hall, 2005). To date, more than 30 bacterial effectors 
and toxins are known to interfere directly or indirectly with RhoA, Rac1 and Cdc42 (Finlay, 
2005). Bacterial factors which modulate Rho GTPase signalling can be placed into three distinct 
groups: 1. Enzymes which chemically modify GTPase. 2. Proteins which are mimics of host 
Regulatory factors. 3. Factors which indirectly modulate GTPase activity.  
1.10.1 Bacterial Enzymes which Chemically Modify Rho GTPases 
 
One of the classic examples of bacterial modification of Rho GTPases are the Clostridial toxins 
(reviewed in (Aktories et al., 2000)). Toxin A and B from Clostridium difficile have a fold which 
is similar to that of type A glycoslytransferases. Toxin A and B can modify RhoA, Rac1 and 
Cdc42 along with many of the less well characterised Rho GTPases family (reviewed in (Jank et 
al., 2007)). Each Rho GTPase substrate of toxin A and B are modified on the same threonine 
residue (T37 for RhoA and T35 for Rac1 and Cdc42) (Just et al., 1995a; Just et al., 1995b).  This 
threonine residue is located in the switch 1 region and is essential for coordinating the Mg2+ ion. 
Glycosylation of this residue by toxin A and B results in an inactivation of Rho GTPases. This 
inactivation is due to the inability of the glycosylated GTPase to interact with its effectors or 
GEFs (Herrmann et al., 1998).   
In addition to Glycosyltransferases, other species of clostridium posses enzymes known as ADP 
ribosyltransferases which include the C3 toxin of C. botulinum. Ribosyltransferases catalyse the 
transfer of an ADP moiety from a cofactor such as Nictotinamide Adenine Di-nucleotide (NAD) 
to a donor amino acid. In the case of toxin C3 the ADP moiety is transferred to an asparagine 
residue at position 63 in Rho GTPases. Toxin C3 ribosyltransferase activity is specific to RhoA 
and other Rho GTPase are very poor targets for the enzyme. The functional consequence of 
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RhoA ribosylation by C3 is the inactivation of the GTPase by two distinct mechanisms, firstly 
the modification prevents RhoA from interacting with its GEFs and secondly the ribosylation can 
lock RhoA in an inactive complex with its GDI (reviewed in (Vogelsgesang et al., 2007). 
The Vibrio T3SS effector VopS was recently described as having a novel ampylation activity 
towards RhoA, Rac1 and Cdc42. Ampylation involves the modification of the same conserved 
threonine targeted by C. difficile toxin A and B with the addition of a adenosine 5’ mono-
phosphate (AMP) moiety. The conserved Fic domain with its invariant histidine residue is 
essential for VopS mediated ampylation of Rho GTPases. The addition of the AMP moiety by 
VopS resulted in Rho GTPases being unable to bind their downstream effectors (Yarbrough et 
al., 2009). 
As well as modifying Rho GTPases by the addition of glycosyl, ADP, or AMP groups several 
bacterial factors such as the T3SS YopT of Yersinia can post translationally modify GTPases by 
proteolytic cleavage. YopT is a member of a family of cysteine proteases and has been 
demonstrated to cleave RhoA, Rac1 and Cdc42. Cleavage of these GTPases by YopT has been 
shown to result in a loss of the CaaX box at the C terminal of the GTPases (Shao et al., 2002). 
The CaaX box is a eukaryotic motif which is a target for prenylation in host cells, addition of a 
prenyl group to Rho GTPases allows them to be anchored in the plasma membrane (Pereira-Leal 
et al., 2001). Cleavage of the GTPase prenylation site by YopT results in the removal of active 
GTPases from the membrane, additionally YopT can also cleave inactive GTPases inhibiting 
their translocation to the membrane even after activation (Shao et al., 2002; Shao et al., 2003).    
In addition to inactivating Rho GTPases, bacterial toxin can also render GTPases constitutively 
active. Cytotoxic necrotizing factor 1 and 2 (CNF) and Dermonecrotizing toxin (DNT) are toxins 
delivered by Escherichia and Bordetella species respectively. CNF and DNT posses’ deaminase 
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activity which results in the removal of the amine group from a target amino acid within the 
GTPase. CNF toxins deaminase activity targets glutamine 63 in RhoA, Rac1 and to a lesser 
extent Cdc42 (Aktories et al., 2000). Glutamine 63 is essential for the hydrolysis of GTP so 
modification of this residue by CNF toxins results in an inability of Rho GTPases or GAPs to 
hydrolyse GTP rendering them constitutively active (Flatau et al., 1997; Paduch et al., 2001). In 
addition to its deaminase activity DNT also posses’ a transglutamase activity which also targets 
glutamine 63 to inactivate GTP hydrolysis and activate Rho GTPases (reviewed in (Aktories et 
al., 2000)).  
1.10.2 Bacterial Mimics of Host Rho GTPase Regulatory Factors 
 
Many secreted bacterial effectors have evolved functional or structural characteristics of GEFs, 
GAPs, and GDIs in order to mimic their cellular activities to subvert GTPase signalling to the 
benefit of the bacteria. Perhaps the most well studied example of bacterial functional mimicry of 
a GTPase regulatory factor is the T3SS effector SopE of Salmonella which mediates bacterial 
invasion of mammalian cells via the formation of membrane ruffles (Hardt et al., 1998). SopE 
acts as a GEF of Cdc42 and Rac1 in order to promote the invasion of the Salmonella bacteria 
(Hardt et al., 1998). SopE is dissimilar in structure to canonical Dbl family mammalian GEFs 
and does not possess DH or PH domains. However upon binding of Cdc42, SopE induces almost 
identical shifts in the Cdc42 Mg2+ binding pocket and switch 1 and 2 regions (Buchwald et al., 
2002). It has been demonstrated that SopE utilises residues which are equivalent to those in Dbl 
family GEFs to interact with Cdc42 (Buchwald et al., 2002). However the catalytic mechanism 
by which SopE promotes nucleotide exchange on Cdc42 is unique and involves the insertion of 
the SopE GAGA loop between the switch 1 and 2 pocket of Cdc42 (Schlumberger et al., 2003). 
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Other bacterial mimics of GEFs include SopE2 and BopE (Stender et al., 2000; Upadhyay et al., 
2008). 
Other bacterial effectors such as the T3SS effector SptP, which down regulates ruffle formation 
after Salmonella invasion, have been demonstrated to have GAP activity towards Rho GTPases 
(Fu and Galan, 1999). Structural determination of the SptP-Rac1 complex revealed that SptP is 
structurally dissimilar from mammalian GAPs. However, SptP still binds Rac1 between the 
switch 1 and 2 regions and donates a catalytic arginine to facilitate GTP hydrolysis (Stebbins and 
Galan, 2000). One key difference between SptP and mammalian RhoGAPs is the placement of 
the catalytic arginine, in cellular RhoGAPs the arginine is on a flexible finger whereas SptP’s 
donor arginine is confined within an alpha helix. Other bacterial GAPs such as Yersinia YopE 
have been demonstrated to have a similar fold to SptP (Evdokimov et al., 2002).   
The Yersinia T3SS effector YpkA forms a complex with Rac1 which is similar to that of Rac1 in 
complex with mammalian GDI proteins (Prehna et al., 2006). YpkA inserts an alpha helix into 
the switch 1 and 2 regions of Rac1 stabilising the GDP bound form of the GTPase. Interestingly, 
YpkA forms an almost identical acidic amino acid contact with Thr35 of Rac1 as host GDIs 
which provides a stable network between Rac1, YpkA and the Mg2+ ion (Prehna et al., 2006). 
YpkA efficiently inhibits both host GEF and GDI interaction with Rac1 suggesting that the 
YpkA-Rac1 interaction is very stable (Prehna et al., 2006) 
 
1.10.3 Bacterial Factors which Indirectly Modulate GTPase Activity  
 
In addition to post translationally modifying Rho GTPases and mimicking their cellular 
regulators, bacteria can also influence their activity utilising a number of indirect strategies.  
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Instead of directly activating GTPases by acting as GEFs several bacterial effector proteins such 
as EspG of the A/E pathogens can activate endogenous mammalian Rho GEFs. EspG 
depolymerises microtubules resulting in the liberation of GEFH1 which subsequently activates 
RhoA resulting in the formation of stress fibres (Matsuzawa et al., 2004). As well as recruiting 
and activating GEFs other bacterial factor such as the Opa adhesins of Neisseria gonorrhoeae 
have been shown to bind the cellular CEACAM family of receptors to trigger Rac1 and Cdc42 
activation (Billker et al., 2002). 
Other bacterial factors such as Staphylococcus enterotoxin B (SEB) have been demonstrated to 
transcriptionally modulate Rho GTPase signalling. Expression of SEB unregulated the transcript 
level of RhoA whilst co-ordinately down regulating the transcript of the RhoA negative regulator 
Rnd3 resulting in a marked increase in the level of stress fibre production during Staphylococci 
infection (Ionin et al., 2008).  
1.11 The WxxxE Family of Effectors.  
 
WxxxE proteins were first described by Alto et al 2006 who grouped together 26 known 
effectors and named them after their conserved motif consisting of an invariant Tryptophan (W) 
and Glutamic acid (E) residue separated by three variable amino acids (Alto et al., 2006) (Figure 
1.8). This new family of proteins includes effectors from EPEC, EHEC Citrobacter rodentium, 
Shigella and Salmonella. In this initial study it was demonstrated that ectopic expression of 
IpgB1 and IpgB2 of Shigella and Map of EHEC resulted in the induction of membrane ruffles, 
stress fibres and filopodia respectively (Alto et al., 2006). These phenotypes are reminiscent of 
those induced by constitutively active Rac1, RhoA and Cdc42 respectively (Etienne-Manneville 
and Hall, 2002). The WxxxE motif was subsequently shown to be essential for the biological 
activity of this novel effector family. Further work on IpgB2 demonstrated that inactivation of 
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RhoA via dominant negatives or the bacterial toxins YopT and C3 did not inhibit IpgB2 
dependent stress fibre formation. Concordantly the authors demonstrated that IpgB2 binds to the 
RhoA effectors ROCK and mDia and stimulates the kinase activity of the former. This led the 
authors to propose that WxxxE effectors act as functional mimics of host Rho GTPases with 
IpgB2 mimicking RhoA, IpgB1 functioning as Rac1 and Map mimicking Cdc42 (Alto et al., 
2006). However, a more recent study by Handa and colleagues reported that IpgB1 rather than 
mimicking Rac1 in fact utilises the mammalian bipartite ELMO-Dock180 GEF complex to 
activate Rac1 (Handa et al., 2007). Thus the mechanism by which WxxxE proteins exert their 
biological effect is in need of further clarification.  
 
 
Figure 1.8 Alignment of the WxxxE region of the founding members of the WxxxE family of effectors. The 
conserved WxxxE motif after which this family of effectors is named is highlighted in red. Founding WxxxE 
family members included Map and TrcA from A/E pathogens, IpgB1 and IpgB2 from Shigella and SifA and 
SifB from Salmonella.  
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1.11.1Map 
 
Map (mitochondrial associated protein) is encoded is a multifunctional T3SS effector protein 
encoded on the LEE pathogenicity island of the A/E pathogens upstream of the translocated 
intimin receptor Tir. Map was first demonstrated to localise to the mitochondria altering their 
morphology (Kenny and Jepson, 2000). Using mitochondria purified from yeast, Map was 
shown to gain access to the mitochondrial matrix using the TOM import machinery and the 
mitochondrial chaperone mtHsp70 resulting in a loss of mitochondrial membrane potential 
(Papatheodorou et al., 2006). Further work has demonstrated that expression of a GST-Map 
fusion in yeast results in a potent growth defect, mislocalisation of cortical actin and abnormal 
septin formation suggesting that map signalling may interfere with yeast polarity (Rodriguez-
Escudero et al., 2005). Other studies have revealed that Map functions to induce formation of 
filopodia in a Cdc42 manner at early time points during EPEC and EHEC infection (Berger et 
al., 2009; Kenny et al., 2002). Map is also known to interact with EBP50/NHERF1 in a PDZ 
domain dependent manner. Deletion of  the DTRL C-terminal region of Map which is a 
consensus PDZ binding motif resulted in a reduction in the longevity of filopodia (Berger et al., 
2009) (Simpson et al., 2006). It has also been demonstrated that depletion of NHERF1 from cells 
can abolish Map mediated filopodia formation (Alto et al., 2006).  Several studies have also 
implicated Map in disruption of tight junctions and inhibition of mitochondrial fission and fusion 
(Dean and Kenny, 2004; Papatheodorou et al., 2006). Interestingly, expression of a Map-GST 
construct which localised specifically to mitochondria lacked toxicity in yeast (Rodriguez-
Escudero et al., 2005), suggesting that import of Map to the mitochondria may be represent a 
mechanism by which  the cytoplasmic functions of Map, such as its ability to trigger Cdc42-
dependent actin rearrangements and disruption of epithelial barrier function, may be regulated 
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(Dean and Kenny, 2004; Kenny et al., 2002) It has also been demonstrated that a C. rodentium 
map mutant is attenuated for virulence in a mouse model (Mundy et al., 2004).  
1.11.2 TrcA 
 
TrcA was first identified as a gene which responded to transcriptional regulation by the 
transcription initiator complex bfpTVW which is known to co-ordinately upregulate bundle 
forming pili (BFP) and intimin expression (Gomez-Duarte and Kaper, 1995; Tobe et al., 1996). 
TrcA was found to act as chaperone for the BfpA component of the BFP and deletion of TrcA 
results in a reduction of BFP expression and a decrease in size of EPEC microcolonies. Pulldown 
assays also detected an interaction between TrcA and Intimin within the bacterial cytoplasmic 
compartment (Tobe et al., 1999). More recently a homolog of TrcA in EHEC Sakai was 
demonstrated to be secreted in a T3SS dependent manner (Tobe et al., 2006).   
1.11.3 IpgB1 
 
 
Shigella is an invasive pathogen which gains entry to host cells in a T3SS dependent manner, 
after initial invasion Shigella species escape from the phagosome to the cytoplasm where they 
can replicate (Cossart and Sansonetti, 2004). Colonisation of the gut by Shigella species is 
characterised by destruction of the host colonic epithelium and a subsequent inflammatory 
response (Schroeder and Hilbi, 2008). IpgB1 was identified in two separate transponson 
mutagenesis screens to identify proteins involved in invasion of Shigella strains into HeLa cells 
and those involved in virulence (Maurelli et al., 1985; Sasakawa et al., 1988). The secretion of 
IpgB1 by the Shigella Mxi/Spa T3SS was then described by Buchrieser and colleagues 
(Buchrieser et al., 2000). Furthermore IpgB1 is translocated into host cells in a T3SS dependent 
manner (Ohya et al., 2005). The study of Ohya et al demonstrated that IpgB1 induced formation 
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of membrane ruffles in Rac1 and Cdc42 dependent manner which participate in invasion of non-
phagocytic cells  by Shigella (Ohya et al., 2005). A follow up study by Handa and co-workers 
has shown that IpgB1 binds to the mammalian protein ELMO which in turn is a binding partner 
for the atypical GEF Dock180. The IpgB1-ELMO-Dock180 tripartite complex activates Rac1 in 
an ELMO and Dock180 dependent manner resulting in formation of membrane ruffles (Handa et 
al., 2007). 
1.11.4 IpgB2 
 
IpgB2 is another substrate of the Shigella Mxi/Spa T3SS which is translocated into host cells 
(Hachani et al., 2008). Alto et al have reported that ectopic expression of IpgB2 induces 
formation of stress fibres in a RhoA independent manner. Furthermore IpgB2 was shown to 
interact with ROCK and mDia and to stimulate the kinase activity of ROCK in vitro (Alto et al., 
2006). IpgB2 has also been implicated in triggering host cell NF-κB activation in response to 
Shigella infection (Fukazawa et al., 2008).  
1.11.5 SifA 
 
Salmonella is an intracellular pathogen that resides within a vacuole which is extensively 
modified by a range of T3SS effector proteins in order to allow the replication of Salmonella 
within epithelial and macrophage cells (Steele-Mortimer, 2008). SifA was first identified in a 
mutagenesis screen to determine virulence factors responsible for the formation of filaments rich 
in lysosomal glycoproteins induced by Salmonella infection. These structures are referred to as 
Salmonella Induced Filaments (Sifs) from where the gene derives its name. It was also shown 
that a sifA mutant was attenuated in a mouse model of infection (Stein et al., 1996). SifA was 
subsequently demonstrated to be secreted by the Spi2 T3SS (Miao and Miller, 2000). SifA is 
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also implicated in the maintenance of the Salmonella Containing Vacuole (SCV) as a sifA mutant 
loses its vacuole and is released into the cytoplasm (Beuzon et al., 2000). It has also been shown 
that SifA is essential for the replication of Salmonella within macrophages and that ectopic 
expression of SifA results in vacuolation of host cell Lamp1 rich compartments (Brumell et al., 
2001). Interestingly, SifA posses a C-terminal CaaX box which is normally associated with 
prenylation and membrane anchoring and is commonly found in Rho GTPase. This C-terminal 
domain was found to be prenylated in host cells and is essential for SifA targeting to the host cell 
membranes and for the formation of Sifs (Boucrot et al., 2003; Reinicke et al., 2005). SifA has 
been shown to bind to the SifA and Kinesin Interacting Protein (SKIP). Interaction of SifA with 
SKIP results in a displacement of kinesin from the SCV (Boucrot et al., 2005). It has also been 
shown that SifA interacts with the Spi1 secreted effector SipA to modulate positioning and 
morphology of the SCV (Brawn et al., 2007). More recently SifA has been shown to be an 
agonist of Rab9 via its interaction with Skip which is also a Rab9 effector (Jackson et al., 2008).  
1.11. 6 SifB 
 
Although SifB is related by sequence homology to SifA little is known about its contribution to 
Salmonella virulence. SifB has been demonstrated to be secreted in conditions which are known 
to upregulate the Spi2 T3SS (Hansen-Wester et al., 2002). A Salmonella mutant in the sifB gene 
is not significantly attenuated for intracellular replication or in a mouse model (Ruiz-Albert et 
al., 2002). It has also been shown that SifB localises to the SCV and subsequently traffics away 
from the vacuole along Sifs (Freeman et al., 2003).   
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1.12 The EspM Family of Effectors and EspT.  
 
Alto and colleagues identified the T3SS protein Map which is conserved in all A/E pathogens as 
one of the founding WxxxE effectors. TrcA was also reported to be a member of the WxxxE 
family (Alto et al., 2006). Interestingly, TrcA is encoded on a poorly conserved genomic loci 
which is present only in a subset of atypical E. coli including EPEC B171 O111:NM.  In order to 
establish if the A/E pathogen group encodes other WxxxE effectors in discrete genomic loci we 
performed a BLAST analysis using Map and IpgB2 as reference proteins. Several IpgB2-like 
proteins were identified in EHEC O157:H7 strain Sakai, C. rodentium and EPEC B171 which we 
termed EspM1, EspM2 and EspM3. EspM1 and EspM2 from EHEC Sakai have previously been 
shown to be secreted in a T3SS dependent manner (Tobe et al., 2006). Additionally we identified 
a protein in C. rodentium and EPEC E110019 O111:H9 which we have named EspT which 
harbours the WxxxE motif but shares little homology with previously identified family members. 
1.13 Aims  
 
The EspM family of proteins and EspT have not been characterised. The current study was 
designed to determine if the EspM proteins and EspT are T3SS WxxxE effectors and to elucidate 
their mechanism of action and their effect on cellular signalling. In order to do this we aim to: 
1. Confirm the status of the EspM proteins and EspT as T3SS effector proteins. 
2. Establish if translocation or ectopic expression of the EspM and EspT proteins results in 
an alteration of the host cell cytoskeleton. 
3. Elucidate the role of Rho GTPases in EspM and EspT mediated phenotypes.   
4. Define the mechanism by which WxxxE proteins modulate Rho GTPase. 
5.  Determine the role of the EspM and EspT WxxxE effectors in A/E pathogen               
     virulence strategies.         
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2.0 Bacteria Strains 
 
Bacterial strains used in this study are listed in Table 1. The E2348/69 ∆escN T3SS null mutant 
strain was constructed using the using the one-step PCR λ-red-mediated mutation protocol 
(Datsenko and Wanner, 2000) by Junkal Garmendia (Garmendia et al., 2004). The C. rodentium 
∆tir and C. rodentiun ∆espT mutants were also constructed using the  λ-red-mediated mutation 
protocol (Datsenko and Wanner, 2000) by Dr. Rosanna Mundy and Dr. Benoit Raymond 
respectively. The λ red phage mediated knock out protocol is based on the amplification of a 
chloramphenicol or kanamycin gene from pKD3 or pKD4 respecively flanked by regions of the 
gene which are targeted for knock out. The antibiotic resistance gene is then inseted into the 
genome in place of the tagetted gene via homologous recombination mediated by the λ red phage 
recombinase encoded on the pKD46 suicide vector.  The O111:H2 E110019 strain was a kind 
gift from James Kaper and was isolated from an outbreak in Finland (Viljanen et al., 1990). 
Salmonella enterica Typhimurium strain SL1344 was kindly provided by Mark Stevens.  
All strains were maintained on Luria–Bertani (LB) broth or agar supplemented with ampicilin 
(100μg/ml) or kanamycin (50μg/ml). Plates were grown for 16 hours at 37°C and liquid cultures 
were incubated at 37°C with agitation of 200 RPM for 16 hours. Bacterial strains used in this 
study as listed in Table 2.  
2.1 Bioinformatics 
 
A PSI-BLAST search (Altschul et al., 1997) was performed under default conditions using 
IpgB2 from Shigella flexneri (gi:13448971) and Map from EPEC (gi:2865296) as query 
sequences to search the latest version of the NCBI NR database and combined with a library of 
peptide sequences derived from all coding sequences ≥50 codons in length from the genome 
sequences of Citrobacter rodentium ICC168, EPEC B171, E110019 and EPEC E2348/69.  
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Using the sequence alignment program ClustalW2 (Larkin et al., 2007), a phenogram was 
constructed based upon hierarchical clustering of EspT, EspM2 and EspM3 form C. rodentium, 
EspM1 from EPEC B171, and IpgB1 and IpgB2 form Shigella flexneri.  
2.2 Constructs and Cloning 
 
Plasmids and primers used to construct them are listed in Table 2 and primer sequences are listed 
in Table 1. The genes encoding the effector proteins were amplified by PCR from genomic DNA 
and cloned into pSA10 with a C-terminal HA tag (YPYDVPDYA). espM2 and espM1 genes 
were amplified from EHEC O157:H7 strain Sakai, trcA and espM1 genes were amplified from 
EPEC O111:H- strain B171 and espM2, espM3 and espT genes were amplified from Citrobacter 
rodentium strain ICC169 to construct plasmids pICC398, pICC401, pICC402, pICC403, 
pICC400, pICC399 and pICC427 respectively. espM2 from EHEC Sakai, espT from C. 
rodentium and ipgB1 from Shigella flexneri were also cloned into pRK5 with an N terminal Myc 
Tag (EQKLISEEDL) to create pICC228, pICC320 and pICC429 respectively. espM2 and 
espM229-196 from EHEC O157:H7 Sakai in addition sifA from S. Typhimurium was inserted into 
the pET28a (Novagen) vector with a C terminal His tag (HHHHHH) for protein purification to 
create the plasmid pICC454. PCRs were performed using Platinum Taq (Invitrogen) using an 
initial temperature of  94°C followed by 30 cycles of  denaturing 94°C for 45 seconds,  annealing 
temperature of 55°C for 60 seconds and an extension of 68°C for 30 seconds per kilobase 
amplified. Annealing temperature was adjusted depending on the melting point of the primers 
used.  PCRs were purified using the QIAquick® Gel Extraction Kit (QIAGEN). The vectors 
pSA10, pRK5 and pet28a were maintained in E. coli Top10 cells and extracted using the 
QIAprep Spin Miniprep Kit (QIAGEN). The Plasmids and PCR products were then digested 
with the appropriate restriction enzymes (NEB) overnight at 37°C. The digested products were 
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repurified using a QIAquick® PCR Purification Kit. All ligations were carried out overnight 
using T4 ligase (NEB) at 16°C.  
The mammalian expression vector pRK5 containing one of RhoN19, RacN17 or Cdc42N17 
dominant negatives used in the transfection assays were generously provided by Nathalie 
Lamarche-Vane. The vector pGEX expressing the binding domain of Rhotekin fused to GST was 
kindly supplied by J. Bertoglio. The pDSRed Wave dominant negative constructs were provided 
by Laura Machesky via Rey Carabeo. The pEGFP-C1 mammalian expression vector containing 
the RhoGN17 and ELMOT625 dominant negatives and ELMO1 along with the pCXN2 vector with 
the FLAG tagged Dock180ISP were kindly supplied by Yutaka Handa and Chihiro Sasakawa 
(Handa et al., 2007). The vector pMW172-His expressing RhoA or Rac1 fused to a His Tag 
(HHHHHH) was a gift from Michael Way. 
2.3 Site Directed Mutagenesis 
 
Site directed mutagenesis was carried out using a Quickchange® II kit (Stratagene) according to 
the manufacturer’s instructions. Primers were designed using the Quickchange mutagenic primer 
design program (Stratagene). Plasmids pRK5::espM229-196 ,pET28::espM229-196 , pSA10::espM2 
and pSA10::espT were used as template for the mutagenic reactions. Colonies were screened by 
sequencing. 
2.4 Cell Culture 
 
Swiss 3T3 cells were maintained in DMEM with 4500mg/ml glucose and supplemented with 
15% foetal calf serum (Gibco) and 4mM Glutamax (Gibco) with non-essential amino acids. 
HeLa cells were cultured in DMEM with 1000 mg/ml glucose and supplemented with 10% foetal 
calf serum (Gibco) and 4mM Glutamax (Gibco). Cells were passaged every two days and by 
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trypsination with EDTA supplemented with 2.5% trypsin. Cells were then re-suspended in the 
appropriate growth media and harvested at 1500 RPM for 3 minutes before re-suspension in an 
appropriate volume to achieve a confluence of 50-75% as required. Caco2 cells were grown in 
DMEM with 4500 mg/ml glucose and supplemented with 20% foetal calf serum (Gibco) and 
4mM Glutamax (Gibco) with non-essential amino acids. The media was changed every day for 
12 days until the cells had polarised. All cell lines were maintained in an incubator at 37°C in a 
5% CO2 atmosphere. Serially cultured cells were not used above a passage of 20.  
2.5 In Vitro Infections 
 
24 well plates were seeded with an autoclaved glass coverslip prior to addition of Swiss 3T3, 
HeLa or Caco2 cells which were split as described above in order to achieve a confluence of 
50%, 70%, and 100% respectively in each well. 6 hours prior to infection the 24 well plates 
seeded with Swiss 3T3, HeLa and Caco2 cells were washed twice in sterile PBS and 500 μl 
serum free media was added to each well. Overnight cultures of the appropriate bacteria were 
inoculated 1:50 into DMEM and primed as described previously (Collington et al., 1998). 
Expression of proteins from pSA10 was induced by the addition of 500mM IPTG 30 minute 
prior to infection. 500μl of primed bacteria were added to the wells, and the plates were then 
centrifuged at 900 RPM for 5 min. Infections were carried out at 37°C in 5% COB2 for the 
appropriate amount of time.  
2.6 β Lactamase (TEM) T3SS Dependent Translocation Assay 
 
HeLa cells were seeded on to glass coverslips for infection as previously described. EPEC 
E2348/69 wild type and the ΔescN T3SS null mutant were transformed with the pCX340 vector 
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encoding a TEM-1 fusion of EspM2, EspM and EspT from C. rodentium and an NleD positive 
control from EHEC O157:H7 Sakai. The bacteria were cultured overnight and primed as 
described previously. Expression of the fusion protein was induced by the addition of 500mM 
IPTG for 1 hour. The strains were then used to infect the HeLa cells for 90 minutes. After 
infection, cells were washed 3 times with PBS and loaded with the fluorescent substrate CCF2-
AM (Invitrogen), and incubated at room temperature in the dark for 1.5 h. Cells were then 
washed 3 more times in PBS. The cells were then visualised using a Nikon Eclipse E600 
fluorescence microscope using a UV-2A filter (330-380nm excitation). Cleavage of the CCF2-
AM substrate by the TEM-1 β-lactamase fusion proteins was detected by an emission of blue 
fluorescence indicating translocation of the effector fusion protein. Conversely, green 
fluorescence due to the presence of uncleaved CCF2-AM substrate is indicative of an absence of 
translocated fusion protein within the eukaryotic cells (Charpentier and Oswald, 2004). Images 
were taken using a Nikon digital camera DXM1200 and processed using Adobe Illustrator.  
 
2.7 Immuno-fluorescence Staining and Microscopy 
 
Coverslips were washed 3 times in PBS and fixed with PBS supplemented with 3% 
paraformaldehyde (PFA) for 15 min before washing 3 more times in PBS. For immuno-staining, 
the cells were permeabilised for 5 min in PBS 0.5% Triton X100, washed 3 times in PBS and 
quenched for 30 min with 50mM NH4Cl. The coverslips were then blocked in PBS 
supplemented with 2% bovine serum albumin (BSA) for 1 hour. Cover slips were incubated with 
primary antibodies diluted to the appropriate concentration in PBS with 1% BSA in a humidified 
chamber for 1 hour at room temperature. A list of primary antibodies and the working 
concentrations used in this study can be found in Table 4. The coverslips were then washed a 
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further 3 times in PBS. The cells were then incubated with secondary antibodies, phalliodin, and 
Dapi stain diluted in PBS with 1% BSA in a humidified chamber for 45 minutes at room 
temperature. A list of secondary antibodies and reagents along with the working concentration 
utilised in this study can be found in Table 5. The coverslips were then washed 3 times in PBS 
before a 10 min incubation in fresh PBS. The coverslips were then washed 1 more time in 
distilled deionised water before mounting on glass cover-slides with Prolong Gold Antifade 
mounting reagent (Invitrogen). Cells were visualized by Zeiss Axioimager immunofluorescence 
microscope (100X objective giving a total magnification of 1000X) using the following 
excitation wavelengths: Cy3 – 605nm, Cy5 – 690nm and Cy2– 525nm. All images were 
analysed using the Axiovision Rel 4.5 software and trimmed to 5 cm2 (300 pixels) using Adobe 
Photoshop. 
2.8 Differential Staining 
 
Coverslips were fixed, washed and quenched as previously described. Pre-permeabilised samples 
were not treated with triton X100. The coverslips were then blocked for 1 h with PBS 1% BSA 
before incubation with a primary rabbit anti O127, O111 or a goat anti-LPS antibody to detect 
JPN15, E110019 and S. Typhimurium respectively. Secondary donkey anti rabbit and goat 
antibodies coupled to a Rhodamine (RRX) fluorophore as described above. Cells were then 
washed 6 times in PBS before permeablisation with Triton X100 as described previously. The 
post permeabilised coverslips were then stained with a primary rabbit anti O127, O111 or a goat 
anti-LPS antibody to detect JPN15, E110019 and S. Typhimurium respectively. Secondary 
Donkey anti-rabbit and -goat antibodies coupled to a Cy2 fluorophore as described previously. 
Other antibodies and phalloidin were added to the second round of primary and secondary 
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antibodies as outlined above. The coverslips were then mounted on coverslides in Prolong Gold 
antifade mounting reagent (Invitrogen). Cells were visulised as described in 2.6.  
2.9 Gentamycin Protection Invasion Assay 
 
Cells seeded into the wells of a 24 well plate were infected as described above for 3 to 6 h at 
37°C in 5% CO2. The pre-gentamycin plates were washed 5 times in PBS and then permeabilzed 
for 15 minutes with 1% saponin in sterile water before plating in triplicate on LB plates in 
dilutions ranging from 100 to 10-7. The post gentamycin samples were washed 5 times with PBS 
after the final wash the PBS was replaced with serum free DMEM containing 200μg/ml of 
gentamycin and the cells incubated for 1 h at 37°C in 5% CO2. The plates were then washed a 
further 5 times in PBS before permeabilisation and plating as described above. The pre and post 
gentamycin plates were then incubated for 15 h in a static 37°C incubator and the colony forming 
units (cfu) were counted. The percentage of invasion was calculated based on the ratio of cfu on 
the pre and post gentamycin plates.  
2.10 Confocal Microscopy  
 
Samples were immuno-stained as described in 2.7 with the addition of phalloidin coupled to a 
Cy5 fluorophore. The cells were then mounted as described previously and were then visualised 
with a Leica Sp2 upright confocal microscope. X stacks were then taken through cells and 
images were processed with Adobe Photoshop.  
2.11 Scanning Electron Microscopy (SEM) 
 
Glass coverslips were seeded with Swiss 3T3 HeLa or Caco2 cells and infected for 2 h with the 
appropriate strains as described above. The cells were washed 3 times in phosphate buffer pH7.2 
and then fixed with 2.5% Gluteraldehyde (Agar) in phosphate buffer pH7.2 for 15 min. The 
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coverslips were then washed with phosphate buffer pH7.2 for a further 3 times before being post 
fixed in 1% Osmium Tetroxide (Agar) for 1 h. The cells were then washed 3 times in phosphate 
buffer before being washed for 15 min in graded ethanol solutions from 50% to 100% to 
dehydrate the samples. The cells were then transferred to an Emitech K850 Critical Point drier 
and processed according to the manufacturer’s instructions. The coverslips were coated in 
gold/palladium mix using a Emitech Sc7620 minisputter to a thickness of approximately 370Ǻ. 
Samples for scanning electron microscopy (SEM) were then examined blindly at an accelerating 
voltage of 25 kV using a Jeol JSM-6390.  
2.12 Transmission Electron Microscopy (TEM) 
 
6 well plates were seeded with HeLa or Swiss 3T3 cells and infected for 2 h with the appropriate 
strains. The cells were washed 3 times in phosphate buffer pH7.2 and then fixed with 2.5% 
Gluteraldehyde in phosphate buffer pH7.2 for 15 min. The plates were then washed with 
phosphate buffer pH7.2 a further 3 times before being removed from the plate using a Teflon 
scraper and subsequently harvested into in eppendorf tube. The eppendorfs were then centrifuged 
at 10,000 RPM to pellet the cells.  The cell pellets were post fixed in 1% Osmium Tetroxide 
(Agar) for 1 h, followed by 1% buffered tannic acid for 30 min and then a 1% aqueous sodium 
sulphate rinse for 10 min. The sample was dehydrated using an ethanol-propylene oxide series 
(with 2% uranyl acetate added at the 30% step) and embedded in Epon-araldite for 24 h at 60°C. 
Ultrathin sections (60nm) were cut with a Leica EMUC6 ultramicrotome, contrasted with uranyl 
acetate and lead citrate, and viewed with an FEI 120-kV Spirit Biotwin TEM. Images were 
obtained with a Tietz F415 digital TemCam. The Post fixation stages and imaging were kindly 
performed by David Goulding (Sanger Centre, Cambridge). 
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2.13 Transfection 
 
Swiss 3T3 and HeLa cells were seeded at a density of 5x106 cells per well 24 hour prior to 
transfection so as to achieve a 70% confluence. 3 hours before transfection the cells were washed 
twice in PBS and 500μl of serum free media was added to each well. Swiss 3T3 cells or HeLa 
cells were transfected with pRK5 encoding RhoAN19, RacN17, Cdc42N17 dominant negatives fused 
to a Myc tag, pEGFP-C1 containing RhoGN17, ELMOT625 dominant negatives with a GFP tag, 
pCNX2 containing Dock180ISP dominant negative with a FLAG tag, pDSRed containing 
Wave2wt, Wave2∆BP, Wave2 ∆A or pRK5 encoding EspT, IpgB1, EspM2 by lipofectamine 
2000 (Invitrogen) at 1μl per well for HeLa cells and 1.5μl per well in Swiss 3T3 cells as per the 
manufacturer’s recommendations. All plasmid constructs were transfected at 0.8μg of DNA per 
well. The DNA and lipofectamine were diluted in 50ul of Optimem media per well for 5 
minutes. The lipofectamine was then added to the DNA for 15 minutes to allow complexes to 
form before addition to the wells.  The cells were incubated at 37 °C in a humidified incubator 
with 5% CO2 for 16 h, washed twice in PBS before having their media replaced with complete 
DMEM as described previously. The transfected cells were then fixed or infected with an 
appropriate strain as described above.  
2.14 siRNA 
 
Swiss 3T3 cells were seeded at a density of approximatetly 5x 106 cells per well 24 h prior to 
transfection of either Wave2 siRNA pool or a non-targeting pool supplied by Dharmacon using 
HiPerFect (Qiagen) according to the manufacturers instructions. The media was changed 16 h 
after transfection and the cells were allowed to recover for 12 h before being trypsinated and 
seeded at a density of 5 x 106 cells. The siRNA procedure was repeated for a total of 3 rounds 
before the cells were used. Levels of Wave2 and tubulin were then detected by western blotting 
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using anti-wave2 (Santa Cruz) and anti-tubulin (Sigma) antibodies. Cells were then infected with 
the appropriate strain and processed for immuno-fluorescence microscopy as previously 
described.      
 
2.15 Pharmacology 
 
Swiss 3T3 or HeLa cells were seeded for infection as described previously. 2 hours prior to 
infection the cells were treated with the cell permeable PI-3K inhibitor Wortmannin at a 
concentration of 50 nM, the Src family kinase inhibitor PP2 and the control compound PP3 at 
concentration of 20 μM, the Rac1 GEF inhibitor NSC23766 at a 100μM concentration and the 
ROCK inhibitor Y-27362 at a concentration of 10μM per well. Cells were then infected with the 
appropriate strain as described previously.  
2.16 GTP Activation GST Pulldown Assays 
 
Overnight cultures of E. coli BL21 expressing pGEX encoding the RhoA binding domain of 
Rhotekin, the Cdc42 and Rac1 interacting domain (CRIB) of WASP and the Rac1 binding motif 
(RBM) of Pak were diluted 1:20 and cultured at 30°C until O.DB260nm  reached 0.7; the cultures 
was induced with 1 mM IPTG and incubated for a further 4 h. The bacterial cultures were then 
aliquoted into 50 ml falcon tubes and centrifuged for 15 min at 4600 rpm at 4°C and the pellets 
stored at -80°C. The pellets were re-suspended in lysis buffer (20% Saccharose, 10% glycerol, 
50mM Tris pH 8, 200mM Na2S2O3, B2mM MgCl2B, 2mM DTT and 1% of protease inhibitor 
cocktail (Sigma)) and sonicated 5 times for 10 seconds. The solutions were centrifuged for 30 
min at 15,000 rpm at 4°C and the supernatants harvested and coupled to GST-glutathione S-
transferase beads for 45 min at 4°C. 75 cm2 cell culture flasks were seeded with Swiss 3T3 cells, 
infected as described above. The cells were then lysed in 750 μl of MgP2+ buffer (25 mM HEPES, 
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pH 7.5, 150 mM NaCl, 1% NP-40, 10 mM MgClB2, 5%P Pglycerol, 1mM EDTA and protease 
inhibitors (Sigma)). The lysate was transferred to a pre-chilled eppendorf tube and centrifuged at 
14,000 RPM for 5 min at 4°C. The cleared lysate was transferred to a fresh pre-chilled eppendorf 
tube containing 30 μl of GST-Rhotekin-RBD, GST-WASP-CRIB or GST- Pak-RBM. The lysate 
was incubated with the beads for 1 h at 4°C. The suspension was washed 3 times in MgP2+ buffer 
spinning down at 14, 000 RPM at 4°C between each wash. The beads were eluted by the addition 
of 45 μl of 2 x protein loading buffer and the samples heated at 100°C for 5 min. The samples 
were loaded on 15% SDS PAGE gels. The gels were then transferred to PVDF membrane using 
wet transfer apparatus for 1 hour at 400V. The membranes were then blocked with 5% BSA in 
PBS 0.1% Tween for 1 hour. RhoA, Cdc42 or Rac1 were detected with monoclonal antibodies 
from Santa Cruz Biotechnology. Primary antibodies were diluted in TBS 0.1% Tween-20 
supplemented with 3% BSA and incubated on the membrane with agitation for 1 hour. The 
membrane was then washed 3 times in TBS 0.1% Tween-20 with shaking. Secondary antibodies 
coupled to HRP were also diluted in TBS 0.1% Tween-20 supplemented with 3% BSA and 
incubated for 45 mins with agitation. The membrane was then washed a further 5 times before 
incubation with ECL reagents (GE healthcare). The Western blots were then detected using 
chemiluminescence in a LAS 3000 Fugi imager. Densitometry was performed using ImageJ 
software. Results shown are representative of at least 4 independent experiments.   
2.17 Detection of Cofilin Phosphorylation 
 
48 h prior to infection Swiss 3T3 cells were seeded onto 6 well plates to attain a confluent 
monolayer. Each well was infected as described above. After a 1.5 h infection cells were lysed 
by addition of 4 x protein SDS-PAGE loading buffer. The lysate was harvested and heated at 
100°C for 5 min before loading in duplicate onto a 12% SDS PAGE gel. The proteins were then 
79 
 
transferred to PVDF by wet transfer as described previously. The PVDF membranes were 
blocked overnight in TBS, supplemented with 5% BSA at 4°C with gentle rocking. Each 
membrane was incubated in either monoclonal mouse anti-cofilin (Cell Signalling Technology) 
or mouse anti Phospho-cofilin (Cell Signalling Technology) at a dilution of 1:1000 in TBS 0.1% 
Tween-20 supplemented with 3% BSA for 1 h at room temperature with gentle rocking. The 
membranes were washed 5 times in TBS 0.1%  Tween-20 for 5 min. and incubated for 45 min 
with 1:3000 dilution of Goat anti-Mouse (Invitrogen) secondary antibody coupled to HRP at 
room temperature diluted in TBS 0.1% Tween-20 supplemented with 3% BSA. The membranes 
were developed using ECL reagents (GE healthcare) before detection using chemiluminescence 
in a LAS 3000 Fugi imager. Western blots were analysed by densitometry using ImageJ 
software. Results presented are the average of 5 independent experiments. 
2.18 Preparation of Recombinant Proteins 
 
B834 cells containing pET28a (Nde1/BamH1 inserted espM229-196 or SifA) were grown at 310 K 
in LB broth containing 25g ml-1 kanamycin until an A600 nm of 0.6 was reached. Protein 
overexpression was induced by the addition of 1.0 mM IPTG. Cells were harvested after 
incubation at 30°C overnight (4500g 20 min 4°C). Cell pellets were resuspended in lysis buffer 
(20mM Tris pH8, 500mM NaCl, 1mM DTT, Complete EDTA-free protease inhibitor cocktail 
(Roche) and homogenised . After centrifugation (14000 g, 30 minutes, 4°C), the soluble fraction 
was applied to a 5ml His trap FF Column (GE Healthcare) in a gradient of 0 – 300mM 
imidazole. EspM2 fractions were pooled and purified using a Superdex 75 26/60 equilibrated in 
20 mM Tris pH 8, 500mM NaCl, 10mM DTT, high salt due to the instability of the protein. 
Protein was liquid Nitrogen flash cooled and frozen at -80°C on the same day, after experiencing 
protein precipitation in samples kept at 4°C over 2-3 days.  
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Preparation of His-RhoA and His-Rac1 was identical with the following exceptions: Expression 
was constitutive; cells were harvested after incubation at 37°C overnight. Lysis buffer was 
20mM Tris, 500mM NaCl, 20mM imidazole, 5mM MgCl2. Size exclusion buffer was 20mM 
Tris, 200mM NaCl, 3mM MgCl2, 1mM DTT. Protein purification was conducted by Ana 
Arbeloa and James Garnett (Imperial College, London). Purified His-GTPases were stripped of 
nucleotides by incubating them for 10 min at room temperature in binding buffer (20 mM Tris-
HCl [pH 7.5], 100 mM NaCl, 2.5 ng of bovine serum albumin per ml, 10 mM EDTA, 0.1% 
Triton X-100, 1 mM dithiothreitol, 10% glycerol) supplemented with a cocktail of protease 
inhibitors.  
2.19 Surface Plasmon Resonance 
 
Surface Plasmon resonance was carried out in collaboration with James Lillington and Prof. 
Susan Lea (Oxford University). Experiments were carried out using a BIAcore™ 2000 System 
(Biacore AB, Sweden) at 20˚C. EspM229-196 was coupled to a CM5 sensor chip leading to a rise 
of 2000 Response Units per minute using standard amine coupling protocols (BIAcore Amine 
Coupling Kit BR-1000-50). HEPES buffered saline containing 5mM MgCl2 was flowed 
throughout the experiment at 50 l min-1. Samples of RhoA/Rac1 were injected (in the same 
buffer) for 180 seconds duration over the EspM229-196 channel and over a RhoA control channel. 
Dissociation was followed for 1000 s from the end of injection after which regeneration of the 
surface was carried out with 25 mM NaOH. No loss of activity was seen after regeneration. 
Experiments (repeated three times) were carried out with i) varying concentrations of RhoA (= 
18825 M-1cm-1) and Rac1 (= 23295 M-1cm-1) (concentration determined by Nanodrop 
Spectrophotometer, 0.005 – 50 M), and with ii) fixed 4M RhoA but varying concentrations of 
GDP/GTP (0.5 – 8 M) added to the buffer. RhoA control channel subtracted signals are 
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presented (BIAEvaluation software). The same conditions were used to analyse the SifA-RhoA 
interaction. BIAcore analysis was performed by James Lillington (Oxford University).  
2.19 Guanine nucleotide exchange analysis 
 
 
In vitro GEF activity assay was carried out using RhoGEF exchange assay biochem kit 
(Cytoskeleton Inc. Denver) according to the manufacturer’s instructions. The assay is based on 
GTP coupled to the fluorescent substrate N-methylanthraniloyl which when unbound has a low 
intrinsic fluorescence. The binding of the N-methylanthraniloyl labelled GTP to the GTP binding 
pocket of the GTPase results in a conformational shift which increases the substrates 
fluorescence emission. When a GEF is present there is marked increase in the loading of the N-
methylanthraniloyl GTP into the GTP binding pocked of the GTPases and the subsequent 
increase in fluorescence is monitored using as fluorometer. Briefly, exchange reaction assay 
mixtures contained 20mM Tris pH 7.5, 50mM NaCl, 10mM MgCl2, 50μg/ml bovine serum 
albumin (BSA), 0.75μM N-methylanthraniloyl(mant)-GTP, and 2μM of Rac1-His, Cdc42-His, 
HRas or RhoA-His GTPase. Fluorescence spectroscopic analysis of mant-GTP was carried out 
using Fluostar Optima spectrometer. The fluorescence measurements were taken every 30 s with 
excitation and emission wavelengths of 360nm and 440nm respectively. After 5 readings (150 s), 
purified EspM229-196 was added and the relative mant fluorescence was monitored every 30 s for 
a total time of 30 min. Experiments were performed in triplicate. 
2.20 NMR sample preparation and backbone assignment of EspM229-196 
 
All NMR experiments were carried out by Professor Steve Matthews and James Garnett, 
Imperial College London. Uniformly 15N 13C-labelled EspM229-196 was expressed in 15N 13C-
labelled rich media (Cambridge isotopes). After purification as described above the sample was 
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dialysed against NMR buffer (50mM NaPO4 pH 7.5, 150mM NaCl, 5mM DTT, 10% (v/v) D2O) 
and concentrated to 0.9mM. Backbone assignment for ~65% of EspM229-196 was achieved using 
standard double- and triple-resonance assignment experiments (Sattler et al., 1999) at 20°C. 
Structural assignment and NMR was carried out by James Garnett and Steve Matthews (Imperial 
College, London)  
2.21 NMR titration of RhoA against EspM229-196 
 
 
15N 13C-labelled EspM229-196 was mixed with unlabelled His-RhoA (dialysed in NMR buffer) 
ranging from 0x to 7x molar excess and 15N TROSY-HSQC experiments were performed at each 
increment at 25°C. 5mM GTP was added to the sample of EspM229-196 saturated with RhoA and 
a final 15N TROSY-HSQC was carried out. NMR work was conducted by James Garnett and 
Steve Matthews (Imperial College, London). 
2.22 Screening of Clinical Isolates 
 
Screening experiments were carried out in collarboration with Prof. Jorge Blanco and Tania 
Gomes. Colonies from clinical isolates were streaked on a plate so as to achieve single colonies. 
Colony PCRs were performed using Taq polymerase (Invitrogen) using an initial temperature of  
94°C for 5 minutes followed by 30 cycles of  denaturing 94°C for 45 seconds,  annealing 
temperature of 55°C for 60 seconds and an extension of 72°C for 30 seconds per kilobase 
amplified. Annealing temperature was adjusted depending on the melting point of the primers 
used (Table 1). 
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Table 1 Primers used in this study 
 
 
Primer 
Number 
Primer Name  Primer Sequence 
   
1 EspM3-
S9A_S12A-F 5'-ccagtgaatgttcaaggtttagcttttaatgcttttggtatcagctgccatc-3' 
2 EspM3-
S9A_S12A-R 5'-gatggcagctgataccaaaagcattaaaagctaaaccttgaacattcactgg-3' 
3 EspM3-W66A-F 5'-gcagagtactaaagatattgatggagcgataaaagatgaacagaaagtgtat-3' 
4 EspM3-W66A-R 5'-atacactttctgttcatcttttatcgctccatcaatatctttagtactctgc-3' 
5 EspM3-H125A-
F 5'-ggagcagctcaaagctccatcaatgctatgataataggaaatggtt-3' 
6 EspM3-H125A-
R 5'-aaccatttcctattatcatagcattgatggagctttgagctgctcc-3' 
7 EspM3-Y188F-F 5'-gtatgattcctcgttatatgaggtttgctatatcgctgtacc-3' 
8 EspM3-Y188F-R 5'-ggtacagcgatatagcaaacctcatataacgaggaatcatac-3' 
9 EspM3-D115A-
F 5'-ttatggcctggaacttgcttctggagcagctcaaa-3' 
10 EspM3-D115A-
R 5'-tttgagctgctccagaagcaagttccaggccataa-3' 
11 EspM3-L114A-F 5'-tttcaaagcattatggcctggaagctgattctggagcagc-3' 
12 EspM3-L114A-
R 5'-gctgctccagaatcagcttccaggccataatgctttgaaa-3' 
13 EspM2Cr-
W66A-F 5'-ggcagagcactaaagatcttttagcagcgaaaaaagatgaaaaagtaatttatc-3' 
14 EspM2Cr-
W66A-R 5'-gataaattactttttcatcttttttcgctgctaaaagatctttagtgctctgcc-3' 
15 EspM2Cr-
H125A-F 5'-gcccgctcagcacaaagttctataaatgctatcataaccggaaa-3' 
16 EspM2Cr-
H125A-R 5'-tttccggttatgatagcatttatagaactttgtgctgagcgggc-3' 
17 EspM3-K149A-
F 5'-cgaggggatgaccaggaatgtagcaaatcatacatcagattacatg-3' 
18 EspM3-K149A-
R 5'-catgtaatctgatgtatgatttgctacattcctggtcatcccctcg-3' 
19 EspM3-W66Y-F 5'-gcagagtactaaagatattgatggatatataaaagatgaacagaaagtgtatcc-3' 
20 EspM3-W66Y-R 5'-ggatacactttctgttcatcttttatatatccatcaatatctttagtactctgc-3' 
21 EspM3-E70D-F 5'-tgatggatggataaaagatgatcagaaagtgtatccatcaagg-3' 
22 EspM3-E70D-R 5'-ccttgatggatacactttctgatcatcttttatccatccatca-3' 
23 EspM2-W70Y-F 5'-gcagagtactaaagatattgatgagtatataaaagatgaacggatagtatatcc-3' 
24 EspM2-W70Y-R 5'-ggatatactatccgttcatcttttatatactcatcaatatctttagtactctgc-3' 
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25 EspM2-E74D-F 5'-taaagatattgatgagtggataaaagatgatcggatagtatatccctc-3' 
26 EspM2-E74D-R 5'-gagggatatactatccgatcatcttttatccactcatcaatatcttta-3' 
27 EspM1-pKK-F 5'-ttgaattcatgccagtaaatgcgacagg-3' 
28 
EspM1-pKK-R 
5'-ccaatgcactgcagttaagcgtagtctgggacgtcgtatgggtacccctgtataacacgactca-
3' 
29 EspM2-pKK-F 5'-tttgaattcatgccgatgaatactacaggtatgt-3' 
30 EspM2-pKK-R 5'-tttctgcagtcaagcgtagtctgggacgtcgtatgggtatccctgtatagcacgcatcaa-3' 
31 EspM2 W70A-F 5'-gcagagtactaaagatattgatgaggcgataaaagatgaacggatagtatat-3' 
32 EspM2 W70A-R 5'-atatactatccgttcatcttttatcgcctcatcaatatctttagtactctgc-3' 
33 EspM3-pKK-F 5'-ttgaattcatgccagtgaatgttcaagg-3' 
34 EspM3-pKK-R 5'-ttgcctgcagttaagcgtagtctgggacgtcgtatgggtacacgatatagcatacctca-3' 
35 EspM2Cr-pKK-
F  5'-ttgaattcatgccagcgaatatatcagg-3' 
36 EspM2Cr-pKK-
R 5'-ttgtcgacttaacttaagcgtagtctgggacgtcgtatgggtatgccgacatggcatttgcca-3' 
37 TrcA-pKK-F 5'-ttgaattcatgccgatgaatactacaagtac-3' 
38 TrcA-pKK-R 5'-aactgcagttaagcgtagtctgggacgtcgtatgggtatgcctgtatagcacacctca-3' 
39 EspM1 B171-
pKK-F 5'-tacccatacgacgtcccagactacgct-3' 
40 EspM1 B171-
pKK2-R 5'-ccaatgcactgcagttaagcgtagtctgggacgtcgtatgccgatatgacgctggcag-3' 
41 EspT-HA-F 5’-ttgaattcatgccgggaacaataagctccag-3’ 
42 EspT-HA-R 5’-ttctgcagttaagcgtagtctgggacgtcgtatgggtaggttctctgagcctcctgaa-3’ 
43 EspT-pRK5-F 5’-cgcggatccatgccgggaacaataagctccag-3’ 
44 EspT-pRK5-R 5’-ccaatgcactgcagttaggttctctgagcctcctgaa-3’ 
45 EspM2-pRK5-F 5’-tttcgatccggatccggagcaatgcaaattctaaacaaaatac-3’ 
46 EspM2-pRK5-R 5’-tttgaattctcatccctgtatagcacgcatca-3’ 
47 IpgB1-pRK5-F 5’-tttggatccggagcaatgcaaattctaaacaaaatac-3’ 
48 IpgB1-pRK5-F 5’-ccaatgcattggttctgcagttaatttgtattgctttgac-3’ 
49 EspT-E110019-F 5’- ttgaattcatgccaggaacagtaaactcc-3’ 
50 EspT-E110019-
R 
5’- ccaatgcattggttctgcattaaacatattttaaatttctc -3’ 
51  espM2(29-196)-
His F 5'-catgccatgggacatcatcatcatcatcacggaggagggaagaaggatatgaggtcgt-3’ 
52 espM2(29-196)-
His R 5'-aagaattctcatccctgtatagcacgca-3' 
53 sifA-His F 5'-ggaattccatatgatgccgattactataggga-3' 
54 sifA-His R 5'-aaagaattcttataaaaaacaacataaacagccgc-3' 
55 espM2(29-196)-
myc F 
5'-tttgaattcagggaagaatgatgaggtcgt-3' 
56 espM2(29-196)-
myc R 
5'-ccaatgcattggttctgcagtcatccctgtatagcacgca-3' 
57 espM2 W70A F 5'-gcagagtactaaagatattgatgaggcgataaaagatgaacggatagtatat-3' 
58 espM2 W70A R 5'-atatactatccgttcatcttttatcgcctcatcaatatctttagtactctgc-3' 
59 espM2 L118A F 5'-ccaggagaatcaactaaccgctgatgttaaggcagcacaa-3' 
60 espM2 L118A R 5'-ttgtgctgccttaacatcagcggttagttgattctcctgg 
61 espM2 Q124A F 5'-actaacccttgatgttaaggcagcagcaagttctattaatcatgtaataatg-3' 
62 espM2 Q124A R 5'-cattattacatgattaatagaacttgctgctgccttaacatcaagggttagt-3' 
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63 espM2 I127A F 5'-gatgttaaggcagcacaaagttctgctaatcatgtaataatggggagtgc-3' 
64 espM2 I127A R 5'-gcactccccattattacatgattagcagaactttgtgctgccttaacatc-3' 
65 EspM-1 
screening 
5’-tctttcagctctttggtat-3’ 
   
66 EspM-2 
screening 
5’-ccaaaagaagcattccccattat-3’ 
67 EspM-3 
screening 
5’-tgatgaggtcatgaaatgttcaat-3’ 
68 EspM-4 
screening 
5’-atgattaatagaactttg-3’ 
69 EspTSc-1 
screening 
5’-aatctcattctcttatc-3’ 
70 EspTSc-2 
screening 
5’-tcatgtgatgagtggatg-3’ 
71 EspTSc-3 
screening 
5’-atagatggtttctttttagg-3’ 
72 EspTSc-4 
screening 
5’catccaacgagaaaccgcaat-3’ 
73 EspTSc-5 
screening 
5’-ccggaattcatgccgggaacaataagctccag-3’ 
74 EspTSc-6 
screening 
5’-gggaagcttttaggttctctgagcctc-3’ 
 
75 
 
EspTSc-7 
screening 
 
5’-ttgaattcatgcatagcatgccagga-3’ 
76 EspTSc-8 
screening 
5’-ccaatgcactgcagggagcattaaacatattttaaatttctc-3’ 
 
 
77 EspTW63AF 5'-gaaaaacgaaggaaaaatgaatgaggcgatgagggaagaatgtatttgcttt-3' 
 
78 EspTW63AR 5'-aaagcaaatacattcttccctcatcgcctcattcatttttccttcgtttttc-3' 
   
 
 
Table 2 Plasmids used in this study 
 
Name Description Primers Reference  
    
pSA10  pKK177-3 with Lacq  (Schlosser-Silverman et al., 
2000) 
pICC398 pSA10::espM2 O157: H7 
Sakai fused to HA 
29 + 30 (Arbeloa et al., 2008) 
pICC399 pSA10::espM3 C. 
rodentium ICC169 fused to 
HA 
33 + 34 (Arbeloa et al., 2008) 
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pICC400 pSA10::espM2 C.rodentium 
ICC169 fused to HA 
35 + 36 (Arbeloa et al., 2008) 
pICC401 pSA10::espM1 O157: H7 
Sakai fused to HA 
27 +28 (Arbeloa et al., 2008) 
pICC402 pSA10::trcA O111:NM 
B171 fused to HA 
37 + 38 (Arbeloa et al., 2008) 
pICC403 pSA10::espM1 O111:NM 
B171 fused to HA 
38 + 40 (Arbeloa et al., 2008) 
pICC404 pSA10::espM2-W70A fused 
to HA 
31 +32 (Arbeloa et al., 2008) 
pICC405 pSA10::espM2-W70Y fused 
to HA 
23 + 24 (Arbeloa et al., 2008) 
pICC406 pSA10::espM2-E74D fused 
to HA 
25 + 26 (Arbeloa et al., 2008) 
pICC407 pSA10::espM3-W66A fused 
to HA 
3 + 4 (Arbeloa et al., 2008) 
pICC408 pSA10::espM3-W66Y fused 
to HA 
19 + 20 (Arbeloa et al., 2008) 
pICC409 pSA10::espM3-S9A + S12A 
fused to HA 
1 + 2 (Arbeloa et al., 2008) 
pICC410 pSA10::espM3-L114A 
fused to HA 
11 + 12 (Arbeloa et al., 2008) 
pICC411 pSA10::espM3-D115A 
fused to HA 
9 + 10 (Arbeloa et al., 2008) 
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pICC412 pSA10::espM3-H125A 
fused to HA 
5 + 6 (Arbeloa et al., 2008) 
pICC413 PSA10::espM3-K149A 
fused to HA 
17 + 18 (Arbeloa et al., 2008) 
pDEST53::espM2 EspM2 transfection vector 45 + 46 (Arbeloa et al., 2008) 
pRK5::myc-rhoAN17 Dominant negative RhoA  (Pelletier et al., 2005) 
pRK5::myc-rac1N17 Dominant negative Rac1  (Pelletier et al., 2005) 
pRK5::myc-cdc42N17 Dominant negative Cdc42  (Pelletier et al., 2005) 
pGex::gst-Rhotekin 
RBD 
pGex::gst-Rhotekin RBD  (Sander and Collard, 1999) 
pEGFPC1::GFP-
rhoGN19P  
Dominant negative RhoG  (Handa et al., 2007) 
pEGFPC1::elmoT625 
 
Dominant negative ELMO  (Handa et al., 2007) 
pCXN2 ::dock180ISP 
 
Dominant negative 
Dock180 
 (Handa et al., 2007) 
pGex ::GST-
CRIBWASP 
 
Cdc42 binding motif of 
WASP 
 (Sander and Collard, 1999) 
pGex ::GST-PAK 
 
Rac1 and Cdc42 binding 
domain of PAk 
 (Sander and Collard, 1999) 
pEGFPC1::elmo 
 
Elmo GFP tagged  (Handa et al., 2007) 
pICC427 
 
pSA10::espT-HA 41 + 42 (Bulgin et al., 2009) 
pICC228 
 
pRK5::espT-Myc 43 + 44 (Bulgin et al., 2009) 
pICC429 pRK5::IpgB1-Myc 47 + 48 (Bulgin et al., 2009) 
pICC320 
 
pRK5::EspM2-Myc 45 + 46 (Bulgin et al., 2009) 
pICC453 
 
pET28::espM229-196 55 + 56 This work 
pMW172-His-RhoA 
F25N 
His Tagged RhoA  (Valderrama et al., 2006) 
pMW172-His-Rac1 
 
His tagged Rac1  (Valderrama et al., 2006) 
pICC454 pET28::sifA 53 + 54 This work 
pICC455 
 
pRK5::myc-espM2 45 + 46 (Bulgin et al., 2009) 
pICC456 
 
pRK5::myc-espM229-196 55 + 56 This work 
pICC457 pRK5::myc-espM229-196 57 + 58 This work 
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 W70A 
pICC458 
 
pRK5::myc-espM229-196 
L118A 
59 + 60 This work 
pICC459 
 
pRK5::myc-espM229-196 
Q124A 
61 + 62 This work 
pICC460 
 
pRK5::myc-espM229-196 
I127A 
63 + 64 This work 
pRK5 :myc-:wave2 
 
Wave2 full length  Gifted by Laura Machesky 
pDSRED ::wave2∆A 
 
Wave2 with truncated VCA  Gifted by Laura Machesky 
pDSRED ::wave2 
∆BP 
Wave2 with truncated WHD  Gifted by Laura Machesky 
pICC461 
 
pSA10 ::espT E110019 76 + 42 This work 
pICC489 pACYC184 ::espt C. 
rodentium 
76 + 42 This work 
    
 
 
Table 3 Strains used in this study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Strain Name Description Reference 
   
E69 E2348/69 Wild type EPEC O127:H6 (Levine et al., 1978) 
 EHEC Sakai Wild type EHEC O157:H7 (Hayashi et al., 2001) 
 EPEC B171 Wild type EPEC O111:NM (Riley et al., 1987) 
ICC168 Citrobacter rodentium (Barthold et al., 1976) 
 Salmonella Typhimurium strain SL1344 (Hueck et al., 1995) 
ICC192 ICC192 EPEC E2348/69ΔescN (Garmendia et al., 2004) 
E110019 EPEC O111:H9 wild type (Viljanen et al., 1990) 
JPN15 EPEC O127:H6∆bfp (Jerse et al., 1990) 
ICC306 Citrobacter rodentium espT B. Raymond 
ICC305 
XL1blue 
BL21 
DH5α 
Citrobacter rodentium tir 
Escherchia coli  
Escherchia coli  
Escherchia coli 
R. Mundy 
Stratagene 
NEB 
Promega 
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Table 4 Primary antibodies used in this study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5 Secondary antibodies used in this study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Antibody (species) Application Dilution Source 
    
0127 (E2348/69) (Rabbit) IF 1:150 VLA 
O111 (E110019) (Rabbit) IF 1:150 VLA 
CSA1 (Salmonella) (Goat) IF 1:500 D. Holden 
HA (Mouse) IF/WB 1:500 Milipore 
MYC (Mouse) IF 1:200 Upstate 
Tir (Rabbit) IF 1:500 This Lab 
IRSp53 (Mouse) IF 1:100 L. Machesky 
Wave2 (Rabbit) IF 1:200 R. Carabeo 
Abi1 (Mouse) IF 1:250 Abcam 
Vinculin (Mouse) IF 1:300 Abcam 
EEA1 (Mouse) IF 1:150 BD Bioscience 
Lamp1 (Mouse) IF 1:100 DSHB University of Iowa 
Cofilin (Mouse) WB 1:1000 Cell Signalling Technology 
P-Cofilin (Mouse) WB 1:1000 Cell Signalling Technology 
RhoA (Rabbit) WB 1:200 Santa Cruz Biotechnology 
Rac1 (Rabbit) WB 1:200 Santa Cruz Biotechnology 
Cdc42 (Rabbit) WB 1:200 Santa Cruz Biotechnology 
Tubulin (Mouse) WB 1:1000 DSHB University of Iowa 
Antibody Application Dilution Source 
    
Oregan Green Phalloidin IF 1:150 Molecular Probes Invitrogen 
Texas Red Phalloidin IF 1:200 Molecular Probes Invitrogen 
Cy5 Phalloidin IF 1:100 Molecular Probes Invitrogen 
Donkey anti Rabbit Cy2 IF 1:200 Jackson Immunology  
Donkey anti Rabbit Cy5 IF 1:200 Jackson Immunology 
Donkey anti Rabbit Cy3 IF 1:200 Jackson Immunology 
Donkey anti Goat Cy2 IF 1:200 Jackson Immunology 
Donkey anti Rabbit Cy3 IF 1:200 Jackson Immunology 
Donkey anti Mouse Cy2 IF 1:200 Jackson Immunology 
Donkey anti Mouse Cy5 IF 1:200 Jackson Immunology 
Donkey anti Mouse Cy3 IF 1:200 Jackson Immunology 
Rabbit anti Mouse HRP WB 1:2000 Invitrogen 
Swine anti Rabbit HRP WB 1:3000 Invitrogen 
Dapi IF 1:1000 Molecular Probes Invitrogen 
Mitotracker CmxROS IF 125nM/well Molecular Probes Invitrogen 
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Chapter 3: The EspM Family of Proteins are WxxxE Effectors 
with RhoA Guanine Nucleotide Exchange Factor Activity 
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Recently a study by Alto et al (Alto et al., 2006) grouped together several previously identified 
T3SS effector proteins into the novel WxxxE family based on their sequence similarity and the 
presence of a common motif consisting of an invariant tryptophan residue separated from a 
conserved glutamic acid by three variable amino acids. Alto et al also noted that the majority of 
T3SS effectors identified as WxxxE proteins induced cytoskeletal rearrangements reminiscent of 
active Rho family GTPases. It was also reported that mutation of either the conserved tryptophan 
or glutamic acid resulted in a loss of the biological activity of these proteins (Alto et al., 2006). 
Alto and colleagues identified IpgB1 and IpgB2 from Shigella, SifA and SifB from Salmonella, 
Map and TrcA from EPEC and EHEC as WxxxE effectors using a BLAST search based on the 
sequence of Map from EHEC (Alto et al., 2006).  
 
3.1 Identification of Novel IpgB2-Like WxxxE Effectors in the A/E {athogen 
Group. 
 
In collaboration with Mark Pallen (University of Birmingham) we utilised IpgB1 and IpgB2 
from Shigella flexneri and Map from EPEC O127:H6 as index proteins in order to perform a 
series of PSI-BLAST searches (Altschul et al., 1997) on the available genomes of A/E 
pathogens. Using this approach we identified the putative effectors EspM1 and EspM2 from 
EHEC O157:H7 Sakai as sharing a considerable identity to the Shigella WxxxE effector IpgB2 
(40 and 41 percent identity respectively) (Arbeloa et al., 2008) (Figure 3.1). Both EspM1 and 
EspM2 harbour an intact WxxxE motif and have previously been demonstrated to be secreted in 
a T3SS dependent manner (Tobe et al., 2006). Alto et al identified TrcA from EPEC B171 
(O111:NM) as a putative WxxxE effector (Alto et al., 2006). Our search revealed an additional 
putative WxxxE effector, EspM1 (Accession#: AM910623), in EPEC B171 which shares 
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3.2 Genomic Context of the EspM Effectors 
 
A/E pathogens conserve the LEE pathogenicity island which encodes a T3SS and several core 
secreted effector proteins (Elliott et al., 1998). In addition to the LEE encoded effectors A/E 
pathogens also encode several other genetic elements which encode T3SS effector proteins 
(reviewed in (Frankel et al., 1998)). The EspM family of proteins are encoded on distinct 
genomic loci in EHEC O157:H7 Sakai, EPEC B171 and C. rodentium suggesting that may have 
been acquired from divergent sources or at different times (Figure 3.2). Interestingly the EspM 
proteins are invariably positioned alongside at least one representative of the NleG family of 
proteins which have also been demonstrated to be T3SS effectors (Figure 3.2) (Tobe et al., 
2006). In EHEC O157:H7 Sakai espM1 is encoded on the same pathogenicity island as the T3SS 
effector espO  (Figure 3.2) which has recently been shown to interact with integrin linked kinase 
(Kim et al., 2009). espM2 is encoded in a distinct insertion element upstream of another T3SS 
effector (hopW) which is a homolog of an effector of unknown function from the plant pathogen 
Pseudomonas syringae (Tobe et al., 2006). Uniquely, espM1 from EPEC B171 is encoded 
immediately downstream of the LEE pathogenicity island (Figure 3.2). The other EspM family 
member TrcA is encoded on an insertion element containing metabolic genes including an ABC 
transporter. In C. rodentium espM2 is positioned on the same pathogenicity island as espO and 
another WxxxE effector espT (Figure 3.2) which is further discussed in chapters 4 and 5. EspM3 
is encoded on the genomic backbone of C. rodentium and is positioned downstream of a lifA 
homolog (Figure 3.2). LifA (limphostatin) has been shown to contribute to the adherence of 
EPEC to epithelial cell (Badea et al., 2003), and to be essential in colonic colonisation and crypt 
cell hyperplasia which is associated with C. rodentium infection of the mouse colon (Babbin et 
al., 2009).  
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Figure 3.2  Genomic context of EspM family members. A graphical representation of the EspM family 
genomic loci in EHEC O157:H7 Sakai, EPEC B171 and C. rodentium. EspM family homolog’s are labelled in 
red, the WxxxE effector EspT is labelled in orange and other putative T3SS effector proteins are marker in 
blue.  
 
3.3 The EspM Effectors are Translocated into host Cells in a T3SS Dependent 
Manner 
 
EspM1 and EspM2 from EHEC O157:H7 Sakai along with TrcA have previously been 
demonstrated to be T3SS effectors (Tobe et al., 2006; Tobe et al., 1999). In order to confirm the 
status of the new EspM proteins as T3SS effectors we performed trasnlocation assays using the 
TEM-1 (β–lactamase) reporter (Charpentier and Oswald, 2004). To this end EspM2 and EspM3 
from C. rodentium were fused to TEM-1 in the pCX340 vector and transformed wild type and 
the T3SS null escN EPEC E2348/69 and used these strains to infect HeLa cells which were pre-
treated with the cell permeable CCF2/AM substrate. The CCF2/AM compound fluoresces green 
when uncleaved and blue when cleaved by β–lactamase. When the effector TEM-1 fusion 
protein is translocated into host cells via the T3SS of E2348/69 the CCF2/AM substrate is 
cleaved and the change in fluorescence is detected uising immuno-fluorescence microscopy. The 
T3SS effector NleD fused to TEM-1 was used as a positive control (Marches et al., 2005). This 
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assay was performed by Georgina MacKenzie (a rotation student in the lab) under my 
supervison.  Both EspM2 and EspM3 from C. rodentium were found to be translocated into host 
cells from the wild type E2348/69 but not from the escN mutant indicating that they are bone 
fide T3SS effectors.  
 
 
Figure 3.3 EspM2 and EspM3 are translocated into host cells in a T3SS dependent manner. HeLa cells were 
infected with E2348/69 (E69) or the E69 T3SS null mutant ∆escN containing the pCX340 β-lactamase fused to 
EspM2 or EspM3. Upon translocation the β-lactamase cleaves the CCF2/AM substrate, which fluoresces in 
green when uncleaved and in blue when cleaved, indicating translocation of the fusion  protein. The 
previouslt identified T3SS effector NleD was used as a positive control.  
 
3.4 The EspM Effectors Trigger Formation of Stress Fibres with Subtly 
Different Architectures 
 
As the EspM effectors share significant homology with IpgB2, which induces formation of stress 
fibres (Alto et al., 2006), we tested the ability of EspM1, EspM2 from EHEC O157:H7 Sakai, 
EspM1 and TrcA from EPEC B171, EspM2 and EspM3 of C. rodentium to remodel the 
mammalian actin cytoskeleton. The genes were cloned into the expression vector pSA10 
(Schlosser-Silverman et al., 2000) and expressed in EPEC E2348/69 which lacks any IpgB2 
homologues. Recombinant E2348/69 were used to infect serum starved Swiss 3T3 cells, which 
generally lack stress fibres (Figure 3.4) and are capable of dynamic actin signalling. Control 
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infections with wild type EPEC E2348/69 trigger efficient Tir-dependent actin-rich pedestals 
(Figure 3.4) while stress fibres were seen only in a small percentage of infected cells (Figure 
3.4). In contrast, infection of Swiss 3T3 cells with E2348/69 expressing EspM2 (Sakai) (Figure 
3.4) EspM2 (C. rodentium) (data not shown as the phenotype is identical to that of EspM2 
(Sakai)) induced simultaneous formation of actin pedestals (inset) and UgUlobal UpUarallel UsUtress 
UfUibres (GP-SF), which were on different focal planes. These stress fibres were observed in ca. 
90% of infected cells after 1.5 h infection (Figure 3.4). Using vinculin antibodies we observed 
intense distal staining of the GP-SF (Figure 3.4), suggesting that the GP-SF triggered by EspM2 
are linked to the plasma membrane through focal adhesions (Ziegler et al., 2006). 
Infection of Swiss 3T3 cells with E2348/69 expressing EspM1 (B171) (Figure 3.4), EspM1 
(Sakai) and TrcA (B171) (data not shown as the stress fibres induced are indistinguishable from 
EspM1 (B171)) resulted in simultaneous formation of actin pedestals and UlUocalized UpUarallel 
UsUtress UfUibers (LP-SF), which were subtly different from those triggered by EspM2 as they were 
confined to the site of bacterial adhesion (Figure 3.4). Immuno-fluorescence using the anti-
vinculin antibodies revealed intense staining at the tip of each of the LP-SF (Figure 3.4). 
 Infection of Swiss 3T3 with E2348/69 expressing EspM3 (C. rodentium) resulted in formation 
of actin pedestals and stress fibers with vinculin-rich tips in ca. 90% of the cells at 1.5 h post 
infection (Figure 3.4). EspM3-triggered formation of a distinct architecture of UlUocalized UrUadial 
(3D) UsUtress UfUibers (LR-SF) (Figure 3.4). The GP-SF, LP-SF and LR-SF appeared as soon as 30 
min post infection and were stable for at least for 3 h. Taken together these results illustrate that 
the IpgB2-like WxxxE effectors from A/E pathogens subvert actin dynamics and trigger 
formation of GP-SF (EspM2), LP-SF (EspM1 and TrcA) or LR-SF (EspM3). We selected 
EspM2 (Sakai) and EspM3 as model effectors for further study. 
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Figure 3.4 IpgB2 like A/E effectors induce formation of actin stress fibres in Swiss 3T3 cells upon infection. 
(A) Fluorescence microscopy of Swiss 3T3 cell uninfected or infected for 1h30 with primed EPEC 2348/69 wt 
(E69) and E69 pSA10 expressing EspM1, EspM2 and EspM3. Actin was stained with Oregon green 
phalloidin, EPEC were detected with rabbit anti 0127 antibody and vinculin was visualised using a 
monoclonal mouse antibody. Typical EPEC pedestals were observed underneath most the bacteria and strong 
stress fibres were only observed in cell infected with EPEC pSA10 harbouring the IpgB2 like effectors. 
EspM2 induces the formation of global parallel stress fibres (GP-SF), while EspM1 nucleates localised 
parallel stress fibres (LP-SF) which are confined to the site of bacterial attachment. EspM3 induces formation 
of local radial stress fibres (LR-SF) which are three dimensional in nature. (B) Quantification of parallel or 
radial stress fibre formation in uninfected Swiss cells or after 1h30 infection with E69 wt, E69 pSA10::espM2 
or E69 pSA10::espM3. One hundred cells were counted in three independent experiments. Results are 
presented as mean±SEM. 
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3.5 The Effect of Site Directed Mutagenesis of the WxxxE motif of EspM2 and 
EspM3 
 
Previous work by Alto and colleagues has demonstrated that the conserved tryptophan and 
glutamic acid residues are essential to the biological activity of WxxxE effectors (Alto et al., 
2006). It was demonstrated that substitituon of either the tryptophan or glutamic acid residue to 
alanine resulted in a marked reduction in the ability of IpgB2 to nucleate actin stress fibres (Alto 
et al., 2006). In order to determine if the same was true of the EspM effectors we mutated the 
invariant tryptophan (W) of EspM2 (W70) and EspM3 (W66) to alanine. Swiss cells infected 
with E2348/69 expressing EspM2W70A and EspM3W66A  triggered actin-rich pedestals with no 
evidence of GP-SF or LP-SF, respectively, and were indistinguishable from cell infected with 
wild type E2348/69 (Figure 3.5). In order to establish if conservative mutation of the invariant 
WxxxE residues also inhibited the biological activity of EspM2 and EspM3 we substituted the 
conserved tryptophan (W) and glutamic acid (E) residues with tyrosine (Y) or aspartic acid (D) 
respectively. Interestingly, conservative substitution of the W and E residues with a Y and D 
respectively did not result in any significant loss of stress fibre formation (Fig 3.5). These 
substitutions did however produce a shift in the architecture of stress fibers induced by EspM3 
from a LR-SF morphology to a LP-SF arrangement. Taken together these results indicate that the 
conserved tryptophan and glutamic acid residues can be substituted by structurally related 
tyrosine and aspartic acid residues but not by alanine suggesting the invariant tryptophan and 
glutamic acid residues may play in role in maintaining the structure or function of WxxxE 
effectors.    
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Figure 3.5 The effect of site directed mutagenesis on the WxxxE motif of EspM2 and EspM3. (A) Merged 
fluorescence microscopy of Swiss 3T3 cells infected for 90 min with primed E2348/69 expressing EspM2 
(Sakai) and EspM3 (CR) wild type prtoteins or derivative mutants within the conserved WxxxE motif. Actin 
was stained with Oregon green phalloidin and EPEC were detected with rabbit anti 0127 antibody. The 
W70A mutant of EspM2 and the W66A mutant of EspM3 were significantly impaired in their ability to form 
stress fibres. Conversely the conservative W70Y and E74D mutant of EspM2 and the W66Y and E70D 
mutant of EspM3 were largely unaffected in their abilty to form stress fibres compared to the wild type 
proteins.  (B) Quantification of stress fibers formation in Swiss cells after 90 min infection. One hundred 
infected cells were counted in triplicate from three independent experiments. Results are presented as mean ± 
SEM 
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3.6 Stress Fibre Induction by EspM2 and EspM3 is Inhibited by Expression of 
a RhoA Dominant Negative.  
 
In mammalian cells formation of stress fibres is normally regulated by the small Rho family 
GTPase RhoA (reviewed in (Etienne-Manneville and Hall, 2002)). The recent study of Alto et al 
proposed that nucleation of stress fibres by the Shigella WxxxE effector IpgB2 was independent 
of the activity of RhoA leading to the hypothesis that IpgB2 was mimicking a Rho GTPase rather 
than activating endogenous RhoA (Alto et al., 2006). In order to determine if the EspM effectors, 
which also induce stress fibre formation (Figure 3.4), require the activity of cellular RhoA we 
utilised dominant negative RhoA (RhoAPN19) dominant negatives Cdc42 (Cdc42PN17P) and Rac1 
(Rac1PN17) were used as control. Infection of transfected cells with E2348/69 expressing EspM2 
or EspM3 for 1.5 h revealed that formation of GP-SF and LR-SF, respectively, was not affected 
by inactivation of Cdc42 or Rac1 (Figure 3.6). In contrast, infection of cells expressing RhoAPN19 
resulted in formation of typical actin-rich pedestals but with a marked reduction in formation of 
GP-SF or LR-SF, respectively (Figure 3.6). This result suggests that, unlike IpgB2, formation of 
stress fibres by EspM2 and EspM3 requires active RhoA.  
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Figure 3.6 EspM2 and EspM3 dependent stress fibre formation is dependent of the small GTPase RhoA and 
independent on Cdc42 and Rac1. (A) Swiss 3T3 cells were transfected for 24h with the mammalian 
transfection vector pRK5 expressing a myc fusion of the Cdc42N19, Rac1N19 or RhoAN17 dominant 
negatives. The Swiss 3T3 cells were then infected 1h30 with EPEC pSA10::espM2 or EPEC pSA10::espM3. 
Actin was stained with Oregon green phalloidin, Myc with anti-myc mouse antibody and EPEC with anti 
O127 rabbit antibody. (B) Formation of stress fibres in one hundred transfected infected cells were counted 
in three independent experiments. Results are presented as mean±SEM. Formation of stress fibres depending 
on EspM2 or EspM3 is inhibited by expression of RhoAN17, but not by expression of Cdc42N19 or RacN19.  
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3.7 EspM2 and EspM3 Activate RhoA to Induce Stress Fibre Formation 
 
Rho GTPases act as molecular switches cycling between an inactive GDP bound form and an 
active GTP bound form (reviewed in (Jaffe and Hall, 2005)). When in the active GTP loaded 
conformation Rho GTPase can bind specific downstream signalling proteins known as effectors 
(Aspenstrom, 1999). In order to determine if translocation of EspM2 and EspM3 into 
mammalian cells results in an activation of RhoA, we performed pull down assays using GST-
Rhotekin, which specifically binds the active GTP-bound form of RhoA. Cells infected with wild 
type E2348/69 were used as a negative control. Swiss 3T3 cells infected with E2348/69 
expressing EspM2 or EspM3 exhibited a significantly higher level of activated RhoA compared 
with cells infected with wild type E2348/69 (Figure 3.7). These results suggest that EspM2 and 
EspM3 activate RhoA and that formation of GP-SF and LR-SF are dependent on RhoA 
signalling. 
 
 
Figure 3.7 EspM2 and EspM3 activate RhoA. Swiss 3T3 cells were infected with wild type E2348/69 or 
E2348/69 expressing EspM2 or EspM3. Cells were lysed and a GST fusion of the Rho binding domain of 
Rhotekin was used to co-purify RhoA-GTP. Total RhoA in the lysates and RhoA-GTP were detected by 
Western blot with anti-RhoA antibodies. In cells infected with wild type E69 there was no significant iduction 
of RhoA GTP. In contrast cells infected with E2348/69 expressing EspM2 or EspM3 displayed a significant 
enrichment of GTP loaded RhoA compared to the cells infected with wild type E2348/69.  The average level of 
RhoA enrichment from 6 independent experiments was calculated using densiometry. Quantified data are 
means ± S.D. of the results of three independent experiments. 
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3.8 Stress Fibres Induced by EspM2 and EspM3 are ROCK-Dependent. 
 
ROCK is one of the major RhoA downstream effectors which mediates formation of stress fibres 
(Jaffe and Hall, 2005). To determine if EspM2 and EspM3 activate the RhoA-ROCK pathway, 
Swiss 3T3 cells were incubated with the ROCK inhibitor Y-27632 for 1 h prior to infection with 
E2348/69 expressing EspM2 or EspM3. Y-27632 is a highly specific inhibitor of ROCK-I and 
ROCK-II which competitively excludes ATP from the catalytic site (Yamaguchi et al., 2006). 
Pre-incubation with Y-27632 completely blocked formation of GP-SF and LR-SF by EspM2 and 
EspM3, respectively (Figure 3.8). The ROCK inhibitor did not affect formation of actin rich 
pedestals. 
 
 
 
Figure 3.8 EspM2 and EspM3 trigger the RhoA-ROCK pathway. (A) Fluorescence microscopy of Swiss 3T3 
cells incubated for 1 h in presence or absence of 10 μM of the ROCK inhibitor Y-27632 and infected for 90 
min with E2348/69 expressing EspM2 or EspM3. Y-27632 did not affect formation of actin-rich pedestals, but 
abolished formation of stress fibers. (B) Percentage of Swiss 3T3 cells presenting stress fibers in the presence 
or absence of Y-27632. One hundred cells were counted in triplicate from three independent experiments. 
Results are presented as mean ± SEM. 
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3.9 EspM2 and EspM3 Induce an Increase in the level of Phospho-Cofilin 
 
Lim kinase (LimK) is downstream effector of ROCK which is involved in stress fibres formation 
(Jaffe and Hall, 2005). It has been shown that phosphorylation of the LimK by ROCK and the 
consequent inactivation (by phosphorylation) of cofilin by LimK contributes to Rho-induced 
stress fibre formation (Maekawa et al., 1999). We examined the phosphorylation state of cofilin 
by immunoblot following infection of Swiss cell with E2348/69 expressing EspM2 or EspM3. 
When compared with uninfected or cells infected with the wild type E2348/69 higher level of 
phospho-cofilin was observed after translocation of EspM2 or EspM3 (Figure 3.9). These results 
suggest that EspM2 and EspM3 trigger stress fibre formation through the RhoA-ROCK- LimK-
cofilin pathway. 
 
 
Figure 3.9 EspM2 and EspM3 induce an increase in cofilin phosphorylation. Swiss 3T3 cells were left 
uninfected or infected for 90 min with wild type E2348/69 carrying empty pSA10 vector or E2348/69 
expressing EspM2 or EspM3. The levels of cofilin and phospho-cofilin were determined by Western blot 
using anti cofilin and anti phospho-cofilin antibodies. Quantification of densitometry was conducted using 
image J software and results presented here represent the mean ratio ± S.D of four independent experiments. 
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3.10 EspM2 Binds RhoA 
 
The following figures and results were contributed by Ana Arbeloa, James Garnet, Steve 
Mathews, James Lillington and Susan Lea. In this section it was investigated if EspM2 can 
directly bind RhoA. To this end espM2 was cloned in the bacterial expression vector pET28a and 
the protein was purified following induction.  Purified His-EspM2 was soluble but appeared in 
two distinct bands corresponding to the full-length effector and a spontaneous degradation 
product; N-terminal sequencing reveal that the latter corresponds to EspM2 lacking the first 28 
amino acids, which we have termed EspM229-196. Full length espM2 and espM229-196 were cloned 
into the mammalian expression vector pRK5 fused to an N terminal Myc tag. Ectopic expression 
of EspM2 and EspM229-196 in Swiss 3T3 cells resulted in the formation of global parallel stress 
fibres which are identical to those observed when EspM2 is translocated from E2348/69 (Figure 
3.4 and 3.10). Stres fibres induced by EspM229-196 were formed in a similar percentage of cells 
and were phenotipically indistiguishale from those envoked by EspM2 (Figure 3.10A). This 
result confirms that the truncated effector retained its biological activity. Consequently we have 
used EspM229-196 throughout the rest of this work.  
In order to conduct protein interaction studies, surface plasmon resonance (SPR) was used to 
probe the interaction between His-EspM229-196 and His-RhoA. This technique allows binding to 
be observed in real time by the change in mass over the surface of a sensor chip.  RhoA was 
flowed (sequential injections ranging from 0.05M to 50M) over an EspM229-196 bound surface 
and displayed an increased rate of binding with concentration confirming a specific interaction 
(Figure 3.10B).  
As a negative control, Rac1 was flowed over the same EspM229-196 surface and for any given 
GTPase concentration showed substantially less binding (Figure 3.10C), confirming the 
106 
 
specificity of EspM229-196 for RhoA over other GTPases. Recent data suggested that the 
Salmonella WxxxE effector SifA can bind RhoA (Ohlson et al., 2008). In order to confirm this 
interaction we cloned sifA from Salmonella enterica serovar Typhimurium into pet28A to create 
a C terminal His tag fusion which was purified using a His bind nickel column.  We found that 
His-SifA and His-RhoA also bound in a concentration dependent manner (Figure 3.10D).  
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3.11 EspM2 is a Guanine Exchange Factor for RhoA 
 
We next investigated the ability of EspM229-196 to stimulate guanine nucleotide exchange in 
RhoA in vitro using a RhoGEF exchange assay (Cytoskeleton, Inc., USA). The Rho GTPases 
Rac1 and Cdc42 in addition to the distantly related H-Ras GTPase were also used in this assay to 
determine the specificity of EspM2 activity. This spectroscopic assay measures fluorescent 
emission upon insertion of N-methylanthraniloyl(mant)-GTP into the nucleotide binding pocket 
of the GTPases. We utilised 250mM EDTA as a positive control in the assay as it induced 
efficient nucleotide exchange in RhoA, Cdc42, Rac1 and HRas, indicating that these proteins 
were biologically functional. A slow intrinsic nucleotide exchange activity was detected in the 
presence of buffer alone (negative control). The fluorescence intensity increased dramatically 
and in a dose dependent manner when increasing amounts of purified EspM229-196 were added to 
RhoA (Figure 3A).  In contrast, EspM229-196 showed a weak exchange activity in Cdc42 (Figure 
3.11), whereas it had no effect on Rac1 (Figure 3.11). Testing the GEF activity of SifA revealed 
that it cannot stimulate nucleotide exchange in any of the tested Rho GTPases or HRas (Figure 
3.11).  These results demonstrate that EspM229-196 is a specific RhoA GEF, and that although 
SifA can bind RhoA it cannot induce nucleotide exchange. It should be noted that the EDTA 
positive contol used in this is experiment does not represent a suitable control as the 
concentration is too high and most likely has a denaturing effect on the GTPases. Additionally 
the high concentration of EDTA present would prohibit the locking of new GTP moieties into 
the GTP binding groove.  
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Figure 3.11 EspM2 is a guanine exchange factor for RhoA. A. EspM2 mediates loading of mant-GTP into 
RhoA. 0.5M mant-GTP was incubated with 2M RhoA in presence of 250mM EDTA (squares), or 0.05- 
50M EspM2 (circles) or in presence of buffer only (triangles). The insertion of the mant-GTP into the 
nucleotide binding pocket of RhoA in presence of EspM2 detected by an increase in the fluorescent emission 
was found to be dose dependent. B. EspM2 weakly induces loading of mant-GTP into Cdc42. 0.5M mant-
GTP was incubated with 2M Cdc42 in presence of 250mM EDTA (squares), or 0.05- 50M EspM2 (circles) 
or in presence of buffer only (triangles). Slow loading of mant-GTP into Cdc42 was only detected when high 
concentrations of EspM2 were added. C. EspM2 does not induce nucleotide exchange for Rac1. 0.5M mant-
GTP was incubated with 2M Rac1 in presence of 250mM EDTA (squares), or 0.05- 50M EspM2 (circles) or 
in presence of buffer only (triangles). No efficient loading of man-GTP into Rac1 was observed after 
incubation with up to 50M of EspM2. D. SifA does not induce nucleotide exchange on RhoA, Cdc42, Rac1 or 
HRas.  0.5M mant-GTP was incubated with 2M of RhoA (blue circles), Cdc42 (pink circles), Rac1 (green 
circles) or HRas (orange circles) in presence of 5SifA. No loading of man-GTP into any of the small 
GTPases tested was observed in these conditions. Results shown are the average of three independent 
experiments. E. Incubation of 50µM of EspM2 in the exchange buffer alone did not change the fluorescence 
intensity. The EDTA used in this experiment is not a suitable positive control. 
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3.12 Mapping the EspM2 Interface of the EspM2-RhoA Complex 
 
 
In collaboration with Ana Arbeloa, James Garnett and Steve Mathews we utilised Nuclear 
Magnetic Resonance spectroscopy (NMR) to elucidate the structure of EspM29-196. Although the 
protein was reasonably unstable we were able to assign ~65% of the backbone using 
heteronuclear multidimensional NMR spectroscopy. NMR was then used to monitor the titration 
of RhoA against EspM229-196 where at least a 1:1 molar ratio was needed to see any change 
within the 15N-HSQC spectra, although at 4-fold molar excess RhoA it was possible to determine 
which of assigned EspM2 residues were within intimate proximity of RhoA upon complex 
formation (Figure 3.12). After the addition of 7-fold molar excess RhoA, peaks corresponding to 
structured regions of EspM29-196 had broadened to such an extent that many were no longer 
visible indicating in an interaction between EspM and RhoA. Furthermore, addition of 5 mM 
GTP to the sample did not result in dissociation of the complex. 
Secondary structure prediction with PSIPRED (Jones, 1999) and NMR data including the 
chemical shift index of 13Cα and 13C’ (Wishart et al., 1993) show that EspM2 is primarily helical, 
(albeit for an unstructured ~30 residue region at the N-terminus) with a helical content similar to 
that of the C-terminal domain of SifA whose crystal structure has been determined (pdb:3cxb; 
(Ohlson et al., 2008). A primary sequence alignment was performed with EspM229-196, Map, 
IpgB1 and IpgB2. This was then used along with the crystal structure of the C-terminal domain 
of SifA containing the WxxxE motif (pdb:3cxb; (Ohlson et al., 2008)) to create a homology 
model using SWISS-MODEL (Arnold et al., 2006) and the data from the RhoA titration was 
mapped onto it (Figure 3.12). A model of the complex with RhoA was created by superimposing 
the EspM229-196 model and the crystal structure of RhoA (pdb:1xcg; (Derewenda et al., 2004)) 
onto the crystal structures of SopE and Cdc42, respectively, within the SopE-Cdc42 complex 
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(pdb:1gzs;(Buchwald et al., 2002)) (Figure 3.12). In this model of EspM2 bound to RhoA, 
almost all of the interactions derived from the titration experiments lie within the interface and 
are situated at both of the switch sites of RhoA giving validity to the EspM2 model. The 
structural data also demonstrated that EspM2 adopts an inverted V shape comprised of six alpha 
helices which is very similar to that of SopE (Figure 3.12 B). Interestingly, EspM2 also has a 
flexible loop, which although is unrelated on a sequence level, occupies a similar position to the 
catalytic GAGA loop of SopE. These results suggest that EspM2 may utilise a similar 
mechanism to SopE in order to GEF RhoA. In addition to its homology with SopE, EspM2 also 
shares a significant degree of structural similarity with the recently structed WxxxE effector Map 
(Huang et al 2009). Both Map and EspM2 adopt a very similar inverted V structure and share a 
common catalytic loop and GTPase interacting domain.  
 
 
113 
 
 
 
Figure 3.12 Model of EspM229-196 and the EspM229-196-RhoA complex. A. 15N HSQC titration of RhoA against 
EspM229-196. Black peaks show no addition of RhoA whilst red peaks show 4-fold molar excess of RhoA. 
Chemical shift changes were deemed significant if the peak intensity was reduced by more than 80% (i.e. 
D145). B. Homology model of EspM229-196 created with SWISS-MODEL (Arnold et al., 2006.) Data from the 
RhoA titration have been mapped onto the model and are coloured red with residues labelled. C. Model of 
the EspM229-196-RhoA complex created by superimposing the EspM229-196 model and the crystal structure of 
RhoA (pdb:1xcg; Derewenda et al., 2004) onto the crystal structure of the SopE-Cdc42 complex (pdb:1gzs; 
Buchwald et al., 2002). All residues identified by the RhoA titration appear at the interface except for those 
within the C-terminal helix. In this model the intimate contacts with EspM2 are through the switch regions I 
and II of RhoA.  
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3.13 Site Directed Mutagenesis of the EspM2 Catalytic Loop. 
 
Based on the titration and modelling we selected three EspM2 residues for mutagenesis, the 
mutant W70A was used as a control. The three residues selected, L118, Q124 and I127, are 
located within the loop equivalent to the catalytic loop of SopE. The EspM229-196 derivatives 
were expressed ectopically in Swiss 3T3 cells and formation of stress fibres was determined 
microscopically (Figure 3.13). As shown in Figure 3.5 a W70A substitution completely 
abolished stress fibre formation (Figure 3.14). The other mutations had diverse effects on the 
capacity of EspM2 to induce stress fibres. We found that replacement Q124A had a mild effect 
on EspM2 activity, while I118 reduces the formation of stress fibres by 50% and L127A by 60% 
(Figure 3.14). These results show that I118, L127 and Q124 play an important role in induction 
of stress fibres by EspM2. Together with the structural shifts in EspM2 upon RhoA interaction 
demonstrated previously (Figure 3.12) these results indicate that I118, Q124 and L127 may be 
part of a catalytic loop analogous to that described for SopE and Cdc42 (Buchwald et al., 2002).  
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Figure 3.13 Site directed mutagenesis of the EspM2 catalytic loop. Serum-starved Swiss 3T3 cells were mock 
transfected or transfected with the mammalian expression vector pRK5 encoding myc-tagged EspM2, 
EspM229-196, EspM229-196 W70A and EspM229-196 I127A for 19 h. Actin was stained with Oregon green 
phalloidin and the myc tag was detected with monoclonal antibody. Transfection of EspM2 and EspM229-196 
induces the formation of parallel stress fibers. Transfection of mutants EspM229-196 L118A, EspM229-196 
Q124A and EspM229-196 I127A abolished to different extent the formation of stress fibers. B. Quantification of 
stress fibers on Swiss 3T3 after 19h transfection with EspM2, EspM229-196, EspM229-196 W70A, EspM229-196 
L118A, EspM229-196 Q124A and EspM229-196 I127A. Fifty cells were counted in duplicate in three independent 
experiments. Results are displayed as mean ± SEM. 
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3.14 Distribution of EspM in EPEC and EHEC Strains  
 
Among the WxxxE effectors, Map, which is encoded on the LEE region, is absolutely conserved 
in all EPEC and EHEC strains. However the EspM family of effectors are carried on cryptic 
prophages and as such it is not currently known how widespread these proteins are amongst 
clinical EPEC and EHEC. In order to address this and determine the prevelance of espM genes 
in EPEC and EHEC, in collaboration with Drs Tania Gomes, Jorge Blanco and Ana Arbeloa, we 
screened several sets of clinical EPEC and EHEC isolates from collections in Spain and South 
America.  
In order to screen for espM by PCR we used the eight espM sequences identified in EHEC O157 
strain Sakai, EPEC strains B171 and E22 and C. rodentium, to design common internal espM-F1 
(5’-TCTTTCAGCTCTTTTGGTAT) and espM-F2 (5’-CCAAAAGAAGCATTCCCCATTAT) 
forward and reverse primers. The identity of representative PCR amplicons was confirmed by 
DNA sequencing. We screened by PCR 943 EHEC and EPEC strains for the presence of espM, 
EHEC O157:H7 Sakai and EPEC E2348/69 were used as positive and negative controls. 
We first screened 45 non-sorbitol fermenting (nsf) EHEC O157:H7 (expressing Stx1 and Stx2) 
isolated in Spain, Canada and Bolivia and two SF EHEC O157:H- (expressing VT2), isolated in 
Germany for the presence of espM genes. espM was found in 43 of the non-SF O157 isolates 
(95%) and in the two sf isolates (Table 3.14). We then screened 151 non-O157 EHEC strains 
and espM was found in 60 of 62 (97%) of the non-O157 EHEC strains belonging to serogroups 
O26, O103, O111, O118 and O145 (Table 3.14). In contrast espM was found in only 17 of 89 
(19%) strains belonging to the other non-O157 serogroups (Table 3.14).  
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We then screened a total of 132 tEPEC strains, isolated in Brazil, Bolivia, Burundi, Spain, Chile, 
Germany, UK and Uruguay and 602 aEPEC strains, isolated in Brazil, Bolivia, Chile and Spain 
for the presence of espM. espM was found in 91 tEPEC isolates (69%) belonging to 16  different 
serogroups (the O serogroup of 6 strains was non-typeable - ONT) (Table 3.15). espM was found 
in 259 aEPEC isolates (43%) belonging to 59 different serogroups (the O serogroup of 109 
strains was ONT (Table 3.16). Of the 109 ONT aEPEC espM was found in 45 isolates (41%). 
Among the atypical EPEC which share serogroups with the some EHEC strains, espM was 
found in 23 of 31 (74%) O26, 4 of 12 (33%) O103, 2 of 4 (50%) O111, 25 of 33 (73%) O145 
and 4 of 7 (57%) O157 isolates; in total 58 of 87 or 66%. Interestingly, espM was found in 100% 
(16 of 16) of the O55 strains, regardless of serotype.  
Table 3.14: Distribution of espM among 151 non-O157 clinical EHEC strains. 
__________________________________________________________ 
Serotype  Stx+ type             espM      
(no. of strains)  
__________________________________________________________ 
 
ONT (14):HND(7), H-(6), H11(1)  1,2 4  
O5 :HND(3)    1,2 2 
O14 :H-(1)   1 1  
O26 (37): HND(17), H-(2), H8(1), H11(17)  1 36  
O32 :H6 (1)   1 1  
O69 :H21 (1)   1 1  
O80 :HND (1)                      1,2 1  
O98 :H21 (1)   1 1  
O103 (6):HND(1), H2(5)  1,2 6  
O111 (10):HND(5), H-(3), H8(1), H10(1),  1,2 9  
O118 (6):HND(3), H-(1), H16(2)  1 6  
O121 (2):H19(1), H40(1)  2 2  
O145 (3):HND(1), H-(2)  1,2 3   
O146 :HND(10)   1,2 1  
O156 :H25(2)   1 2  
O139, O141 :HND(1)   1,2 1  
_____________________________________________________________________ 
 
 
espM negative strains :- ONT :HNT (2), ONT :H5 (1), ONT :H8(1),ONT :H18 (1), ONT :H39 (1), O2 :H27 (1), 
O8 :H2 (1), O8 :H19(1), O15 :H16 (1), O15:H28 (1), O18 :ND (2), O22:H42 (1), O55:H- (1), O63 :HND (2), 
O64:H21 (1), O76 :ND (2), O76:H19 (2) O84:HNT (1), O84 :HND (1), O91:H- (2), O98:H- (1), O104 (4), 
O113 :HND  (2), O113:H21 (2), O117 :HND (1), O136 :HND (1), O141 :HND (1), O146:H- (1), O146:H21 (4), 
O148 :HND (2), O148:H8 (1), O165:H- (1), O166 :HND (1), O166:H28 (1), O168:H8 (1), O174:H21 (1), 
O183:H- (1) 
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Table 3.15: Distribution of espM among 132 tEPEC strains. 
_____________________________________________________________________ 
Serotype Origin espM  
(no. of strains)  
_____________________________________________________________________ 
 
ONT (2) :H6(1), H10(1) Bolivia 2  
O23 (2) :HND(1), H8(1) Spain 2  
O49 :H10(5) Spain, Bolivia 5  
O55 (22) :H-(8), H6(6), H51(8) Uruguay, Bolivia, Brazil, UK 19  
O86 (6): H-(2), H34(4) Bolivia, Brazil, 6  
O88 (17) :H-(1), H6(1), H25(15) Spain, Bolivia 3  
O103 (3) : H-(1), H7(2) Bolivia 3  
O109 :H-(2) Spain, Chile 1  
O111 (20) :H-(12), H2(7), H25(1) Spain, Bolivia, Brazil, Uruguay 19  
O118 (4) : HND(1), H-(1), H5(2) Spain, Germany 4  
O119 (17) :H-(2), H6(15) Bolivia, Brazil, Uruguay 16  
O125 :H-(1) Burundi 1  
O127 :H6(3) Bolivia, Brazil,  1 
O132 :H8(1) Bolivia 1  
O142 (6) :H6(2), H34(4) Brazil, Spain 4  
O145 :H45(3) Brazil 3  
O153 :H11(1) Spain 1  
_____________________________________________________________________ 
 
espM negative strains: ONT :HND (1), ONT :H1, H12 (1), ONT :H8 (1), ONT :H25 (1), O1 :H1, H12 (1), 
O55 :H8 (1), O86 :H8 (1), O88 :H5 (2), O98 :HND (1), O127 :H40 (3), O131 :H46 (2), O153 :H8 (1), 
O157 :H45 (1) 
 
 
 
Table 3.16  Distribution of espM among 602 aEPEC strains. 
_____________________________________________________________________ 
Serotype Origin espM  
(no. of strains)  
___________________________________________________________________ 
ONT(92)* :                    Spain, Brazil, Bolivia, Chile 45  
O1 (3): H7(1),H40(1),H45(1) Brazil, Spain 3  
O2 (11) :ND(3), H40(8) Spain 3  
O4 (4) : ND(2), H-(1), H1(1) Spain, Brazil 3  
O5 :ND(7) Spain 2  
O6 (2) :ND(1), H19(1) Spain 2  
O8 (5): HND(3), H11(1), H19(1) Spain 3  
O10 (5): HN(3), H-(2) Spain 4  
O11 :HND(4)  Spain 4  
O14 :H5(1)  Brazil 1  
O15 (17): HND(9), H2(8)  Spain 12  
O18 :HND(2) Spain 2  
O20 :HND(2) Spain 2  
O22 :HND(2) Spain 2  
O25 :H2(1) Spain 1  
O26 (30) :ND(20), H-(6), H11(4) Spain, Brazil 23  
O28 : H28(1) Bolivia 1   
O33 :HND(3) Spain 1  
O49 (12): HND(6),H-(3), H2(1), H10(2) Spain, Brazil 6  
O51 (16): HND(5), H-(2), H1(1), H40(6), H49(2)  Spain, Brazil 7  
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O52 : H10(1) Spain 1  
O57 : H7(3) Spain 3  
O55 (16) :HND(4), H-(1), H6(1), H7(9), H51(1) Spain, Brazil, Bolivia 16  
O56 :H-(1) Spain 1  
O63 (6) : H6(5), H33(1) Spain, Brazil 2  
O64 :H25(2)     Spain 1  
O70 :H2(1) Brazil 1  
O76 :HND(3) Spain 2  
O80 (9): ND(5), H2(4)                 Spain 4  
O82 (2): HND(1), H10(1) Spain 2  
O85 (13) :HND(5), H-(2), H31(5), H43(1) Spain 4  
O101 (7): HND(2), H-(5) Spain, Brazil 7  
O103 (12): HND(11), H2 (1) Spain 4  
O104 (4) :HND(1), H2(2), H12(1) Spain, Brazil 2  
O109 :H9(1) Brazil 1  
O111 (2) :HND(1), H-(1) Spain 2  
O113 :H6(4) Spain 1  
O115 (4): HND(1), H8(3) Spain 3  
O117 :HND(4) Spain 2  
O119 :HND(2) Spain 2  
O120 :HND(2) Spain 1  
O123 :H-(2) Brazil 2  
O125 :H28(1) Spain 1  
O127 :H40(5) Spain, Bolivia 1  
O128 (4) : HND(1), H-(1), H2(1), H27(1) Spain 4  
O132 :H34(3) Spain 3  
O139 :H19(1) Spain 1  
O145 (33) : HND(19), H-(8),  H4(1), H5(1), H28(4) Spain, Germany 25  
O146 :HND(1) Spain 1  
O153 :HND(15) Spain 2  
O154 :H9(1)          Brazil 1  
O156 (8) : HND(6), H-(2) Spain 4  
O157 (5): ND(2), H7(3) Spain 4  
O162 (4) :H-(2), H21(1), H33(1) Spain, Brazil 3  
O166 :HND(1) Spain 1  
O167 (4) :ND(2), H9(1), H11(1) Spain 3  
O177 :H11(1) Spain 1  
O178 :H7(1) Spain 1  
O179 :H31(1) Spain 1  
O115, O152(15) : HND(13), H8(1), H10(1) Spain 10  
R (2): H11,21(1), H28(1)           Brazil 1  
_____________________________________________________________________ 
EspM negative strains ONT :H2 (2), ONT :H6 (4), ONT:H9 (1), ONT:H10 (2), ONT : H11, 21, 34 (1), 
ONT :H19 (2), ONT : H21,39 (1), ONT:H34 (1), ONT :H40, 43 (2), ONT:H51 (1), O1:H2 (1), O1:H11 (1), 
O1 :H46 (1), O1 :H49 (1), O2ab : H45 (1), O2 : NT (1), O2 :H6 (1), O2 :H16 (1),  O2 :H45 (1), O2 :H49 (2), 
O3 :H4 (1), O5 :H6 (1), O5 :H40 (1), O5 :H49 (1), O6 :H4 (1), O6 :H16 (1), O9 :HND (2), O11 :H16 (2), 
O12 :HND (1), O13 : H11 (1), O15 :H- (2), O15 :H7 (1), O16 :H- (1), O18 :H7 (1), O18 :H16 (1), O20 :H6 (1), 
O21 :HND (2), O21 :H15 (1), O23 :HND (1), O24 :H2 (1), O25 :HND (2), O25 :H1 (1), O26 :H2 (1), O28 :HND 
(1), O33 :HNT (1), O33 :H6 (1), O33 :H34 (1), O34 :H- (1), O41 :H- (1), O49 :H40 (1), O51 :H41 (1), O55 :H40 
(1), O56 :H6 (1), O63 :HND (1), O64 :H40 (1), O71 :H1, H12 (2), O76 :H19 (1), O84 :HND (1), O84 :H- (2), 
O85 :H8 (1), O85 :H49 (1), O86 :HNT (1), O86 :HND(1), O88, O168:HND (1), O98 :H- (1), O98 : H8 (1), 
O101 :H33 (2), O103 :H- (3), O103 :H4 (1), O103 :H19 (1), O103 :H40 (1), O104 :H- (2), O105 :HND (1), 
O105 :H4 (2), O108 :HND (3), O110 :HND (5), O111 :H9 (1), O111 :H38 (1), O112 :H15 (1), O113 :HND (4), 
O113 :H- (1), O114 :HND (1), O117 :H11 (1), O117 :H40 (2), O121 :HND (1), O123 :HND (1), O123 :H19 (1), 
O123 :H45 (1), O125:H6 (3), O127 :HND (1), O127 :H6 (1), O128 :H40 (1), O129 :HND (1), O129 :H- (1), 
O132 :HND (3), O132 :H5 (3), O137:HND (3), 
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3.15 Discussion 
 
In 2006 Alto et al. (Alto et al., 2006) assembled several known T3SS effectors into a single 
family which share a common motif consisting of an invariant tryptophan and glutamic acid 
residue separated by three variable amino acids (WxxxE). The authors suggested that IpgB1, 
IpgB2 and Map (the founder WxxxE effectors) mimic, in a GTP independent mechanism, the 
activated form of Rac1, RhoA and Cdc42, respectively. In this chapter we report the discovery 
and characterization of an array of T3SS effector proteins in A/E pathogens which belong to the 
WxxxE family. These new effectors share a high degree of homology with each other (47-86% 
identity) and with the Shigella effector IpgB2 (40-47% identity). We have defined this novel 
family of A/E effectors as the EspM family of proteins. Map is encoded on the LEE 
pathogenicity island which is conserved by all A/E pathogens, however the EspM proteins 
identified in this study are found mainly on prohages or other insertion elements. While a core 
set of T3SS effectors are encoded on LEE, the genome of clinical isolates of EPEC and EHEC 
are often enriched by mobile genetic elements which carry novel virulence factors which can 
increase the T3SS effector repetiore. The number of T3SS effector proteins is highly variable 
between different A/E pathogen strains ranging from 26 in EPEC E2348/69 to over 50 in EHEC 
Sakai. In order to determine the prevelance of the espM family in the A/E pathogens we screened 
several collections of clinical isolates. Screening of EPEC and EHEC clinical isolates revealed 
that the espM family members are well represented in most clinical isolates suggesting this 
family of effectors may play an important role in the virulence of A/E pathogens. 
The founder WxxxE effectors are potent modulators of the host actin cytoskeleton (Alto et al., 
2006; Handa et al., 2007; Kenny et al., 2002). In order to determine if the new proteins we 
studied are true WxxxE effectors that can subvert actin dynamics, we utilised EPEC 
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EPEC234/69 as a vehicle for protein translocation into Swiss cells. EPEC234/69 is a suitable 
host as it only harbours the WxxxE effector Map, which only induces transient filopodia at early 
time points post infection (Kenny and Jepson, 2000). 
Using this infection model, we demonstrate that over-expression EspM1, EspM2, EspM3 and 
TrcA in EPEC E2348/69 triggers formation of stress fibres; similar to those induced by the 
Shigella effector IpgB2 (Alto et al., 2006). Importantly, the stress fibres triggered by these 
WxxxE effectors had distinct architectures. Althoughthe EspM homologues were expressed from 
isogenic plasmids, we cannot exclude the possibility that differences in expression levels or 
translocation efficiency may contribute to their distinct stress fibre morphologies which appear 
as global parallel stress fibres (GP-SF) throughout the cell for EspM2, and local parallel stress 
fibres (LP-SF) restricted to the site of bacterial attachment in the case of EspM1 and TrcA. Most 
striking was the phenotype associated with translocation of EspM3, which induced formation of 
local radial stress fibres (LR-SF), which are reminiscent of the phenotypes linked to 
constitutively active Rho Kinase and phorbal ester treatment such as TPA (Imamura et al., 1998). 
To our knowledge, this is the first time that such a phenotype has been described in an infection 
context. The fact that ectopic expression of EspM2 results in GP-SF formation confirms that 
EspM proteins are sufficient to induce stress fibre formation independently of other bacterial 
factors. Despite the global and localized stress fibres triggered by EspM2 and EspM1 and 
EspM3, respectively, all proteins were found diffusely in the cytsol. Vinculin was found at the 
tip of the EspM family effector-triggered stress fibres suggesting that they are linked to the 
plasma membrane via focal adhesins.  
As EspM2 and EspM3 trigger the two extreme stress fibre phenotypes they were chosen for 
detailed functional analysis. We confirmed that the GP-SF and LR-SF triggered by EspM2 and 
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EspM3 are dependent on the conserved WxxxE motif via substitution of the conserved Trp with 
an Ala. However, using conservative substitutions, Tyr and Asp for the Trp and Glu respectively, 
we did not observe any significant loss in biological activity. Translocation of EspM2 YxxxE 
and EspM2 WxxxD resulted in global stress fibre formation, while translocation of EspM3 
YxxxE and WxxxD resulted in formation of mainly LP-SF as compared to the LR-SF observed 
in the wild type phenotype. The reason for the change of morphology observed for EspM3 
YxxxE and WxxxD is currently not known but may be resultant from a decreased efficiency of 
translocation or reduction in the stability of the mutant proteins. These results suggest that the 
biological activity of the WxxxE proteins does not require the presence of the conserved 
tryptophan or glutamic acid but rather the presence of a bulky aromatic residue and an amino 
acid carrying a carbocylic acid side group suffices. Carboxylic side groups are involved in a 
range of biological functions such as protease activity (Kakudo et al., 1992) and interactions 
particularly with positively charged moieties such as metal ions. Structural analysis of EspM2 
reveled that the conserved W70 residue of EspM229-196, is situated at the junctional region of two 
three-helix bundles. Recombinant EspM229-196 W70A was completely unstable, demonstrating 
the essential structural role of this residue in EspM229-196. A recent study by Ohlson and 
colleagues (Ohlson et al., 2008) determined the structure of the WxxxE effector SifA, and in 
agreement with the proposed role of the WxxxE motif in protein stability, it was reported that the 
conserved tryptophan forms multiple hydrophobic contacts with neighbouring residues and that 
the glutamic acid residue forms a hydrogen bond with an adjacent alpha helix.  
The Ras superfamily of the small GTPases is the target of many bacterial effectors and toxins 
due to its role in the control of a wide range of cellular processes including cytoskeletal 
dynamics, membrane trafficking and growth (Etienne-Manneville and Hall, 2002). Several T3SS 
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effectors, such as YopT from Yersinia spp. Which proteolytically cleaves RhoA, Rac1 and 
Cdc42, are known to directly modify the small GTPases (Shao et al., 2002). Other effectors can 
either modify or mimic GEFs or GAPs (reviewed in (Finlay, 2005)). Although IpgB1, IpgB2 and 
Map do not share any sequence homology with the Rho GTPases, Alto et al. suggested that they 
may mimic, in a GTP-independent mechanism, the activated form of Rac1, RhoA and Cdc42, 
respectively (Alto et al., 2006). The authors showed that stress fibre formation was RhoA 
independent as IpgB2 was functional in the presence of RhoA inhibitors (e.g. C3 botulinum 
toxin) or dominant negative RhoAT19N. Moreover, it was shown that IpgB2 interacts with two of 
the major effectors of RhoA namely mDIA and ROCK, activating the latter directly. Alto et al. 
also reported that transfection of IpgB1 stimulated formation of actin-rich membrane ruffles at 
the dorsal cell surface, which resembled membrane ruffles induced by Rac1 (Alto et al., 2006). 
Dorsal ruffles were not produced by IpgB1E80A. A recent study by Handa et al. (Handa et al., 
2007) has shown that IpgB1 mimics RhoG and triggers membrane ruffling by binding ELMO 
and recruiting the ELMO - Dock180 complex to the membrane where it functions as a GEF for 
Rac1.  
In this chapter we found that EspM2 and EspM3 activate RhoA. Using dominant negative 
RhoAPT19NP we observed a 60% and 40% reduction in stress fibre formation after infection of 
Swiss cell with E2348/69 expressing EspM2 and EspM3, respectively. In agreement with Alto et 
al 2006 (Alto et al., 2006), using the specific  ROCK inhibitor Y27632 we showed that the stress 
fibres induced by EspM2 and EspM3 are totally dependent upon ROCK activity. Consistent with 
this we have shown that EspM2 and EspM3 trigger phosphorylation of cofilin, a classical 
downstream ROCK target. Further characterisation of EspM2 using surface plasmon resonance 
(BiaCore) showed that EspM229-196 forms a stable complex with nucleotide free RhoA. The 
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dissociation of the EspM2-RhoA complex was very slow and as a consequence we were unable 
to measure the dissociation rate constant. In order to induce the nucleotide exchange GEFs form 
an initial low affinity complex, through binding the Switch 1 and 2 regions of the GDP-bound 
Rho GTPase, which favours GDP and Mg2+ release. This is then rapidly converted into a high 
affinity GEF-GTPase binary complex; loading with free GTP leads to dissociation of the GEF 
and formation of a tight Rho GTPase-GTP complex, which binds downstream effectors. To test 
if EspM2 has a GEF activity we incubated RhoA with mant-GTP and increasing concentrations 
of EspM229-196. We found that EspM229-196 induced loading of GTP into RhoA in a dose 
dependent manner. This activity was specific for RhoA as EspM229-196 only induced weak 
nucleotide exchange in Cdc42, while no nucleotide exchange was seen for Rac1 and the distant 
related GTPase HRas. Interestingly, the Salmonella WxxxE effector SifA, which also binds 
RhoA did not exhibit a detectable GEF activity.  
SopE from Salmonella was the first described T3SS effector GEF (Hardt et al., 1998). SopE 
activates Cdc42 and Rac1 leading to formation of membrane ruffles and bacterial invasion 
(Hardt et al., 1998). The crystal structure of the SopE-Cdc42 complex illuminated the 
mechanism by which SopE functions as GEF (Buchwald et al., 2002). SopE is composed of six 
-helixes arranged in two three-helix bundles forming a V-shape (Buchwald et al., 2002). The 
junction connecting the two arms consists on small  sheet followed by a loop consisting of the 
GAGA motif, which is proposed to be the catalytic loop of SopE. Insertion of the GAGA motif 
between the switch regions of Cdc42 induces a push and pull type movement and release of GDP 
(Buchwald et al., 2002). Although SopE does not share sequence or structural similarity with 
eukaryotic GEFs, they induce similar conformational changes in the Rho GTPases. NMR 
analysis of EspM229-196 revealed that it also has six alpha helixes arranged in a V shape structure 
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similar to SopE and a loop connecting the two arms (Buchwald et al., 2002; Ohlson et al., 2008) 
Interestingly, the sequence of this putative catalytic loop is conserved between EspM229-196 and 
other WxxxE effectors, apart from SifA, which might provide an explanation to the inability of 
SifA to GEF RhoA. We substituted three residues located within the putative catalytic loop of 
EspM229-196, L118, Q124 and I127, with alanine, a W70A substitution was used as a control as it 
has previously been demonstrated to lack biological activity. While transfection of Swiss 3T3 
cells with EspM2 L118A and I127A had a substantial effect on stress fibre formation, little effect 
was seen for Q124A. A recent study by Huang et al (Huang et al., 2009) has solved the crystal 
structure of Map in complex with Cdc42. In this study the authors demonstrate that Map binds 
the variable β2-3 inter-switch region of Cdc42 with a structure similar to that of SopE and 
EspM2 (Buchwald et al., 2002). Furthermore, Huang and colleagues demonstrate that the β2-3 
region acts as the determining factor in WxxxE effector GTPases specificity, as substitution of 
the β2-3 region of Cdc42 with that of RhoA or Rac1 severely inhibits interaction with Map. It 
was also demonstrated that IpgB1and IpgB2 act as a GEF of Rac1 and RhoA respectively 
(Huang et al., 2009).  
Together these results demonstrate that the EspM family of proteins and other WxxxE effectors 
act as GEFs of the Rho family of small G proteins rather than mimics of the small GTPases 
themselves. Although the WxxxE effectors do not share any significant homology with SopE at a 
sequence level they do adopt highly similar 3 dimensional structures when in complex with Rho 
GTPases suggesting a convergent evolution of bacterial mammalian GEF mimics.  
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Chapter 4 - EspT is a Novel WxxxE Effector Which Activates 
Rac1 and Cdc42 
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4.1 Identification of the Novel WxxxE Effector EspT 
 
In addition to identifying the EspM family of proteins as WxxxE effectors (Arbeloa et al., 2008) 
we also used a BLAST algorithm with Map as an index protein to search for additional WxxxE 
family members within the A/E pathogen group. We identified a new putative effector, whose 
encoding gene we have named espT, in C. rodentium. EspT is encoded within the same 
pathogenicity island as EspM2 which also encodes an EspO/OspE homologue (Figure 3.2). EspT 
shares 29% identity with EspM2, 27% identity with IpgB2, and 19% identity to IpgB1. A 
phylogram based upon multiple sequence alignment with hierarchical clustering (Mackey et al., 
2002) shows that EspT is divergent from the EspM/IpgB2 group and does not cluster well with 
either IpgB1 or Map (Figure 4.1).  
 
 
 
Figure 4.1 Phylogeny of the novel WxxxE effector EspT. (A) Multiple sequence alignment with hierarchical 
clustering of Shigella flexneri IpgB1 and IpgB2 along with Map, EspM2, EspM3 and EspT from C. rodentium 
and EspM1 from EPEC B171 O111:NM. Residues which are identical are highlighted in grey. The conserved 
WxxxE motif is boxed (B) Phenogram created using ClustalW2 showing the phylogeny of aligned WxxxE 
effectors in addition to SifA and SifB from Salmonella. 
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4.2 EspT is Translocated into Host Cells in a T3SS Dependent Manner 
 
In order to confirm the status of the EspT as a WxxxE effector protein, we utilised a TEM β – 
lactamase fusion assay to detect translocation of the EspT into host cells as described for espM 
(Chapter 4). espT from C. rodentium was fused to a β – lactamase in the pCX340 vector which 
was transformed into wild type and the T3SS null escN E2348/69. These strains were then used 
to infect HeLa cells which were pre-treated with CCF2/AM. The NleD-TEM fusion was used as 
a positive control (Marches et al., 2005). This assay was performed by Georgina MacKenzie (a 
student in the laboratory) under my supervision. EspT was found to be translocated into host 
cells from the wild type E2348/69 strain but not from the escN strain indicating that EspT is 
translocated in a T3SS dependent manner.  
 
 
 
 
Figure 4.2 EspT is translocated into host cells in a T3SS dependent manner. HeLa cells were infected with 
E2348/69 (E69) containing the pCX340 β-lactamase fused to EspT. β-lactamase cleaves the  CCF2/AM 
substrate, which fluoresces in green when uncleaved and in blue when cleaved, indicating  translocation of the 
fusion  protein. The previouslt identified T3SS effector NleD was used as a positive control. The ∆escN T3SS 
null derivative of E2348/69 was used as a negative contol for translocation.  
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4.3 EspT Induces Formation of Lamellipodia and Membrane Ruffles on Swiss 
3T3 and HeLa Cells Respectively.  
 
Previously characterised WxxxE effectors have been reported to induce a plethora of actin 
structures normally associated with activated Rho GTPases (Alto et al., 2006; Arbeloa et al., 
2008; Handa et al., 2007). In order to determine if EspT has the ability to remodel actin within 
eukaryotic cells, espT was cloned into the expression vector pSA10 (Schlosser-Silverman et al., 
2000) and expressed in EPEC E2348/69 which does not contain any WxxxE effectors other than 
Map (Arbeloa et al., 2008). E2348/69 with or without the vector encoding EspT was used to 
infect serum starved Swiss 3T3 and HeLa cells. E2348/69 with no plasmid or carrying empty 
pSA10 triggered formation of actin-rich pedestals beneath adherent bacteria on both Swiss 3T3 
and HeLa cells, without any other major cytoskeletal rearrangements (Figure 4.3). In contrast, 
E2348/69 carrying pSA10 encoding EspT induced formation of pedestals on both cell lines and 
additionally triggered formation of lamellipodia on Swiss 3T3 cells and membrane ruffles on 
HeLa cells, which were not restricted to the site of bacterial attachment (Figure 4.3A and B). The 
lamellipodia induced by EspT have a strong leading edge, wide lamella, well defined 
microspikes and filopodia which extend beyond the cell periphery (Figure 4.3A). These 
lamellipodia and membrane ruffles were found in 90% and 80% of cells infected with E2348/69 
respectively after 1.5 h (Figure 4.3C) and were still present at 3 h post infection. These results 
demonstrate that EspT is a T3SS effector that upon tranlocation triggers formation of 
lamellipodia and membrane ruffles and that the nature of actin rearrangement was cell type-
specific.  
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Figure 4.3 EspT induces lamellipodia and membrane ruffles on Swiss 3T3 and HeLa cells respectively. (A) 
Fluorescence microscopy of serum starved Swiss 3T3 cells uninfected or infected with wild type E2348/69 or 
E2348/69 expressing EspT for 90 min. Actin was stained with Oregon green phalloidin and E2348/69 was 
detected with a rabbit O127 antibody. Distinctive lamellipodia, which have a strong leading edge, wide 
lamella and well defined microspikes and filopodia which extend beyond the cell boundary, were observed on 
cells infected with E2348/69 expressing EspT but not in the wild type control. Both strains induced formation 
of actin rich pedestals beneath adherent bacteria. (B) Serum starved HeLa cells infected with E2348/69 
expressing EspT exhibited membrane ruffles whereas those infected with wild type E2348/69 did not. Both 
strains formed actin pedestals. (C) Quantification of Lamellipodia and membrane ruffles on Swiss 3T3 and 
HeLa cells respectively after 90 min infection with wild type E2348/69 or E2348/69 expressing EspT. 100 cells 
were counted in triplicate in three independent experiments. Results are displayed as mean ± SEM 
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4.4 Ultrastructure Analysis of the EspT-Induced Membrane Protrusions 
 
In order to further characterise the membrane protrusions triggered by expression of EspT we 
processed HeLa and Swiss 3T3 for Scanning Electron Microscopy (SEM). Serum starved HeLa 
and Swiss 3T3 cells were infected for 3 h with E2348/69 or E2348/9 expressing EspT. As in the 
immuno-fluorescence staining, SEM analysis revealed that HeLa and Swiss 3T3 cells infected 
with E2348/69 wild type did not display any significant membrane structure other than pedestals 
(Figure 4.4). HeLa cells infected with E2348/69 expressing EspT displayed wide spread ruffling 
over their entire surface, when these ruffles coincide with adherent E2348/69 they appear to form 
a pocket which can engulf the bacteria (Figure 4.4). Swiss 3T3 cells infected with E2348/69 
expressing EspT have strong dorsal membrane ruffles and lamellipodia similar to those observed 
via immuno-fluorescence (Figure 4.4). Interestingly the SEM also shows that strong ruffles can 
be observed at the site of bacterial attachment which are not so apparent by fluorescence 
microscopy (Figure 4.4).  
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4.5 Ectopic Expression of EspT Results in Characteristic Actin Cytoskeletal 
Reorganisations  
 
In order to determine if EspT alone is responsible for the observed lamellipodia, espT was cloned 
in the mammalian expression vector pRK5 to allow the ectopic expression of a Myc-tagged 
EspT. Transfection of Swiss 3T3 cells resulted in formation of lamellipodia that were 
indistinguishable from those visualised when EspT was delivered via infection with E2348/69 
(Figure 4.5). Thus, EspT is necessary and sufficient for the re-arrangements of the actin 
cytoskeleton observed previously. It has been previously shown that ectopic expresion of the 
Shigella effector IpgB1 induces formation of membrane ruffles in HeLa cells (Alto et al., 2006; 
Handa et al., 2007). As a control we cloned IpgB1 into pRK5 for expression as an N-terminal 
Myc tagged effector. Transfection of IpgB1 into Swiss 3T3 cells revealed that in contrast to 
EspT, IpgB1 induces membrane ruffles and not lamellipodia (Figure 4.5).  
Additionally, we found that at 16 h post-transfection EspT and IpgB1 were targeted to the 
mitochondria, as shown by double staining with anti-Myc antibodies and Mitotracker CMXRos 
(Figure 4.5). Although the mitochondria appeared swollen and sometimes aggregated the fact 
that they were well-stained with Mitotracker CMXRos is indicative that they were metabolically 
active. Moreover, we did not observed any signs of apoptosis in EspT or IpgB1 transfected cells, 
indicating that the mitochondrial membrane has not been compromised. However, as EspT and 
IpgB1 contain no canonical mitochondrial targeting sequences, the mechanism involved in 
mitochondrial targeting remains unknown. 
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Figure 4.5 Ectopic expression of EspT induces characteristic cytoskeletal rearrangement in Swiss 3T3 cells. 
Serum starved Swiss 3T3 cells were mock transfected or transfected with the mammalian expression vector 
pRK5 encoding myc-tagged EspT, or IpgB1 for 16 h. Actin was stained with Alexifluor 633 phalloidin, the 
myc tag was detected with monoclonal antibody and mitochondria were stained with Mitotracker CMXRos. 
On transfection EspT induces the formation of lamellipodia identical to those observed during infection. 
Transfection of IpgB1 resulted in the induction of membrane ruffles. EspT and IpgB1 were found to be well 
colocalised with the mitochondrial marker Mitotracker.  
 
 
 
4.6 EspT Triggered Lamellipodia Formation is Inhibited by Dominant 
Negative Rac1 and Cdc42.  
 
WxxxE effectors have previously been demonstrated to act independently, as IpgB2, (Alto et al., 
2006) or dependently, as the EspM (Arbeloa et al., 2008; Handa et al., 2007) (Figure 3.6) of the 
Rho GTPases. In order to determine if EspT activity was dependent on RhoA, Rac1, Cdc42 or 
RhoG we transfected the dominant negative forms of each of these GTPases (RhoAN19, Rac1N17, 
Cdc42N17 and RhoGN17), which competitively and specifically inhibit the wild type GTPase 
activation, into Swiss 3T3 cells. Additionally, we transfected the Cdc42 and Rac1 binding 
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domain (CRIB) of Pak which efficiently inhibits the downstream signalling of Rac1 and Cdc42 
(Carreno et al., 2002). Transfected cells were subsequently infected with E2348/69 expressing 
EspT for 1.5 h and the presence of lamellipodia was assessed. Inactivation of either RhoA or 
RhoG had no affect on induction of lamellipodia by EspT on Swiss 3T3 (Figure 4.6). Conversely 
inhibition of Rac1 or Cdc42 significantly compromised the ability of EspT to form lamellipodia 
(Figure 4.6). The residual lamellipodia observed in the presence of the Rac1 and Cdc42 
dominant negatives were shorter and less pronounced than those induced in mock transfected 
cells (Figure 4.6). Inhibition of both Rac1 and Cdc42 downstream signalling using the CRIB of 
Pak reduced the number and extent of EspT induced lamellipodia to a level comparable with the 
Rac1 dominant negative. This suggests that activation and subsequent downstream signalling of 
Rac1, Cdc42, or both is involved in the EspT signalling pathway.   
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Figure 4.6 EspT-induced cytoskeletal rearrangements are dependent on Rac1 and Cdc42. (A) Swiss 3T3 cells 
were transfected with the dominant negative forms of RhoA, RhoG, Rac1 and Cdc42 18 h prior to infection 
for 90 min with E2348/69 expressing EspT. Actin was stained with Oregon green phalloidin, the Myc-tagged 
RhoA, Rac1 and Cdc42 dominant negatives were stained with a Myc tag monoclonal antibody, RhoG was 
detected via its GFP tag and E2348/69 was visualized using a rabbit O127 antibody. Actin pedestals were 
observed beneath all adherent bacteria. Lamellipodia were observed in cells transfected with dominant 
negative RhoAN19 and the RhoGN17. The majority of cells transfected with dominant negative Rac1N17 did not 
display lamellipodia. Dominant negative Cdc42N17 reduced the number of cells expressing lamellipodia as well 
as reducing the extent of the lamellipodia compared to the mock or dominant negative RhoAN19 and RhoGN17. 
(B) Quantification of lamellipodia in transfected Swiss 3T3 after 90 min infection with E2348/69 expressing 
EspT. 100 cells were counted in triplicate in three independent experiments. Results are displayed as mean ± 
SEM. Stars demonstrate the results are significant as demonstated by a student T test with p-value 0.01. 
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4.7 EspT Activates Rac1 and Cdc42 to Trigger Formation of Lamellipodia 
and Membrane Ruffles.  
 
It has been previously demonstrated that EspM activates RhoA in order to induce formation 
stress fibres (Arbeloa et al., 2008) (Figure 3.7). In order to assess whether or not EspT activates 
Rac1 and Cdc42 we performed pulldown assays using the Cdc42 Rac1 interacting binding 
domain (CRIB) of Pak, which binds activated Rac1 and Cdc42 and the CRIB of WASP, which 
binds only activated Cdc42. Pull-downs were blotted with specific antibodies for Rac1 and 
Cdc42. Cells incubated with CNF1 toxin which activates Rho GTPases (Pei et al., 2001) were 
used as a positive control and E2348/69 containing empty pSA10 was used as a negative control. 
Swiss 3T3 cells infected with E2348/69 expressing EspT exhibited a marked increase in the level 
of activation of both Rac1 and Cdc42 compared to uninfected cells or those infected with the 
control E2348/69 strain (Figure 4.7). These results suggest that EspT-triggered actin 
rearrangements are dependent upon activation of the Rac1 and Cdc42 signalling cascades. 
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Figure 4.7 EspT activates Rac1 and Cdc42. Swiss 3T3 cells were left untreated or infected with wild type 
E2348/69 or E2348/69 expressing EspT. Cells treated with CNF1 toxin were used as a positive control. Cells 
were lysed and added to GST beads bound to either the CRIB of WASP or the Rac1 binding motif of Pak to 
capture active Cdc42 and Rac1 respectively. Total Cdc42 and Rac1 along with GTP bound Cdc42 and Rac1 
were detected by western blotting with Cdc42 and Rac1 monoclonal antibodies. Quantified data are 
presented as mean ± SEM from three independent experiments.  
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4.8 Ectopic Expression of ELMO in Swiss 3T3 Cells Infected with E2348/69 
Expressing EspT Causes a Shift from Lamellipodia to Membrane Ruffles  
 
Despite the limited homology between EspT and IpgB1, the phenotype produced by the Shigella 
effector is reminiscent of the membrane ruffles induced by EspT in HeLa cells (Ohya et al., 
2005). IpgB1 triggered membrane ruffles occur in a RhoG independent and Rac1 dependent 
manner (Handa et al., 2007). IpgB1 has been reported to interact with ELMO1 and ELMO2 and 
subsequently recruit DocK180 in order to activate Rac1 in a manner analogous to RhoG (Handa 
et al., 2007). Furthermore, Handa and co-workers show that ELMO is localised to the membrane 
ruffles produced during Shigella invasion (Handa et al., 2007). In order to determine if ELMO 
was also localised to EspT-induced dorsal ruffles and lamellipodia, we ectopically expressed 
ELMO1 from the mammalian expression vector pGFP. Surprisingly, when Swiss 3T3 cells 
expressing ELMO were infected with E2348/69 expressing EspT a shift from production of 
lamellipodia to membrane ruffles was observed with ELMO localized to these ruffles (Figure 
4.8). These results suggest that while EspT may utilise a distinct mechanism to IpgB1 in order to 
induce lamellipodia in Swiss 3T3 cells that it may also be able to interact directly or indirectly 
with ELMO. Alternatively, over-expression of ELMO might interfere with the interaction 
between EspT and its typical partner proteins or affect the pathway normally used by EspT to 
activate Rac1 and Cdc42.  
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Figure 4.8 Expression of ELMO1 causes a shift from lamellipodia to membrane ruffles.  (A) Swiss 3T3 cells 
were mock transfected or transfected with GFP tagged ELMO1 18 h prior to infection with wild type 
E2348/69 or E2348/69 expressing EspT. While wild type E2348/69 displayed only pedestal formation in mock 
transfected or cells transfected with ELMO1, E2348/69 expressing EspT induced formation of lamellipodia 
on mock transfected cells but in cells transfected with ELMO there was a shift from lamellipodia to 
membrane ruffles. (B) Quantification of lamellipodia and membrane ruffles on mock transfected Swiss 3T3 
or Swiss 3T3 cells transfected with ELMO1 after 90 min infection with wild type E2348/69 or E2348/69 
expressing EspT. 100 cells were counted in triplicate in three independent experiments. Results are displayed 
as mean ± SEM.  
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4.9 EspT Induced Cytoskeletal Rearrangements are Independent of ELMO or 
Dock180 Activity.  
 
As EspT can induce membrane ruffles in HeLa cells and ectopically expressed ELMO induces a 
shift from lamellipodia to membrane ruffles in Swiss 3T3 cells (Figure 4.8) we utilized dominant 
negative constructs in order to investigate the role of ELMO and its binding partner Dock180 in 
the induction of lamellipodia and membrane ruffles by EspT on Swiss 3T3 and HeLa cells 
respectively. The ELMO-Dock180 complex is proposed to be a novel two part GEF which forms 
a trimeric complex with Rac1 where Dock180 recognises nucleotide free Rac1 and ELMO is 
involved in the nucleotide exchange (Brugnera et al., 2002). Handa and co-workers have 
previously demonstrated that IpgB1 hijacks the ELMO-Dock180 complex to activate Rac1 and 
induce membrane ruffles (Handa et al., 2007). In addition to its role in ELMO mediated Rac1 
nucleotide exchange Dock-180 has also been shown to interact with other adaptor proteins such 
as CrkII and paxillin in order to mediate Rac1 activation (Valles et al., 2004). In order to 
determine if ELMO and Dock180 are required for EspT mediated activation of Rac1, cells were 
transfected with ELMOT625 (a dominant negative of ELMO unable to interact with Dock180) or 
Dock180ISP (a dominant negative form of Dock180 incapable of interacting with Rac1) (Handa 
et al., 2007). Transfection of ELMOT625 or Dock180ISP had no effect on the production of EspT 
dependent lamellipodia in Swiss 3T3 cells (Figure 4.9) or membrane ruffles in HeLa cells 
(Figure 4.9B). In contrast double transfection of ELMOT625 or Dock180ISP with pRK5 expressing 
IpgB1 resulted marked reduction of membrane ruffles compared to mock transfected cells 
(Figure 4.9B). Together these results indicate that EspT induces lamellipodia and membrane 
ruffles via a mechanism which is distinct from IpgB1 and independent of ELMO or Dock180.  
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Figure 4.9 EspT induced cytoskeletal rearrangements are independent of ELMO or Dock180 activity. Swiss 
3T3 were transfected with the dominant negative forms of ELMO and Dock180 18 h prior to infection with 
E2348/69 expressing EspT. Neither ELMOT625 nor Dock180ISP had any effect on lamellipodia induction by 
EspT. (B) Quantification of lamellipodia or membrane ruffles in Swiss 3T3 and HeLa cells transfected with 
dominant negative ELMOT625 or Dock180ISP and infected with E2348/69 expressing EspT or co-transfected 
with IpgB1 from S. flexneri as control. 100 cells were counted in triplicate from 3 independent experiments. 
Results are displayed as mean ± SEM. 
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4.10 EspT Triggered Lamellipodia are Not Inhibited by Antagonists of 
Canonical Rac1 Activation Signalling Pathways. 
 
Rac1 activation is mediated by a complex signalling network of typical and atypical GEFs as 
well as kinases and other mammalian adaptor proteins (reviewed in (Bosco et al., 2009)). Typical 
Rac1 GEFs including Tiam and Trio bind a conserved region of Rac1 between the switch 1 and 
switch 2 region (Gao et al., 2001). This binding can be inhibited by addition of the NSC23766 
compound which preferentially fits the Tiam/Trio recognition groove in Rac1 (Gao et al., 2004). 
Atypical Rac1 GEFs such as Vav proteins require upstream activation by Src family kinases 
before they can catalyse nucleotide exchange on Rac1 (Kawakatsu et al., 2005). In addition to 
GEFs, Rac1 can also be activated by phosphoinositol 3 kinase (PI3K) (Pan et al., 2005). As we 
have demonstrated that EspT mediated induction of membrane ruffles and lamellipodia are 
independent of RhoG (Figure 4.7), ELMO and Dock180 (Figure 4.9) we utilised inhibitors of the 
remaining canonical Rac1 activation pathways in order to determine the mechanism of EspT 
mediated Rac1 activation. NSC23766 was used to inhibit typical Rac1 GEFs such as Trio and 
Tiam, PP2 was utilised to inhibit Src kinase dependent activation of the Vav family of atypical 
GEFs and Wortmannin was used to inhibit PI3K. Swiss 3T3 cells were pretreated with inhibitory 
doses of the chemical inhibitors as described in the literature and then infected with E2348/69 
expressing EspT for 90 min. Lamellipodia formation was unaffected by NSC23766, Wortmannin 
or PP2 treatment. These results suggest that EspT activates Rac1 in a manner which is 
independent of previously identified Rac1 regulatory factors.      
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Figure 4.10 EspT triggered lamellipodia are not inhibited by agonists of canonical Rac1 activation signalling 
pathways. A Swiss 3T3 cells were left untreated or treated with the typical Rac1 GEF inhibitor NSC23766, 
the PI3K inhibitor Wortmannin and the Src kinase inhibitor PP2 at inhibitory concentrations. The cells were 
then left uninfected or infected with E2348/69 or E2348/69 expressing EspT. Cells treated with the chemical 
inhibitors and infected with E2348/69 or E2348/69 pSA10::espT formed typical actin rich pedestals which 
were indistinguishable for untreated cells. B. Cells infected with E2348/69 expressing EspT retained 
lamellipodia formation to a similar level as untreated cells in the presence of NSC23766, Wortmannin and 
PP2.  
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4.11 EspT Induces the Phosphorylation of Cofilin 
 
 
As EspT mediated lamellipodia and membrane ruffles are stable for upward of 3 h after infection 
of Swiss 3T3 or HeLa cells respectively (Bulgin et al., 2009) we next investigated whether EspT 
inhibits the activity of the cofilin which is known to depolymerise actin filaments (reviewed in 
(Maciver, 1998)) and lamellipodia (Lai et al., 2008). Rac1 activates a plethora of downstream 
effectors including the PAK family of serine/threonine kinases (reviewed in (Bokoch, 2003)). It 
has been demonstrated that PAK isoforms can phosphorylate and activate LimK resulting in a 
downstream phosphorylation and inactivation of cofilin (Dan et al., 2001). In order to determine 
if Rac1 activated by EspT also stimulates the phosphorylation and subsequent inactivation of 
cofilin we left serum starved HeLa cells uninfected or infected them for 90 min with E2348/69 or 
E2348/69 expressing EspT. The cells were then lysed and a western blot was performed to detect 
total cofilin and phosphorylated cofilin (Figure 4.11). The western blots were then analysed by 
densitometry and a ratio between cofilin and phospho-cofilin was determined. Uninfected cells 
and cells infected with E2348/69 did not show any significant induction of cofilin 
phosphorylation. Cells infected with E234/69 expressing EspT exhibited a 2 fold increase in the 
levels of cofilin phosphorylation. These results demonstrate that EspT mediates lamellipodia 
stability by inducing the phosphorylation and subsequent inactivation of cofilin.  
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Figure 4.11 EspT induces a phosphorylation of cofilin. HeLa cells were left uninfected on infected with 
E2348/69 or E2348/69 expressing EspT. The cells were then then lysed and the lysate was run on an SDS 
PAGE gel before transfer to a PVDF membrane for western blotting. Cofilin and phospho-cofilin were 
detected using monoclonal antibodies. Densitometry was then utilised to generate a ratio of cofilin to 
phospho-cofilin for each sample. Quantification of densitometry was conducted using image J software and 
results presented here represent the mean ratio ± S.D of four independent experiments. Cells infected with 
E2348/69 expressing EspT induce a two fold induction of cofilin phosphorylation compared to the uninfected 
or E2348/69 infected cells.  
 
  
 
 
4.12 Distribution of espT Among Clinical EPEC and EHEC Strains   
 
In collaboration with Drs. Tania Gomes and Jorge Blanco we determined the prevalence of espT 
in range of circa 1000 EPEC and EHEC clinical isolates which were described in chapter 3 (Fig. 
3.14). Using BLAST analysis of the unfinished genome of EPEC E110019 O111:H9, we 
identified an espT gene which shared around 78% homology with espT from C. rodentium. We 
used the espT sequences from C. rodentium and E110019 to design common internal espT-F1 
(5’-AATCTCATTCTCTTATC) and espT-F2 (5’- TCATGTGATGAGTGGATG) primers to be 
used in a PCR screen. C. rodentium and EPEC E2348/69 were used as positive and negative 
controls respectively. All the O157 and non-O157 EHEC strains were espT negative. We also 
     E2348/69              E2348/69             Uninfected 
  pSA10::espT 
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used the additional primers EspTSc-1 to EspTSc-8 to confirm that all strains screened were truly 
espT negative (Table 1).  
Among the 132 tEPEC and 602 aEPEC strains espT was found in only one (0.8%) tEPEC strain 
(O111:H-) isolated in Spain and in 12 of aEPEC strains (1.9%) (Figure 4.12). Sequencing of 
espT revealed high level of sequence conservation (Figure 4.12). In eight strains espT was 
identical to that of E110019, defined as group 1 EspT. In two strains we detected one single 
amino acid difference (group 2) and in 3 other strains we found 6 amino acids that differ from 
EspT of E110019 (group 3) (Figure 4.12).  
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Figure 4.12 Prevalence and sequence of EspT in clinical EPEC and EHEC Isolates. (A) Characteristics of 
EspT positive strains. (B) Multiple sequence alignment of representative EspT sequences. The conserved 
motif WxxxE is boxed. When compared with EspTE110019, eight of the 13 EspT showed 100% sequence 
identity (ONT:H-, O49:H-, O85:H-, O109:H9, O111:H-, O123:H- (2), O154:H9) as represented by sequence 1. 
Two strains belonging to serotype O2:H49 had one amino acid difference (sequence 2, shown in dark grey), 
while three strains (O104:H2 (2), ONT:H7) differed in six amino acids (sequence 3). 
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4.13 Discussion 
 
In this chapter we have identified and characterised the C. rodentium effector protein EspT. 
Previously identified effectors, Map, EspM, IpgB1 and IpgB2, which are grouped together with 
EspT as WxxxE effectors have all been reported to be potent modulators of the host cell 
cytoskeleton (Handa et al., 2005, Alto et al., 2007, Kenny et al., 2002, Arbeloa et al., 2008). 
Consistent with this, using E2348/69 as a delivery system to translocate EspT along with ectopic 
expression we have shown that EspT also subverts host actin dynamics. Interestingly, the effect 
of EspT was cell-line specific. While expression in Swiss 3T3 led to formation of lamellipodia, 
EspT triggered membrane ruffles on HeLa cells. When EspT was delivered by infection via 
E2348/69 the lamellipodia and membrane ruffles appeared as early as 15 min post infection and 
were stable for over 3 h. 
Based on the initial examination of IpgB1, IpgB2 and Map it was suggested that these effector 
proteins are molecular mimic of Rho GTPases and function in a GTP independent manner (Alto 
et al., 2006). More recently, Handa et al showed that IpgB1 activates Rac1 via the ELMO-
Dock180 machinery (Handa et al., 2007). Despite EspT sharing limited sequence identity with 
other family members, the membrane ruffles observed on HeLa cells were reminiscent of those 
induced by IpgB1 (Ohya et al., 2005) except that the EspT induced ruffles were not restricted to 
the site of bacterial attachment. Interestingly, expressing EspT in Swiss cells led to formation of 
lamellipodia, which have a strong leading edge, wide lamella and well defined microspikes and 
filopodia which extend beyond the cell boundary. In contrast, IpgB1 expression induced 
membrane ruffles on Swiss cells.  
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Lamellipodia and membrane ruffles are normally regulated by interplay between Rac1, Cdc42, 
RhoG and RhoA (Sander et al., 1999, Kurokawa et al., 2004, Ladwein and Rottner., 2008). In 
order to determine the pathway by which EspT subverts the host cell cytoskeleton we utilized 
dominant negative forms of these GTPases to competitively inhibit the wild type proteins. In the 
presence of dominant negative Rac1TN17 a 60% reduction in formation of lamellipodia was 
observed. Transfection of Cdc42TN17 reduced lamellipodia formation by 30%. These dominant 
negative constructs attenuated EspT-induced membrane ruffles in HeLa cells to a similar 
magnitude. These results demonstrate that the actin re-arrangements induced by EspT are 
dependent on the activation of Rac1 and to a lesser extent Cdc42. Furthermore, using the CRIB 
domains of PAK and WASP which bind activated Rac1 and Cdc42 respectively, we demonstrate 
that EspT activates both Rac1 and Cdc42 during infection of Swiss 3T3 cells. These results are 
consistent with the report of Handa et al who have previously demonstrated that IpgB1 activates 
Rac1 (Handa et al., 2007).  
Handa and co-workers also show that IpgB1 interacts with ELMO and subsequently recruits 
Dock180 to a trimeric complex which brings about the activation of Rac1 (Handa et al., 2007). 
As EspT induces a Rac1 dependent phenotype similar to IpgB1 in HeLa cells we investigated the 
role of ELMO during EspT triggered actin modulation. We transfected a GFP-tagged ELMO into 
Swiss 3T3 cells and infected these cells with wild type E2348/69 or E2348/69 expressing EspT. 
No ruffles were observed during E2348/69 infection. Surprisingly, when ELMO was transfected 
into Swiss 3T3 cells infected with E2348/69 expressing EspT we observed a shift from the 
lamellipodia to membrane ruffles similar to those induced by IpgB1. This result might suggest 
that EspT is able to interact with ELMO.  Alternatively, over-expression of ELMO could have an 
effect on the typical downstream signalling pathway employed by EspT. To determine if the 
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lamellipodia observed in Swiss 3T3 cells or the membrane ruffles formed in HeLa cells are 
dependent upon the ELMO–Dock180 machinery we used the dominant negative forms of ELMO 
(ELMOT625) and Dock180 (Dock180ISP) which have been demonstrated to abolish IpgB1 
induced membrane ruffles (Handa et al., 2007). As previously observed (Handa et al., 2007) 
these dominant negatives greatly reduced the formation of membrane ruffles induced by IpgB1. 
However, neither the ELMOT625 nor Dock180ISP had any significant affect on the formation of 
lamellipodia or membrane ruffles induced by EspT. Further inhibition of typical Rac1 GEFs and 
activating pathways demonstrated that EspT activates Rac1 independently of canonical upstream 
signalling. Due to the insoluble nature of recombinant EspT we currently do not know whether 
the observed activation of Rac1 and Cdc42 is direct or indirect however given the recent 
evidence that the EspM, Map, IpgB1 and IpgB2 are GEFs it seems likely that EspT will also 
directly activate Rac1 and perhaps also Cdc42 (Arbeloa et al 2009) (Huang et al., 2009).   
Map, which triggers filopodia formation via activation of Cdc42 (Berger et al., 2009; Huang et 
al., 2009), contains an N-terminus mitochondrial targeting sequence (Paptheodorou et al., 2006), 
while EspM2, IpgB1 and EspT do not have any obvious mitochondrial targeting sequences. 
EspM2, which triggers formation of parallel stress fibres upon transfection, localizes in the 
cytoplasm. In contrast, we found here that EspT and IpgB1 are targeted to mitochondria 
following 16 h ectopic expression. It is interesting to note that mitochondrial trafficking and 
morphology is regulated by the atypical Rho GTPases Mitochondrial Rho (Miro) 1 and 2 
(Franson et al., 2006, Frederick et al., 2004). The mitochondrial localization of IpgB1 and EspT 
may suggest a role for these proteins in regulating mitochondrial dynamics as well as subversion 
of the host actin cytoskeleton. However, although ectopic expression of EspM leads to cytosolic 
localization, we cannot rule out the possibility that mitochondria targeting by EspT and IpgB1 is 
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an artefact due to the over-expression. Further studies are needed to determine if EspT and IpgB1 
have a physiological mitochondrial function. 
Interestingly, although espT is absent from the common EPEC strains (including the prototypes 
E2348/69 and B171) and EHEC O157, we recently found an espT homologue (78% identity) in 
the atypical EPEC strain E110019, which caused a particularly severe outbreak in Finland in 
1987 which affected adults and children alike (Viljanen et al., 1990). However, the overall 
prevalence of espT among clinical EPEC and EHEC strains is very limited. This may suggest 
that EspT is an emerging effector which is still being acquired by A/E pathogens or that 
conversely it is an evolutionary remnant which is being lost.   
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Chapter 5 - EspT is a Novel A/E Pathogen Invasin 
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EPEC, EHEC and C. rodentium are generally considered extracellular pathogens and their 
attachment sites on epithelial cells are normally characterized by the assembly of an actin-rich 
pedestals rather than membrane ruffles (reviewed in (Frankel and Phillips, 2008)). However, in 
both rabbit and human biopsies EPEC have been visualized inside enterocytes and detected in 
the submucosa, mesenteric lymph nodes and spleen (Drucker et al., 1970) (reviewed in 
(Donnenberg and Kaper, 1992)). Recently, Hernandes et al has shown that the atypical EPEC 
strain 1551-2 is capable of invading cultured epithelial cells in an intimin omicron dependent 
manner (Hernandes et al., 2008). As EspT induces membrane ruffles similar to those triggered 
by IpgB1 (Ohya et al., 2005) we investigated whether EspT can mediate EPEC invasion into 
non-phagocytic cells.  
5.1 EspT-Induced Membrane Ruffles Surround Adherent Bacteria  
 
In order to investigate if EspT plays a role in cell invasion we selected to use the espT positive 
strain E110019; the espT negative strain JPN15 (Jerse et al., 1990), a derivative of E2348/69 
lacking the EAF plasmid encoding BFP, was used as a control. Due to its lack of BFP 
expression, JPN15 does not form tight microcolnies which can hinder invasion assays and is 
more comparable to the atypical EPEC E110019. In addition, we generated a JPN15 clone that 
expresses EspT encoded by E110019 from the bacterial expression vector pSA10.  
We infected serum starved HeLa, Swiss 3T3 and Caco2 cells with E110019, JPN15 and JPN15 
expressing EspT; the cells were then fixed and processed for scanning electron microscopy 
(SEM). The JPN15-infected HeLa and Swiss 3T3 cells displayed characteristic diffuse bacterial 
adhesion without any noteworthy surface structures. Caco2 cells infected with JPN15 also show 
a diffuse pattern of bacterial adherence and a concordant localized effacement of microvili 
(Figure 5.1). HeLa cells infected with JPN15 expressing EspT or E110019 displayed extensive 
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membrane ruffling over the entire cell surface (Figure 5.1); in the vicinity of adherent bacteria 
the ruffles surrounded and wrapped individual bacterial cells forming structures which appear 
permissive for internalization. Swiss 3T3 cells infected with JPN15 expressing EspT or E110019 
exhibited extensive dorsal ruffles and lamellipodia in addition to localized membrane ruffles at 
the site of bacterial attachment (Figure 5.1). Caco2 cells infected with JPN15 expressing EspT or 
E110019 displayed prominent membrane ruffles at the site of bacterial adherence in addition to 
effacement of micovili (Figure 5.1). These results show that EspT from E110019 can induce 
actin remodeling and surface structures identical to those induced by EspT from C. rodentium. 
Interesting the membrane remodeling induced by EspT expressing strains is strikingly similar to 
those associated with Shigella and Salmonella invasion (reviewed in (Cossart and Sansonetti, 
2004)) 
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Figure 5.1 EspT-induced membrane ruffles surround adherent bacteria. Scanning electron microscopy of 
HeLa, Swiss 3T3 and polarized Caco2 cells infected with JPN15, JPN15 expressing EspT or E110019 for 2 h. 
JPN15 displayed a pattern of diffuse  adherence on HeLa, Swiss 3T3 and Caco2 cells but did not induce any 
significant membrane remodeling. JPN15 expressing EspT and E110019 also adhered to HeLa, Swiss 3T3 and 
Caco2 cells in a diffuse pattern but induced membrane ruffles at the site of bacterial attachment, which were 
more pronounced on Caco2 cells. In addition to membrane ruffles JPN15 expressing EspT and E110019 also 
induced formation of lamellipodia and dorsal ruffles at locations distal from the site of bacterial attachment 
on Swiss 3T3 cells. Magnifications: HeLa cells X5000; Swiss 3T3 X3500; Caco2 X10000 and X6500 (middle) 
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5.2 EspT Dependent Lamellipodia Formation is Independent of N-WASP 
 
We have shown that EspT activates both Rac1 and Cdc42 (Figure 4.7). However inhibition of 
Cdc42 using dominant negative constructs only reduces EspT mediated lamellipodia by 
approximately 30% compared to a 65% reduction when Rac1 is inhibited (Figure 4.6). Cdc42 is 
generally associated with membrane protrusions such as filopodia but is also considered to play a 
role in stabilising Rac1 dependent lamellipodia (Kurokawa et al., 2004). Consistently, we 
observed that inhibition of Cdc42 reduces the size and stability of EspT induced lamellipodia 
(Figure 4.6).  Cdc42 dependent actin modulation occurs primarily through the WASP/N-WASP 
proteins which are activated by GTP bound Cdc42 and subsequently recruits and activates the 
Arp2/3 complex (Carlier et al., 1999a). N-WASP has also been implicated in formation of dorsal 
ruffles and lamellipodia in fibroblasts (Legg et al., 2007).  In order to investigate the role of 
Cdc42 in lamellipodia formation we utilised N-WASP deficient fibroblasts. The N-WASP 
knockout fibrobalsts were infected with JPN15 and JPN15 expressing EspT from the pSA10 
vector for 2 h. As pedestal formation is N-WASP dependent (Gruenheid et al., 2001; Lommel et 
al., 2001) no pedestals were observed upon infection with either JPN15 or JPN15 pSA10::espT 
(Figure 5.2). Knockout cells infected with JPN15 expressing EspT formed lamellipodia and 
dorsal ruffles at a similar rate as Swiss 3T3 cells (Figure 5.2). The lamellipodia formed on the N-
WASP knockout cells were not as pronounced as those induced on Swiss 3T3 cells (Figure 5.2). 
These results further support the assertion that Cdc42 and N-WASP are not required for EspT 
mediated lamellipodia formation but may play a role in stabilising the lamellipodia after 
formation.   
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Figure 5.2 EspT dependent formation of lamellipodia is independent of N-WASP. Knockout N-WASP 
fibroblasts were infected with JPN15 or JPN15 expressing EspT for 2 hours. Actin is stained in green with 
phalloidin and JPN15 was detected with a rabbit polyclonal anti O127 antibody in Red. Neither JPN15 nor 
JPN15 pSA10::espT formed pedestals on the N-WASP knockout fibroblasts. JPN15 expressing EspT formed 
lamellipodia to a similar level to Swiss 3T3 fibroblasts although the lamellipodia were smaller. Quantified 
lamellipodia were counted in one hundred cells in three independent experiments. Results are presented as 
mean±SEM.  
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5.3 Wave2 and Abi1 are Localized to Membrane Ruffles and Lamellipodia 
Induced by EspT 
 
Remodeling of the host cell actin cytoskeleton by EspT is mainly dependent on Rac1 (Figure 4.6, 
4.7 and 5.2). Rac1 utilizes a plethora of downstream effectors in order to regulate cytoskeletal 
dynamics (reviewed in (Etienne-Manneville and Hall, 2002) and (Chhabra and Higgs, 2007)). 
Several GTPase effectors including IRSp53, N-WASP, Pak, Wave2 and Abi1 have been 
previously been implicated in formation of membrane ruffles (Innocenti et al., 2004; Legg et al., 
2007; Machuy et al., 2007; Miki et al., 2000). N-WASP is not required for EspT induced 
lamellipodia formation (Figure 5.2). Wave2 is a member of the WASP superfamily of proteins 
and is a prominent downstream effector of Rac1 which can mediate activation of the Arp2/3 
complex (reviewed in (Takenawa and Miki, 2001)). Wave2 cannot bind Rac1 directly; Innocenti 
et al and Steffen et al have proposed a model in which Wave2 binds to Abl Interactor 1 (Abi1) 
and two accessory proteins PIR121 and Nap1 which then mediate Rac1 binding (Innocenti et al., 
2004; Steffen et al., 2004). We transfected Swiss 3T3 and HeLa cells with the mammalian 
ectopic expression vector pRK5 encoding EspT for 16 h. Using immuno-fluorescence 
microscopy we found that both Wave2 and Abi1 were present and co-localized with actin at 
membrane ruffles and the leading edge of lamellipodia induced by EspT (Figure 5.3). 
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Figure 5.3 Wave2 and Abi1 are localized to membrane ruffles and lamellipodia induced by ectopically 
expressed EspT. Actin was stained with Oregon Green phalloidin (Green), Wave2 was detected with a 
polyclonal rabbit antibody (Red) and Abi1 was visualized using a mouse monoclonal antibody (Yellow). Mock 
transfected cells did not display any significant actin structures and Wave2 and Abi1 were localized diffusely 
in the cytoplasm. HeLa cells transfected with pRK5::espT exhibit prominent membrane ruffles on their 
apical surface which were enriched with Wave2 and Abi1. Ectopic expression of EspT in Swiss 3T3 cells 
resulted in formation of distinctive lamellipodia to which Wave2 and Abi1 were extensively recruited and co-
localized. 
 
5.4 IRSp53 is Recruited to EspT Induced Membrane Ruffles but not 
Lamellipodia 
 
 
The signaling protein IRSp53 has been proposed to participate in Abi1-Wave2-Rac1 complex 
formation (Miki et al., 2000; Suetsugu et al., 2006). We transfected HeLa and Swiss 3T3 cells 
with the mammalian ectopic expression vector encoding EspT for 16 h. Interestingly, while we 
did not detect any significant enrichment of IRSp53 in lamellipodia, IRSp53 was localized to 
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membrane ruffles nucleated by EspT (Figure 5.4). This suggests that IRSp53 may play a 
subsidury role in EspT induced membrane remodeling.  
 
Figure 5.4 IRSp53 is enriched in membrane ruffles induced by EspT. HeLa and Swiss 3T3 cells were 
transfected with the ectopic expression vector pRK5 encoding EspT for 12 h. Actin was labeled with Oregon 
Green phalloidin (green), Wave2 was detected with polyclonal rabbit antisera and IRSp53 was detected using 
a monoclonal mouse antibody (Yellow). Transfection of EspT resulted in formation of membrane ruffles and 
lamellipodia in HeLa and Swiss 3T3 cells respectively. Wave2 was localized to membrane ruffles and 
lamellipodia induced by EspT. IRSp53 was recruited to EspT dependent ruffles in HeLa cells but was not 
present in lamellipodia induced on Swiss 3T3 cells. 
 
5.5 Wave2 is Essential for EspT-Induced Membrane Remodeling 
 
 
Wave2 is a ubiquitously expressed member of the WASP superfamily of actin regulators which 
potently activates the Arp2/3 complex (Suetsugu et al., 1999). Wave2 has been demonstrated to 
be required for the formation of membrane ruffles induced by Salmonella to invade epithelial 
cells (Shi et al., 2005). We utilized siRNA in order to determine if Wave2 is essential for 
formation of the EspT-dependent membrane ruffles. Depletion of endogenous Wave2 from 
Swiss 3T3 cells, confirmed by Western blotting (Fig. 5.5A), resulted in a marked decrease in 
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formation of membrane ruffles and lamellipodia induced by JPN15 expressing EspT or E110019, 
compared with cells treated with scrambled siRNA (Fig. 5.5B).  
 
 
 
Figure  5.5 Wave2 is essential for EspT induced membrane remodeling and invasion. (A) Swiss 3T3 cells were 
treated with Non Targeting (NT) siRNA or siRNA targeted against Wave2. (A) Western blot with lysates 
from Swiss 3T3 cells treated with NT and Wave2 siRNA. Wave2 and Tubulin were detected with monoclonal 
antibodies. Non Targeting siRNA did not alter Wave2 expression whereas treatment with Wave2 siRNA 
depleted the protein. Protein levels in the lysates were normalized using anti tubulin antibodies. (B) 
Quantification of membrane remodeling induced by E110019 and JPN15 expressing EspT in Swiss 3T3 cells 
treated with NT and Wave2 siRNA after 3 h of infection. 100 cells were counted in triplicate resulted are 
presented as mean  SEM. (C) Cells were infected with E110019 for 3 h were fixed and stained prior to 
permeabilization (extracellular labeling) (Red). The cells were then washed, permeabilized, re-labeled (Total 
labeling) (Green) along with Alexaflour 633 Phalloidin (Cyan) and Dapi (Blue). In cells treated with the NT 
siRNA E110019 induced formation of membrane ruffles and a large proportion of bacteria were labeled by 
the total stain which were absent from the extracellular labeling. Depletion of Wave2 using siRNA inhibited 
formation of membrane ruffles by E110019 and the majority of bacteria were detected by both the 
extracellular and total staining demonstrating that depletion of Wave2 inhibits EPEC invasion 
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5.6 Wave2 WHD and VCA Domains are Required for EspT-Induced 
Membrane Remodeling 
 
The Wave family of proteins have a modular structure consisting of a N terminal Wave 
homology domain (WHD), a central proline rich region (PRR) and a C terminal Arp2/3 binding 
domain (VCA module) (reviewed in (Takenawa and Miki, 2001)). The WHD domain has been 
shown to bind Abi1 (Innocenti et al., 2004) and the PRR has been shown to interact with the SH3 
domain of IRSp53 (Miki et al., 2000). In order to determine which regions of Wave2 were 
required for formation of lamellipodia and membrane ruffles by EspT Swiss 3T3 and HeLa cells 
were transfected with full length Wave2 or dominant negative forms of Wave2 lacking the WHD 
(∆BP) which can no longer bind to wave2 or the Arp2/3 interacting domain (∆A) which cannot 
interact with Arp2/3 and is so deficient in actin nucleation activity. Transfected cell were 
infected for 1.5 h with JPN15 expressing EspT and the presence of lamellipodia or membrane 
ruffles was assessed. Mock transfected cells or cells transfected with full length Wave2 had 
lamellipodia and membrane ruffles on 80 to 90 % of infected cells (Figure 5.6). Transfection 
with either the ∆BP or the ∆A Wave2 dominant negative constructs resulted in significant 
reduction in lamellipodia and membrane ruffle formation (Figure 5.6). This result demonstrates 
that binding of Arp2/3 and of Abi1 to Wave2 is essential for EspT-mediated formation of 
lamellipodia and membrane ruffles. Furthermore, the observation that the ∆BP construct, which 
is capable of binding IRSp53 but not Abi1, has a dominant negative effect further suggests that 
IRSp53 does not play a prominent role in EspT mediated signaling. 
 
164 
 
 
Figure 5.6 Wave2 WHD and VCA domains are needed for EspT-induced membrane remodeling. (A) Swiss 
cells were left untransfected or transfected with pDSRed encoding wild type Wave2 and Wave2∆A (lacking 
the acidity Arp2/3 interacting region) or Wave2∆BP (lacking the WHD needed for Abi1 binding). 
Transfected cells were infected with JPN15 expressing EspT for 2 h and processed for immuno-fluorescence 
microscopy. Actin was stained with Oregon green phalloidin (Green), the Wave constructs were detected with 
a polyclonal rabbit Wave2 antibody (Red) and JPN15 expressing EspT were visualized by Dapi. Mock 
transfected cells or cell transfected with wild type Wave2 displayed lamellipodia in 80-90% of transfected 
cells. Cells transfected with Wave2∆A or Wave2∆BP were severely attenuated in lamellipodia formation 
compared to the mock or Wave2 wild type transfected cells. (B) Quantification of lamellipodia and 
membrane ruffles on Swiss and HeLa cells respectively after 2 h infection with JPN15 expressing EspT. 100 
cells were counted in triplicate in three independent experiments. Results are displayed as mean ± SEM. 
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5.7 EspT Facilitates EPEC Invasion  
 
 
Induction of membrane ruffles is a mechanism employed by a range of pathogenic bacteria in 
order to facilitate cell invasion. This method of bacterial invasion is referred to as the trigger 
mechanism and relies upon induction of actin polymerization to form an entry foci and a 
macropinocytic pocket (reviewed in (Cossart and Sansonetti, 2004)). JPN15 expressing EspT 
and E110019 induce membrane remodeling which is reminiscent of entry foci and membrane 
ruffles induced by Shigella and Salmonella (reviewed in (Cossart and Sansonetti, 2004)) (Figure 
5.1).  
We used differential staining to visualize invasion of Swiss 3T3 cells by JPN15, JPN15 
expressing EspT, and E110019; Salmonella enterica serovar Typhimurium strain SL1344 was 
used as a control. In addition, we conducted gentamycin protection assays to quantify cell 
invasion of Swiss 3T3, HeLa and Caco2 cells after 3 h infection. Differential immuno-
fluorescence staining and gentamycin protection assays were also performed in HeLa and Swiss 
3T3 cells infected for 6 h with wild type C. rodentium, C. rodentium ∆espT and complemented 
C. rodentium ∆espT. Prior to use in this infection the C. rodentium wild type C. rodentium ∆espT 
were tested and no significant differences were observed in cell adhesion, pedestal formation of 
growth rate were observed. Furthermore, testing via polymerase chain reaction demonstrated that 
the C. rodentium ∆espT mutation was unaffected via serial culturing or infection of mammalian 
cells and also that the complemented C. rodentium ∆espT pSa10:;espT maintained the plasmid 
thoughout. For immuno-fluorescence extracellular bacteria were stained prior to cell 
permeabilzation with primary anti-O127 (JPN15), anti-O111 (E110019) or anti-LPS (S. 
Typhimurium) antibodies and a secondary antibody coupled to a Cy3 fluorophore (red). The 
cells were then permeabilized and total bacteria were stained with the same primary antibodies 
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and a secondary antibody coupled to a Cy2 fluorophore (green), Alexafluor 633 phalloidin and 
Dapi were used to visualize actin and DNA respectively.  
Adherent JPN15 bacteria were homogenously stained by both the extracellular and total bacterial 
probes, indicating that this strain is not significantly invasive (Fig. 5.7A). In cells infected with 
JPN15 expressing EspT or E110019 a significant proportion of the bacteria were labeled with the 
total bacterial stain but not by the extracellular probe (Fig. 5.7A). S. Typhimurium-infected cells 
exhibited characteristic membrane ruffling at the entry foci and a high proportion of bacteria 
were labeled only with the total bacterial probe (Fig. 5.7A).  
The quantitative gentamycin protection assay revealed that JPN15 does not efficiently invade 
HeLa, Swiss 3T3 or Caco2 cells, exhibiting an invasion rate of less than 1.5% (Fig. 5.7B). JPN15 
expressing EspT was significantly more invasive with an invasion rate of 15.5% in Swiss 3T3, 
14.3% in HeLa and 7.2% in Caco2 cells (Fig. 5.7B).  E110019 invaded Swiss 3T3, HeLa and 
Caco2 cells at a rate of 9.2%, 11.4% and 5.8% respectively. The invasive capacity of EPEC was 
significantly less than S. Typhimuriumin (Fig. 5.7B).  
E110019 is multi drug resistant, which limits the ability to genetically modified the isolate. In 
order to determine if cell invasion is mediated by EspT, we infected Swiss 3T3 and HeLa cells 
for 6 h with wild type C. rodentium and C. rodentium ∆espT and C. rodentium espT 
complemented with pACYC184::espT. Infection with wild type C. rodentium resulted in a 
moderate level of cell invasion, while the espT mutant exhibited little or no invasion (Fig. 5.7B). 
Complementing C. rodentium ∆espT with espT expressed from pACYC184 restored the 
invasiveness of the mutant to a level which was greater than the wild type strain (Fig. 5.7B).  
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Figure 5.7. EspT-dependent actin remodeling facilitates bacterial invasion of epithelial cells. (A) Swiss 3T3 
cells infected with JPN15, JPN15 expressing EspT, E110019 or S. Typhimurium for 3 h were fixed and 
stained prior to permeabilization (extracellular labeling) (Red). The cells were then washed, permeabilized, 
re-labeled (Total labeling) (Green) along with Alexaflour 633 Phalloidin (Cyan) and Dapi (Blue). In cells 
infected with JPN15 all the bacteria labeled by the total staining were also detected with the extracellular 
probe indicating that there was no significant invasion (highlighted with arrows). Significant numbers of 
bacteria labeled with the total stain, which were not represented in the extracellular staining, were seen in 
cells infected JPN15 expressing EspT, E110019 and S. Typhimurium indicating that there was a significant 
degree of bacterial invasion (highlighted with arrows). (B) Gentamycin protection assay of Swiss 3T3 and 
HeLa cells infected JPN15, JPN15 expressing EspT, E110019, S. Typhimurium, C. rodentium, C. rodentium 
espT or complemented C. rodentium espT and polarized Caco2 cells infected with JPN15, JPN15 expressing 
EspT , E110019 or S. Typhimurium. Results are representative of 3 independent experiments carried out in 
duplicate and are displayed as mean ± SEM. 
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5.8 The Conserved WxxxE Motif is Essential for EspT Mediated Membrane 
Remodelling and Invasion.  
 
Previous studies have demonstrated that mutation of either the conserved typtophan or glutamic 
acid motif results in a loss of activity of WxxxE effectors (Alto et al., 2006, Arbeloa et al., 2008) 
(Figure 3.5). Thus we mutated the conserved tryptophan (W63) of EspT to alanine in order to 
create the plasmid pSA10::espTW63A. HeLa cells were then infected with JPN15 pSA10::espT or 
JPN15 pSA10::espTW63A in order to determine the role of the WxxxE motif during EspT induced 
membrane remodelling and invasion. Approximately 90% of HeLa cells infected with JPN15 
pSA10::espT exhibited membrane ruffles which surrounded adherent bacteria in addition to 
pedestals. In contrast cells infected with JPN15pSA10::espTW63A only induced ruffles in around 
15% of cells whilst pedestal formation was unaffected (Figure 5.8). Quantitative gentamycin 
protection assays were used to quantify the invasiveness of JPN15 pSA10::espT and JPN15 
pSA10::espTW63A in HeLa cells infected for 3 h, JPN15 and S. Typhimurium were used as 
negative and positive controls respectively. We found that JPN15 expressing EspTW63A was 
significantly less invasive that JPN15 expressing the wild type protein (Figure 5.8C).  
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Fig.ure  5.8 EspT mediated membrane remodeling and invasion is dependent on the conserved WxxxE motif. 
HeLa cells infected with JPN15, JPN15 expressing wild type EspT, or JPN15 expressing EspTW63A for 3 h 
were fixed and stained with phalliodin (green) to detect actin and Dapi stain to label bateria (blue). In cells 
infected with JPN15 and JPN15 expressing EspTW63A there was no significant induction of membrane 
ruffling. Infection of HeLa cells with JPN15 expressing wild type EspT resulted in the formation of 
characteristic membrane ruffles. (B) Gentamycin protection assay of HeLa cells infected JPN15 and JPN15 
expressing EspT or EspTW63A. Results are representative of 3 independent experiments carried out in 
duplicate and are displayed as mean ± SEM. 
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5.9 Ectopic Expression of EspT Induces Membrane Ruffles which Facilitate 
the Invasion of T3SS Null Mutants.  
 
 
A/E pathogens encode a plethora of T3SS effector proteins which can modulate the host cell 
cytoskeleton including; Map which activates Cdc42 to induce filopodia (Berger et al., 2009; 
Kenny and Jepson, 2000), EspM proteins which activate RhoA to induce stress fibres (Arbeloa et 
al., 2008) and Tir which mediates the formation of actin rich pedestals (Gruenheid et al., 2001). 
In order to confirm that EspT can promote EPEC invasion of non-phagocytic cells independently 
of other T3SS effectors we ectopically expressed EspT in HeLa cells prior to infection with 
EPEC ∆escN. Extracellular and intracellular bacteria were labeled as described above. Cells 
ectopically expressing EspT displayed membrane ruffling which facilitated the uptake of ∆escN 
bacteria (Figure 5.9). These results demonstrate that EspT is sufficient to induce the 
internalization of EPEC bacteria independently of other T3SS effectors.   
 
 
 
 
Figure  5.9 Ectopic expression of EspT can facilitate invasion of epithelial cells by a T3SS null mutant. HeLa 
cells were transfected with pRK5 encoding EspT for 12 h and subsequently infected with a ∆escN T3SS 
mutant for 1.5 h. The cells were then fixed and processed for immuno-fluorescence microscopy. Actin was 
stained using Alexafluor 633 phalloidin (Cyan), external and internal bacteria were labeled in red and green 
respectively. Ectopic expression of EspT led to the formation of actin rich membrane ruffles and a significant 
proportion of ∆escN bacteria became internalized (highlighted with arrows).  
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5.10 Rac1 and Wave2 are Essential for EspT Mediated Bacterial Cell Invasion 
 
 
As actin remodeling by EspT is dependent on the activation of Rac1, Cdc42 (Figure 4.7) and 
Wave2 (Figure 5.5 and 5.6), we utilized dominant negative constructs of these signaling proteins 
and monitored the effect on invasion of  JPN15 expressing EspT and E110019. HeLa cells 
transfected with dominant negative Rac1 (Rac1N17), Cdc42 (Cdc42N17), Wave2∆A and 
Wave2∆BP were infected for 3 h. The cells were fixed and stained for bacterial invasion as 
described above. Cells transfected with Cdc42N17 were still permissive of bacterial invasion 
while cells transfected with the Rac1N17, Wave2∆A or Wave2∆BP dominant negative constructs 
were not (Figure 5.10). Depletion of Wave2 using siRNA in Swiss 3T3 cells significantly 
reduced the invasive capacity of both JPN15 expressing EspT and E110019 compared to cells 
treated with non-targeting siRNA (Fig. 5.5C and 5.10B).  Thus, Rac1, Wave2 and Abi1 are 
essential mediators of EspT-induced bacterial invasion. 
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Figure 5.10 Rac1 and Wave2 are essential for EspT-mediated bacterial invasion. (A) Swiss 3T3 cells were left 
untransfected or transfected with Non Targeting (NT) or Wave2 siRNA oligos, the ectopic expression vector 
pDSRed encoding Wave2∆A, Wave2∆BP or pRK5 expressing dominant negative Rac1 and Cdc42 and 
infected with JPN15, JPN15 expressing EspT or E110019. Mock transfected cells or cells transfected with 
dominant negative Cdc42 were efficiently invaded by both JPN15 expressing EspT and E110019. Cells 
transfected with dominant negative Rac1 were significantly more resistant to bacterial invasion. The 
Wave2∆A and Wave2∆BP constructs also had a potent dominant negative effect on bacterial internalization. 
(B) Quantification of bacterial invasion; cells which had 3 or more internalized bacteria were scored as 
invaded. 100 cells were counted in triplicate in three independent experiments. Results are displayed as mean 
± SEM. 
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5.11 Internalized EPEC Bacteria are Enclosed Within a Vacuole 
 
After the initial invasion of host cells internalized bacteria are often bound within a vacuole 
which resembles early endosomes (reviewed in (Kumar and Valdivia, 2009)). Intracellular 
bacteria either remain within the vacuole or rapidly escape to the cytoplasm (Cossart and 
Sansonetti, 2004).  In order to determine whether invasive EPEC are bound within a vacuole or 
free in the cytoplasm HeLa cells were infected with JPN15, JPN15 pSA10::espT and E110019 
for 5 min up to 12 h and stained with various vacuolar markers including Early Endosome 
Antigen 1 (EEA1) and Vacuolar ATPase (VATPase). Internalized JPN15 pSA10:::espT and 
E110019 were labeled with EEA1 while external bacteria and JPN15 lacking EspT were not 
(Figure 5.11 shows staining at 45 min post infection). EEA1 staining was apparent after 5 min 
and persists up until 1 h post infection (data not shown). At 3 h and up to 12 h post infection the 
EPEC containing vacuole (ECV) was labeled with VATPase whilst external bacteria were not 
(Figure 5.14A). Unlike invasive Salmonella, at 12 h post infection we did not observe 
intracellular EPEC microcolonies. However, similarly to the Salmonella containing vacuole 
(SCV), ECVs appear to adopt a perinuclear localization (Figure 5.12). 
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Figure 5.11 Internalized EPEC bacteria are enclosed within a vacuole. Internalized bacteria bound within a 
vacuole were detected by anti EEA1 and a secondary antibody coupled to a CY5 (magenta). DNA was 
detected using Dapi staining. Extracellular JPN15 bacteria which were detected by both the total stain and 
the extra-cellular probes were not co-localized with EEA1 staining. Intracellular JPN15 pSA10::espT and 
E110019 which were detected by the total bacterial probe but not by the pre permeabilization stain were 
contained within EEA1 rich structures indicative of early endosome like vacuoles.   
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5.12 The ECV Matures to Become Lamp1 Positive at Late Time Points of 
Infection.  
 
Intracellular pathogens which are bound by a vacuolated must evade host cell lysosome mediated 
degradation and maintain the integrity of the vacuole. Salmonella is one such intracellular 
pathogen which after initial invasion of host cells is contained in a vacuole which resembles an 
early endosome before maturation and acquisition of late endosomal and lysosomal components 
such as VATPase and Lamp1 (Reviewed in (Kumar and Valdivia, 2009)). Other intracellular 
pathogens such as Legionella modify their vacuole by enriching it with membrane derived from 
the endoplasmic reticulum (Machner and Isberg, 2007). The vacuole containing Chlamydia 
species is devoid of typical endo-membrane components and instead disrupts the  Golgi 
apparatus in order to scavenge lipids to maintain its vacuole (Heuer et al., 2009). In order to 
determine the longevity and membrane composition of the EPEC Containing Vacuole (ECV) we 
infected HeLa cells for 30 min with E110019 and then killed extracellular bacteria with a 
gentamycin wash before incubation for a further 16 or 24 h. We utilized immuno-fluorescence 
microscopy to stain for the late endosomal marker Lamp1. At 16 hours post infection the ECVs 
begins to acquire Lamp1 staining which progressed to label a sub-population of internalized 
bacteria after 24 h (Figure 5.12). Interestingly the ECV was found to be associated with actin 
around its boundary (Figure 5.12B). Where the actin staining is prominent there is no 
localization with the Lamp1 marker (Figure 5.12B).    
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Figure 5.12 The ECV matures to become Lamp1 positive at late time points of infection. HeLa cells were 
infected for 30 min before extracellular bacteria were eliminated by a gentamycin wash. The cells were then 
incubated for a further 16 or 24 h. Actin was detected with phalloidin in Red, Lamp1 was detected with a 
monoclonal antibody in cyan and bacteria were detected with Dapi staining in blue  (A) At 16 h post infection 
the ECV begins to acquire the Lamp1 marker. At 24 h almost all intracellular E110019 are associated with 
Lamp1. (B) The ECV is associated with actin and where the actin staining is prominent the Lamp1 marker is 
excluded. 
 
 
 
 
 
 
 
177 
 
5.13 Internalized EPEC are Associated with Actin Comets 
 
 
After escaping from the vacuole many intracellular pathogens such as Shigella and Listeria 
utilize specialized outer membrane proteins to recruit actin nucleating factors in order to produce 
a propulsive force (reviewed in (Cossart and Sansonetti, 2004)). Extracellular EPEC is 
synonymous with actin nucleation which leads to formation of Tir-dependent actin rich pedestals 
(Frankel et al., 2001). During the course of this study we observed that invasive EPEC contained 
within the ECV were associated with filamentous actin comets reminiscent of pedestals. In order 
to confirm that intracellular bacteria are associated with actin we infected Swiss 3T3 cells for 3 h 
with E110019. We utilized Confocal X-stacks and observed that the intracellular EPEC bacteria 
were associated with pedestal-like filamentous actin structures (Figure 5.13).  
 
 
 
Figure 5.13 Intracellular EPEC are associated with actin comets. Swiss 3T3 cells were infected with E110019 
and processed for immuno-fluorescence confocal microscopy. A series of confocal X-stacks were taken 
through the infected cells. The cell boundaries are defined by a yellow line and the coverslip is represented by 
the blue bar. The staining shows intracellular E110019 (green) associated with actin comet-like structures 
(magenta). The cell boundary was defined using actin staining. 
 
 
 
 
 
 
 
 
 
178 
 
5.14 Internalized EPEC Bacteria Incorporate Tir into the Vacuolar 
Membrane which Nucleates Intracellular Actin Pedestals. 
 
 
In order to determine if intracellular EPEC actin recruitment was mediated by Tir, we infected 
HeLa cells for 30 min with JPN15, JPN15 pSA10::espT and E110019; following washes the 
cells were incubated in the presence of gentamycin for a further 8 h. The cells were then stained 
with anti-VATPase and anti-Tir antisera in conjunction with phalloidin and Dapi staining. In 
HeLa cells infected with JPN15 pSA10::espT and E110019 internalized bacteria were labeled 
with anti-VATPase and were associated with filamentous actin (Figure 5.14A). In contrast, 
JPN15 formed pedestals which were associated with Tir but not with VATPase staining (Figure 
5.14A). Interestingly, internalized bacteria, which were co-localized with VATPase, were also 
associated with Tir. Additionally, intracellular EPEC escN, internalized by cells ectopically 
expressing EspT, were not associated with actin pedestals (Figure 5.9). These results suggest that 
the actin filaments associated with EPEC contained within the ECV is nucleated in a Tir-
dependent mechanism analogous to pedestal formation by extracellular bacteria.  
In order to confirm this assertion we infected HeLa cells with E110019 for 2 h and processed the 
cells for transmission electron microscopy (TEM). The TEM confirmed that E110019 bacteria 
are internalized via ruffle formation (Figure 5.14B). E110019 can also be seen forming multiple 
pedestals with the membrane on opposing surfaces during ruffle formation and closure (Figure 
5.14C). Moreover, internalized EPEC bacteria contained within the ECV are associated actin 
pedestals, which are strikingly similar to those normally associated with extracellular EPEC 
(Figure 5.14B-D). Interestingly, bacteria bound within ECVs can form multiple pedestals around 
their circumference (Figure 5.14D). 
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Figure 5.14 Internalized EPEC bacteria incorporate Tir into the vacuolar membrane which nucleates 
intracellular actin pedestals. (A) HeLa cells were infected for 30 min with JPN15, JPN15pSA10::espT, and 
E110019 were processed for immuno-fluorescence microscopy after 8 h gentamycin treatment. Actin was 
stained using Oregon Green phalloidin (Green), Tir was detected using polyclonal Tir antisera (Magenta), 
Vacuolar ATPase (VATPase) was detected using a monoclonal antibody (Red) and bacteria were detected 
using Dapi staining. Cells infected JPN15 recruited Tir to the site of bacterial attachment and form canonical 
actin rich pedestals but do not display any bacterial co-localization with the VATPase vacuolar marker. In 
cells infected with JPN15 pSA10::espT or E110019 a proportion of bacteria were co-localized with VATPase, 
Tir and actin. (B) A TEM micrograph showing membrane ruffles engulfing E110019. (C) E110019 has the 
capacity to form multiple pedestals during ruffle formation and closure. (D) E110019 bacteria bound within a 
vacuole with intracellular pedestals formed around its circumference. 
 
 
 
A 
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5.15 Intracellular Pedestal Formation is Tir Dependent. 
 
As E110019 is multi-antibiotic resistant and as a result difficult to genetically modify we utilised 
Citrobacter rodentium which encodes a genomic copy of espT in order to determine if Tir is 
required for the formation of intracellular pedestals. Swiss 3T3 cells were infected with C. 
rodentium or C. rodentium ∆tir for 1 h and extracellular bacteria did not form pedestals at this 
time (data not shown). Extracellular bacteria were eliminated using a gentamycin wash, and the 
infected cells were then incubated for a further 16 h. We observed that wild type C. rodentium 
formed intracellular pedestals at a similar rate to that observed for E110019 whereas C. 
rodentium ∆tir failed to accumulate any actin around ECVs (Figure 5.15). Interestingly, in the C. 
rodentium ∆tir mutant all of the intracellular bacteria were homogenously labelled with Lamp1 
wheras the wild type had a sub-population associated with actin which was Lamp negative. 
These results demonstrate that intracellular pedestal formation by invasive A/E pathogens is a 
Tir dependent process.  
 
Figure  5.15. Tir is essential for the formation of intracellular pedestals. HeLa cells were infected for 1 h with 
C. rodentium and C. rodentium tir , before extracellular bacteria were killed with a gentamycin wash. The 
cells were then incubated for a further 16 h in the presence of gentamycin and fixed for immuno-fluorescence 
microscopy.  Actin was labeled with phalliodin (Red), Lamp1 was detected with a monoclonal antibody (Blue) 
and bacteria were detected with Dapi stain. C. rodentium formed intracellular pedestals whereas C. rodentium 
tir did not. 
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5.16 Internalised EPEC Bacteria can Replicate within Host Cells. 
 
The majority of intracellular bacterial pathogens have the ability to survive and replicate within 
host cells (Kumar and Valdivia, 2009). In order to determine if E110019 can replicate with host 
cells we infected HeLa cells for 90 min, killed extracellular bacteria with a gentamycin wash and 
then incubated the HeLa cells in the presence of gentamycin for a further 2, 8, 16 and 24 h. We 
found that the number of E110019 bacteria within host cells increased in a time dependent 
manner consistent with bacterial replication (Figure 5.16). The rate of replication observed for 
internalised E110019 was significantly lower than what has been previously reported for 
Salmonella or Shigella species. Furthermore, HeLa cells infected with E110019 for 8, 16 and 24 
h display a substantial amount of actin rich blebbing (Figure 5.16). However, the nuclei were not 
condensed and the cells do not display any other signs of apoptosis (Figure 5.16).  
In order to determine if the formation of intracellular pedestals by A/E pathogens plays a role in 
bacterial replication and survival within host cells we infected Swiss cells with wild type C. 
rodentium and C. rodentium ∆tir for 1.5 h and with E110019 for 30 min. Extracellular bacteria 
were then killed by a gentamycin wash and the cells incubated for a further 6, 12 or 24 h. We 
observed that both wild type C. rodentium and E110019 were capable of intracellular replication 
whereas the C. rodentium ∆tir mutant failed to replicate and instead exhibited a slow decline in 
bacterial numbers over time (Figure 5.16B). These results demonstrate that formation of 
pedestals by invasive A/E pathogens may play a functional role during intracellular survival. 
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Figure 5.16 (A) Internalized A/E pathogens survive and replicate in epithelial cells. HeLa cells were infected 
with E110019 for 30 min before the cells were washed with gentamycin to eliminate non invasive-bacteria. 
The cells were then incubated for 2, 8, 16 and 24 h in the presence of gentamycin. Cells were processed for 
immuno-fluorescence microscopy, bacteria were detected with Dapi (Dlue) and actin was labeled with 
phalliodin (Red). There was a time dependent increase in the level of intracellular bacteria. (B) Quantitative 
gentamycin protection assay of intracellular growth. HeLa cells were infected for 3 h with C. rodentium, C. 
rodentium tir and E110019 before extracellualr bacteria were eliminated with gentamycin. Cells were then 
incubated in the presence of gentamycin for 6, 12 or 24 h before the cells were lysed and plated for CFU 
counting. Results are representative of 3 independent experiments and are presents as mean ± SEM. 
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5.17 Discussion 
 
 
A/E pathogens have been long considered to be extracellular bacteria which do not invade 
mammalian cells (Celli et al., 2000). However, sporadic reports have shown that atypical EPEC 
strains can invade non-phagocytic cells (Donnenberg et al., 1989; Hernandes et al., 2008). The 
invasive ability has been linked to the adherence pattern and tight association of EPEC with the 
host cell membrane which is hypothesized to produce a passive push effect by which the intimate 
association of the bacteria with the host cell results in the formation of an invagination which of 
the membrane leading to internalization (Donnenberg and Kaper, 1992; Hernandes et al., 2008). 
In this chapter we have demonstrated for the first time that EPEC can actively invade non-
phagocytic cells by inducing formation of membrane ruffles, defining a new category of invasive 
EPEC. Furthermore, we demonstrate that this phenomenon is dependent on the T3SS effector 
EspT which we have shown activates Rac1 and Cdc42 (Bulgin et al., 2009).  
Intracellular pathogens have evolved a variety of mechanisms to promote invasion of 
mammalian cells, including the trigger (employed by Salmonella and Shigella) and zipper 
(employed by Yersinia and Listeria) mechanisms (reviewed in (Cossart and Sansonetti, 2004)). 
The trigger invasion mechanism is characterized by formation of actin rich membrane ruffles at 
the site of bacterial attachment, which are regulated by Rho GTPases, particularly Rac1 and 
Cdc42 and other cytoskeletal regulators such as PI3K (Ladwein and Rottner, 2008). Shigella and 
Salmonella utilize T3SS effector and translocator proteins such as IpgB1 and IpaC and SopB and 
SopE/2 to hijack host cell GTPase and phospho-inositol signaling to modulate membrane 
ruffling and formation of the macropinocytic pocket (Hardt et al., 1998; Ohya et al., 2005; Patel 
and Galan, 2006; Tran Van Nhieu et al., 1999). Importantly, although both IpgB1 and EspT 
belong to the WxxxE family of effectors and play a prominent role in bacterial invasion by 
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inducing membrane ruffles, we have recently shown that they activate Rac1 by distinct 
mechanisms (Bulgin et al., 2009).    
Downstream of Rho GTPase signaling, membrane ruffle formation is nucleated by the WASP 
superfamily proteins including N-WASP and Wave2. Salmonella invasion has been 
demonstrated to be at least in part dependent upon the Arp2/3 binding activity of Wave2 and also 
the association of Wave2 with Abi1 (Shi et al., 2005). Wave2 cannot bind Rac1 directly; two 
different mechanisms have been proposed to describe how a Wave2-Rac1 complex is formed. 
Innocenti et al and Steffen et al demonstrate that Wave2 binds to Abi1 and two accessory 
proteins PIR121 and Nap1 which mediate Rac1 binding (Innocenti et al., 2004; Steffen et al., 
2004). A report by Miki et al proposed that IRSp53 is the protein which links Rac1 to Wave2 
(Miki et al., 2000). In this study we demonstrate that EspT activation of Rac1 leads to a 
downstream recruitment of Wave2, Abi1 and IRSp53 to membrane ruffles. Depletion of 
endogenous Wave2 using siRNA resulted in a significant reduction in both the level of 
membrane ruffles induced by strains expressing EspT and their associated invasive capacity. We 
also show that the Arp2/3 and Abi1 binding regions of Wave2 are required for EspT-induced 
membrane ruffles. Furthermore, a construct of Wave2 which retained the IRSp53 and Arp2/3 
binding regions but lacked the Abi1 interacting domain had a dominant negative effect on 
membrane ruffle formation, suggesting that IRSp53 is not required for, but may play an 
accessory role in, EspT-mediated actin rearrangements. Additionally we demonstrate that 
inhibition of Rac1, depletion of Wave2 or expression of Wave2 constructs lacking the Arp2/3 or 
Abi1 binding regions abolishes the invasion capacity of EPEC strains expressing EspT.   
Once internalized Shigella and Listeria quickly escape the vacuole (reviewed in (Schroeder and 
Hilbi, 2008)). In contrast, Salmonella remains vacuole bound and utilizes different virulence 
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factors to modify the vacuolar environment, position and interaction with the host 
endomembrane system in order to create an intracellular replicative SCV (reviewed in (Steele-
Mortimer, 2008)). In this study we demonstrated that after invasion EPEC is bound within a 
vacuole (ECV) and remains vacuolated until at least 12 h post infection. We found that the ECV 
is EEA1 positive for up to 1 h post infection and progresses to being VATPase positive from 3 h 
to 12 h post infection and eventually becoming enriched in the lysosomal glycolprotein Lamp1. 
Furthermore, 12 h after infection the ECV appears to adopt a peri-nuclear position, which 
resembles the properties of the SCV. Importantly, we found that the ECV is associated with 
filamentous actin tails which are reminiscent of the actin-rich pedestals that are induced by 
extracellular adherent EPEC.  
Formation of extracellular pedestals is dependent upon the T3SS effector Tir (Kenny et al 1997). 
The interaction of Tir with intimin triggers recruitment of the mammalian adaptor Nck which in 
turn recruits and activates N-WASP leading to Arp2/3 recruitment and actin polymerization 
(Campellone et al., 2002; Gruenheid et al., 2001; Kenny et al., 1997; Lommel et al., 2001). In 
this study we found that internalized EPEC can translocate Tir to the vacuolar membrane in a 
T3SS dependent manner and that the localization of Tir can promote actin nucleation. 
Additionally, we found that a C. rodentium tir mutant is still invasive but does not form 
intracellular pedestals, demonstrating that pedestal formation by internalized bacteria is a Tir-
dependent process analogous to that of extracellular bacteria. Furthermore, using TEM we found 
that invasive EPEC bound within a vacuole are associated with intracellular pedestals around the 
circumference of the bacteria. Interestingly, membrane ruffles seen engulfing invading EPEC 
were occasionally associated with pedestals, suggesting the pedestals can be formed during or 
after internalization. 
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Canonically actin is recruited to the surface of intracellular pathogens which are non-vacuolated 
and this recruitment is mediated by outer-membrane proteins which are free to interact with host 
cell signaling molecules present in the cytoplasm. For example following escape from the 
vacuole Shigella and Listeria utilize IcsA/VirG and ActA, respectively, to trigger actin 
polymerization and motility (reviewed in (Cossart, 1995)). The Vaccinia virus uses the viral 
membrane protein A36R in order to generate actin based motility in a similar manner to the 
extracellular EPEC pedestals (Frischknecht et al., 1999). Importantly, the SCV is also associated 
with an actin nest which is required to maintain the integrity of the vacuole and support the 
intracellular replication of Salmonella (reviewed in (Guiney and Lesnick, 2005)).  
Due to the positioning of the actin extensions around the entire circumference of EPEC it is 
unlikely these intracellular pedestals are involved in classical actin-based motility. However, 
there are reports suggesting that actin polymerization and depolymerization around the periphery 
of E-cadherin-coated beads can lead to directional movement in process referred to as flashing 
(Yam and Theriot, 2004); for this reason at this stage we cannot rule out the possibility that 
intracellular pedestals confer actin based motility. Furthermore, formation of intracellular 
pedestals by invasive EPEC may play a role in maintaining the vacuole integrity in a similar way 
to that described for other vacuolated pathogens (Guiney and Lesnick, 2005). To the best of our 
knowledge the current study demonstrates for the first time that an intracellular bacteria is able to 
recruit filamentous actin comets to the pathogen cell surface whilst encapsulated in a vacuole. 
In order to survive within an intracellular niche vacuolated bacteria must evade host cell 
lysosome mediated degradation. In this study we provide evidence that internalised EPEC 
bacteria can survive and replicate for at least 24 h post infection. Furthermore, we also report that 
a C. rodentium ∆tir mutant was attenuated for intracellular replication. We propose that 
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formation of actin rich intracellular pedestals around the circumference of the ECV by invasive 
EPEC may constitute a physical barrier to lysosome fusion. A similar phenomenon has been 
described for the trafficking of endosomes and lysosomes to wounded sites of plasma membrane. 
At sites of plasma membrane disruption lysosomes and endosomes are recruited to seal the 
breach, this process is inhibited if the cortical actin meshwork is stabilized and enhanced when it 
is disrupted (Miyake et al., 2001). Similarly the lysosome dependent internalization of 
Trypanosoma cruzi requires a depolymerization of the cortical actin network to allow lysosome 
transit to the plasma membrane (Rodriguez et al., 1995). 
Recently, while screening ca. 1000 clinical EPEC and EHEC isolates we found that none of the 
EHEC strains and only 1.8% of the EPEC strains contain espT (Arbeloa et al., 2009). 
Interestingly, espT was found in EPEC E110019 which was linked to a particularly severe 
outbreak of gastroenteritis in Finland (Viljanen et al., 1990). E110019 was found to be 
particularly infectious and unusually for EPEC was associated with person to person spread and 
adult disease (Viljanen et al., 1990). Although we have no clinical data of the other espT positive 
isolates it is tempting to speculate that the expression of EspT could be at least in part 
responsible for the hyper virulence of the E110019 strain. Further studies of the invasive EPEC 
category are needed to assess the risk they pose to human health.   
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Chapter 6 – General Discussion 
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6.1 Attaching and Effacing Pathogens and the Eukaryotic Cytoskeleton  
 
Attaching and effacing bacteria are a group of related pathogens which mediate gastroenteritis 
and other more serious conditions such as hemolytic uremic syndrome (HUS) and hemorrhagic 
colitis (Kaper et al., 2004). The pathogenesis of A/E pathogens is dependent upon their tight 
adherence to the host cell gut epithelium and subsequent subversion of host cell signaling 
networks. Intimate adherence to host enterocytes and the modulation of eukaryotic cell processes 
by A/E pathogens is dependent upon their conserved T3SS. EPEC, EHEC and Citrobacter 
rodentium utilize their T3SS to translocate anywhere between twenty five to fifty effector 
proteins directly from the bacterial cell to the host cytosol. These effector proteins then interact 
with a plethora of eukaryotic proteins in order to usurp host cell signaling to mediate bacterial 
survival and proliferation. A common theme in A/E pathogen subversion of host signaling is the 
modulation of the eukaryotic cytoskeleton. Uniquely, A/E pathogens translocate their own 
receptor, Tir, into host cells (Kenny et al., 1997). Upon translocation to the cytoplasm, Tir is 
phosphorylated and targeted to the host cell plasma membrane where it acts as a docking 
receptor for the bacterial outer membrane adhesin intimin. The interaction between Tir and 
intimin results in a recruitment and activation of N-WASP either through the eukaryotic adaptor 
Nck or the bacterial T3SS effector TccP resulting in actin polymerization and the assembly of 
pedestal structures on which extracellular bacteria rest (reviewed in (Frankel and Phillips, 2008)) 
Interestingly, although TccP can bind and activates N-WASP directly it requires members of the 
IRSp53/MIM homology domain proteins in order to interact with Tir (Vingadassalom et al., 
2009; Weiss et al., 2009). Other A/E pathogen T3SS effectors such as EspG mediate the 
depolymerisation of microtubules and consequent formation of stress fibres (Matsuzawa et al., 
2004), EspL interacts with the eukaryotic protein annexin2 to mediate crosslinking of actin 
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(Miyahara et al., 2009) and TccP interacts with N-WASP to relieve its auto-inhibitory 
confirmation and allow actin polymerization (Cheng et al., 2008). Subversion of the eukaryotic 
cytoskeleton by T3SSs is not limited to the A/E pathogen effectors and is in fact utilized by an 
array of bacterial pathogens. Salmonella utilises the kinase SteC to aid in the formation of an F-
actin meshwork in proximity to the SCV (Poh et al., 2008), SipA enhances Salmonella invasion 
and vacuole maturation by both stimulating actin polymerisation and protecting already 
polymerized actin filaments from disassembly (McGhie et al., 2004) (Brawn et al., 2007). 
Another Salmonella effector SipC has been demonstrated to posses both actin nucleating and 
bundling properties (Hayward and Koronakis 1999). Similarly, Vibrio species translocate the 
effector VopL which contains homologs of eukaryotic actin binding domains which can mediate 
actin polymerization (Liverman et al., 2007). The Shigella translocator IpaC can mediate 
membrane ruffle formation via the subversion of eukaryotic Src kinase signaling (Mounier et al., 
2009; Tran Van Nhieu et al., 1999) to name but a few.  
6.2 Bacterial Pathogens and GTPases  
 
Small GTPases are a common target of bacterial toxins and effector proteins due to their pivotal 
role in eukaryotic cell biology (Etienne-Manneville and Hall, 2002). The Rho family of GTPases 
are fundamental regulators of the host cell cytoskeleton and as such act as an “achilles heel” 
which is often targeted by pathogens in order to promote adherence, invasion and evasion of the 
host immune response (Finlay, 2005). Some bacterial toxins modify GTPases by adding 
carbohydrate moieties or by chemically altering constituent amino acids in order to activate or 
inactivate small G proteins signaling (Aktories et al., 2000; Yarbrough et al., 2009). The T3SS 
effector YopT has been demonstrated to cleave the membrane retention sequences from active 
Rho GTPases in order to inhibit their function (Shao et al., 2002). Other T3SS effectors have 
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been shown to mimic Rho GTPase regulator factors including activating GEFs, Inactivating 
GAPs and Inhibitory GDIs (Fu and Galan, 1999; Hardt et al., 1998; Prehna et al., 2006). 
6.3 Evolution of the Mechanism of WxxxE Effectors 
 
In 2006 Alto and colleagues grouped 26 previously identified effectors into a family based on 
their conservation of a motif comprising an invariant tryptophan and glutamic acid residue 
separated by three variable amino acids (Alto et al., 2006). Alto et al also noted that several of 
the effector proteins within this group were capable of inducing phenotypes which were 
reminiscent of active Rho GTPases including IpgB2, IpgB1 and Map which induce the formation 
of stress fibres, membrane ruffles and filopodia respectively. In the same study the authors 
demonstrate formation of stress fibres by IpgB2 was independent of the activity of RhoA. 
Furthermore, it was found that IpgB2 was capable of binding the canonical GTP bound RhoA 
partners ROCK and mDia and activating the former in vitro. This led the authors to propose that 
WxxxE effectors act as functional mimics of Rho GTPases (Alto et al., 2006). This mechanism 
of WxxxE effectors was augmented by a report from Handa et al who provided evidence that the 
WxxxE effectors IpgB1 can mimic RhoG by binding its partner proteins ELMO and Dock180 
which act as a bipartite GEF of Rac1 (Handa et al., 2007). This mechanism differs from that 
proposed by Alto et al who suggested that IpgB1 would act as a functional mimic of Rac1.  
 In the current study we identify a family of IpgB2 homologues within the A/E pathogens which 
we have defined as the EspM family of effectors.  In contrast to the data reported in Alto et al., 
(Alto et al., 2006 ) for IpgB2, our results indicate that EspM triggered formation of stress fibres 
is dependent on RhoA. Furthermore, we have demonstrated that EspM proteins significantly 
activate RhoA when translocated into mammalian cells (Arbeloa et al., 2008). We also identified 
the novel effector EspT which induces membrane ruffles and lamellipodia similar to those 
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formed by expression of IpgB1. In an analogous manner to reliance of EspM proteins on RhoA 
to induce stress fibres we demonstrated that membrane ruffle and lamellipodia formation by 
EspT requires the activity of Rac1 and to a lesser extent Cdc42. Concurrently, we show that 
EspT activates both Rac1 and Cdc42. Interestingly, we report here that EspT can activate Rac1 
and form membrane ruffles and lamellipodia independently of ELMO or Dock180. Furthermore, 
we demonstrate that EspT mediated induction of actin protrusions is also independent of other 
canonical Rac1 activation pathways including typical mammalian GEFs, Src family kinases and 
PI3K (Bulgin et al., 2009). Together these results challenge the model by which WxxxE effector 
would act as functional mimics of Rho GTPases and lends weight to the hypothesis that WxxxE 
effectors stimulate the activity of endogenous Rho family GTPases. The fact that EspT can 
activate Rac1 independently of ELMO, Dock180, Src kinases and Pi3K further suggests that 
WxxxE mediated activation of Rho GTPases may be direct. 
In 2008 the structure of the WxxxE effector SifA was solved; interestingly it was demonstrated 
that the carboxy terminus of SifA which harbors its WxxxE motif adopts a fold which is similar 
to the bacterial Rho GEF SopE (Ohlson et al., 2008). Further characterisation of EspM family of 
proteins, in collaboration with Professors Steve Mathews and Susan Lea, demonstrated that 
EspM2 is capable of binding in a dose dependent manner to RhoA favoring its nucleotide free 
form. This interaction is similar to that of a mammalian GEF with its partner GTPases. In order 
to determine if EspM2 posses GEF activity we performed a nucleotide exchange assay on RhoA, 
Rac1, Cdc42 and H-Ras. We report that EspM acts specifically as a GEF of RhoA with only 
residual activity towards the other GTPases. The structure of EspM2 confirms that it too adopts 
an inverted V shape consisting of 6 alpha helixes which is similar to that of SopE (Arbeloa et al 
unpublished information). Several regions of EspM2 were found to move when in contact with 
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RhoA, one of these regions was predicted to be a flexible loop in an analogous position to the 
functional GAGA loop of SopE which is required for its nucleotide exchange activity. Although 
the regions do not share any sequence homology mutagenesis of the loop in EspM2 resulted in a 
severe attenuation of stress fibre formation (Arbeloa et al unpublished information). A study by 
Huang et al has also demonstrated that the WxxxE effector Map binds directly to Cdc42 in a 
SopE like conformation (Huang et al., 2009). In the same study it was also reported that IpgB1, 
IpgB2 and Map acts as GEFs of Rac1, RhoA and Cdc42 respectively (Huang et al., 2009). Thus 
it has become clear that rather than mimicking Rho GTPases WxxxE effectors act as GEFs. 
Interestingly, although there is very little sequence similarity between the WxxxE effectors and 
SopE their 3D structures are strikingly similar suggesting they have arisen through convergent 
evolution. The catalytically active loop is similarly positioned in SopE and the WxxxE effectors 
but is dissimilar in respect to its constituent residues. The flexible loop region of IpgB1, IpgB2, 
Map, EspT and the EspM are very well conserved the corresponding region of SifA is divergent 
from the other WxxxE effectors. Although SifA has been demonstrated to bind RhoA (Ohlson et 
al., 2008) we did not detect any GEF activity of SifA towards RhoA in the nucleotide exchange 
assay. This demonstrates that the interaction of WxxxE effectors with Rho GTPase can be 
uncoupled from their GEF activity and may represent a regulatory mechanism. Huang et al have 
also demonstrated that the variable β2-3 inter-switch region of the Rho GTPase determines the 
specificity of WxxxE effector binding (Huang et al., 2009), the authors also identified residues 
within alpha helix 4 and 6 of the WxxxE effectors which interact with the β2-3 region of Rho 
GTPases and are predicted to generate WxxxE effector GTPase targeting (Huang et al., 2009). In 
this study we report that conservative substitution of the WxxxE motif’s invariant tryptophan or 
glutamic acid residues, with tyrosine or aspartic acid respectively, allows retention of the 
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biological activity of EspM2. This data is in agreement with the positioning of the WxxxE motif 
within core region of  EspM2, SifA and Map (Huang et al., 2009) (Ohlson et al., 2008). The 
WxxxE motif contributes many hydrophobic interactions involved in stabilizing the catalytic 
loop and alpha helices 3, 4 and 6. In addition the conserved glutamic acid residue of the WxxxE 
motif contributes two hydrogen bonds to the interface of Map and the switch 2 region of Cdc42 
(Huang et al., 2009). 
6.4 Other Factors which Contribute to WxxxE Mediated Activation of 
GTPases 
 
Although the mechanism by which WxxxE effectors activate RhoA GTPases has now been 
elucidated there are still several open questions which need to be addressed. Although IpgB1 is 
capable of acting as a GEF in vitro it has been demonstrated that in a cellular environment it 
requires the ELMO-Dock180 complex for efficient formation of membrane ruffles (Handa et al., 
2007). We have also demonstrated that although EspT activity is independent of the ELMO-
Dock180 complex over-expression of ELMO in conjunction with translocation of EspT results in 
a shift from lamellipodia to membrane ruffle sin Swiss 3T3 fibroblasts. IpgB2 has been found to 
bind ROCK and mDia as well as acting as a GEF for RhoA (Alto et al., 2006). This may 
represent the formation of a tripartite complex between the WxxxE proteins, Rho GTPases and 
their downstream effctors which may have a role in enhancing or regulating the biological 
activities of the WxxxE effectors. The A/E pathogen effector Map has a C terminal PDZ binding 
domain which is required for its interaction with the membrane associated NHERF proteins 
(Simpson et al., 2006) (Berger et al., 2009). It is also interesting to note the presence of a CaaX 
motif at the C-terminus of SifA which is found in many host GTPases and is recognition site for 
host cell prenylation which is required for membrane anchoring (Boucrot et al., 2003). Together 
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these results suggest that there is a further layer of complexity in WxxxE effector signaling 
which is generated by additional interactions with cellular partners other than there cognate 
GTPases. These interactions may be required for the proper localization, regulation or cell line 
specific activities of WxxxE effectors.   
6.5 WxxxE Effectors Contribution to Pathogenesis 
 
The complete functional significance of WxxxE effectors in the virulence strategies of their 
respective pathogens is still relatively poorly understood. Several reports have demonstrated that 
WxxxE effectors can circumvent more than just the eukaryotic cytoskeleton. Map is trafficked to 
cellular mitochondria where it has been shown to induce a loss of membrane potential and to 
limit mitochondrial damage induced by other A/E pathogen T3SS effectors (Kenny et al., 2002; 
Papatheodorou et al., 2006).  A recent study has implicated IpgB2 in a signalling cascade which 
via activation of RhoA, RiP2 and ROCK results in an activation of NF-kB (Fukazawa et al., 
2008). SifA has been reported to induce the formation of membranous tubular filaments rich in 
lysosomal glycoproteins which are required for Salmonella intracellular replication and survival 
(Beuzon et al., 2000; Brumell et al., 2001; Stein et al., 1996). However, the most striking and 
apparent effect of the majority of WxxxE effectors is their GTPase dependent reorganisation of 
the actin cytoskeleton. Perhaps the most well studied example of cytoskeletal rearrangement in 
respect to virulence is the membrane ruffle formation induced by IpgB1. The entry of Shigella 
into non-phagocytic cells is largely dependent upon the trigger mechanism of invasion generated 
by the engulfment of bacteria by membrane ruffles induced by IpgB1 (Handa et al., 2007; Ohya 
et al., 2005). The membrane ruffle mediated engulfment of Shigella results in the formation of a 
maco-pinocytic pocket which leads to bacterial internalisation. Salmonella also utilises the 
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trigger mechanism of invasion which is mediated via the action of SopE1/2 effectors which act 
as GEFs of Rac1 and Cdc42 (Buchwald et al., 2002; Hardt et al., 1998; Patel and Galan, 2006).  
Attaching and effacing pathogens are generally considered to be extracellular pathogens 
although sporadic reports have linked then with invasion cultured cells in a passive adherence 
pattern dependent manner (Donnenberg et al., 1989; Hernandes et al., 2008). In this study we 
have identified the WxxxE effector EspT in C. rodentium, EPEC E110019 and a small 
percentage of atypical EPEC clinical isolates (Arbeloa et al., 2009; Bulgin et al., 2009). EspT has 
been demonstrated to activate Rac1 and Cdc42 to promote formation of membrane ruffles 
(Bulgin et al., 2009). Further characterisation of EspT, EPEC E110019 and C. rodentium in this 
study has revealed that EspT dependent subversion of host cell Rho GTPases and subsequent re-
organisation of the actin cytoskeleton facilitates invasion of A/E pathogens into eukaryotic cells. 
This shows for first time that EPEC and C. rodentium can invade host cells in a T3SS dependent 
manner.  Additional insights into the mechanism by which EspT mediated membrane ruffles and 
lamellipodia are formed revealed that Wave2 and its interacting partner Abi1 are essential 
downstream signalling proteins required for cytoskeletal organisation. These results demonstrate 
that the WxxxE effectors EspT and IpgB1 in addition to sharing mechanistic similarities also 
have a common role in the virulence strategies of their respective bacteria. It will prove 
interesting to carry out in vivo studies using C. rodentium in order to establish the contribution of 
EspT to virulence in an animal model of infection. 
6.6 EPEC as an Intracellular Pathogen 
 
Once internalised bacterial pathogens are contained within a membrane bound vacuole. The 
bacteria then either escape to the cytosol or remain within the vacuole (Kumar and Valdivia, 
2009). Intracellular pathogens such as Shigella and EIEC quickly escape from the initial 
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phagosome using components of their T3SS allowing them access to the mammalian cytoplasm 
(Cossart and Sansonetti, 2004). Once in the cytosol Shigella and EIEC species encode a protein 
called IcsA/VirG which directs recruitment of N-WASP which subsequently triggers actin 
polymerisation (Suzuki et al., 2002). This actin polymerisation at the surface of the bacteria 
facilitates movement and intracellular spread of the pathogens. In contrast Salmonella, 
Legionella and Mycobacterium species are examples of intracellular bacteria which remain 
encapsulated within a vacuole. These vacuoles are often extensively modified by the pathogens 
which are bound within them in order to promote bacterial survival and replication ((reviwed in 
Kumar and Valdivia, 2009)).   
The best studied example of an intracellular bacteria which resides within a vacuole is 
Salmonella. After invasion of host cells Salmonella translocates a plethora of T3SS effectors 
from two independent secretion apparatus which modify and direct the maturation of the 
Salmonella containing vacuole (SCV). The SCV matures from an early endosome like vacuole 
characterised by EEA1 and transferrin receptor enrichment, through intermediate stages 
characterised by Rab5, Rab7 and VATPase towards a late endosomal/lysosomal compartment 
which is marked by the lysosomal glycoproteins Lamp1 and Lamp2 (reviewed in (Steele-
Mortimer, 2008)).  Interestingly, although the SCV is associated with lysosomal proteins such as 
lamps it is rarely labelled Mannose 6-phosphate receptor or hydrolases which are also normally 
associated with degradative lysosomes (Garcia-del Portillo and Finlay, 1995). This data suggests 
that salmonella can inhibit the fusion of degradative lysosomes whilst recruiting other 
components of the endomembrane network. In this study we have demonstrated that after EspT 
mediated invasion, EPEC are also contained within a vacuole which we have termed ECV for 
EPEC containing vacuole. The ECV also matures in a similar pattern to the SCV moving from 
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an early endosome like structure to an intermediate VATPase rich compartment and a subgroup 
of ECVs also become enriched in lysosomal glycoproteins.  
 Although invasive EPEC encoding EspT were found to be vacuolated, we noted that the 
internalised bacteria were still associated with filamentous actin. As mentioned previously EPEC 
is generally considered to be an extracellular pathogen which intimately associates with host 
cells via the interaction between the bacterial outer membrane protein intimin and the T3SS 
effector protein Tir. Tir is translocated into the plasma membrane and acts as a receptor for 
intimin. Interaction between intimin and Tir results in a Tir mediated recruitment of the 
mammalian adaptor protein Nck which subsequently activates N-WASP resulting in actin 
polymerisation and the formation of pedestal like structures upon which extracellular bacteria 
rest. Further examination of the actin structures associated with the ECV demonstrated that Tir 
was present in the vacuolar membrane at sites of actin polymerisation, this suggests that 
intracellular EPEC can form pedestals in an analogous manner to extracellular bacteria. 
Transmission electron microscopy images confirmed that EPEC which are contained within a 
vacuole are capable of forming actin rich pedestals around the circumference of the bacteria. 
Furthermore, these images indicate that EPEC may form pedestals both during and after the 
internalisation process. This to the best of our knowledge is the first time an intracellular 
pathogen has been shown recruit actin to the bacterial surface across a vacuolar membrane. It has 
yet to be determined if internalised EPEC can utilise their intracellular pedestal to drive 
movement through the cytoplasm, although the presence of pedestals around the entire bacterial 
surface would seem to preclude with idea.  
After internalisation EPEC strains encoding EspT were found to remain bound within a vacuole 
for at least 24 hours post infection. Intracellular vacuolated pathogens must overcome a serious 
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of hurdles in order to successfully survive and replicate within the host cell including membrane 
and nutrient acquisition, avoidance of the host degradative lysosome fusion and maintenance of 
the vacuole.  
Upon closer examination we found that ECVs which had strong pedestal formation around the 
circumference of the vacuole were lamp negative whilst those which had irregular or weak actin 
polymerisation were lamp positive. We also often observed an accmulatuion of unfused lamp1 
rich vesicles in close proximity to ECVs which had strong actin staining. These results lead us to 
hypothesis that the dense actin network found in pedestals may constitute a physical barrier to 
lysosome fusion. The observation that a C. rodentim ∆tir mutant, which did not form 
intracellular pedestals, was attenuated for intracellular survival adds further weight to this theory.  
Similar physical inhibition of lysosome movement has been described in the cell cortex where 
the cortical actin meshwork must first be depolymerised to allow vesicle trafficking to the cell 
periphery (Miyake et al., 2001). Further work is required in order to establish other factors which 
may contribute to stability and longevity of the ECV.  
Maturation of the SCV is a highly dynamic and active process (Steele-Mortimer 2008) and so it 
is likely that EPEC factors which act downstream of internalisation may play a role in ECV 
maintenance and evolution. The fact that we observed Tir in the vacuolar membrane, which 
mediates the formation of intracellular pedestals, suggests that EPEC can traslocate T3SS 
effectors across the vacuolar membrane in an analogous manner to Salmonella. EPEC secretes 
several factors such as EspF, EspI and EspG which have been demonstrated to affect various 
aspects of vesicle trafficking  (Alto et al., 2007; Kim et al., 2007, Matsuzawa et al., 2004). It 
would be interesting to investigate further the role of these and other EPEC T3SS effectors on 
intracellular bacterial survival and replication as well as in the maturation of the ECV.  
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6.7 The distribution of EspM and EspT proteins 
 
The distribution of EspM proteins and EspT is markedly different, EspM appears to be relatively 
widespread whereas EspT is found only in a small percentage of strains. This suggests that while 
EspM proteins are established T3SS effectors, EspT may be an emerging virulence factor of A/E 
pathogens. However the fact that we found EspT in an outbreak strain first described in 1987 
may preclude this idea. Another possibility is that EspT is a remnant of a time when EPEC may 
have been an intracellular pathogen. The effect of EspM proteins and EspT on the virulence of 
A/E pathogen strains which harbour these WxxxE effector is not yet clearly defined. However, 
our results show that espM is found predominantly in the major EPEC and EHEC serogroups 
associated with severe disease outbreaks including: O26, O103, O111, O118, O145 and O157. 
These results suggest that espM is more commonly found in EPEC and EHEC serogroups that 
are linked to severe human infections. Due to the poor conservation of EspT in screened EPEC 
and EHEC strains it is difficult to ascertain the role of EspT in A/E pathogen infection at the 
current time. However, the presence of EspT in the E110019 strain which was linked with a 
particularly virulent outbreak of EPEC mediated gastroenteritis which uncharacteristically of 
EPEC infection was capable of person to person spread provides anecdotal evidence for a role of 
EspT during EPEC infection (Viljanen et al., 1990). This increase in infectivity and severity of 
infection attributed to this strain may be linked to the invasive qualities provided by EspT 
mediated actin rearrangements. Further work will be required on E110019 and other EspT 
positive strains in order to fully establish the role of EspT during EPEC infection.  
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6.8 Concluding Remarks 
 
In this study we have characterised two novel families of WxxxE effector proteins encoded by 
the A/E pathogen group. We have demonstrated that both EspM and EspT mediate the 
reorganisation of the host cell cytoskeleton in a GTPase dependent manner. Furthermore, we 
have shown that these novel WxxxE effectors activate host cell Rho GTPases in cells. Detailed 
examination of the mechanism by which EspM2 activates RhoA has demonstrates that EspM2 is 
able to bind and GEF RhoA. Additionally structural determination of an EspM2-RhoA complex 
has shown that EspM2 although sharing little homology with SopE (19% protein identity) adopts 
a similar fold to the Salmonella GEF effector. Mutagenesis of the putative catalytic loop of 
EspM2 which is similarly positioned to that of SopE led to a drastic reduction in the formation of 
stress fibres by EspM2. Similarly we demonstrate that EspT mediated activation of Rac1 and 
Cdc42 is independent of ELMO, Dock180, typical mammalian Rac1 GEFs, Pi3K and Src 
kinases. We also show that EspT mediated formation of membrane ruffles and lamellipodia 
facilitates the invasion of epithelial cells by EPEC strains which harbour this effector. This is the 
first time EPEC has been shown to mediate its own internalisation in a T3SS dependent manner. 
Furthermore, we describe for the first time the polymerisation of actin to a bacterial cell surface 
across a vacuolar membrane as internalised EPEC bacteria are capable of forming intracellular 
Tir dependent pedestals after and during EspT mediated uptake. Together these results increase 
the WxxxE effector protein repertoire of A/E pathogens and demonstrate novel functions of 
these effectors in EPEC virulence. Structural and functional analysis of EspM2 has also provided 
novel insights into the mechanism of action of WxxxE effectors. The role of EspT in mediating 
EPEC invasion of epithelial cells has contributed significantly to breaking the dogma of EPEC as 
strictly extracellular pathogens.  Further in vivo studies will be required in order to fully 
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determine the effects of EspM and EspT proteins in A/E pathogen virulence strategies. It will 
also prove interesting to investigate the role of these novel effectors in other cell lines such as 
polarised epithelial cells and macrophages. Finally a more stringent screening and examination 
of EspM and EspT positive strains is required in order to fully understand their contribution to 
the clinical outcome of disease caused by the A/E pathogens. 
In conclusion we have demonstrated that the novel A/E pathogen WxxxE effectors EspM and 
EspT are complex modulators of host cell GTPases which contribute to A/E pathogen virulence 
strategies by mediating a plethora of cellular signalling events particularly those associated with 
cytoskeletal re-arrangement.  
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Summary
Rho GTPases are common targets of bacterial toxins
and type III secretion system effectors. IpgB1 and
IpgB2 of Shigella and Map of enteropathogenic (EPEC)
and enterohemorrhagic (EHEC) Escherichia coli were
recently grouped together on the basis that they share
a conserved WxxxE motif. In this study, we character-
ized six WxxxE effectors from attaching and effacing
pathogens: TrcA and EspM1 of EPEC strain B171,
EspM1 and EspM2 of EHEC strain Sakai and EspM2
and EspM3 of Citrobacter rodentium. We show that
EspM2 triggers formation of global parallel stress
fibres, TrcA and EspM1 induce formation of localized
parallel stress fibres and EspM3 triggers formation of
localized radial stress fibres. Using EspM2 and EspM3
as model effectors, we report that while substituting
the conserved Trp with Ala abolished activity, conser-
vative Trp to Tyr or Glu to Asp substitutions did not
affect stress-fibre formation. We show, using domi-
nant negative constructs and chemical inhibitors, that
the activity of EspM2 and EspM3 is RhoA and ROCK-
dependent. Using Rhotekin pull-downs, we have
shown that EspM2 and EspM3 activate RhoA; translo-
cation of EspM2 and EspM3 triggered phosphorylation
of cofilin. These results suggest that the EspM effec-
tors modulate actin dynamics by activating the RhoA
signalling pathway.
Introduction
Colonization, invasion and transversion of mucosal sur-
faces are alternative strategies used by pathogenic bac-
teria to cause infectious diseases. Many Gram-negative
bacteria employ a type III secretion system (T3SS) to
inject effector proteins into the cytosol of their mammalian
host (reviewed in Galan and Wolf-Watz, 2006), which
facilitate their unique infection strategies. T3SS effectors
are targeted to different subcellular compartments and
affect diverse signalling pathways and physiological
processes. For example, enteropathogenic (EPEC) and
enterohemorrhagic (EHEC) Escherichia coli belong to a
family of medically important extracellular diarrhoegenic
pathogens (reviewed in Kaper et al., 2004) that colonize
the gut mucosa by the attaching and effacing (A/E)
mechanism (Knutton et al., 1987). EHEC and EPEC inject
dozens of T3SS effector proteins (Tobe et al., 2006),
including EspG and EspG2 which disrupt the microtubule
network which may lead to formation of stress fibres at
late stages of the infection via an indirect activation of
RhoA (Matsuzawa et al., 2004; Shaw et al., 2005), Map
which induces transient formation of filopodia (Kenny and
Jepson, 2000), Tir which triggers extensive localized actin
polymerization leading to formation of pedestal-shaped
structures under adherent bacteria (Kenny et al., 1997)
and TccP/EspFU which connects Tir to the actin cytoskel-
eton (Campellone et al., 2004; Garmendia et al., 2004).
The actin cytoskeleton (reviewed in Cossart and San-
sonetti, 2004) and Rho GTPases (reviewed in Jaffe and
Hall, 2005) are prominent targets of T3SS effectors
(Finlay, 2005). There are 22 Rho GTPases in man which
regulate various cellular processes, including actin poly-
merization, microtubule dynamics and cell cycle, morpho-
genesis and migration (reviewed in Jaffe and Hall, 2005).
GTPases act as molecular switches cycling between
GTP-bound (active) and GDP-bound (inactive) confor-
mations. Switching a GTPase on and off is mediated
by guanine nucleotide exchange factors (GEFs) and
GTPase-activating proteins (GAPs) respectively. The Rho
GTPases transmit signals in a GTP-dependent manner by
activating and/or recruiting downstream effector proteins
to their sites of action (reviewed in Jaffe and Hall, 2005).
Recently, Alto et al. (2006) assembled several known
T3SS effectors into a single family that share the common
motif Trp-xxx-Glu (WxxxE). This family includes the
Received 4 January, 2008; revised 21 February, 2008; accepted 21
February, 2008. *For correspondence. E-mail g.frankel@imperial.ac.
uk; Tel. (+44) 20 7594 5253; Fax (+44) 20 7594 3069. †These authors
are equal contributors.
Re-use of this article is permitted in accordance with the Creative
Commons Deed, Attribution 2.5, which does not permit commercial
exploitation.
Cellular Microbiology (2008) 10(7), 1429–1441 doi:10.1111/j.1462-5822.2008.01136.x
First published online 26 March 2008
© 2008 The Authors
Journal compilation © 2008 Blackwell Publishing Ltd
Salmonella effectors SifB and SifA, which is involved in
intracellular survival and replication by maintaining the
integrity of the Salmonella-containing vacuole (Beuzon
et al., 2000), the Shigella effectors IpgB2 and IpgB1,
which is involved in bacterial cell invasion (Ohya et al.,
2005), the EPEC and EHEC effector Map (Kenny and
Jepson, 2000) and the EPEC protein TrcA (bfpT-regulated
chaperone-like protein gene) (Tobe et al., 1999; Alto et al.,
2006). Although sharing no sequence homology with the
Rho GTPases, Alto et al. (2006) suggested that IpgB1,
IpgB2 and Map mimic, in a GTP-independent mechanism,
the activated form of Rac-1, RhoA and Cdc42 respectively.
It was shown that ectopic expression of IpgB2 induces
formation of new stress fibres, while IpgB2W62A and
IpgB2E66A were not biologically active; stress-fibre forma-
tion was RhoA-independent as IpgB2 was functional in the
presence of RhoA inhibitors (e.g. C3 botulinum toxin) or
dominant negative RhoAT19N. In addition, IpgB2 was shown
to directly stimulate the activity of Rho-associated kinase
(ROCK) and to interact with mDIA, two downstream effec-
tors of RhoA.
The completed and ongoing genome projects of the A/E
pathogens EHEC O157:H7 (strains Sakai and EDL933),
EPEC O127:H6 (strain E2348/69), EPEC O111:NM
(strain B171) and the mouse pathogen Citrobacter roden-
tium (strain ICC168) have revealed that the number of
T3SS effector proteins encoded by this family has been
greatly underestimated. A comprehensive study of the
T3SS repertoire of EHEC O157:H7 has shown that
among the dozens of T3SS effectors are two new putative
members of the WxxxE proteins, EspM1 and EspM2
(Tobe et al., 2006). Using Map and IpgB2 as index genes,
we identified additional putative WxxxE effectors in the
A/E pathogens, including EspM1 in EPEC B171 and
EspM2 and EspM3 in C. rodentium. The aim of this
study was to investigate the function and mechanism of
cell signalling triggered by the A/E pathogen WxxxE
effectors.
Results
Identification of novel WxxxE effectors in the A/E
pathogen group
EspM1 and EspM2 of EHEC O157 are putative WxxxE
effectors (Tobe et al., 2006), sharing 76% identity (Fig. 1).
EspM1 and EspM2 are closely related to the Shigella
WxxxE effector IpgB2 (40% and 41% identity respec-
tively) while sharing only 23% and 22% identity, respec-
tively, with Map of EPEC E2348/69 (Fig. 1).
In order to define the repertoire of WxxxE proteins in
EPEC strains E2348/69 and B171 and C. rodentium, we
searched their genomes using the BLAST algorithm with
IpgB2 and Map as index proteins. In EPEC B171, one
homologue, TrcA, had already been identified (Tobe et al.,
1999; Alto et al., 2006). Here we report an additional
putative WxxxE effector, EspM1 (Accession #: AM910623)
(Fig. 1), which is closely related to proteins encoded in the
LEE of rabbit EPEC and EHEC O103:H2. We demon-
strated that HA-tagged TrcA and EspM1 (B171) are
translocated in a T3SS-dependent mechanism (data not
shown). TrcA and EspM1 (B171) exhibit 41% and 46%
identity, respectively, with IpgB2 (Fig. 1). Importantly, the
BLAST searches revealed that EPEC E2348/69 harbours
no other functional WxxxE effector than Map.
Searching the C. rodentium ICC168 genome
sequence, we identified two putative WxxxE effectors,
EspM2 (Accession #: AM910622) and EspM3 (Accession
#: AM910621), which share 42% and 47% identity,
respectively, with IpgB2. Using a TEM-1-b-lactamase
fusion assay (Charpentier and Oswald, 2004), we dem-
onstrated that EspM2 (CR) and EspM3 are translocated
in a T3SS-dependent mechanism (data not shown).
BLAST hits that we did not follow up include one open
reading frame (ROD40861) that has a frame shift deletion
upstream of the WxxxE motif and a distantly related
IpgB2 homologue.
A radial phylogenetic tree, created based upon multiple
sequence alignment with hierarchical clustering (Corpet,
1988), showed that all the IpgB2-like A/E effectors indeed
cluster with IpgB2 and are distant from IpgB1 and Map
(Fig. 1B). The nomenclature of the A/E WxxxE effectors
was based on functional homology rather than sequence
identity (see below).
The WxxxE A/E effectors trigger formation of three
distinct actin stress fibre architectures
In order to determine if similarly to IpgB2, the EspM1,
EspM2, TrcA and EspM3 homologues can remodel actin in
the mammalian host cells, the genes were cloned into the
expression vector pSA10 (Schlosser-Silverman et al.,
2000) and expressed in wild-type EPEC E2348/69 (lacking
any of the IpgB2 homologues). Recombinant E2348/69
were used to infect serum-starved Swiss 3T3 cells, which
generally lack stress fibres (Fig. 2) and are capable of
dynamic actin signalling. Control infections with wild-type
EPEC E2348/69 (Fig. 2) or EPEC E2348/69 carrying the
empty pSA10 vector (results not shown) trigger efficient
Tir-dependent actin-rich pedestals, while stress fibres
were seen only in a small percentage of infected Swiss 3T3
cells (Fig. 2). In contrast, infection of Swiss 3T3 cells with
E2348/69 expressing EspM2 (Sakai) (Fig. 2) and EspM2
(CR) (data not shown) induced simultaneous formation of
actin pedestals and global parallel stress fibres (GP-SF),
which were on different focal planes. These stress fibres
were observed in c. 90% of cells after 1.5 h infection
(Fig. 2). Applying anti-HA antibodies, we could only detect
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diffuse cytosolic EspM2 staining (data not shown) while,
using vinculin antibodies, we observed intense distal stain-
ing of the GP-SF (Fig. 2), suggesting that the GP-SF
triggered by EspM2 are linked to the plasma membrane
through focal adhesions (Ziegler et al., 2006).
Infection of Swiss 3T3 cells with E2348/69 expressing
EspM1 (B171) (Fig. 2), EspM1 (Sakai) and TrcA (data not
shown) resulted in simultaneous formation of actin pedes-
tals and localized parallel stress fibres (LP-SF), which were
subtly different from those triggered by EspM2 as they
were confined to the site of bacterial adhesion (Fig. 2).
Inmunofluorescence using the anti-vinculin antibodies
revealed intense staining at the tip of each of the LP-SF
(Fig. 2). Swiss cells infected with wild-type B171 for 90 min
exhibited widespread stress fibres of the LP-SF morphol-
ogy alongside well-developed actin pedestals (data not
shown).
Infection of Swiss 3T3 with E2348/69 expressing
EspM3 (CR) resulted in simultaneous formation of actin
pedestals and stress fibres with vinculin-rich tips in c. 90%
of the cells at 1.5 h post infection (Fig. 2). EspM3 trig-
gered formation of a distinct architecture of localized
radial (3D) stress fibres (LR-SF) (Fig. 2); despite the local-
ized nature of the stress fibres, using anti-HA antibodies
we only observed a diffuse cytosolic EspM3 straining
(data not shown). To our knowledge, LR-SF have not
been previously described in an infection context, but are
reminiscent of cells treated with phorbal esters such as
TPA (Imamura et al., 1998).
The GP-SF, LP-SF and LR-SF appeared as soon as
30 min post infection and were stable for at least 3 h
(data not shown). In control experiments, Swiss 3T3
cells were infected with E2348/69DescN (T3SS mutant),
E2348/69Dmap, E2348/69Dtir and E2348/69DespG/
espG2 expressing EspM2 (Sakai). While no GP-SF or
actin pedestal structures were seen after infection with
the E2348/69DescN mutant, GP-SF and actin pedestals,
similar to those seen after infection with wild-type
E2348/69, were seen after infection with all other mutant
strains. In addition, ectopic expression of EspM2 in
transfected cells also triggers formation of GP-SF (data
not shown).
Fig. 1. The EspM WxxxE effector proteins in A/E pathogen group.
A. Multiple sequence alignment with hierarchical clustering of S. exneri IpgB2, EspM1 and EspM2 from EHEC O157:H7 Sakai, EspM2 and
EspM3 from C. rodentium (CR) and TrcA and EspM1 from EPEC B171. Similar and identical residues are highlighted in bright and dark grey
respectively. The conserved motif WxxxE is boxed. Conserved residues subjected to mutagenesis in this study are tagged with a star.
B. Radial phylogeny tree showing the subfamily of IpgB2-like WxxxE effectors in the A/E group, EPEC E2348/69 Map and Shigella IpgB1
and IpgB2.
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Taken together, these results illustrate that the A/E
EspM WxxxE effectors subvert actin dynamics and trigger
formation of GP-SF (EspM2), LP-SF (EspM1 and TrcA) or
LR-SF (EspM3). We selected EspM2 (Sakai) and EspM3
as model effectors for further study.
The effect of site-directed mutagenesis on the
activity of EspM2 and EspM3
The actin modulation activity of the WxxxE effectors Map,
IpgB1 and IpgB2 were previously shown to be dependent
Fig. 2. The EspM A/E effectors trigger
formation of actin stress fibres in infected
Swiss 3T3 cells.
A. Fluorescence microscopy of uninfected
Swiss 3T3 cell or cells infected for 90 min
with wild-type E2348/69 and E2348/69
expressing EspM2 (Sakai), EspM1 (B171)
and EspM3 (CR). Actin was stained with
Oregon green phalloidin, EPEC were detected
with rabbit anti-0127 antibody (merged
column) and vinculin was visualised using a
monoclonal mouse antibody. GP-SF, LP-SF
and LR-SF were observed in cell infected with
EPEC expressing EspM2, EspM1 and EspM3
respectively. All the recombinant strains also
induced formation of actin pedestals (insets).
B. Quantification of parallel and radial
stress-fibre formation in uninfected Swiss cells
or after 90 min infection with wild-type
E2348/69 and E2348/69 expressing EspM2
and EspM3. One hundred cells were counted
in triplicate in three independent experiments.
Results are presented as mean  SEM.
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on their invariant WxxxE motif (Alto et al., 2006). To deter-
mine if this is also true for EspM2 and EspM3, the
conserved residues W70 and W66, respectively, were
substituted by Ala. Swiss cells infected with E2348/69
expressing EspM2W70A and EspM3W66A triggered actin-rich
pedestals with no evidence of GP-SF or LP-SF respec-
tively, and were indistinguishable from cell infected with
wild-type E2348/69 (Fig. 3). Conversely, conservative sub-
stitution of the Trp and Glu residues with a Tyr and Asp,
respectively, did not result in any significant loss of stress-
fibre formation (Fig. 3). These substitutions did, however,
produce a shift in the architecture of stress fibres induced
by EspM3 from a LR-SF morphology to a LP-SF arrange-
ment. In addition, we mutated additional conserved resi-
dues located within the core region of the WxxxE effectors
(Fig. 1). Mutagenesis of L114, D115 and H125 of EspM3 to
Ala also resulted in a similar conformational change in the
stress fibres (data not shown). Mutagenesis of other con-
served residues within this group of effectors in EspM3
(Fig. 1) did not have any significant effect on stress-fibre
formation or morphology (data not shown).
EspM2 and EspM3 activate RhoA
The formation of actin stress fibres in eukaryotic cells is
regulated by the GTP-binding protein RhoA (Jaffe and
Hall, 2005). However, IpgB2 has been shown to trigger
formation of stress fibres through a mechanism which is
independent of RhoA (Alto et al., 2006). In order to deter-
mine whether formation of GP-SF or LR-SF by EspM2
Fig. 3. Effect of site-directed mutagenesis on stress-fibre formation.
A. Merged fluorescence microscopy of Swiss 3T3 cells infected for 90 min with primed E2348/69 expressing EspM2 (Sakai) and EspM3 (CR)
derivative mutants within the conserved WxxxE motif. Actin was stained with Oregon green phalloidin and EPEC were detected with rabbit
anti-0127 antibody.
B. Quantification of stress-fibre formation in Swiss cells after 90 min infection. One hundred infected cells were counted in triplicate from three
independent experiments. Results are presented as mean  SEM.
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and EspM3 is dependent on activation of small Rho
GTPases, we transfected Swiss cells with dominant nega-
tive Cdc42N17, Rac1N17 and RhoAN19 (which competitively
and specifically inhibit activation of the small GTPases).
Infection of transfected cells with E2348/69 expressing
EspM2 or EspM3 for 1.5 h revealed that formation of
GP-SF and LR-SF, respectively, was not affected by inac-
tivation of Cdc42 or Rac1 (Fig. 4A and B). In contrast,
infection of cells expressing RhoAN19 resulted in formation
of typical actin-rich pedestals, but with a marked reduction
in formation of GP-SF or LR-SF respectively (Fig. 4A and
B). This suggests that, unlike IpgB2, formation of stress
fibres by EspM2 and EspM3 is RhoA-dependent.
In order to determine if EspM2 and EspM3 activate
RhoA, we performed pull-down assays using GST-
Rhotekin, which specifically binds the active GTP-bound
form of RhoA. Cells incubated with 20 mM nocodazole,
which destabilizes microtubules (DeBrabander et al.,
1976), for 40 min (data not shown), were used as a posi-
tive control and cell infected with wild-type E2348/69 were
used as negative control. Swiss 3T3 cells infected with
E2348/69 expressing EspM2 or EspM3 exhibited a sig-
nificantly higher level of activated RhoA compared with
cells infected with the wild-type E2348/69 (Fig. 4C).
These results suggest that formation of GP-SF and LR-SF
is dependent on RhoA signalling.
EspM2 and EspM3 stimulate the Rho-ROCK pathway
The p160 Rho-associated coiled-coil-containing protein
kinase (ROCK) is one of the main RhoA downstream
effectors which mediates the formation of stress fibres
(Jaffe and Hall, 2005). To determine if EspM2 and EspM3
activate the RhoA-ROCK pathway, Swiss 3T3 cells were
incubated with the ROCK inhibitor Y-27632 for 1 h prior to
infection with E2348/69 expressing EspM2 or EspM3.
Y-27632 is a highly specific inhibitor of ROCK-I and
ROCK-II which competitively excludes ATP from the cata-
lytic site (Yamaguchi et al., 2006). Pre-incubation with
Y-27632 completely blocked formation of GP-SF and
LR-SF by EspM2 and EspM3 respectively (Fig. 5). The
ROCK inhibitor did not affect formation of actin-rich
pedestals.
LIM kinase (LIMK) is downstream effector of ROCK
which is involved in stress-fibres formation (Jaffe and Hall,
2005). It has been shown that phosphorylation of the
LIMK by ROCK and the consequent inactivation (by phos-
phorylation) of cofilin by LIMK contribute to Rho-induced
formation of stress fibres (Maekawa et al., 1999). We
examined the phosphorylation state of cofilin by immuno-
blot following infection of Swiss cell with E2348/69
expressing EspM2 or EspM3. When compared with unin-
fected or cells infected with the wild-type E2348/69,
higher level of phospho-cofilin was observed after trans-
location of EspM2 or EspM3 (Fig. 5). These results
suggest that EspM2 and EspM3 trigger stress-fibre for-
mation through the RhoA-ROCK-LIMK-cofilin pathway.
Discussion
In 2006, Alto et al. (2006) assembled several known T3SS
effectors into a single family that share the common motif
Trp-xxx-Glu (WxxxE). They suggested that IpgB1, IpgB2
and Map (the founder WxxxE effectors) mimic, in a GTP-
independent mechanism, the activated form of Rac-1,
RhoA and Cdc42 respectively. In this study, we report the
discovery and characterization of an array of T3SS effec-
tor proteins in A/E pathogens which belong to the WxxxE
family. These new effectors share a high degree of homol-
ogy with each other (47–86% identity) and with the Shi-
gella effector IpgB2 (40–47% identity).
The founder WxxxE effectors are potent modulators of
the host actin cytoskeleton (Kenny et al., 2002; Alto et al.,
2006; Handa et al., 2007). In order to determine if the new
proteins we studied are true WxxxE effectors that can
subvert actin dynamics, we utilized EPEC EPEC234/69
as a vehicle for protein translocation into Swiss cells.
EPEC234/69 is a suitable host as it only harbours the
WxxxE effector Map, which induces transient filopdia at
early time points post infection (Kenny and Jepson, 2000).
Using this infection model, we demonstrated that overex-
pression of EspM1, EspM2, EspM3 and TrcA in EPEC
E2348/69 triggers formation of stress fibres, related to
those induced by the Shigella effector IpgB2 (Alto et al.,
2006). Importantly, the stress fibres triggered by these
WxxxE effectors had distinct architectures. Although the
EspM homologues were expressed from isogenic plas-
mids, we cannot exclude the possibility that differences
in expression levels or translocation efficiency might con-
tribute to their distinct stress fibre morphologies which
appear as GP-SF throughout the cell cytosol for EspM,
and LP-SF restricted to the site of bacterial attachment in
the case of EspM1 and TrcA. Most striking was the phe-
notype associated with translocation of EspM3, which
induced formation of LR-SF, which are reminiscent of the
phenotypes linked to constitutively active Rho Kinase and
phobal ester treatment such as TPA (Imamura et al.,
1998). To our knowledge, this is the first time that such a
phenotype has been described in an infection context.
Despite the global and localized stress fibres triggered by
EspM2 and EspM1 and EspM3, respectively, all proteins
were found diffusely in the cytsol. Vinculin was found at
the tip of the WxxxE effector-triggered stress fibres, sug-
gesting that they are linked to the plasma membrane via
focal adhesion. The molecular basis for the different
stress fibre architectures triggered by EspM1, EspM2,
EspM3 and TrcA is not currently known. Of note is the fact
that TrcA (bfpT-regulated chaperone-like protein gene)
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Fig. 4. Stress-fibre formation by EspM2 and EspM3 is RhoA-dependent.
A. Swiss 3T3 cells were transfected with dominant negative GTPase contracts 24 h prior to infection with E2348/69 expressing EspM2.
Actin was stained with Oregon green phalloidin, the Myc-tagged GTPases with mouse anti-myc and EPEC with rabbit anti-O127. Actin-rich
pedestals are observed under adherent bacteria in all transfected cells. GP-SF are observed, at the level of mock transfection, in cells
transfected with dominant negatives Cdc42N17 or Rac1N17. In contrast, transfection with RhoN19 inhibited formation of GP-SF.
B. Quantification of stress-fibre formation in transfected Swiss 3T3 cells infected for 90 min with E2348/69 expressing EspM2 or EspM3.
Formation of stress fibres in one hundred transfected infected cells were counted in triplicate from three independent experiments. Results are
presented as mean  SEM. Formation of stress fibres depending on EspM2 or EspM3 is affected by expression of RhoAN19, but not by
expression of Cdc42N17 or RacN17.
C. Swiss 3T3 cells were infected with wild-type E2348/69 or E2348/69 expressing EspM2 or EspM3. Cells were lysed and a GST fusion of the
Rho binding domain of Rhotekin was used to co-purify RhoA-GTP. Total RhoA in the lysates and RhoA-GTP were detected by Western blot
with anti-RhoA antibodies. Quantified data are means  SD of the results of three independent experiments.
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was originally reported to bind the pilin protein BfpA and
the outer membrane adhesion intimin (Tobe et al., 1999),
suggesting that the TrcA might have a role in the bacterial
cytosol prior to translocation into the host cell.
As EspM2 and EspM3 trigger the two extreme stress
fibre phenotypes, they were chosen for detailed functional
analysis. We confirmed that the GP-SF and LR-SF trig-
gered by EspM2 and EspM3 are dependent on the con-
served WxxxE motif via substitution of the conserved Trp
with an Ala. However, using conservative substitutions,
Tyr and Asp for the Trp and Glu, respectively, we did not
observe any significant loss in biological activity. Translo-
cation of EspM2 YxxxE and EspM2 WxxxD resulted in
global stress-fibre formation, while translocation of EspM3
YxxxE and WxxxD resulted in formation of mainly LP-SF
as compared with the LR-SF observed in the wild-type
phenotype. The reason for the change of morphology
observed for EspM3 YxxxE and WxxxD is currently not
known.
These results suggest that the biological activity of the
WxxxE proteins is not reliant upon the presence of
the conserved tryptophan or glutamic acid, but rather the
presence of a bulky aromatic residue and an amino acid
carrying a carbocylic acid side group. Carboxylic side
groups are involved in a range of biological functions such
as protease activity (Kakudo et al., 1992) and interactions
particularly with positively charged moieties such as metal
ions.
Fig. 5. EspM2 and EspM3 trigger the ROCK-LIMK-cofilin pathway.
A. Fluorescence microscopy of Swiss 3T3 cells incubated for 1 h in presence or absence of 10 mM of the ROCK inhibitor Y-27632 and
infected for 90 min with E2348/69 expressing EspM2 or EspM3. Y-27632 did not affect formation of actin-rich pedestals, but abolished
formation of stress fibres.
B. Percentage of Swiss 3T3 cells presenting stress fibres in the presence or absence of Y-27632. One hundred cells were counted in triplicate
from three independent experiments. Results are presented as mean  SEM.
C. Swiss 3T3 cells were infected for 90 min with wild-type E2348/69 or E2348/69 expressing EspM2 or EspM3. The levels of cofilin and
phospho-cofilin were determined by Western blot using anti-cofilin and anti-phospho-cofilin antibodies. Quantification of densitometry was
conducted using image J software and results presented here represent the mean ratio  SD of four independent experiments.
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Further alanine substitutions of conserved residues did
not abolish stress-fibre formation, suggesting that none of
the selected residues on their own, other than the Typ and
Glu, are essential for function. Structural data will be
essential in order to gain further insights into the mecha-
nism by which the conserved motif and surrounding resi-
dues lead to formation of the plethora actin structures
associated with this family of effector proteins.
Using specific E2348/69 mutants, we have shown that
stress-fibre formation was dependent on type III secretion
but independent of other T3SS effectors, including Map,
Tir, and EspG and EspG2. The later two were shown to
induce late RhoA-dependent stress fibres by liberation of
an active form of the RhoA-specific GEF, GEF-H1, as a
result of disruption of the host cell microtubule network
(Matsuzawa et al., 2004). This EspG activity might repre-
sent the small percentage (15%) of stress fibre seen in
Swiss cells infected with wild-type E2348/69. The fact that
EspM2 is necessary and sufficient for stress-fibre forma-
tion is supported by the fact that transfection of EspM2
into HeLa cells resulted in formation of characteristic
GP-SF (data not shown).
The Ras superfamily of the small GTPases is the target
of many bacterial effectors and toxins because of its role
in the control of a wide range of cellular processes includ-
ing cytoskeletal dynamics, membrane trafficking and
growth. Several T3SS effectors, such as YopT from Yers-
inia spp., are known to directly modify the small GTPases
(Wong and Isberg, 2005; Fueller et al., 2006). Other effec-
tors can either modify or mimic GEFs or GAPs (Finlay,
2005). Although sharing no sequence homology with the
Rho GTPases, Alto et al. (2006) suggested that IpgB1,
IpgB2 and Map mimic, in a GTP-independent mechanism,
the activated form of Rac1, RhoA and Cdc42,
respectively. They showed that stress-fibre formation was
RhoA-independent as IpgB2 was functional in the pres-
ence of RhoA inhibitors (e.g. C3 botulinum toxin) or domi-
nant negative RhoAT19N. Moreover, it was shown that
IpgB2 interacts with two of the major effectors of RhoA,
namely mDIA and ROCK, activating the latter directly.
Alto et al. (2006) reported that transfection of IpgB1
stimulated formation of actin-rich membrane ruffles at the
dorsal cell surface, which resembled membrane ruffles
induced by Rac-1. Dorsal ruffles were not produced by
IpgB1E80A.A recent study by Handa et al. (2007) has shown
that IpgB1 mimics RhoG and triggers membrane ruffling by
binding ELMO and recruiting the ELMO–Dock180 complex
to the membrane where it functions as a GEF for Rac1.
In this investigation, we found that EspM2 and EspM3
activate RhoA. Using dominant negative RhoAT19N, we
observed a 60% and 40% reduction in stress-fibre forma-
tion after infection of Swiss cell with E2348/69 expressing
EspM2 and EspM3 respectively. In agreement with Alto
et al. (2006), using the specific ROCK inhibitor Y27632,
we showed that the stress fibres induced by EspM2 and
EspM3 are totally dependent upon ROCK activity. Con-
sistent with this, we have shown that EspM2 and EspM3
trigger phosphorylation of cofilin, a classical downstream
ROCK target. Although our data do not exclude the pos-
sibility that EspM2 and EspM3 are capable of mimicking
RhoA to some degree, these effectors appear to contrib-
ute to stress-fibre production by activating endogenous
RhoA. Alternatively, as was recently shown for IpgB1
(Handa et al., 2007), EspM might mimic GTPases
upstream of RhoA activation. Further studies are needed
to determine the mechanism of RhoA activation by EspM.
Experimental procedures
Bacterial strains, growth conditions and cell culture
The bacterial strains used in this study are listed in Table 1.
Bacteria were grown from single colonies in Luria–Bertani (LB)
broth in a shaking incubator at 37°C or maintained on LB plates.
Culture media was supplemented with Ampicillin (100 mg ml-1) as
appropriate.
Bacterial cultures were primed prior to infection by growth in
Dulbecco’s modified Eagles media (DMEM) with 4500 mg ml-1
glucose supplemented with 1% mannose for 3 h (Collington et al.,
1998) before addition of 1 mM IPTG to induce protein expression.
Swiss NIH 3T3 cells were maintained in DMEM with
4500 mg ml-1 glucose and supplemented with 10% fetal calf
serum (Gibco) and 4 mM Glutamax (Gibco).
Bioinformatics
A PSI-BLAST search (Altschul et al., 1997) was performed under
default conditions using IpgB2 from Shigella flexneri
Table 1. List of strains.
Strain Description Source/reference
E2348/69 Wild-type EPEC O127:H6 Levine et al. (1978)
ICC168 C. rodentium Barthold et al. (1976); Wiles et al. (2004)
EHEC Sakai Wild-type EHEC O157:H7 (RIMD 0509952) Hayashi et al. (2001)
EPEC B171 Wild-type EPEC O111:NM Riley et al. (1987)
ICC192 EPEC E2348/69DescN Garmendia et al. (2004)
ICC202 EPEC E2348/69Dmap Simpson et al. (2006)
ICC225 EPEC E2348/69Dtir Bai et al. (2008)
ICC243 EPEC E2348/69DespG-espG2 Marchès et al. (2008)
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(gi:13448971) and Map from EPEC (gi:2865296) as query
sequence to search the latest version of the NCBI NR database
and combined with a library of peptide sequences derived from all
coding sequences  50 codons in length from the genome
sequences of C. rodentium ICC168, EPEC B171 and EPEC
E2348/69.
Multiple alignment and phylogenetic analysis of
WxxxE effectors
Using the sequence alignment program Multalign, a radial phy-
logenetic tree was constructed based upon hierarchical cluster-
ing of the global sequence homology of the A/E pathogen group
WxxxE proteins and IpgB1 compared with that of IpgB2. Protein
sequences identified in the BLAST search that did not show near
full-length homology to other EspM proteins were excluded from
further analysis on the grounds that they are likely to represent
non-functional pseudogenes.
Plasmids and molecular techniques
Plasmids used in this study are listed in Table 2; primers are
listed in Table 3. The genes encoding effector proteins were
amplified by PCR from genomic DNA and cloned into pSA10 with
a C-terminal HA tag. espM2 and espM1 genes were amplified
from EHEC O157:H7 strain Sakai, trcA and espM1 genes were
amplified from EPEC O111:NM strain B171 and espM2 and
espM3 genes were amplified from C. rodentium. All constructs
were verified by DNA sequencing.
The mammalian expression vector pRK5 containing one of
RhoN19, RacN17 or Cdc42N17 dominant negatives used in the trans-
fection assays was a gift from Nathalie Lamarche-Vane.The
vector pGEX expressing the binding domain of Rhotekin fused to
GST was a gift from J. Bertoglio.
Site-directed mutagenesis
Site-directed mutagenesis was carried out using a Quickchange
II kit (Stratagene) according to the manufacturer’s instructions.
Primers were designed using the Quickchange mutagenic primer
design program (Stratagene). Plasmids pSA10 containing
espM1, espM2, espM3 and trcA were used as templates for the
mutagenic reactions. Colonies were screened by sequencing
and alignment to wild-type sequences to confirm mutagenesis.
Infection of Swiss 3T3 cells with EPEC E2348/69
Forty-eight hours prior to infection, Swiss 3T3 cells were seeded
onto glass coverslips at a density of approximately 5 ¥ 105 cells
per well and maintained in DMEM 4500 supplemented with 10%
FCS at 37°C in 5% CO2. Three hours before infection, the cells
were washed three times with PBS and the media replaced with
fresh DMEM 4500 without FCS supplemented with 1% mannose.
Overnight cultures of the appropriate bacteria were inoculated
1:50 into DMEM and primed as described previously (Collington
et al., 1998). Five hundred microlitres of primed bacteria was
added to the wells and infections were carried out at 37°C in 5%
CO2 for 1.5 h.
Transfection
Swiss 3T3 cells were transfected with the mammalian expression
vector pRK5 containing one of RhoAN19, RacN17 or Cdc42N17
dominant negatives fused to a Myc tag by lipofectamine2000
(Invitrogen) according to the manufacturer’s recommendations.
The cells were incubated at 37°C in a humidified incubator with
5% CO2 for 24 h, washed twice in PBS before having their media
replaced with DMEM as described previously. Transfected cells
were infected with the appropriate strain as described above.
Table 2. List of plasmids.
Name Description Reference
pSA10 pKK177-3 with Lacq Schlosser-Silverman et al. (2000)
pICC398 pSA10::espM2 from O157:H7 Sakai fused to HA This study
pICC399 pSA10::espM3 from C. rodentium ICC169 fused to HA This study
pICC400 pSA10::espM2 from C. rodentium ICC169 fused to HA This study
pICC401 pSA10::espM1 from O157:H7 Sakai fused to HA This study
pICC402 pSA10::trcA from O111:NM B171 fused to HA This study
pICC403 pSA10::espM1 from O111:NM B171 fused to HA This study
pICC404 pSA10::espM2-W70A fused to HA This study
pICC405 pSA10::espM2-W70Y fused to HA This study
pICC406 pSA10::espM2-E74D fused to HA This study
pICC407 pSA10::espM3-W66A fused to HA This study
pICC408 pSA10::espM3-W66D fused to HA This study
pICC409 pSA10::espM3-S9A + S12A fused to HA This study
pICC410 pSA10::espM3-L114A fused to HA This study
pICC411 pSA10::espM3-D115A fused to HA This study
pICC412 pSA10::espM3-H125A fused to HA This study
pICC413 PSA10::espM3-K149A fused to HA This study
pDEST53::espM2 Invitrogen, This study
pRK5::myc-rhoAN17 Pelletier et al. (2005)
pRK5::myc-rac1N17 Pelletier et al. (2005)
pRK5::myc-cdc42 N17 Pelletier et al. (2005)
pGex::gst-RBD Sander et al. (1999)
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Immunofluorescence staining and microscopy
Coverslips were washed three times in PBS and fixed with 3%
Paraformaldehyde for 15 min before washing three more times in
PBS. For immunostaining, the cells were permeabilized for 5 min
in PBS 0.5%/Triton X-100, washed three times in PBS and
quenched for 30 min with 50 mM NH4Cl. The coverslips were
then blocked for 1 h with PBS/0.5% BSA before incubation with
primary and secondary antibodies. The primary antibody Mouse
aVinculin (Abcam) and mouse anti-Myc (Millipore) were used at
a dilution of 1:200, while Rabbit aO127 was used at a dilution of
1:150. Coverslips were incubated with the primary antibody for
1 h, washed three times in PBS and incubated with the second-
ary antibodies. Donkey anti-rabbit IgG conjugated to a Cy5
fluorophore or Donkey anti-mouse IgG conjugated to a Cy3 fluo-
rophore (Jackson laboratories) was used at a 1:200 dilution. Actin
was stained using Oregon Green phalloidin (Invitrogen) at a
1:100 dilution. All dilutions were in PBS/0.5% BSA. Coverslips
were mounted on slides using ProLong Gold anti-fade reagent
(Invitrogen) and visualized by Zeiss Axioimager immunofluores-
cence microscope (100¥ objective giving a total magnification of
1000¥) using the following excitation wavelengths: Cy3 –
605 nm, Cy5 – 690 nm and Oregon Green – 525 nm. All images
were analysed using the Axiovision Rel 4.5 software and trimmed
to 5 cm2 (300 pixels) using Adobe photoshop.
Chemical inhibition of ROCK activity
Coverslips were set up for infection as described above. One
hour prior to infection, Y-27632 (Sigma) was added to cells to
attain a final concentration of 10 mM per well. Coverslips were
infected and processed for immunofluorescence.
Quantification of cofilin phosphorylation
Forty-eight hours prior to infection, Swiss 3T3 cells were seeded
onto 6-well plates to attain confluent monolayer. Each well was
infected as described above. After a 1.5 h infection, cells were
lysed by addition of 4¥ protein SDS-PAGE loading buffer. The
lysate was harvested and heated at 100°C for 5 min before
loading in duplicate onto a 12% SDS-PAGE gel. The proteins
were then transferred to PVDF by wet transfer. The PVDF mem-
Table 3. List of primers.
Primer Sequence
EspM3-S9A_S12A-F 5′-ccagtgaatgttcaaggtttagcttttaatgcttttggtatcagctgccatc-3′
EspM3-S9A_S12A-R 5′-gatggcagctgataccaaaagcattaaaagctaaaccttgaacattcactgg-3′
EspM3-W66A-F 5′-gcagagtactaaagatattgatggagcgataaaagatgaacagaaagtgtat-3′
EspM3-W66A-R 5′-atacactttctgttcatcttttatcgctccatcaatatctttagtactctgc-3′
EspM3-H125A-F 5′-ggagcagctcaaagctccatcaatgctatgataataggaaatggtt-3′
EspM3-H125A-R 5′-aaccatttcctattatcatagcattgatggagctttgagctgctcc-3′
EspM3-Y188F-F 5′-gtatgattcctcgttatatgaggtttgctatatcgctgtacc-3′
EspM3-Y188F-R 5′-ggtacagcgatatagcaaacctcatataacgaggaatcatac-3′
EspM3-D115A-F 5′-ttatggcctggaacttgcttctggagcagctcaaa-3′
EspM3-D115A-R 5′-tttgagctgctccagaagcaagttccaggccataa-3′
EspM3-L114A-F 5′-tttcaaagcattatggcctggaagctgattctggagcagc-3′
EspM3-L114A-R 5′-gctgctccagaatcagcttccaggccataatgctttgaaa-3′
EspM2Cr-W66A-F 5′-ggcagagcactaaagatcttttagcagcgaaaaaagatgaaaaagtaatttatc-3′
EspM2Cr-W66A-R 5′-gataaattactttttcatcttttttcgctgctaaaagatctttagtgctctgcc-3′
EspM2Cr-H125A-F 5′-gcccgctcagcacaaagttctataaatgctatcataaccggaaa-3′
EspM2Cr-H125A-R 5′-tttccggttatgatagcatttatagaactttgtgctgagcgggc-3′
EspM3-K149A-F 5′-cgaggggatgaccaggaatgtagcaaatcatacatcagattacatg-3′
EspM3-K149A-R 5′-catgtaatctgatgtatgatttgctacattcctggtcatcccctcg-3′
EspM3-W66Y-F 5′-gcagagtactaaagatattgatggatatataaaagatgaacagaaagtgtatcc-3′
EspM3-W66Y-R 5′-ggatacactttctgttcatcttttatatatccatcaatatctttagtactctgc-3′
EspM3-E70D-F 5′-tgatggatggataaaagatgatcagaaagtgtatccatcaagg-3′
EspM3-E70D-R 5′-ccttgatggatacactttctgatcatcttttatccatccatca-3′
EspM2-W70Y-F 5′-gcagagtactaaagatattgatgagtatataaaagatgaacggatagtatatcc-3′
EspM2-W70Y-R 5′-ggatatactatccgttcatcttttatatactcatcaatatctttagtactctgc-3′
EspM2-E74D-F 5′-taaagatattgatgagtggataaaagatgatcggatagtatatccctc-3′
EspM2-E74D-R 5′-gagggatatactatccgatcatcttttatccactcatcaatatcttta-3′
EspM1-pKK-F 5′-ttgaattcatgccagtaaatgcgacagg-3′
EspM1-pKK-R 5′-ccaatgcactgcagttaagcgtagtctgggacgtcgtatgggtacccctgtataacacgactca-3′
EspM2-pKK-F 5′-tttgaattcatgccgatgaatactacaggtatgt-3′
EspM2-pKK-R 5′-tttctgcagtcaagcgtagtctgggacgtcgtatgggtatccctgtatagcacgcatcaa-3′
EspM2 W70A-F 5′-gcagagtactaaagatattgatgaggcgataaaagatgaacggatagtatat-3′
EspM2 W70A-R 5′-atatactatccgttcatcttttatcgcctcatcaatatctttagtactctgc-3′
EspM3-pKK-F 5′-ttgaattcatgccagtgaatgttcaagg-3′
EspM3-pKK-R 5′-ttgcctgcagttaagcgtagtctgggacgtcgtatgggtacacgatatagcatacctca-3′
EspM2Cr-pKK-F 5′-ttgaattcatgccagcgaatatatcagg-3′
EspM2Cr-pKK-R 5′-ttgtcgacttaacttaagcgtagtctgggacgtcgtatgggtatgccgacatggcatttgcca-3′
TrcA-pKK-F 5′-ttgaattcatgccgatgaatactacaagtac-3′
TrcA-pKK-R 5′-aactgcagttaagcgtagtctgggacgtcgtatgggtatgcctgtatagcacacctca-3′
EspM1 B171-pKK-F 5′-tacccatacgacgtcccagactacgct-3′
EspM1 B171-pKK2-R 5′-ccaatgcactgcagttaagcgtagtctgggacgtcgtatgccgatatgacgctggcag-3′
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branes were blocked overnight in TBS 5%/BSA at 4°C with gentle
rocking. Each membrane was incubated in either monoclonal
mouse anti-cofilin (Cell Signalling Technology) or mouse anti-
Phospho-cofilin (Cell Signalling Technology) at a dilution of
1:1000 in TBS 5%/BSA for 1 h at room temperature with gentle
rocking. The membranes were washed five times in TBS
1%/Tween for 5 min and incubated for 45 min with a 1:3000
dilution of Goat a Mouse (Invitrogen) secondary antibody
coupled to HRP at room temperature. The membranes were
developed using ECL reagents (GE healthcare) before detection
using chemiluminescence in a LAS 3000 Fugi imager. Western
blots were analysed by densitometry using ImageJ software.
Results presented are the average of five independent
experiments.
Preparation of GST-Rhotekin and
RhoA-GTP pull-downs
An overnight culture of E. coli BL21 expressing pGEX encoding
the RhoA binding domain of Rhotekin was diluted 1:20 and cul-
tured at 30°C until OD260nm reached 0.7; the culture was induced
with 1 mM IPTG and incubated for a further 4 h. The bacterial
culture was aliquoted into 50 ml falcon tubes and centrifuged for
15 min at 4600 r.p.m. at 4°C and the pellets stored at -80°C. The
pellets were resuspended in lysis buffer [20% Saccharose, 10%
glycerol, 50 mM Tris pH 8, 200 mM Na2S2O3, 2 mM MgCl2, 2 mM
DTT and 1% protease inhibitor cocktail (Sigma)] and sonicated
five times for 10 s. The solution was centrifuged for 30 min
at 15 000 r.p.m. at 4°C and the supernatants harvested and
coupled to GST-glutathione S transferase beads for 45 min at 4°C.
The 75 cm2 cell culture flasks were seeded with Swiss 3T3 cells,
infected as described above and the cells lysed in 750 ml of Mg++
buffer [25 mM Hepes, pH 7.5, 150 mM NaCl, 1% NP-40, 10 mM
MgCl2, 5% glycerol, 1 mM EDTA and protease inhibitors (Sigma)].
The lysate was transferred to a pre-chilled eppendorf tube and
centrifuged at 14 000 r.p.m. for 5 min at 4°C. The cleared lysate
was transferred to a fresh pre-chilled eppendorf tube containing
30 ml of GST-Rhotekin-RBD beads. The lysate was incubated with
the beads for 1 h at 4°C. The suspension was washed three times
in Mg++ buffer spinning down at 14 000 r.p.m. at 4°C between each
wash. The beads were eluted by the addition of 45 ml of 2¥ protein
loading buffer and the samples heated at 100°C for 5 min. The
samples were loaded on a 15% SDS-PAGE gel. The gels were
transferred to PVDF and blotted as previously described using
monoclonal RhoA antibody (Santa Cruz).
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EspT triggers formation of lamellipodia and membrane
ruffles through activation of Rac-1 and Cdc42
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Summary
Subversion of the eukaryotic cell cytoskeleton is a
virulence strategy employed by many bacterial
pathogens. Due to the pivotal role of Rho GTPases
in actin dynamics they are common targets of
bacterial effector proteins and toxins. IpgB1, IpgB2
(Shigella), SifA, SifB (Salmonella) and Map and
EspM (attaching and effacing pathogens) consti-
tute a family of type III secretion system effectors
that subverts small GTPase signalling pathways. In
this study we identified and characterized EspT
from Citrobacter rodentium that triggers formation
of lamellipodia on Swiss 3T3 and membrane ruffles
on HeLa cells, which are reminiscent of the mem-
brane ruffles induced by IpgB1. Ectopic expres-
sion of EspT and IpgB1, but not EspM, resulted in
a mitochondrial localization. Using dominant nega-
tive constructs we found that EspT-induced actin
remodelling is dependent on GTP-bound Rac-1
and Cdc42 but not ELMO or Dock180, which are
hijacked by IpgB1 in order to form a Rac-1 specific
guanine nucleotide exchange factor. Using pull-
down assays with the Rac-1 and Cdc42 binding
domains of Pak and WASP we demonstrate that
EspT is capable of activating both Rac-1 and
Cdc42. These results suggest that EspT modulates
the host cell cytoskeleton through coactivation of
Rac-1 and Cdc42 by a distinct mechanism.
Introduction
Subversion and modulation of host cell signalling networks
is essential for effective invasion and colonization of a wide
variety of bacterial pathogens. In order to facilitate the
hijacking of essential host processes many bacterial
pathogens employ one or a combination of secretion
systems (reviewed in Filloux et al., 2008). These complex
machines are capable of delivering a wide variety of toxins,
colonization factors and effectors either in proximity to
epithelium or directly into the host cell (reviewed in Gerlach
and Hensel, 2007). A wide variety of Gram-negative patho-
gens utilize type III secretion systems (T3SS) in order to
translocate effector proteins directly from the bacterial cell
into the cytoplasm of the mammalian cell (reviewed in
Galan and Wolf-Watz, 2006). The translocated effector
proteins are directed to distinct cellular compartments
where, by interacting with indigenous proteins, they form
novel complexes that modulate a variety of signalling
networks for the benefit of the bacterial cell.
The medically important enteropathogenic and
entero-haemorrhagic Escherchia coli (EPEC and EHEC)
(reviewed in Nataro and Kaper, 1998), along with the
murine pathogen Citrobacter rodentium (reviewed in
Mundy et al., 2005), are extracellular bacterial pathogens,
which intimately adhere to host enterocytes causing dis-
tinctive attaching and effacing (A/E) lesions characterized
by the local disruption of the brush border microvili
(Knutton et al., 1987). Colonization and persistence of
EPEC, EHEC and C. rodentium is dependent upon a
T3SS-encoded within the locus of enterocyte effacement
(LEE) (McDaniel et al., 1995). This T3SS translocates a
plethora of effector proteins that are located both within
the LEE and on a variety of other pathogenicity islands
and prophages (Tobe et al., 2006). EPEC, EHEC and
C. rodentium translocate their own receptor, Tir (Kenny
et al., 1997), into mammalian cells that binds the bacterial
outer membrane adhesisn intimin (reviewed in Frankel
et al., 2001), resulting in Tir clustering and formation of
actin-rich pedestals beneath adherent bacteria in vitro
(reviewed in Frankel and Phillips, 2008). Other A/E bac-
terial effectors that target and modulate the host cell
cytoskeleton include EspG and EspG2, which disrupt the
host cell microtubule network (Matsuzawa et al., 2004;
Shaw et al., 2005), Map, which induces transient filopodia
formation (Kenny and Jepson, 2000) and EspM, which
activates the small GTPase RhoA and induces formation
of stress fibres (Arbeloa et al., 2008).
Small GTPases act as molecular switches that cycle
between an inactive GDP bound form and an active GTP
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bound form. The switch from inactive to active forms of the
GTPase results in a conformational change. This process
is regulated by a variety of accessory proteins. Guanine
exchange factors (GEFs) activate GTPases by promoting
the dissociation of GDP and the binding of GTP, GTPase-
activating proteins (GAPs) inactivate the small GTPases
by stimulating their intrinsic GTPase activity. Guanine dis-
sociation inhibitor (GDI) proteins cap the small GTPases
preventing the dissociation of GDP and membrane local-
ization (reviewed in Jaffe and Hall, 2005). Rho GTPases
modulate a variety of host cell processes in a GTP-
dependent manner by activating a plethora of down-
stream effectors at specific host cell compartments
(Stebbins and Galan, 2001). The three best characterized
Rho GTPases are RhoA, Rac-1 and Cdc42, which are
implicated in formation of stress fibres, lamellipodia and
filopodia respectively (Jaffe and Hall, 2005).
Recently, Alto and co-workers grouped together several
previously known T3SS effector proteins which share a
conserved WxxxE motif and induce the same actin struc-
tures as active Rho family GTPases (Alto et al., 2006).
These effectors include IpgB1 and IpgB2, which are
required during Shigella invasion (Ohya et al., 2005),
SifA and SifB which are involved in maintenance of the
Salmonella containing vacuole (Beuzon et al., 2000) and
Map. In addition, we recently identified EspM effectors in
EPEC, EHEC and C. rodentium, which share significant
homology with IpgB2 (Arbeloa et al., 2008). Using IpgB1,
IpgB2 and Map, Alto et al. (2006) showed that the activity
of these proteins in modulating actin dynamics requires
the conserved tryptophan and glutamic acid residues.
They also demonstrated that the formation of stress fibres
induced by IpgB2 and the filopodia nucleated by Map
occurred independently of the activity of RhoA and Cdc42
respectively. It was suggested that IpgB1 mimics Rac-1,
IpgB2 mimics RhoA and Map mimics Cdc42 (Alto et al.,
2006). However, a recent report by Handa et al. (2007)
demonstrated that IpgB1 binds to the RhoG effector
ELMO which in turn recruits the GEF Dock180 and sub-
sequently activates endogenous Rac-1 to produce the
membrane ruffles, while we demonstrated that EspM-
induced stress fibre formation is dependent on the activa-
tion of RhoA (Arbeloa et al., 2008). Browsing the ongoing
genome sequencing projects of A/E pathogens we
recently identified a novel WxxxE effector gene, we
named espT, in C. rodentium. The aim of this study was to
conduct phenotypic and functional analysis of EspT.
Results
Identification of EspT
Recently, we identified EspM1 and EspM2 in EHEC
O157:H7 (strains Sakai and EDL933), TrcA and EspM1 in
EPEC O111:NM (strain B171) and EspM2 and EspM3 in
C. rodentium as members of the WxxxE family of effectors
(Arbeloa et al., 2008). Using the BLAST algorithm with
IpgB2 and Map as index proteins to search for new
WxxxE family members within the A/E pathogen group,
we identified a new putative effector, whose encoding
gene we have named espT, in C. rodentium (Accession
number: FM210026). EspT is encoded within the same
pathogenicity island as EspM2, which also encodes an
EspO/OspE homologue (Fig. 1A). OspE2 is a T3SS effec-
tor, which localizes to focal adhesions and regulate cell
shape upon Shigella sonnei infection (Miura et al., 2006).
EspT shares 29% identity with EspM2, 27% identity with
IpgB2, and 19% identity with IpgB1. A phylogram based
upon multiple sequence alignment with hierarchical clus-
tering (Mackey et al., 2002) shows that EspT is divergent
from the EspM/IpgB2 and does not cluster well with either
IpgB1 or Map (Fig. 1C).
EspT triggers formation of lamellipodia and
membrane ruffles
Previously characterized WxxxE effectors have been
reported to induce a plethora of actin structures normally
associated with activated Rho GTPases (Alto et al., 2006;
Handa et al., 2007; Arbeloa et al., 2008). In order to deter-
mine if EspT has the ability to remodel actin within eukary-
otic cells, espT was cloned into the expression vector
pSA10 (Schlosser-Silverman et al., 2000) and expressed
in EPEC E2348/69, which does not contain any WxxxE
effectors other than Map (Arbeloa et al., 2008). T3SS-
dependent translocation of EspT from E2348/69 into mam-
malian cells was confirmed using a b-lactamase fusion
assay (data not shown). E2348/69 with or without the
vector-encoding EspT was used to infect serum-starved
Swiss 3T3 and HeLa cells. E2348/69 with no plasmid or
carrying empty pSA10 triggered formation of actin-rich
pedestals beneath adherent bacteria on both Swiss 3T3
and HeLa cells, without any other major cytoskeletal alter-
ations (Fig. 2). In contrast, E2348/69 carrying pSA10-
encoding EspT induced formation of pedestals on both cell
lines and additionally triggered formation of lamellipodia on
Swiss 3T3 cells and membrane ruffles on HeLa cells,
which were not restricted to the site of bacterial attachment
(Fig. 2A and B). The lamellipodia induced by EspT have
a strong leading edge, wide lamella, well-defined
microspikes and filopodia, which extend beyond the cell
periphery (Fig. 2A). These lamellipodia and membrane
ruffles were found in 90% and 80% of cells infected with
E2348/69, respectively, after 1.5 h (Fig. 2C) and were still
present at 3 h post infection. The E2348/69 type III secre-
tion null mutant, DescN, carrying pSA10::espT did not
produce actin-rich pedestals, lamellipodia or membrane
ruffles (data not shown). These results demonstrate that
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EspT is a T3SS effector that upon tranlocation triggers
formation of lamellipodia and membrane ruffles and that
the nature of actin rearrangement was cell type-specific.
EspT is sufficient for lamellipodia and
membrane ruffle formation
Ectopic expression of espT, fused to a myc tag, from the
mammalian expression vector pRK5 in Swiss 3T3 cells
resulted in formation of lamellipodia that were indistin-
guishable from those visualized when EspT was delivered
by E2348/69 (Fig. 3). Tranfection of EspT into HeLa cells
induced formation of membrane ruffles identical to those
observed during infection (data not shown). Thus, EspT is
necessary and sufficient for these re-arrangements of the
actin cytoskeleton. It has been previously shown that
ectopic expresion of the Shigella effector IpgB1 induces
formation of membrane ruffles in HeLa cells (Alto et al.,
2006; Handa et al., 2007). As such we transfected IpgB1,
fused to a N-terminal myc tag, into HeLa and Swiss 3T3
cells as a control. In agreement with previous data (Handa
et al., 2007), we found that IpgB1 induce membrane
ruffles on HeLa cells. However, in contrast to the result we
obtained for EspT, we found that IpgB1 also induces
membrane ruffles in Swiss 3T3 cells (Fig. 3).
Additionally, we found that at 16 h post transfection
EspT was targeted to the mitochondria, as shown by
double staining with anti-myc antibodies and Mitotracker
CMXRos (Fig. 3). Similarly, 16 h post transfection IpgB1
was also found in the mitochondria, while EspM2 was
uniformly distributed in the cytosol (Fig. 3). Although the
mitochondria appeared swollen and sometimes aggre-
gated, the fact that they were well-stained with Mitotracker
CMXRos is indicative that they were metabolically active.
Moreover, we did not observed any signs of apoptosis in
EspT or IpgB1 transfected cells, indicating that the mito-
chondrial membrane has not been compromised (data not
shown). However, as EspT and IpgB1 contain no canoni-
cal mitochondrial targeting sequences, the mechanism
involved in mitochondrial targeting remains unknown.
Lamellipodia and membrane ruffles induced by EspT
are dependent on activation of Rac-1 and Cdc42
WxxxE effectors have previously been demonstrated to
act both independently (Alto et al., 2006) and dependently
Fig. 1. A. A graphical representation of the espT pathogenicity island of C. rodentium.
B. Multiple sequence alignment with hierarchical clustering of Shigella flexneri IpgB1 and IpgB2 along with Map, EspM2, EspM3 and EspT
from C. rodentium and EspM1 from EPEC B171 O111:NM. Residues that are identical are highlighted in grey. The conserved WxxxE motif is
boxed.
C. Phenogram created using ClustalW2 showing the phylogeny of aligned WxxxE effectors.
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(Handa et al., 2007; Arbeloa et al., 2008) of the Rho
GTPases. In order to determine if EspT activity was
dependent on RhoA, Rac-1, Cdc42 or RhoG, we trans-
fected the dominant negative forms of each of these
GTPases (RhoAN19, Rac-1N17, Cdc42N17 and RhoGN17),
which competitively and specifically inhibit the wild-type
GTPase activation, into both Swiss 3T3 and HeLa cells.
Additionally, we transfected the Cdc42 and Rac1 binding
domain (CRIB) of Pak, which efficiently inhibits the down-
stream signalling of Rac1 and Cdc42 (Carreno et al.,
2002). Transfected cell were subsequently infected with
E2348/69 expressing EspT from pSA10 for 1.5 h and
the presence of lamellipodia or membrane ruffles was
assessed. Inactivation of either RhoA or RhoG had no
effect on the induction of lamellipodia or membrane ruffles
by EspT on Swiss 3T3 and HeLa cells respectively
(Fig. 4A). Conversely inhibition of Rac-1 or Cdc42 signifi-
cantly compromised the ability of EspT to form either
lamellipodia or membrane ruffles (Fig. 4B). The residual
lamellipodia observed in the presence of the Rac-1 and
Cdc42 dominant negatives were shorter and less pro-
nounced than those induced in mock transfected cells
(Fig. 4A). Inhibition of both Rac1 and Cdc42 downstream
signalling using the CRIB of Pak reduced the number and
extent of EspT-induced lamellipodia to a level comparable
with the Rac1 dominant negative (Fig. 4B). This suggests
that activation and subsequent downstream signalling of
Rac-1, Cdc42, or both are involved in the EspT signalling
pathway.
In order to assess whether or not EspT activates Rac-1
and Cdc42, we performed pull-down assays using the
Cdc42 Rac-1 interacting binding domain (CRIB) of Pak,
which binds activated Rac-1 and Cdc42 and the CRIB of
WASP, which binds only activated Cdc42. Pull-downs
were blotted with specific antibodies for Rac-1 and Cdc42.
Cells incubated with CNF1 toxin that activates Rho
GTPases (Pei et al., 2001) were used as a positive
control, and E2348/69-containing empty pSA10 was used
Fig. 2. A. Fluorescence microscopy of
serum-starved Swiss 3T3 cells uninfected or
infected with wild-type E2348/69 or E2348/69
expressing EspT for 90 min. Actin was stained
with Oregon green phalloidin and E2348/69
was detected with a rabbit O127 antibody.
Distinctive lamellipodia, which have a strong
leading edge, wide lamella and well defined
microspikes and filopodia that extend beyond
the cell boundary, were observed on cells
infected with E2348/69 expressing EspT but
not in the wild-type control. Both strains
induced formation of actin-rich pedestals
beneath adherent bacteria.
B. Serum-starved HeLa cells infected with
E2348/69 expressing EspT exhibited
membrane ruffles whereas those infected with
wild-type E2348/69 did not. Both strains
formed actin pedestals.
C. Quantification of Lamellipodia and
membrane ruffles on Swiss 3T3 and HeLa
cells, respectively, after 90 min infection with
wild-type E2348/69 or E2348/69 expressing
EspT. One hundred cells were counted in
triplicate in three independent experiments.
Results are displayed as mean  SEM.
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as a negative control. Swiss 3T3 cells infected with
E2348/69 expressing EspT exhibited a marked increase
in the level of activation of both Rac-1 and Cdc42 com-
pared with uninfected cells or those infected with the
control E2348/69 strain (Fig. 5B). These results suggest
that EspT-triggered actin rearrangements are dependent
upon activation of the Rac-1 and Cdc42 signalling
cascades.
Ectopic expression of ELMO causes a shift from
lamellipodia to membrane ruffles
Despite the limited homology between EspT and IpgB1,
the phenotype produced by the Shigella effector is remi-
niscent of the membrane ruffles induced by EspT in HeLa
cells (Ohya et al., 2005). Additionally, IpgB1-triggered
membrane ruffles also occur in a RhoG-independent and
Rac-1-dependent manner (Handa et al., 2007). IpgB1 has
been reported to interact with ELMO1 and ELMO2 and
subsequently recruit DOCK180 in order to activate Rac-1
in a manner analogous to RhoG (Handa et al., 2007).
Furthermore, Handa and co-workers show that ELMO is
localized to the membrane ruffles produced during Shi-
gella invasion. In order to determine if ELMO was also
localized to EspT-induced dorsal ruffles and lamellipodia,
we ectopically expressed ELMO1 from the mammalian
expression vector pGFP. Surprisingly, when Swiss 3T3
expressing ELMO were infected with E23348/69 carrying
pSA10::espT, a shift from production of lamellipodia to
membrane ruffles was observed with ELMO weakly local-
ized to these ruffles (Fig. 6). These results suggest that
while EspT may have a preferred binding partner in Swiss
cells, it may also be able to interact directly or indirectly
with ELMO. Alternatively, expression of ELMO might inter-
fere with the pathway used by EspT to activate Rac-1 and
Cdc42.
Fig. 3. Ectopic expression of EspT induces cytoskeletal rearrangement in Swiss 3T3 cells. Serum-starved Swiss 3T3 cells were mock
transfected or transfected with the mammalian expression vector pRK5 encoding myc-tagged EspT, IpgB1 or EspM2 for 16 h. Actin was
stained with Alexifluor 633 phalloidin, the myc tag was detected with monoclonal antibody and mitochondria were stained with Mitotracker
CMXRos. On transfection EspT induces the formation of lamellipodia identical to those observed during infection. Transfection of IpgB1 and
EspM2 resulted in the induction of membrane ruffles and stress fibres respectively. EspT and IpgB1 were found in the mitochondria while
EspM2 remained cytoplasmic.
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Fig. 4. EspT-induced cytoskeletal rearrangements are dependent on Rac-1 and Cdc42.
A. Swiss 3T3 cells were transfected with the dominant negative forms of RhoA, RhoG, Rac-1 and Cdc42 18 h prior to infection for 90 min with
E2348/69 expressing EspT. Actin was stained with Oregon green phalloidin, the myc-tagged RhoA, Rac-1 and Cdc42 dominant negatives
were stained with a myc tag monoclonal antibody, RhoG was detected via its GFP tag and E2348/69 was visualized using a rabbit O127
antibody. Actin pedestals were observed beneath all adherent bacteria. Lamellipodia were observed in cells transfected with dominant
negative RhoAN19 and the RhoGN17. The majority of cells transfected with dominant negative Rac-1N17 did not display lamellipodia. Dominant
negative Cdc42N17 reduced the number of cells expressing lamellipodia as well as reducing the extent of the lamellipodia compared with the
mock or dominant negative RhoAN19 and RhoGN17.
B. Quantification of lamellipodia in transfected Swiss 3T3 after 90 min infection with E2348/69 expressing EspT. One hundred cells were
counted in triplicate in three independent experiments. Results are displayed as mean  SEM.
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EspT-induced cytoskeletal rearrangements are
independent of ELMO or Dock180 activity
As ectopically expressed ELMO induces a shift from
lamellipodia to membrane ruffles we utilized dominant
negatives in order to investigate the role of the ELMO-
Dock180 machinery in the induction of lamellipodia and
membrane ruffles by EspT on Swiss 3T3 and HeLa
cells respectively. Cells were transfected with ELMOT625 (a
dominant negative of ELMO unable to interact with
Dock180) or Dock180ISP (a dominant negative form of
Dock180 incapable of interacting with Rac-1) (Handa
et al., 2007). Transfection of ELMOT625 or Dock180ISP had
no effect on the production of EspT-dependent lamellipo-
dia in Swiss 3T3 cells (Fig. 7) or membrane ruffles in
HeLa cells (data not shown). In contrast, double transfec-
tion of ELMOT625 or Dock180ISP with pRK5 expressing
IpgB1 resulted in a marked reduction of membrane ruffles
compared with mock transfected cells (Fig. 7B). These
results suggest that EspT induces lamellipodia and mem-
brane ruffles via a mechanism that is distinct from IpgB1.
Discussion
In this study, we identified the C. rodentium effector
protein EspT. Previously identified effectors, Map, EspM,
IpgB1 and IpgB2, which are grouped together with EspT,
have all been reported to be potent modulators of the host
cell cytoskeleton (Kenny and Jepson, 2000; Alto et al.,
2006; Handa et al., 2007; Arbeloa et al., 2008). Consis-
tent with this, using E2348/69 as a delivery system to
translocate EspT along with ectopic expression we have
shown that EspT also subverts host actin dynamics. Inter-
estingly, the effect of EspT was cell-line specific. While
expression in Swiss 3T3 led to formation of lamellipodia,
EspT-triggered membrane ruffles on HeLa cells. When
EspT was delivered by infection via E2348/69, the lamel-
lipodia and membrane ruffles appeared as early as
15 min post infection and were stable for over 3 h.
Based on the initial examination of IpgB1, IpgB2 and
Map, it was suggested that these effector proteins are
molecular mimics of Rho GTPases and function in a GTP-
independent manner (Alto et al., 2006). More recently,
Handa et al. showed that IpgB1 activates Rac-1 via the
ELMO-Dock180 machinery (Handa et al., 2007). In addi-
tion, we recently identified a new subfamily in the A/E
pathogen group, which share a high degree of similarity to
IpgB2 named EspM. We have shown that EspM2 and
EspM3 activate RhoA via a mechanism which is yet to be
determined (Arbeloa et al., 2008).
Despite EspT sharing limited sequence identity with
other family members, the membrane ruffles observed on
HeLa cells were reminiscent of those induced by IpgB1
(Handa et al., 2007) except that the EspT-induced ruffles
were not restricted to the site of bacterial attachment. As
IpgB1 plays a role in Shigella cell invasion (Ohya et al.,
2005), we tested if overexpression of EspT affects the
level of E2348/69 cell entry. Invasion assay of wild-type
E2348/69 and E2348/69 expressing EspT did not reveal
any significant difference in the level of intracellular bac-
teria (data not shown). Interestingly, expressing EspT in
Swiss cells led to formation of lamellipodia, which have
a strong leading edge, wide lamella and well-defined
microspikes and filopodia that extend beyond the cell
boundary. In contrast, IpgB1 expression induced mem-
brane ruffles on Swiss cells.
Lamellipodia and membrane ruffles are normally regu-
lated by interplay between Rac-1, Cdc42, RhoG and
RhoA (Sander and Collard, 1999; Kurokawa et al., 2004;
Ladwein and Rottner, 2008). In order to determine the
pathway by which EspT subverts the host cell cytoskel-
eton, we utilized dominant negative forms of these
GTPases to competitively inhibit the wild-type proteins.
Fig. 5. EspT activates Rac-1 and Cdc42.
Swiss 3T3 cells were left untreated or infected
with wild-type E2348/69 or E2348/69
expressing EspT. Cells treated with CNF1
toxin were used as a positive control. Cells
were lysed and added to GST beads bound
to either the CRIB of WASP or the Rac-1
binding motif of Pak to capture active Cdc42
and Rac-1 respectively. Total Cdc42 and
Rac-1 along with bound Cdc42 and Rac-1
were detected by Western blotting with Cdc42
and Rac-1 monoclonal antibodies. Quantified
fold activation data are presented as
mean  SEM from three independent
experiments.
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In the presence of dominant negative Rac-1TN17 a 60%
reduction in formation of lamellipodia was observed.
Transfection of Cdc42TN17 reduced lamellipodia formation
by 30%. These dominant negative constructs attenuated
EspT-induced membrane ruffles in HeLa cells to a similar
magnitude. These results demonstrate that the actin
re-arrangements induced by EspT are dependent on the
activation of Rac-1 and to a lesser extent Cdc42. Further-
more, using the CRIB domains of PAK and WASP that
bind activated Rac-1 and Cdc42, respectively, we demon-
strate that EspT activates both Rac-1 and Cdc42 during
infection of Swiss 3T3 cells. These results are consistent
Fig. 6. Expression of ELMO1 causes a shift from lamellipodia to membrane ruffles.
A. Swiss 3T3 cells were mock transfected or transfected with GFP tagged ELMO1 18 h prior to infection with wild-type E2348/69 or E2348/69
expressing EspT. While wild-type E2348/69 displayed only pedestal formation in mock transfected or cells transfected with ELMO1, E2348/69
expressing EspT induced formation of lamellipodia on mock transfected cells but in cells transfected with ELMO there was a shift from
lamellipodia to membrane ruffles.
B. Quantification of Lamellipodia and membrane ruffles on mock transfected Swiss 3T3 or Swiss 3T3 cells transfected with ELMO1 after
90 min infection with wild-type E2348/69 or E2348/69 expressing EspT. One hundred cells were counted in triplicate in three independent
experiments. Results are displayed as mean  SEM.
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with the report of (Handa et al. (2007) who have previ-
ously demonstrated that IpgB1 activates Rac-1. We cur-
rently do not know whether EspT activates Rac-1 directly,
via activation of Cdc42 or through a yet unknown GEF or
adaptor.
Handa and co-workers also show that IpgB1 interacts
with ELMO and subsequently recruits Dock180 to a trim-
eric complex which brings about the activation of Rac-1
(Handa et al., 2007). As EspT induces a Rac-1-dependent
phenotype similar to IpgB1 in HeLa cells we investigated
the role of ELMO during EspT-triggered actin modulation.
We transfected a GFP-tagged ELMO into Swiss 3T3
cells and infected these cells with wild-type E2348/69 or
E2348/69 expressing EspT. No ruffles were observed
during E2348/69 infection. Surprisingly, when ELMO was
transfected into Swiss 3T3 cells infected with E2348/69
expressing EspT, we observed a shift from the lamellipo-
dia to membrane ruffles similar to those induced by IpgB1.
This result might suggest that EspT is able to interact with
ELMO. Alternatively, overexpression of ELMO could have
an effect downstream of the signalling pathway employed
by EspT. To determine if the lamellipodia observed in
Swiss 3T3 cells or the membrane ruffles formed in
HeLa cells are dependent upon the ELMO – Dock180
Fig. 7. A. EspT-induced cytoskeletal rearrangements are not dependent on ELMO or Dock180. Swiss 3T3 were transfected with the dominant
negative forms of ELMO and Dock180 18 h prior to infection with E2348/69 expressing EspT. Neither ELMOT625 nor Dock180ISP had any effect
on lamellipodia induction by EspT.
B. Quantification of lamellipodia or membrane ruffles in Swiss 3T3 cells transfected with dominant negative ELMOT625 or Dock180ISP and
infected with E2348/69 expressing EspT or cotranfected with IpgB1 from S. flexneri as control. One hundred cells were counted in triplicate
from three independent experiments. Results are displayed as mean  SEM.
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machinery, we used the dominant negative forms of
ELMO (ELMOT625) and Dock180 (Dock180ISP), which have
been demonstrated to abolish IpgB1 induced membrane
ruffles (Handa et al., 2007). As previously observed
(Handa et al., 2007) these dominant negatives greatly
reduced the formation of membrane ruffles induced by
IpgB1. However, neither the ELMOT625 nor Dock180ISP had
any significant affect on the formation of lamellipodia or
membrane ruffles induced by EspT, suggesting that EspT
activates Rac-1 and Cdc42 by a novel mechanism.
Map, which triggers filopodia formation via activation
of Cdc42 (Berger et al., 2008), contains an N-terminus
mitochondrial targeting sequence (Papatheodorou et al.,
2006), while EspM2, IpgB1 and EspT do not have any
obvious mitochondrial targeting sequences. EspM2,
which triggers formation of parallel stress fibres upon
transfection, localizes in the cytoplasm. In contrast, we
found here that EspT and IpgB1 are targeted to mitochon-
dria following 16 h ectopic expression. It is interesting to
note that mitochondrial trafficking and morphology is
regulated by the atypical Rho GTPases Mitochondrial
Rho (Miro) 1 and 2 (Frederick et al., 2004; Fransson et al.,
2006). The mitochondrial localization of IpgB1 and EspT
may suggest a role for these proteins in regulating mito-
chondrial dynamics as well as subversion of the host actin
cytoskeleton. However, although ectopic expression of
EspM leads to cytosolic localization, we cannot rule out
the possibility that mitochondria targeting by EspT and
IpgB1 is due to the overexpression. Further studies are
needed to determine if EspT and IpgB1 have a physiologi-
cal mitochondrial function.
Further work is also required to elucidate the mecha-
nism by which EspT activates Rac-1 and Cdc42. Interest-
ingly, although espT is absent from the common EPEC
strains (including the prototypes E2348/69 and B171)
and EHEC O157, we recently found an espT homologue
(78% identity) in the atypical EPEC strain E110019, which
caused a particularly severe outbreak in Finland in 1987
(Viljanen et al., 1990). However, the overall prevalence of
espT among clinical EPEC and EHEC strain is not yet
known. Finally, additional studies are required to elucidate
what role EspT plays in vivo during infection of A/E
pathogens.
Experimental procedures
Bacterial strains, growth conditions and cell culture
The bacterial strains used in this study are listed in Table 1.
Bacteria were grown in Luria–Bertani (LB) broth at 37°C or main-
tained on LB plates. Culture media were supplemented with
Ampicillin (100 mg ml-1) as appropriate.
Bacterial cultures were primed prior to infection by growth
in Dulbecco’s modified Eagle’s media (DMEM) 4500 mg ml-1
glucose supplemented with 1% mannose for 3 h (Collington
et al., 1998) before addition of 1 mM IPTG to induce protein
expression.
Swiss 3T3 cells were maintained in DMEM with 4500 mg ml-1
glucose and supplemented with 10% fetal calf serum (Gibco) and
4 mM Glutamax (Gibco). HeLa cells were cultured in DMEM with
1000 mg ml-1 glucose and supplemented with 10% fetal calf
serum (Gibco) and 4 mM Glutamax (Gibco).
Bioinformatics
A PSI-BLAST search (Altschul et al., 1997) was performed
under default conditions using IpgB2 from Shigella flexneri
(gi:13448971) and Map from EPEC (gi:2865296) as query
sequences to search the latest version of the NCBI NR database
and combined with a library of peptide sequences derived from all
coding sequences 50 codons in length from the genome
sequences of C. rodentium ICC168, EPEC B171, E110019 and
EPEC E2348/69.
Multiple alignment and phylogenetic analysis
Using the sequence alignment programme ClustalW2 (Larkin
et al., 2007), a phenogram was constructed based upon hierar-
chical clustering of EspT, EspM2 and EspM3 form C. rodentium,
EspM1 from EPEC B171, and IpgB1 and IpgB2 form S. flexneri.
Plasmids and molecular techniques
Plasmids used in this study are listed in Table 2; primers are
listed in Table 3. The gene encoding the effector protein espT
was amplified by PCR from C. rodentium genomic DNA and
cloned into pSA10 with a C-terminal HA tag using primer pairs 1
and 2 (Table 3). The gene encoding the effector protein espT was
amplified by PCR from C. rodentium genomic DNA and cloned
into pRK5 with an N-terminal Myc tag using primer pair 3 and 4
(Table 3). The gene encoding the effector protein IpgB1 was
amplified by PCR from S. flexneri genomic DNA and cloned into
pRK5 with a N-terminal Myc tag using primer pairs 7 and 8
(Table 3). All constructs were verified by DNA sequencing.
The mammalian expression vector pRK5 containing one of
RhoN19, RacN17 or Cdc42N17 dominant negatives used in the
transfection assays was a gift from Nathalie Lamarche-Vane.
The pEGFP-C1 mammalian expression vector containing the
RhoGN17 and ELMOT625 dominant negatives and Elmo1 along
with the pCXN2 vector with the FLAG tagged Dock180ISP were
kindly supplied by Yutaka Handa and Chihiro Sasakawa (Handa
et al., 2007). The vector pGEX expressing the Rac-1 binding
domain of Pak, the CRIB of WASP and CNF1 toxin fused to GST
were a gift from J. Bertoglio. The pRK5 vector encoding the CRIB
of Pak fused to a myc tag was kindly provided by Dr Emmanuelle
Caron (CMMI).
Table 1. List of strains.
Strain Description Source/reference
E2348/69 EPEC O127:H6 wild-type Levine et al. (1978)
ICC168 Citrobacter rodentium Barthold et al. (1976)
ICC192 EPEC E2348/69DescN Garmendia et al. (2004)
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Infection of Swiss 3T3 and HeLa cells
with EPEC E2348/69
48 h prior to infection cells were seeded onto glass coverslips at
a density of approximately 5 ¥ 105 cells per well and maintained
in DMEM supplemented with 10% FCS at 37°C in 5% CO2. Three
hours before infection, the cells were washed three times with
PBS, the media replaced with fresh DMEM without FCS supple-
mented with 1% mannose and 500 ml of primed bacteria were
added to each well and infections were carried out at 37°C in 5%
CO2 for 1.5 h.
Transfection
Swiss 3T3 cells or Hela cells were transfected with pRK5 encod-
ing RhoAN19, RacN17, Cdc42N17 dominant negatives fused to a
Myc tag, pEGFP-C1 containing RhoGN17 or ELMOT625 dominant
negatives with a GFP tag, pCNX2 containing Dock180ISP domi-
nant negative with a FLAG tag or pRK5 encoding EspT, IpgB1,
EspM2 or the CRIB of Pak fused to a Myc tag by lipofectamine
2000 (Invitrogen), according to the manufacturer’s recommenda-
tions. The cells were incubated at 37°C in a humidified incubator
with 5% CO2 for 16 h, washed twice in PBS before having their
media replaced with DMEM as described previously. Transfected
cells were infected with the appropriate strain as described
above.
Immunofluorescence staining and microscopy
Coverslips were washed three times in PBS and fixed with 3%
paraformaldehyde for 15 min before washing three more times in
PBS. For immunostaining, the cells were permeabilized for 5 min
in PBS 0.5% Triton X-100, washed three times in PBS and
quenched for 30 min with 50 mM NH4Cl. The coverslips were
then blocked for 1 h with PBS 0.5% BSA before incubation with
primary and secondary antibodies. The primary antibody mouse
aFLAG, mouse anti-HA (Cell Signalling Technology) and mouse
anti-Myc (Millipore) were used at a dilution of 1:500, while rabbit
anti-O127 (a gift from Dr Roberto La Ragione, VLA, UK) was
used at a dilution of 1:150. Coverslips were incubated with the
primary antibody for 1 h, washed three times in PBS and incu-
bated with the secondary antibodies. Donkey anti-rabbit IgG
conjugated to a Cy5 fluorophore or donkey anti-mouse IgG con-
jugated to a Cy3 fluorophore (Jackson laboratories) were used at
a 1:200. Actin was stained using Oregon Green phalloidin or
Rhodamine phalliodin (Invitrogen) at a 1:100 dilution. Mitochon-
dria were visualized using Mitotracker CMX-Ros (Invitrogen) as
recommended by the manufacturer. All dilutions were in PBS/
0.5% BSA. Coverslips were mounted on slides using ProLong
Gold antifade reagent (Invitrogen) and visualized by Zeiss Axio-
imager immunofluorescence microscope using the following exci-
tation wavelengths: Cy3 – 550 nm, Cy5 – 650 nm and Oregon
Green – 488 nm. All images were analysed using the Axiovision
Rel 4.5 software.
GST-PAK and GST-WASP Rho GTPase pull-down
An overnight culture of E. coli BL21 expressing pGEX encoding
the Rac-1 binding domain of Pak or the CRIB of WASP was
diluted 1:20 and cultured at 30°C until OD260 reached 0.7; the
culture was induced with 1 mM IPTG and incubated for a further
4 h. The bacterial culture was aliquoted into 50 ml falcon tubes
Table 2. List of Plasmids.
Name Description Source/reference
pSA10 pKK177-3 with LacP Schlosser-Silverman et al. (2000)
pRK5::myc-rhoAN17 Dominant negative RhoA Pelletier et al. (2005)
pRK5::myc-rac1N19 Dominant negative Rac1 Pelletier et al. (2005)
pRK5::myc-cdc42N19 Dominant negative Cdc42 Pelletier et al. (2005)
pEGFPC1::GFP-rhoGN19 Dominant negative RhoG Handa et al. (2007)
pEGFPC1::elmoT625 Dominant negative ELMO Handa et al. (2007)
pCXN2::dock180ISP Dominant negative Dock180 Handa et al. (2007)
pGex::GST-CRIBWASP Cdc42 binding motif of WASP Sander and Collard (1999)
pGex::GST-PAK Rac1 and Cdc42 binding domain of PAk Sander and Collard (1999)
pEGFPC1::elmo Elmo GFP tagged Handa et al. (2007)
pICC427 pSA10::espT-HA This study
pICC228 pRK5::espT-Myc This study
pICC429 pRK5::IpgB1-Myc This study
pICC320 pRK5::EspM2-Myc This study
Table 3. List of primers.
Name Sequence
EspT-HA-F 5′-TTGAATTCATGCCGGGAACAATAAGCTCCAG-3′
EspT-HA-R 5′-TTCTGCAGTTAAGCGTAGTCTGGGACGTCGTATGGGTAGGTTCTCTGAGCCTCCTGAA-3′
EspT-pRK5-F 5′-CGCGGATCCATGCCGGGAACAATAAGCTCCAG-3′
EspT-pRK5-R 5′-CCAATGCACTGCAGTTAGGTTCTCTGAGCCTCCTGAA-3′
EspM2-pRK5-F 5′-TTTGGATCCGGAGCAATGCAAATTCTAAACAAAATAC-3′
EspM2-pRK5-R 5′-TTTGAATTCTCATCCCTGTATAGCACGCATCA-3′
IpgB1-pRK5-F 5′-TTTGGATCCGGAGCAATGCAAATTCTAAACAAAATAC-3′
IpgB1-pRK5-F 5′-CCAATGCATTGGTTCTGCAGTTAATTTGTATTGCTTTGAC-3′
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and centrifuged for 15 min at 4600 r.p.m. at 4°C and the pellets
stored at -80°C. The pellets were re-suspended in lysis buffer
[20% Saccharose, 10% glycerol, 50 Mm Tris pH 8, 200 mM
Na2S2O3, 2 mM MgCl2, 2 mM DTT and 1% of protease inhibitor
cocktail (Sigma)] and sonicated five times for 10 s. The lysate
was centrifuged for 30 min at 15 000 r.p.m. at 4°C. The cleared
lysate was coupled to GST-glutathione S transferase beads
(GE healthcare) for 45 min at 4°C.
Cell culture flasks of 75 cm2 were seeded with Swiss 3T3 cells,
infected as described above and the cells lysed in 750 ml of
Mg++ buffer [25 mM HEPES, pH 7.5, 150 mM NaCl, 1% NP-40,
10 mM MgCl2, 5% glycerol, 1 mM EDTA and protease inhibitors
(Sigma)]. The lysate was transferred to a pre-chilled eppendorf
tube and centrifuged at 14 000 r.p.m. for 5 min at 4°C. The
cleared lysate was transferred to a fresh pre-chilled eppendorf
tube containing 30 ml of GST-Pak-RBD or GST-WASP-CRIB
beads as appropriate. The lysate was incubated with the beads
for 1 h at 4°C. The suspension was washed three times in Mg++
buffer spinning down at 14 000 r.p.m. at 4°C between each wash.
The protein was eluted from the beads by the addition of 45 ml of
2¥ protein loading buffer and the samples heated at 100°C for
5 min. The samples were loaded on a 15% SDS-PAGE gel. The
gels were transferred to PVDF by wet transfer. The PVDF mem-
branes were blocked overnight in TBS, 5% BSA at 4°C with
gentle rocking. Each membrane was incubated in either mono-
clonal rabbit anti-Rac-1 (Santa Cruz) or rabbit anti-Cdc42 (Santa
Cruz) as appropriate at a dilution of 1:500 in TBS 5% BSA for
24 h at 4°C with gentle rocking. The membranes were washed
five times in TBS 1% Tween for 5 min and incubated for 45 min
with 1:10000 dilution of goat anti-rabbit (Invitrogen) secondary
antibody coupled to HRP at room temperature. The membranes
were developed using ECL reagents (GE healthcare) before
detection using chemiluminescence in a LAS 3000 Fugi imager.
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Enterohaemorrhagic Escherichia coli (EHEC) and enteropathogenic E. coli (EPEC) translocate
dozens of type III secretion system effectors, including the WxxxE effectors Map, EspM and EspT
that activate Rho GTPases. While map, which is carried on the LEE pathogenicity island, is
absolutely conserved among EPEC and EHEC strains, the prevalence of espM and espT is not
known. Here we report the results of a large screen aimed at determining the prevalence of espM
and espT among clinical EPEC and EHEC isolates. The results suggest that espM, detected in
51% of the tested strains, is more commonly found in EPEC and EHEC serogroups that are
linked to severe human infections. In contrast, espT was absent from all the EHEC isolates and
was found in only 1.8% of the tested EPEC strains. Further characterization of the virulence gene
repertoire of the espT-positive strains led to the identification of a new f2 intimin variant. All the
espT-positive strains but two contained the tccP gene. espT was first found in Citrobacter
rodentium and later in silico in EPEC E110019, which is of particular interest as this strain was
responsible for a particularly severe diarrhoeal outbreak in Finland in 1987 that affected 650
individuals in a school complex and an additional 137 associated household members. Comparing
the protein sequences of EspT to that of E110019 showed a high level of conservation, with only
three strains encoding EspT that differed in 6 amino acids. At present, it is not clear why espT is so
rare, and what impact EspM and EspT have on EPEC and EHEC infection.
INTRODUCTION
Enterohaemorrhagic Escherichia coli (EHEC) comprise a
subgroup of Shiga-toxin producing E. coli that can cause
bloody diarrhoea, haemorrhagic colitis and haemolytic-
uraemic syndrome (reviewed by Tarr, 1995). EHEC
O157 :H7 is the most common and virulent serotype that
is implicated worldwide in human disease, although non-
O157 EHEC serotypes, particularly O26, O103, O111,
O118 and O145, are also prevalent (reviewed by Nataro &
Kaper, 1998). Enteropathogenic E. coli (EPEC) is the
leading cause of mortality due to infantile diarrhoea in the
developing world (reviewed by Chen & Frankel, 2005).
EPEC strains comprise a diverse group of serotypes that
may be divided into typical EPEC (tEPEC) and atypical
EPEC (aEPEC) based on the presence or absence of a large
virulence plasmid (EAF), respectively (Kaper, 1996)
EPEC and EHEC, as well as the mouse pathogen
Citrobacter rodentium (reviewed by Mundy et al., 2005),
colonize the gut mucosa via attaching and effacing (A/E)
Abbreviations: A/E, attaching and effacing; aEPEC, atypical
enteropathogenic Escherichia coli; EHEC, enterohaemorrhagic
Escherichia coli; EPEC, enteropathogenic Escherichia coli; SF, sorbitol
fermenting; tEPEC, typical enteropathogenic Escherichia coli.
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The GenBank/EMBL/DDBJ accession numbers for the eae-f2 variant
gene sequences of E110019 and T2381-8 are FM872419 and
FM872420, respectively.
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lesions, which are characterized by the close association of
the bacteria with the enterocyte plasma membrane and
localized breakdown of the brush border microvilli
(Knutton et al., 1987; reviewed by Frankel & Phillips,
2008). The ability to induce A/E lesions is associated with
the LEE pathogenicity island, which encodes gene regula-
tors, intimin (Jerse et al., 1990), a type III secretion system
(Jarvis et al., 1995), chaperones, translocator and effector
proteins (reviewed by Garmendia et al., 2005a). The
principal effector protein needed for A/E lesion formation
is Tir, which, once translocated, is integrated into the
mammalian cell plasma membrane where it serves as a
receptor for intimin (Kenny et al., 1997). Recent studies
have shown that different EPEC and EHEC strains encode
distinct intimin and Tir types; currently there have been 27
intimin and 8 Tir types reported (Blanco et al., 2006a, b;
Garrido et al., 2006; J. Blanco, unpublished data).
EPEC E2348/69, which is the prototype strain used
worldwide to study EPEC infection, encodes 21 LEE and
non-LEE effectors (Iguchi et al., 2009). Other EPEC strains
encode a greater number of T3SS effectors: 28 in EPEC
B171 (Ogura et al., 2008), 40 in EPEC E22 and 24 in EPEC
E110019 (Iguchi et al., 2009). EHEC O157 Sakai encodes
50 effectors, representing the most complex repertoire
among A/E pathogens (Tobe et al., 2006). This shows that
the A/E pathogen class is much more heterogeneous than
was previously thought, comprising strains expressing
unique complements of T3SS effector proteins and as a
result employing diverse infection strategies.
A novel family of T3SS effectors, known as the WxxxE
proteins, was recently described (Alto et al., 2006), which
include IpgB1 and IpgB2 from Shigella, SifA and SifB from
Salmonella, and Map (Kenny & Jepson, 2000), EspM
(Arbeloa et al., 2008) and EspT (Bulgin et al., 2008) from
EPEC and EHEC. Members of the WxxxE family are
important virulence factors. For example, SifA is essential
for intracellular Salmonella survival (Beuzon et al., 2000)
and IpgB1 is essential for Shigella cell invasion (Ohya et al.,
2005). Map, which is encoded on the LEE pathogenicity
island and is absolutely conserved among EPEC and EHEC
strains, plays a role in colonization in vivo (Mundy et al.,
2004) and triggers transient filopodia by activating the Rho
GTPase Cdc42 (Kenny et al., 2002; Berger et al., 2009). The
different EspM variants induce formation of stress fibres by
activating RhoA (Arbeloa et al., 2008), while EspT from the
C. rodentium induces formation of extensive lamellipodia
by activation of Rac-1 and Cdc42 (Bulgin et al., 2009). By
sequence homology searches we recently identified homo-
logues of espM and espT in EPEC strain E110019 (Bulgin
et al., 2009), a clinical isolate from a diarrhoeal outbreak in
Table 1. Distribution of espM and espT among 151 non-O157 clinical EHEC strains (Spain)
The strains were isolated in Spain, except for strain FV10110 O111 :H8, which was isolated in Germany. espM–espT negative
strains were: ONT :HNT (2), ONT :H5 (1), ONT :H8 (1), ONT :H18 (1), ONT :H39 (1), O2 :H27 (1), O8 :H2 (1), O8 :H19
(1), O15 :H16 (1), O15 :H28 (1), O18 :ND (2), O22 :H42 (1), O55 :H- (1), O63 :HND (2), O64 :H21 (1), O76 :ND (2),
O76 :H19 (2), O84 :HNT (1), O84 :HND (1), O91 :H- (2), O98 :H- (1), O104 :HNT (4), O113 :HND (2), O113 :H21 (2),
O117 :HND (1), O136 :HND (1), O141 :HND (1), O146 :H- (1), O146 :H21 (4), O148 :HND (2), O148 :H8 (1), O165 :H-
(1), O166 :HND (1), O166 :H28 (1), O168 :H8 (1), O174 :H21 (1), O183 :H- (1).
Serotype (no. of strains) VT type espM espT
O H
ONT (14) HND (7), H- (6), H11 (1) 1, 2 4 0
O5 HND (3) 1, 2 2 0
O14 H- (1) 1 1 0
O26 (37) HND (17), H- (2), H8 (1), H11 (17) 1 36 0
O32 H6 (1) 1 1 0
O69 H21 (1) 1 1 0
O80 HND (1) 1, 2 1 0
O98 H21 (1) 1 1 0
O103 (6) HND (1), H2 (5) 1, 2 6 0
O111 (10) HND (5), H- (3), H8 (1)*, H10 (1) 1, 2 9 0
O118 (6) HND (3), H- (1), H16 (2) 1 6 0
O121 (2) H19 (1), H40 (1) 2 2 0
O145 (3) HND (1), H- (2) 1, 2 3 0
O146 HND (10) 1, 2 1 0
O156 H25 (2) 1 2 0
O139, O141 HND (1) 1, 2 1 0
VT, Verocytotoxin.
*Strain FV10110 O111 :H8 was isolated in Germany.
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Finland in 1987 (Viljanen et al., 1990). EspME110019 is
100% identical to the EspM of EHEC O157 Sakai, while
EspTE110019 shares 79% sequence homology with the C.
rodentium EspT, including the WxxxE motif. The aim of
this study was to determine the prevalence of espM and
espT among clinical EPEC and EHEC isolates.
METHODS
Bacterial strains. The bacterial strains used in this study included
EPEC strains E2348/69 (Levine et al., 1978) and E110019 (Viljanen et
al., 1990), EHEC O157 :H7 strain Sakai (Hayashi et al., 2001), C.
rodentium strain ICC169 (Barthold et al., 1976; Wiles et al., 2004),
and 932 clinical EHEC and EPEC isolates.
Serotyping. The determination of O and H antigens was carried out
using the method described by Guine´e et al. (1981) employing all
available O (O1–O185) and H (H1–H56) antisera. All antisera were
obtained and absorbed with the corresponding cross-reacting
antigens to remove the non-specific agglutinins. The O antisera were
produced in the Laboratorio de Referencia de E. coli and the H
antisera were obtained from the Statens Serum Institut, Copenhagen,
Denmark.
Prevalence of espT and espM among clinical EPEC and EHEC
strains. In order to screen for espM by PCR we used the eight espM
sequences identified in EHEC O157 strain Sakai, EPEC strains B171
and E22, and C. rodentium to design common internal espM-1 (59-
TCTTTCAGCTCTTTTGGTAT-39) and espM-2 (59-CCAAAAGAA-
GCATTCCCCATTAT-39) forward and reverse primers (30 cycles of
94 uC for 45 s, 48 uC for 1 min and 72 uC for 1 min). The identity of
representative PCR amplicons was confirmed by DNA sequencing. A
second round of PCR was employed to screen representative espM-1
and espM-2 PCR negative strains using primers espM-3 (59-
TGATGAGGTCATGAAATGTTCAAT-39) and espM-4 (59-ATGATT-
AATAGAACTTTG-39) (30 cycles of 94 uC for 45 s, 50 uC for 1 min
and 72 uC for 1 min).
We used the espT sequences from C. rodentium and E110019 to design
internal espT-1 (59-AATCTCATTCTCTTATC-39) and espT-2 (59-
TCATGTGATGAGTGGATG-39) primers for PCR (30 cycles of 94 uC for
45 s, 55 uC for 1 min and 72 uC for 1 min).
A further three rounds of PCR were employed to screen representative
espT-1 and espT-2 PCR-negative strains using additional common
internal primers espT-3 (59-ATAGATGGTTTCTTTTTAGG-39) and
espT-4 (59-CATCCAACGAGAAACCGCAAT-39), and primers espT-5
(59-CCGgaattcATGCCGGGAACAATAAGCTCCAG-39) and espT-6
(59-GGGAAGCTTTTAGGTTCTCTGAGCCTC-39) and espT-7 (59-
TTGAATTCATGCATAGCATGCCAGGA-39) and espT-8 (59-CCAA-
TGCACTGCAGGGAGCATTAAACATATTTTAAATTTCTC-39), which
correspond to the 59 and 39 ends of the C. rodentium and E110019 espT
homologue, respectively (30 cycles of 94 uC for 45 s, 52 uC for 1 min
and 72 uC for 1 min).
EHEC O157 :H7 Sakai, C. rodentium and EPEC E2348/69 were used
as positive and negative controls.
Intimin, Tir and TccP typing of the espT-positive strains. Intimin
and Tir typing was performed by PCR and sequencing as previously
described (Blanco et al., 2006b; Garrido et al., 2006). The nucleotide
sequence of the amplification products purified using a QIAquick
DNA purification kit (Qiagen) was determined by the dideoxynu-
cleotide triphosphate chain-termination method of Sanger, with a
BigDye terminator v3.1 cycle sequencing kit and an ABI 3100 genetic
analyzer (Applied Biosystems). The new eae sequences of the strains
analysed were deposited in the European Bioinformatics Institute
EMBL nucleotide sequence database. The presence of tccP2 was
determined by PCR as described by Whale et al. (2007).
Table 2. Distribution of espM and espT among 132 tEPEC strains
espM–espT negative strains were: ONT :HND (1), ONT :H1, H12 (1), ONT :H8 (1), ONT :H25 (1), O1 : H1, H12 (1),
O55 :H8 (1), O86 :H8 (1), O88 :H5 (2), O98 :HND (1), O127 :H40 (3), O131 :H46 (2), O153 :H8 (1), O157 :H45 (1).
Serotype (no. of strains) Origin espM espT
O H
ONT (2) H6 (1), H10 (1) Bolivia 2 0
O23 (2) HND (1), H8 (1) Spain 2 0
O49 H10 (5) Spain, Bolivia 5 0
O55 (22) H- (8), H6 (6), H51 (8) Uruguay, Bolivia, Brazil, UK 19 0
O86 (6) H- (2), H34 (4) Bolivia, Brazil 6 0
O88 (17) H- (1), H6 (1), H25 (15) Spain, Bolivia 3 0
O103 (3) H- (1), H7 (2) Bolivia 3 0
O109 H- (2) Spain, Chile 1 0
O111 (20) H- (12), H2 (7), H25 (1) Spain, Bolivia, Brazil, Uruguay 19 1
O118 (4) HND (1), H- (1), H5 (2) Spain, Germany 4 0
O119 (17) H- (2), H6 (15) Bolivia, Brazil, Uruguay 16 0
O125 H- (1) Burundi 1 0
O127 H6 (3) Bolivia, Brazil 1 0
O132 H8 (1) Bolivia 1 0
O142 (6) H6 (2), H34 (4) Brazil, Spain 4 0
O145 H45 (3) Brazil 3 0
O153 H11 (1) Spain 1 0
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Table 3. Distribution of espM and espT among 602 aEPEC strains
espM–espT negative strains were: ONT :H2 (2), ONT :H6 (4), ONT :H9 (1), ONT :H10 (2), ONT :H11, 21, 34 (1), ONT :H19 (2), ONT :H21, 39
(1), ONT :H34 (1), ONT :H40, 43 (2), ONT :H51 (1), O1 :H2 (1), O1 :H11 (1), O1 :H46 (1), O1 :H49 (1), O2ab :H45 (1), O2 : NT (1), O2 :H6
(1), O2 :H16 (1), O2 :H45 (1), O2 :H49 (2), O3 :H4 (1), O5 :H6 (1), O5 :H40 (1), O5 :H49 (1), O6 :H4 (1), O6 :H16 (1), O9 :HND (2),
O11 :H16 (2), O12 :HND (1), O13 :H11 (1), O15 :H- (2), O15 :H7 (1), O16 :H- (1), O18 :H7 (1), O18 :H16 (1), O20 :H6 (1), O21 :HND (2),
O21 :H15 (1), O23 :HND (1), O24 :H2 (1), O25 :HND (2), O25 :H1 (1), O26 :H2 (1), O28 :HND (1), O33 :HNT (1), O33 :H6 (1), O33 :H34 (1),
O34 :H- (1), O41 :H- (1), O49 :H40 (1), O51 :H41 (1), O55 :H40 (1), O56 :H6 (1), O63 :HND (1), O64 :H40 (1), O71 :H1, H12 (2), O76 :H19
(1), O84 :HND (1), O84 :H- (2), O85 :H8 (1), O85 :H49 (1), O86 :HNT (1), O86 :HND (1), O88, O168 :HND (1), O98 :H- (1), O98 :H8 (1),
O101 :H33 (2), O103 :H- (3), O103 :H4 (1), O103 :H19 (1), O103 :H40 (1), O104 :H- (2), O105 :HND (1), O105 :H4 (2), O108 :HND (3),
O110 :HND (5), O111 :H9 (1), O111 :H38 (1), O112 :H15 (1), O113 :HND (4), O113 :H- (1), O114 :HND (1), O117 :H11 (1), O117 :H40 (2),
O121 :HND (1), O123 :HND (1), O123 :H19 (1), O123 :H45 (1), O125 :H6 (3), O127 :HND (1), O127 :H6 (1), O128 :H40 (1), O129 :HND (1),
O129 :H- (1), O132 :HND (3), O132 :H5 (3), O137 :HND (3), O137 :H6 (2), O139 :HND (4), O139 :H2 (1), O141 :HND (10), O145 :H2 (1),
O146 :H28 (1), O148 :H8 (1), O153 :H11 (1), O153 :H31 (1), O153 :H40 (1), O156 :H4 (1), O156 :H8 (3), O156 :H33 (1), O157 :H16 (2),
O159 :HND (1), O164 :H- (1), O167 :H27 (1), O168 :H- (1), O171 :H19 (1), O173 :H- (1), O178 :H6 (1), O180 :HND (1), O180 :H2 (1), R : H28
(1).
Serotype (no. of strains) Origin espM espT
O H
ONT (92) HND (38), HNT (4), H- (24), H4 (3), H7 (4), H8 (3), H11 (4), H23 (1),
H33 (2), H40 (6), H45 (3)
Spain, Brazil, Bolivia,
Chile
O1 (3) H7 (1), H40 (1), H45 (1) Brazil, Spain 3 0
O2 (11) ND (3), H40 (8) Spain 3 2
O4 (4) ND (2), H- (1), H1 (1) Spain, Brazil 3 0
O5 ND (7) Spain 2 0
O6 (2) ND (1), H19 (1) Spain 2 0
O8 (5) HND (3), H11 (1), H19 (1) Spain 3 0
O10 (5) HN (3), H- (2) Spain 4 0
O11 HND (4) Spain 4 0
O14 H5 (1) Brazil 1 0
O15 (17) HND (9), H2 (8) Spain 12 0
O18 HND (2) Spain 2 0
O20 HND (2) Spain 2 0
O22 HND (2) Spain 2 0
O25 H2 (1) Spain 1 0
O26 (30) ND (20), H- (6), H11 (4) Spain, Brazil 23 0
O28 H28 (1) Bolivia 1 0
O33 HND (3) Spain 1 0
O49 (12) HND (6), H- (3), H2 (1), H10 (2) Spain, Brazil 6 1
O51 (16) HND (5), H- (2), H1 (1), H40 (6), H49 (2) Spain, Brazil 7 0
O52 H10 (1) Spain 1 0
O57 H7 (3) Spain 3 0
O55 (16) HND (4), H- (1), H6 (1), H7 (9), H51 (1) Spain, Brazil, Bolivia 15 0
O56 H- (1) Spain 1 0
O63 (6) H6 (5), H33 (1) Spain, Brazil 2 0
O64 H25 (2) Spain 1 0
O70 H2 (1) Brazil 1 0
O76 HND (3) Spain 2 0
O80 (9) ND (5), H2 (4) Spain 4 0
O82 (2) HND (1), H10 (1) Spain 2 0
O85 (13) HND (5), H- (2), H31 (5), H43 (1) Spain 4 1
O101 (7) HND (2), H- (5) Spain, Brazil 7 0
O103 (12) HND (11), H2 (1) Spain 4 0
O104 (4) HND (1), H2 (2), H12 (1) Spain, Brazil 2 2
O109 H9 (1) Brazil 1 1
O111 (2) HND (1), H- (1) Spain 2 0
O113 H6 (4) Spain 1 0
O115 (4) HND (1), H8 (3) Spain 3 0
O117 HND (4) Spain 2 0
Distribution of espM and espT among EPEC and EHEC
http://jmm.sgmjournals.org 991
RESULTS AND DISCUSSION
Screening O157 and non-O157 EHEC strains for
the presence of espM and espT
We determined the prevalence of espM and espT among 45
non-sorbitol fermenting (non-SF) EHEC O157 :H7
(expressing VT1 and VT2), isolated in Spain, Canada and
Bolivia, and two SF EHEC O157 :H- (expressing VT2),
isolated in Germany. espM was found in 43 of the non-SF
O157 isolates (96%) and in the 2 SF isolates. We then
screened 151 non-O157 EHEC strains. espM was found in
60 of the 62 (97%) non-O157 EHEC strains belonging to
Table 3. cont.
Serotype (no. of strains) Origin espM espT
O H
O119 HND (2) Spain 2 0
O120 HND (2) Spain 1 0
O123 H- (2) Brazil 2 2
O125 H28 (1) Spain 1 0
O127 H40 (5) Spain, Bolivia 1 0
O128 (4) HND (1), H- (1), H2 (1), H27 (1) Spain 4 0
O132 H34 (3) Spain 3 0
O139 H19 (1) Spain 1 0
O145 (33) Spain, Germany 25 0
O146 HND (1) Spain 1 0
O153 HND (15) Spain 2 0
O154 H9 (1) Brazil 1 1
O156 (8) HND (6), H- (2) Spain 4 0
O157 (5) ND (2), H7 (3) Spain 4 0
O162 (4) H- (2), H21 (1), H33 (1) Spain, Brazil 3 0
O166 HND (1) Spain 1 0
O167 (4) ND (2), H9 (1), H11 (1) Spain 3 0
O177 H11 (1) Spain 1 0
O178 H7 (1) Spain 1 0
O179 H31 (1) Spain 1 0
O115, O152 (15) HND (13), H8 (1), H10 (1) Spain 10 0
R (2) H11, 21 (1), H28 (1) Brazil 1 0
Table 4. Characterization of the espT-positive strains
Serotype
(no.
of strains)
Origin Pathotype espM Intimin Tir Tccp2 GenBank
accession no.
Group 1
O111 :H9 (1) Finland aEPEC + f2 a1 +
ONT :H- (1) Brazil aEPEC + e2 a1 + FM992854
O49 :H- (1) Brazil aEPEC + f2 a1 + FM992855
O85 :H- (1) Brazil aEPEC – i1 a1 + FM992856
O109 :H9 (1) Brazil aEPEC + e2 a1 + FM992857
O111 :H- (1) Spain tEPEC + f2 a1 + FM992858
O123 :H- (2) Brazil aEPEC + e2 a1 + FM992859
O154 :H9 (1) Brazil aEPEC + f2 a1 + FM992860
Group 2
O2 :H49 (1) Spain aEPEC – h1 h1 + FM992862
O2 :H49 (1) Spain aEPEC – i1 a1 – FM992861
Group 3
ONT :H7 (1) Brazil aEPEC + b1 b1 – FM992863
O104 :H2 (1) Spain aEPEC – b1 b1 + FM992864
O104 :H2 (1) Brazil aEPEC – b1 b1 + FM992865
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serogroups O26, O103, O111, O118 and O145 (Table 1).
In contrast espM was found in only 17 of 89 (19%) strains
belonging to the other non-O157 serogroups (Table 1).
All the O157 and non-O157 strains were espT gene
negative.
In order to confirm the absence of espM and espT from the
PCR gene-negative strains, we screened 50 O157 and non-
O157 EHEC strains with a second set of conserved espM
primers (espM-3 and espM-4) and three sets of espT
primers (espT-3 and espT-4, espT-5 and espT-6, and
espT-7 and espT-8). All the isolates remained espM and
espT gene negative in these tests.
Screening tEPEC and aEPEC isolates for the
presence of espM and espT
We screened a total of 132 tEPEC strains, isolated in Brazil,
Bolivia, Burundi, Spain, Chile, Germany, the UK and
Uruguay, and 602 aEPEC strains, isolated in Brazil, Bolivia,
Chile and Spain, for the presence of espM and espT. espM
was found in 91 tEPEC isolates (69%) belonging to 16
different serogroups (the O serogroup of 6 strains was non-
typable – ONT) (Table 2). espM was found in 258 aEPEC
isolates (43%) belonging to 59 different serogroups [the O
serogroup of 109 strains was ONT and of 2 isolates was O
rough (R)] (Table 3). Of the 109 ONT aEPEC, espM was
found in 45 isolates (41%). Among the aEPEC that shared
a serogroup with the major EHEC strains, espM was found
in 23 of 31 (74%) O26, 4 of 12 (33%) O103, 2 of 4 (50%)
O111, 25 of 33 (76%) O145 and 4 of 7 (57%) O157
isolates; in total 58 of 87 (67%). Interestingly, espM was
found in 94% (15 of 16) of the O55 strains, regardless of
serotype. espT was found in only 1 (0.8%) tEPEC strain
(O111 :H-) isolated in Spain and in 12 aEPEC strains (2%)
(Table 3).
In order to confirm the absence of espM and espT from
the PCR gene-negative EPEC strains, we screened 50
tEPEC and 100 aEPEC strains with espM primers 3 and 4,
and espT primers 3 and 4, 5 and 6, and 7 and 8. All the
isolates remained espM and espT gene negative in these
tests.
Further characterization of the espT-positive
strains
Considering that espT was found in only 13 of the total 932
isolates tested, we sequenced their amplicons, and char-
acterized their virulence genes implicated in colonization
(e.g. intimin type) and pedestal formation (e.g. Tir type and
TccP2) as described previously (Garmendia et al., 2005b);
strain E110019 was used as a reference strain. Sequencing of
espT revealed a high level of sequence conservation (Table
4). In the eight strains EspT was identical to that of E110019,
defined as group 1 EspT. In two strains we detected a single
amino acid difference (group 2) and in three other strains we
found 6 amino acids that differed from the EspT of E110019
(group 3) (Fig. 1). All the espT-positive strains encoded a Tir
that can undergo tyrosine phosphorylation and thus trigger
strong actin polymerization in vitro via the Nck-N-WASP
pathway (Kenny, 1999; Gruenheid et al., 2001). All the
strains but two encoded TccP2, which can also activate the
N-WASP actin-signalling pathway (Whale et al., 2007).
Eight of the espT-positive strains (as well as E110019) also
encoded EspM.
Intimin typing was performed by sequencing the variable
39 end of the eae gene from the 14 espT-positive strains
(including E110019) (Table 4) (Blanco et al., 2006b). This
revealed known intimin types in 10 strains: b1 (3 strains),
e2 (4 strains), h1 (1 strain) and i1 (2 strains). Importantly,
we identified a new intimin variant, f2, in 4 of the espT
gene-positive strains (Table 4). We determined the
complete nucleotide sequence of two of the new eae-f2
variant genes (accession numbers FM872419 and
FM872420 for E110019 and T2381-8, respectively). Using
CLUSTAL W software for optimal sequence alignment with
the known 27 eae alleles, we found 98, 92 and 91%
sequence identity with the eae-f1 (AJ271407), eae-a1
(M58154) and eae-a2 (AF530555) genes, respectively.
Conclusions
Our results show that espM is found in approximately 96%
of the strains belonging to the major EHEC serogroups:
O26, O103, O111, O118, O145 and O157, and in a
Fig. 1. Multiple sequence alignment of
representative EspT sequences. The con-
served motif WxxxE is boxed. When compared
with EspTE110019, 8 of the 13 EspT showed
100% sequence identity (ONT :H-, O49 :H-,
O85 :H-, O109 :H9, O111 :H-, O123 :H-
(2), O154 :H9) as represented by sequence
EspT 1. Two strains belonging to serotype
O2 :H49 had 1 amino acid difference, indi-
cated by dark grey (sequence EspT 2), while
three strains O104 :H2 (2), ONT :H (7)
differed in 6 amino acids, indicated by dark
grey and light grey (sequence EspT 3).
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significantly higher proportion than in other non-O157
EHEC strains (P,0.05). Similarly, espM was also more
commonly found in EPEC serogroups O26, O55, O145 and
O157 than in other aEPEC. Among the tEPEC strains espM
was detected in approximately 69% of the tested isolates.
These results suggest that espM is more commonly found
in EPEC and EHEC serogroups that are linked to severe
human infections. In contrast, espT was found only
infrequently and only among EPEC strains (1 tEPEC and
12 aEPEC isolates). espT was first found in C. rodentium
and later in silico in EPEC E110019, which is of particular
interest as it was responsible for a particularly severe
diarrhoeal outbreak in Finland in 1987 that affected 650
individuals, including adults, in a school complex and an
additional 137 associated household members (Viljanen
et al., 1990). Comparing the protein sequences of EspT to
that of E110019 showed a high level of conservation, with
only three strains encoding EspT that differed in 6 amino
acids from the EspT of E110019. At present, it is not clear
why espT is so rare and what impact EspM and EspT have
on EPEC and EHEC infection.
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Abstract
Enteropathogenic Escherichia coli (EPEC) strains are defined as extracellular pathogens which nucleate actin rich pedestal-
like membrane extensions on intestinal enterocytes to which they intimately adhere. EPEC infection is mediated by type III
secretion system effectors, which modulate host cell signaling. Recently we have shown that the WxxxE effector EspT
activates Rac1 and Cdc42 leading to formation of membrane ruffles and lamellipodia. Here we report that EspT-induced
membrane ruffles facilitate EPEC invasion into non-phagocytic cells in a process involving Rac1 and Wave2. Internalized
EPEC resides within a vacuole and Tir is localized to the vacuolar membrane, resulting in actin polymerization and formation
of intracellular pedestals. To the best of our knowledge this is the first time a pathogen has been shown to induce formation
of actin comets across a vacuole membrane. Moreover, our data breaks the dogma of EPEC as an extracellular pathogen and
defines a new category of invasive EPEC.
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Introduction
The human pathogens enteropathogenic Escherichia coli (EPEC)
and enterohemorrhagic E. coli (EHEC) [1] and the mouse pathogen
Citrobacter rodentium [2] are closely related extra-cellular diarrhoeal
agents characterized by their ability to colonize the gut epithelium
via attaching and effacing (A/E) lesion formation (reviewed in [3])
[4]. Similarly to other Gram-negative bacteria EPEC, EHEC and
C. rodentium encode a type III secretion system (T3SS), which is
central to their infection strategy (reviewed in [5]) [6]. This complex
machinery translocate dozens of effector proteins [7,8] directly from
the bacteria to the eukaryotic cell cytoplasm (reviewed in [9]). The
translocated effectors are targeted to various sub-cellular compart-
ments where they subvert a plethora of cell signaling pathways via
interactions with a range of host cell proteins.
The host cell cytoskeleton is a common target of T3SS effectors
[10]. EPEC, EHEC and C. rodentium translocate the effector Tir
into the plasma membrane where it functions as a receptor for the
bacterial outer membrane protein intimin [11]. Intimin:Tir
interaction leads to activation of N-WASP and formation of actin
rich pedestals on which the extracellular bacteria rest [12]. In
addition to Tir, A/E pathogens translocate a variety of other
effectors which also modulate the host cell cytoskeleton including
EspG/EspG2, which induce depolymerization of the microtubule
network [13], Map, which induces formation of transient filopodia
early in infection [14] and EspM which directs formation of actin
stress fibers [15]. Map and EspM are members of the WxxxE
family [15,16,17], which was first grouped together based on
conserved peptide motif consisting of an invariant tryptophan and
glutamic acid residues separated by three variable amino acids and
their shared ability to subvert host cell small GTPase signaling.
Small GTPases cycle between an inactive GDP bound and an
active GTP bound form, allowing them to function as molecular
switches in response to a variety of stimuli. The switch from
inactive to active forms results in a conformational change, which
allows the GTPase to bind downstream mammalian effectors.
Small GTPases are regulated by guanine exchange factors (GEFs),
GTPase activating proteins (GAPs) and guanine dissociation
inhibitor (GDI) proteins (reviewed in [18,19]). The three best
characterized Rho GTPases are RhoA, Rac1 and Cdc42 which
are implicated in formation of stress fibers, lamellipodia and
filopodia respectively (reviewed in [20]).
The WxxxE effectors were originally proposed to be functional
mimics of mammalian small GTPases [16]. However, we have
recently shown that EspM activates RhoA [15] whereas Map induces
filopodia via activation of Cdc42 and RhoA [17]. In addition to Map
and EspM we have recently discovered the novel WxxxE effector
EspT, which is encoded by C. rodentium and a subset of EPEC strains
[21], including EPEC E110019 which caused a sever outbreak in
Finland in 1987 that affected children and adults alike [22]. We have
shown that EspT induces formation of lamellipodia and membrane
ruffles in epithelial cells via activation of Rac1 and Cdc42 [23].
Membrane ruffles are sheet like structures which are induced by
mammalian cells in order to facilitate crawling movement, macro-
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pinocitosis and receptor recycling (reviewed in [24]). These
protrusion are regulated through activity of Rho family GTPases
and their downstream effectors (reviewed in [25]). Importantly, a
subset of invasive bacterial pathogens hijack and subvert mammalian
signal transduction pathways which facilitate formation membrane
ruffles in order to promote bacterial entry into mammalian cells.
Perhaps the best studied of these pathogens are Salmonella and Shigella
which induce extensive membrane ruffles at the site of bacterial
attachment (reviewed in [26,27]). Salmonella invasion is dependent
upon the activity of several T3SS effector proteins including SopE/
E2 which act as GEFs for Rac1 and Cdc42 [28] and SopB which
activates the RhoG GEF SGEF [29]. Shigella has also evolved several
invasive mechanisms. For example the translocator IpaC has been
shown to induce ruffles at the site of Shigella entry via the activation of
Cdc42 [30], recruitment of Src kinase [31] and activation of Abl
kinase [32]. The Shigella WxxxE effector IpgB1 has also been shown
to induce membrane ruffles via interaction with the ELMO
DOCK180 complex which results in activation of Rac1 [33].
EPEC, EHEC and C. rodentium are generally considered
extracellular pathogens and their attachment sites on epithelial
cells are normally characterized by the assembly of an actin rich
pedestal rather than membrane ruffles (reviewed in [3]). However,
in both rabbit and human biopsies EPEC have been visualized
inside enterocytes and detected in the sub mucosa, mesenteric
lymph nodes and spleen [34] (reviewed in [35]). Recently
Hernandes et al has shown that the atypical EPEC strain 1551-2
is capable of invading cultured epithelial cells in an intimin
omicron dependent manner [36]. As EspT induces membrane
ruffles similar to those triggered by IpgB1 [37] the aim of this study
was to investigate if expression of EspT leads to EPEC cell
invasion and to define the underlying mechanism.
Results
EspT-induced membrane ruffles surround adherent
bacteria
A large screen of clinical EPEC isolates for the presence of espT,
a T3SS effector (Fig. S1), has shown that the gene is present in ca.
1.8% of the tested strains [21]. In order to investigate the role of
EspT in cell invasion we selected to use the espT positive strains
E110019 and C. rodentum; the espT negative EPEC, strain JPN15
[38], was used as a control. In addition, we generated a JPN15
clone that expresses EspT from the bacterial expression vector
pSA10 (pICC461).
We infected serum starved HeLa, Swiss 3T3 and Caco2 cells
with E110019, JPN15 and JPN15 expressing EspT; the cells were
then fixed and processed for scanning electron microscopy (SEM).
The JPN15-infected HeLa and Swiss 3T3 cells displayed
characteristic diffuse bacterial adhesion without any noteworthy
surface structures. Caco2 cells infected with JPN15 also show a
diffuse pattern of bacterial adherence and a concordant localized
effacement of microvili (Fig. 1). HeLa cells infected with JPN15
expressing EspT or E110019 displayed extensive membrane
ruffling over the entire cell surface (Fig. 1); in the vicinity of
adherent bacteria the ruffles surrounded and wrapped individual
bacterial cells forming structures which appear permissive for
internalization. Swiss 3T3 cells infected with JPN15 expressing
EspT or E110019 exhibited extensive dorsal ruffles and lamelli-
podia in addition to localized membrane ruffles at the site of
bacterial attachment (Fig. 1). Caco2 cells infected with JPN15
expressing EspT or E110019 displayed prominent membrane
ruffles at the site of bacterial adherence in addition to effacement
of micovili (Fig. 1). These results show that EspT can induce actin
remodeling and surface structures, similar to those associated with
Shigella and Salmonella invasion (reviewed in [26]).
Wave2 and Abi1 are localized to membrane ruffles and
lamellipodia induced by EspT
We have recently shown that remodeling of the host cell actin
cytoskeleton by EspT is dependent on Rac1 and to a lesser extent
Cdc42 [23]. Rac1 and Cdc42 utilize a plethora of downstream
effectors in order to regulate cytoskeletal dynamics (reviewed in
[19] and [25]). Several GTPase effectors including IRSp53, N-
WASP, Pak, Wave2 and Abi1 have been previously been
implicated in formation of membrane ruffles [39,40,41,42]. By
using immuno-fluorescence microscopy we found that both Wave2
and Abi1 were present and co-localized with actin at membrane
ruffles and the leading edge of lamellipodia induced by EspT
(Fig. 2), while N-WASP was not (data not shown). The signaling
protein IRSp53 has been proposed to participate in Abi1-Wave2-
Rac1 complex formation [39,43]. While we did not detect any
significant enrichment of IRSp53 in lamellipodia, IRSp53 was
localized to membrane ruffles nucleated by EspT (Fig. S2). Taken
together these results show that Abi1 and Wave2 are localized to
membrane ruffles and lamellipodia induced by EspT but IRSp53
is only recruited to EspT-induced membrane ruffles.
Wave2 is essential for EspT-induced membrane
remodeling
Wave2 is a ubiquitously expressed member of the WASP super
family of actin regulators which potently activates the Arp2/3
complex [44]. The Wave family of proteins have a modular
structure consisting of a N terminal Wave homology domain
(WHD), a central proline rich region (PRR) and a C terminal
Arp2/3 binding domain (VCA module) (reviewed in [45]). The
WHD domain has been shown to bind Abi1 [42] and the PRR has
been shown to interact with the SH3 domain of IRSp53 [39]. We
utilized siRNA in order to determine if Wave2 is essential for
formation of the EspT-dependent membrane ruffles. Depletion of
endogenous Wave2 from Swiss 3T3 cells, confirmed by Western
blotting (Fig. 3A), resulted in a marked decrease in formation of
Author Summary
Enteropathogenic E. coli (EPEC) is an important diarrheal
pathogen responsible for significant infant mortality in the
developing world and is increasingly associated with
sporadic outbreaks in the developed world. The virulence
strategy of EPEC revolves around a conserved Type 3
secretion system (T3SS) which translocates bacterial
effector proteins directly into host cells. EPEC is considered
to be a non-invasive pathogen which intimately adheres to
host cells and polymerizes actin rich pedestals on which
extracellular bacteria rest. Recently we have identified the
T3SS effector EspT which activates the mammalian Rho
GTPases Rac1 and Cdc42, resulting in the formation of
membrane ruffles and lamellipodia. In this study we
dissect the signaling pathway utilized by EspT to nucleate
membrane ruffles and demonstrate that these ruffles can
promote EPEC invasion of host cells. Furthermore, we
show that internalized EPEC are bound within a vacuole.
We also report for the first time the ability of a bacterial
pathogen to form actin comet tails across a vacuole
membrane. In addition to providing novel insights into the
subversion of cellular signaling by invasive pathogens, our
study also breaks the long held dogma of EPEC as an
extracellular pathogen and will have implications on how
future EPEC infections are diagnosed and treated.
Invasive EPEC Form Intracellular Pedestals
PLoS Pathogens | www.plospathogens.org 2 December 2009 | Volume 5 | Issue 12 | e1000683
membrane ruffles and lamellipodia induced by JPN15 expressing
EspT or E110019, compared with cells treated with scrambled
siRNA (Fig. 3B). In order to determine which of the Wave2
domains is required for formation of lamellipodia and membrane
ruffles by EspT, we transfected Swiss 3T3 and HeLa cells with full
length Wave2 or dominant negative forms of Wave2 lacking the
WHD (DBP) or the acidic Arp2/3 interacting domain (DA).
Transfected cell were infected for 1.5 h with JPN15 expressing
EspT and the presence of lamellipodia or membrane ruffles was
assessed. Mock transfected cells or cells transfected with full length
Wave2 had lamellipodia and membrane ruffles on 80 to 90% of
infected cells (Fig. S3). In contrast, transfection with either the
DBP or the DA Wave2 dominant negative constructs resulted in
significant reduction in lamellipodia and membrane ruffle
formation (Fig. S3). This result demonstrates that binding of
Arp2/3 to Wave2 is essential for EspT-mediated formation of
lamellipodia and membrane ruffles. Furthermore, the observation
that the N terminal truncated Wave2 DBP construct has a
dominant negative effect suggests that the WHD motif is also
required for EspT mediated cytoskeletal rearrangements. The fact
that the Wave2 DBP construct, which is capable of binding
IRSp53 but not Abi1, is not sufficient to induce EspT dependent
actin remodeling further indicates that IRSp53 does not play a
prominent role in EspT mediated signaling.
EspT facilitates EPEC invasion
Induction of membrane ruffles is a mechanism employed by a
range of pathogenic bacteria in order to facilitate cell invasion.
This method of bacterial invasion is referred to as the trigger
mechanism and relies upon induction of actin polymerization to
form an entry foci and a macropinocytic pocket (reviewed in [26]).
JPN15 expressing EspT and E110019 induce host cell membrane
remodeling which is reminiscent of entry foci and membrane
ruffles induced by Shigella and Salmonella (reviewed in [26]) (Fig. 1).
We used differential staining to visualize invasion of Swiss 3T3
cells by JPN15, JPN15 expressing EspT, and E110019; Salmonella
enterica serovar Typhimurium strain SL1344 was used as a control.
In addition, we conducted gentamycin protection assays to quantify
Figure 1. Scanning electron microscopy of HeLa, Swiss 3T3 and polarized Caco2 cells infected with JPN15, JPN15 expressing EspT
or E110019 for 2 h. JPN15 displayed a pattern of diffused adherence on HeLa, Swiss 3T3 and Caco2 cells but did not induce any significant
membrane remodeling. JPN15 expressing EspT and E110019 also adhered to HeLa, Swiss 3T3 and Caco2 cells in a diffuse pattern but induced
membrane ruffles at the site of bacterial attachment, which were more pronounced on Caco2 cells. In addition to membrane ruffles JPN15 expressing
EspT and E110019 also induced formation of lamellipodia and dorsal ruffles at locations distal from the site of bacterial attachment on Swiss 3T3 cells.
Magnifications: HeLa cells X5000; Swiss 3T3 X3500; Caco2 X10000 and X6500 (middle).
doi:10.1371/journal.ppat.1000683.g001
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cell invasion of Swiss 3T3, HeLa and Caco2 cells after 3 h infection.
Differential immuno-fluorescence staining and gentamycin protec-
tion assays were also performed in HeLa and Swiss 3T3 cells
infected for 6 h with wild type C. rodentium, C. rodentium DespT and
complemented C. rodentium DespT. For immuno-fluorescence
extracellular bacteria were stained pre cell permeabilzation with
primary anti O127 (JPN15), anti O111 (E110019), anti O152 (C.
rodentium) or anti LPS (S. Typhimurium) antibodies and a secondary
antibody coupled to a Cy3 fluorophore (red). The cells were then
permeabilized and total bacteria were stained with the same
primary antibodies and a secondary antibody coupled to a Cy2
fluorophore (green), Alexafluor 633 phalloidin and Dapi were used
to visualize actin and DNA respectively.
Adherent JPN15 bacteria were homogenously stained by both
the extracellular and total bacterial probes, indicating that this
strain is not significantly invasive (Fig. 4A). In cells infected with
JPN15 expressing EspT or E110019 a significant proportion of the
bacteria were labeled with the total bacterial stain but not by the
extracellular probe (Fig. 4A). S. Typhimurium-infected cells
exhibited characteristic membrane ruffling at the entry foci and
a high proportion of bacteria were labeled only with the total
bacterial probe (Fig. 4A).
The quantitative gentamycin protection assay revealed that
JPN15 does not efficiently invade HeLa, Swiss 3T3 or Caco2 cells,
exhibiting an invasion rate of less than 1.5% (Fig. 4B). JPN15
expressing EspT was significantly more invasive with an invasion
rate of 15.5% in Swiss 3T3, 14.3% in HeLa and 7.2% in Caco2
cells (Fig. 4B). E110019 invaded Swiss 3T3, HeLa and Caco2 cells
at a rate of 9.2%, 11.4% and 5.8% respectively. The invasive
capacity of EPEC was significantly less than S. Typhimuriumin
(Fig. 4B). Infection of HeLa cells with JPN15 expressing EspTW63A
for 3 h confirmed that the WxxxE motif plays a major role in
membrane ruffling and cell invasion (Fig. S4).
E110019 is multi drug resistant, which limits the ability to
genetically modified the isolate. In order to determine if cell invasion
is mediated by EspT, we infected Swiss 3T3 cells for 6 h with wild
type C. rodentium and C. rodentium DespT. Infection with wild type C.
rodentium resulted in membrane ruffles and cell invasion, while the
espT mutant exhibited neither (Fig. 4B). Complementing the mutant
with espT expressed from pACYC184 (pICC489) restored mem-
brane ruffle formation and cell invasion (Fig. 4B and S5).
In order to confirm that EspT can promote EPEC invasion of
non-phagocytic cells independently of other T3SS effectors we
ectopically expressed EspT in HeLa cells prior to infection with
Figure 2. Wave2 and Abi1 are localized to membrane ruffles and lamellipodia induced by ectopically expressed EspT. Actin was
stained with Oregon Green phalloidin (Green), Wave2 was detected with a polyclonal rabbit antibody (Red) and Abi1 was visualized using a mouse
monoclonal antibody (Yellow). Mock transfected cells did not display any significant actin structures and Wave2 and Abi1 were localized diffusely in
the cytoplasm. HeLa cells transfected with pRK5::espT exhibit prominent membrane ruffles on their apical surface which were enriched with Wave2
and Abi1. Ectopic expression of EspT in Swiss 3T3 cells resulted in formation of distinctive lamellipodia to which Wave2 and Abi1 were extensively
recruited and co-localized.
doi:10.1371/journal.ppat.1000683.g002
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EPEC DescN, a T3SS null mutant. Cells ectopically expressing
EspT displayed membrane ruffling which facilitated the uptake of
DescN bacteria (Fig. S6). No membrane ruffles were observed in
cells ectopically expressing EspTW63A (data not shown). These
results show that EspT induces EPEC cell invasion by a trigger
mechanism, analogous to that of Shigella and Salmonella.
Rac1 and Wave2 are essential for EspT mediated bacterial
cell invasion
As actin remodeling by EspT is dependent on activation of
Rac1, Cdc42 [23] and Wave2 (Fig. 3), we utilized dominant
negative constructs of these signaling proteins and Wave2 siRNA
to monitor the effect on invasion of JPN15 expressing EspT and
E110019. Swiss 3T3 cells transfected with dominant negative
Rac1 (Rac1N17), Cdc42 (Cdc42N17), Wave2DA truncated in the
acidic Arp2/3 interacting region and Wave2DBP lacking the
WHD were infected for 3 h. The cells were fixed and stained for
bacterial invasion as described above. Cells transfected with
Cdc42N17 were still permissive of bacterial invasion while cells
transfected with the Rac1N17, Wave2DA or Wave2DBP dominant
negative constructs were not (Fig. 5B). Depletion of Wave2 using
siRNA in Swiss 3T3 cells significantly reduced the invasive
Figure 3. Wave2 is essential for EspT induced membrane remodeling and invasion. (A) Swiss 3T3 cells were treated with Non Targeting
(NT) siRNA or siRNA targeted against Wave2. (A) Western blot with lysates from Swiss 3T3 cells treated with NT and Wave2 siRNA. Wave2 and Tubulin
were detected with monoclonal antibodies. Non Targeting siRNA did not alter Wave2 expression whereas treatment with Wave2 siRNA depleted the
protein. Protein levels in the lysates were normalized using anti tubulin antibodies. (B) Quantification of membrane remodeling induced by E110019
and JPN15 expressing EspT in Swiss 3T3 cells treated with NT and Wave2 siRNA after 3 h of infection. 100 cells were counted in triplicate resulted are
presented as mean6SEM. Treatment with Wave2 siRNA oligos reduced the level of membrane remodeling induced by JPN15 pSA10::espT and
E110019 to 10% and 5% respectively. This is comparable to the 9% of cells which display membrane ruffle and lamellipodia formation in cells infected
with EPEC not expressing EspT. (C) Cells were infected with E110019 for 3 h were fixed and stained prior to permeabilization (extracellular labeling)
(Red). The cells were then washed, permeabilized, re-labeled (Total labeling) (Green) along with Alexaflour 633 Phalloidin (Cyan) and Dapi (Blue). In
cells treated with the NT siRNA E110019 induced formation of membrane ruffles and a large proportion of bacteria were labeled by the total stain
which were absent from the extracellular labeling. Depletion of Wave2 using siRNA inhibited formation of membrane ruffles by E110019 and the
majority of bacteria were detected by both the extracellular and total staining demonstrating that depletion of Wave2 inhibits EPEC invasion.
doi:10.1371/journal.ppat.1000683.g003
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Figure 4. EspT-dependent actin remodeling facilitates bacterial invasion of epithelial cells. (A) Swiss 3T3 cells infected with JPN15, JPN15
expressing EspT, E110019 or S. Typhimurium for 3 h were fixed and stained prior to permeabilization (extracellular labeling) (Red). The cells were then
washed, permeabilized, re-labeled (Total labeling) (Green) along with Alexaflour 633 Phalloidin (Cyan) and Dapi (Blue). In cells infected with JPN15 all
the bacteria labeled by the total staining were also detected with the extracellular probe indicating that there was no significant invasion
(highlighted with arrows). Significant numbers of bacteria labeled with the total stain, which were not represented in the extracellular staining, were
seen in cells infected JPN15 expressing EspT, E110019 and S. Typhimurium indicating that there was a significant degree of bacterial invasion
(highlighted with arrows). (B) Gentamycin protection assay of Swiss 3T3 and HeLa cells infected JPN15, JPN15 expressing EspT, E110019, S.
Typhimurium, C. rodentium, C. rodentium DespT or complemented C. rodentium DespT and polarized Caco2 cells infected with JPN15, JPN15
expressing EspT, E110019 or S. Typhimurium. Results are representative of 3 independent experiments carried out in duplicate and are displayed as
mean6SEM.
doi:10.1371/journal.ppat.1000683.g004
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capacity of both JPN15 expressing EspT and E110019 compared
to cells treated with non-targeting siRNA (Fig. 3A and 5B). Thus,
Rac1, Wave2 and Abi1 are essential mediators of EspT-induced
bacterial invasion.
Internalized EPEC are bound within a vacuole
After the initial invasion of host cells internalized bacteria are
often bound within a vacuole which resembles early endosomes
(reviewed in [46]). Intracellular bacteria either remain within the
vacuole or rapidly escape to the cytoplasm [26]. In order to
determine whether invasive EPEC are bound within a vacuole or
free in the cytoplasm HeLa cells were infected with JPN15, JPN15
over expressing EspT (pICC461) and E110019 for 5 min up to
24 h and stained with various vacuolar markers including Early
Endosome Antigen 1 (EEA1), Vacuolar ATPase (VATPase) and
Lamp1. Internalized JPN15 expressing EspT and E110019 were
labeled with EEA1 while external bacteria and JPN15 lacking
EspT were not (Fig. 6 shows staining at 45 min post infection).
EEA1 staining was apparent after 5 min and persists up to 1 h
post infection (data not shown). At 3 h and up to 12 h post
Figure 5. Rac1 and Wave2 are essential for EspT-mediated bacterial invasion. (A) Swiss 3T3 cells were left untransfected or transfected with
Non Targeting (NT) or Wave2 siRNA olgos, the ectopic expression vector pDSRed encoding Wave2DA, Wave2DBP or pRK5 expressing dominant
negative Rac1 and Cdc42 and infected with JPN15, JPN15 expressing EspT or E110019. Mock transfected cells or cells transfected with dominant
negative Cdc42 were efficiently invaded by both JPN15 expressing EspT and E110019. Cells transfected with dominant negative Rac1 were
significantly more resistant to bacterial invasion. The Wave2DA and Wave2DBP constructs also had a potent dominant negative effect on bacterial
internalization. (B) Quantification of bacterial invasion; cells which had 3 or more internalized bacteria were scored as invaded. 100 cells were counted
in triplicate in three independent experiments. Results are displayed as mean6SEM.
doi:10.1371/journal.ppat.1000683.g005
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infection the EPEC containing vacuole (ECV) was labeled with
VATPase whilst external bacteria were not (Fig. 7B). Similarly to
the Salmonella containing vacuole (SCV), a subset of ECVs became
enriched with the lysosomal glycoprotein Lamp1 after 16 h (Fig.
S7 and S8) and appear to adopt a perinuclear localization (Fig. 6B).
In order to determine if EPEC bacteria can multiply
intracellularly we infected Swiss 3T3 cells with E110019 for
30 min before extracellular bacteria were killed by gentamycin.
Infected cells were fixed for immuno-fluorescence microscopy at 2,
8, 16 and 24 h post infection. We observed a time dependent
increase in the level of intracellular bacteria suggesting that
internalized EPEC can multiply within host cells (Fig. S8).
Internalized EPEC and C. rodentium form intracellular
actin pedestals
After escaping from the vacuole many intracellular pathogens
such as Shigella, Burkholderia and Listeria utilize specialized outer
membrane proteins to recruit actin nucleating factors in order to
produce a propulsive force (reviewed in [26]). EPEC is
synonymous with actin nucleation which leads to formation of
Tir-dependent actin rich pedestals [12]. During the course of this
study we observed that invasive EPEC were associated with
filamentous actin comets reminiscent of pedestals. Confocal X-
stacks confirmed that the intracellular EPEC bacteria were
associated with pedestal-like filamentous actin structures (Fig. 7A).
In order to determine if Tir was localized at the actin nucleation
sites, we infected HeLa cells for 1 h with JPN15, JPN15 expressing
EspT and E110019; following washes the cells were treated with
gentamycin for a further 8 h. The cells were then stained with
anti-VATPase and anti-Tir antisera in conjunction with phalloidin
and Dapi staining. HeLa cells infected with JPN15 exhibited
extracellular, pedestal-associated, bacteria which were associated
with Tir but not with VATPase (Fig. 7B). In contrast, internalized
JPN15 expressing EspT and E110019 bacteria were co-labeled
with anti-VATPase, actin and Tir (Fig. 7B). Similarly, invasive C.
rodentium also formed intracellular pedestals (Fig. S5), while C.
rodentium Dtir was invasive but failed to trigger actin polymerization
(Fig. S8). In addition, the intracellular EPEC DescN, internalized
by ectopically expressing EspT, were not associated with actin
pedestals (Fig. S6). These results suggest that the actin filaments
associated with EPEC contained within the ECV is nucleated in a
Tir-dependent mechanism analogous to pedestal formation by
extracellular bacteria.
In order to confirm this assertion we infected HeLa cells with
E110019 for 2 h and processed the cells for transmission electron
microscopy (TEM). The TEM confirmed that E110019 bacteria
are internalized via ruffle formation (Fig. 7C). E110019 can also be
seen forming multiple pedestals with the membrane on opposing
surfaces during ruffle formation and closure (Fig. 7D). Moreover,
internalized EPEC bacteria contained within the ECV are
associated actin pedestals, which are strikingly similar to those
normally associated with extracellular EPEC (Fig. 7C–E).
Figure 6. Internalized EPEC bacteria are enclosed within a vacuole. HeLa cells were infected with JPN15, JPN15 expressing EspT and E110019
for 45 min. Internalized bacteria bound within a vacuole were detected by anti EEA1 and a secondary antibody coupled to a CY5 (magenta). DNA was
detected using Dapi staining. Extracellular JPN15 bacteria, which were detected by both the total stain and the extra-cellular probe, were not co-
localized with EEA1. Intracellular JPN15 expressing EspT and E110019 which were detected by the total bacterial probe but not by the pre
permeabilization stain were co localized within EEA1 rich structures indicative of early endosome like vacuoles.
doi:10.1371/journal.ppat.1000683.g006
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Figure 7. Internalized EPEC bacteria incorporate Tir into the vacuolar membrane which nucleates intracellular actin pedestals. (A)
Swiss 3T3 cells were infected with E110019 and processed for immuno-fluorescence confocal microscopy. A series of confocal X-stacks were taken
through the infected cells. The cell boundaries were defined based on actin staining and are marked by a yellow line, the coverslip is represented by
the blue bar. The staining shows intracellular E110019 (Green) associated with actin pedestal-like structures (Magenta). (B) HeLa cells were infected
for 60 min with JPN15, JPN15 expressing EspT, and E110019 were processed for immuno-fluorescence microscopy after 8 h gentamycin treatment.
Actin was stained using Oregon Green phalloidin (Green), Tir was detected using polyclonal Tir antisera (Magenta), Vacuolar ATPase (VATPase) was
detected using a monoclonal antibody (Red) and bacteria were detected using Dapi staining. Cells infected JPN15 recruited Tir to the site of bacterial
attachment and form canonical actin rich pedestals but do not display any bacterial co-localization with the VATPase vacuolar marker. In cells
infected with JPN15 expressing EspT or E110019 a proportion of bacteria were co-localized with VATPase, Tir and actin. (C) A TEM micrograph
showing membrane ruffles engulfing E110019. (D) E110019 has the capacity to form multiple pedestals during ruffle formation and closure. (E)
E110019 bacteria bound within a vacuole with intracellular pedestals formed around its circumference.
doi:10.1371/journal.ppat.1000683.g007
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Interestingly, bacteria bound within ECVs can form multiple
pedestals around their circumference (Fig. 7E).
In order to determine if the formation of intracellular pedestals
by A/E pathogens plays a role in bacterial replication and survival
within host cells we infected Swiss cells with wild type C. rodentium
and C. rodentium Dtir for 1.5 h and with E110019 for 30 min.
Extracellular bacteria were then killed by a gentamycin wash and
the cells incubated for a further 6, 12 or 24 h. We observed that
both wild type C. rodentium and E110019 were capable of
intracellular replication whereas the C. rodentium Dtir mutant failed
to replicate and instead exhibited a slow decline in bacterial
numbers over time (Fig. S8). These results demonstrate that
formation of pedestals by invasive A/E pathogens may play a
functional role during intracellular survival.
Discussion
A/E pathogens have been long considered to be extracellular
bacteria which do not invade mammalian cells [47]. However,
sporadic reports have shown that atypical EPEC strains can
invade non-phagocytic cells [36,48]. The invasive ability has been
linked to intimin-Tir mediated tight association of EPEC with the
host cell membrane which is hypothesized to produce immature
phagocytosis cups leading to a passive push effect and inefficient
internalization [35,36]. In this study we demonstrated for the first
time that EPEC can actively invade non-phagocytic cells by
inducing formation of membrane ruffles, defining a new category
of invasive EPEC. Furthermore we demonstrate that this
phenomenon is dependent on the T3SS effector EspT which has
previously shown activate Rac1 and Cdc42 [23]. We also show
that both actin remodeling and invasion is dependent upon a
functional EspT as JPN15 expressing a EspTW63A failed to induce
membrane ruffles or to invade. Importantly, in a previous report
we indicated that expression of EspT might not confer bacterial
invasion of epithelial cells [23]. However, these experiments were
conducted using EPEC E2348/69, which in contrast to JPN15, C.
rodentium and E110019, forms tight microclonies that mask the
invasion phenotype (data not shown).
Intracellular pathogens have evolved a variety of mechanisms to
promote invasion of mammalian cells, including the trigger
(employed by Salmonella and Shigella) and zipper (employed by
Yersinia and Listeria) mechanisms (reviewed in [26]). The trigger
invasion mechanism is characterized by formation of actin rich
membrane ruffles at the site of bacterial attachment, which are
regulated by Rho GTPases, particularly Rac1 and Cdc42 and
other cytoskeletal regulators such as PI3K [49]. Shigella and
Salmonella utilize T3SS effector and translocator proteins such as
IpgB1 and IpaC and SopB and SopE/2 to hijack host cell GTPase
and phospho-inositol signaling to modulate membrane ruffling
and formation of the macropinocytic pocket [28,29,30,37].
Importantly, although both IpgB1 and EspT belong to the WxxxE
family of effectors and play a prominent role in bacterial invasion
by inducing membrane ruffles, we have recently shown that they
activate Rac1 by distinct mechanisms [23].
Downstream of Rho GTPase signaling, membrane ruffle
formation is nucleated by the WASP super family proteins
including N-WASP and Wave2. Salmonella invasion has been
demonstrated to be at least in part dependent upon the Arp2/3
binding activity of Wave2 and also the association of Wave2 with
Abi1 [50]. Wave2 cannot bind Rac1 directly; two different
mechanisms have been proposed to describe how a Wave2-Rac1
complex is formed. Innocenti et al and Steffen et al demonstrate
that Wave2 binds to Abi1 and two accessory proteins PIR121 and
Nap1 which mediate Rac1 binding [42,51]. A report by Miki et al
proposed that IRSp53 is the protein which links Rac1 to Wave2
[39]. In this study we demonstrate that EspT activation of Rac1
leads to a downstream recruitment of Wave2, Abi1 and IRSp53 to
membrane ruffles. Depletion of endogenous Wave2 using siRNA
resulted in a significant reduction in both the level of membrane
ruffles induced by strains expressing EspT and their associated
invasive capacity. We also show that the Arp2/3 and Abi1 binding
regions of Wave2, but not N-WASP, are required for EspT-
induced membrane ruffles and invasion. Furthermore, a construct
of Wave2 which retained the IRSp53 and Arp2/3 binding regions
but lacked the Abi1 interacting domain had a dominant negative
effect on membrane ruffle formation, suggesting that IRSp53 is
not required for, but may play an accessory role in, EspT-
mediated actin rearrangements.
Once internalized Shigella and Listeria quickly escape the vacuole
(reviewed in [52]). In contrast, Salmonella remains vacuole bound
and utilizes different virulence factors to modify the vacuolar
environment, position and interaction with the host endomem-
brane system in order to create an intracellular replicative SCV
(reviewed in [53]). In this study we demonstrated that after
invasion EPEC is bound within a vacuole (ECV) and remains
vacuolated until at least 16 h post infection. We found that the
ECV is EEA1 positive for up to 1 h post infection and progresses
to being VATPase positive from 3 h to 12 h post infection.
Furthermore, 12 h after infection the ECV appears to adopt a
peri-nuclear position, which resembles the properties of the SCV.
Similarly to the SCV (reviewed in [53]) we found that a subset of
ECVs become enriched in the lysosomal glycoprotein Lamp1
(data not shown) indicating lysosomal fusion with the ECV. We
also demonstrate that internalized EPEC bacteria can survive and
replicate within host cells in a time dependent manner.
Importantly and uniquely, we found that the ECV is associated
with filamentous actin tails, which are reminiscent of the
extracellular pedestals normally nucleated by EPEC stains.
Formation of intracellular actin pedestal were essential for
bacterial survival, as the intracellular population of invasive tir
mutant declined over time.
Formation of extracellular pedestals is dependent upon the
T3SS effector Tir [11]. The interaction of Tir with intimin triggers
recruitment of the mammalian adaptor Nck which in turn recruits
and activates N-WASP leading to Arp2/3 recruitment and actin
polymerization [11,54,55,56]. In this study we found that
internalized EPEC can localize Tir to the vacuolar membrane in
a T3SS dependent manner and that the localization of Tir can
promote actin nucleation. Furthermore, we found that a C.
rodentium Dtir mutant is still invasive but does not form intracellular
pedestals, demonstrating that pedestal formation by internalized
bacteria is a Tir-dependent process analogous to that of
extracellular bacteria. Additionally using TEM we found that
invasive EPEC bound within a vacuole are associated with
intracellular pedestals around the circumference of the bacteria.
Interestingly, membrane ruffles seen engulfing invading EPEC
were occasionally associated with pedestals, suggesting the
pedestals can be formed during or after internalization.
Canonically actin is recruited to the surface of intracellular
pathogens which are non-vacuolated and this recruitment is
mediated by outer-membrane proteins which are free to interact
with host cell signaling molecules present in the cytoplasm. For
example following escape from the vacuole Shigella and Listeria
utilize IcsA/VirG and ActA, respectively, to trigger actin
polymerization and motility (reviewed in [57]). The Vaccinia
virus uses the viral membrane protein A36R in order to generate
actin based motility in a similar manner to the extracellular EPEC
pedestals [58]. Importantly, the SCV is also associated with an
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actin nest which is required to maintain the integrity of the vacuole
and support the intracellular replication of Salmonella (reviewed in
[59]).
Due to the positioning of the actin extensions around the entire
circumference of EPEC it is unlikely these intracellular pedestals
are involved in classical actin-based motility. However, there are
reports suggesting that actin polymerization and depolymerization
around the periphery of E-cadherin-coated beads can lead to
directional movement in process referred to as flashing [60]; for
this reason at this stage we cannot rule out the possibility that
intracellular pedestals confer actin based motility. Furthermore,
formation of intracellular pedestals by invasive EPEC may play a
role in maintaining the vacuole integrity in a similar way to that
described for other vacuolated pathogens [59]. To the best of our
knowledge the current study demonstrates for the first time that an
intracellular bacteria is able to recruit filamentous actin comets to
the pathogen cell surface whilst encapsulated in a vacuole.
In order to survive within intracellular niche vacuolated bacteria
must evade host cell lysosome mediated degradation. Interestingly,
during the course of this study we observed that internalized
EPEC, which were enclosed in ECVs, displaying strong actin
staining around their circumference were rarely Lamp1 positive,
whereas ECVs which had little or no actin polymerization
associated with them were homogenously labeled with Lamp1
(data not shown). Furthermore, we observed that a C. rodentium Dtir
mutant was attenuated for intracellular replication. We propose
that formation of actin rich intracellular pedestals around the
circumference of the ECV by invasive EPEC may constitute a
physical barrier to lysosome fusion protecting the enclosed bacteria
from lysosomal degradation; however this hypothesis requires
further testing. A similar phenomenon has been described for the
trafficking of endosomes and lysosomes to wounded sites of plasma
membrane. At sites of plasma membrane disruption lysosomes and
endosomes are recruited to seal the breach, this process is inhibited
if the cortical actin meshwork is stabilized and enhanced when it is
disrupted [61]. Similarly the lysosome dependent internalization of
Trypanosoma cruzi requires a depolymerization of the cortical actin
network to allow lysosome transit to the plasma membrane [62].
Recently, while screen ca. 1000 clinical EPEC and EHEC
isolates we found that none of the EHEC strains and only 1.8% of
the EPEC strains contain espT [21]. Interestingly, espT was found
in EPEC E110019 which was linked to a particularly sever
outbreak of gastroenteritis in Finland [22]. E110019 was found to
be particularly infectious and unusually for EPEC was associated
with person to person spread and adult disease [22]. Although we
have no clinical data of the other espT positive isolates it is
tempting to speculate that the expression of EspT could be at least
in part responsible for the hyper virulence of the E110019 strain.
Further studies of the invasive EPEC category are needed to assess
the risk they pose to human health.
Materials and Methods
Bacteria strains
Bacterial strains used in this study are listed in Table 1. The C.
rodentium DespT were constructed using the using the one-step PCR
l-red-mediated mutation protocol [63] The O111:H2 E110019
strain was isolated from an outbreak in Finland [22]. All the strains
were maintained on Luria–Bertani (LB) broth or agar supple-
mented with ampicilin (100mg/ml) or Kanamycin (50 mg/ml).
Plasmids and molecular techniques
Plasmids used in this study are listed in Table 2; primers are
listed in Table 3. espT was amplified by PCR using E110019
genomic DNA as template and cloned into pSA10 [64] (primer
pair 1 and 2). All constructs were verified by DNA sequencing. Site
directed mutagenesis of EspT was carried out using a Quick-
changeH II kit (Stratagene) and primers 3 and 4 according to the
manufacturers instructions. Plasmids pSA10::espT was used as
template for the mutagenic reactions. The pCX340 vector
encoding EspT-TEM fusion was constructed after amplification
of espT from C. rodentium using primer pair 5 and 6.
The mammalian expression vector pRK5 containing one of
RacN17 or Cdc42N17 dominant negatives used in the transfection
Table 1. List of strains.
Strain Description Source/Reference
E110019 EPEC O111:H9 wild type [22]
E2348/69 EPEC O127:H6 wild type [66]
ICC192 EPEC O127:H6 DescN [67]
JPN15 EPEC O127:H6 lacking the EAF plasmid encoding BFP [38]
Salmonella Typhimurium Strain SL1344 [68]
ICC169 Citrobacter rodentium This study
ICC306 Citrobacter rodentium DespT This study
ICC305 Citrobacter rodentium Dtir R. Mundy
doi:10.1371/journal.ppat.1000683.t001
Table 2. List of plasmids.
Name Description Source/Reference
pSA10 pKK177-3 with Lac [64]
pRK5::myc-rac1N17 Dominant negative Rac1 [69]
pRK5::myc-cdc42N17 Dominant negative Cdc42 [69]
pRK5:myc-:wave2 Wave2 full length Gifted by Laura Machesky
pDSRED::wave2DA Wave2 with truncated VCA Gifted by Laura Machesky
pDSRED::wave2DBP Wave2 with truncated WHD Gifted by Laura Machesky
pICC228 pRK5::espT-Myc [23]
pICC461 pSA10::espT E110019 This Study
pICC489 pACYC184::espt C. rodentium This Study
pICC488 pCX340::espT C. rodentium This Study
pICC490 pRK5::espTW63A This Study
doi:10.1371/journal.ppat.1000683.t002
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assays were a gift from Nathalie Lamarche-Vane. The pRK5
encoding Wave2, and the pDSRED Wave2DA and Wave2DBP
were a kind gift from Laura Machesky via Ray Carabeo.
Infection of Swiss 3T3, HeLa and Caco2 cells
48 h prior to infection cells were seeded onto glass coverslips at
a density of 56105 cells per well and maintained in DMEM
supplemented with 10% FCS at 37uC in 5% CO2. Caco2 cells
were grown in DMEM supplemented with 20% FCS at 37uC in
5% CO2. The cells were washed in PBS and the media changed
every 24 h for 12 days until the cells polarized. 3 h before
infection, the cells were washed 3 times with PBS, the media
replaced with fresh DMEM without FCS supplemented with 1%
mannose and 500 ml of primed bacteria were added to each well,
the plates were then centrifuged at 1000 rpm for 5 min at room
temperature and infections were carried out at 37uC in 5% CO2.
b Lactamase (TEM) T3SS dependent translocation assay
HeLa cells were seeded on to glass coverslips for infection as
previously described above. Wild type EPEC E2348/69 and DescN
T3SS null mutant were transformed with the pCX340 vector
encoding EspT-TEM-1 fusion; an NleD-TEM fusion was used as
a positive control. Translocation assay was performed as described
previously [65].
Immunofluorescence staining and microscopy
Coverslips were washed 3 times in PBS and fixed with 3%
Paraformaldehyde (PFA) for 15 min before washing 3 more times
in PBS. For immuno-staining, the cells were permeabilized for
5 min in PBS 0.5% Triton X100, washed 3 times in PBS and
quenched for 30 min with 50 mM NH4Cl. Pre prermeabilized
samples were not treated with triton X100. The coverslips were
then blocked for 1 h with PBS 0.5% BSA before incubation with
primary and secondary antibodies. The primary antibody mouse
anti EEA1 (BD biosciences) and mouse anti VATPase (Gifted by
Prof. D. Holden) were used at a dilution of 1:100, while rabbit anti
O127, anti O111, anti O152, anti Tir and goat anti CSA-1
(salmonella LPS, gifted by Prof D. Holden) were used at a dilution
of 1:500. Rabbit anti Wave2 (SantaCruz Biotechnology) and
Mouse anti Abi1 (Abcam) were used at 1:200 dilutions. Coverslips
were incubated with the primary antibody for 1 h, washed three
times in PBS and incubated with the secondary antibodies.
Donkey anti-rabbit IgG conjugated to a Cy2 or Cy3 fluorophore,
donkey anti-mouse IgG conjugated to a Cy5 or Cy5 fluorophore,
donkey anti goat IgG conjugated to a Cy2 or Cy3 fluorophore
(Jackson laboratories) were used at a 1:200. Actin was stained
using AlexaFluor 633 phalloidin, Oregon Green phalloidin or
Rhodamine phalliodin (Invitrogen) at a 1:100 dilution. All
dilutions were in PBS/0.5% BSA. Coverslips were mounted on
slides using ProLongH Gold antifade reagent (Invitrogen) and
visualized by Zeiss Axioimager immunofluorescence microscope
using the following excitation wavelengths: Cy3 – 550nm, Cy5 –
650nm and Oregon Green – 488nm. All images were analyzed
using the Axiovision Rel 4.5 software. Confocal X stacks were
taken using a Leica Sp2 microscope. Cell boundaries were
determined using actin staining and Abobe photoshop software.
Transfection
Swiss 3T3 cells or HeLa cells were transfected with pRK5
encoding EspT, RhoAN19, RacN17, Cdc42N17 dominant negatives
fused to a Myc tag, pDSRED encoding Wave2, Wave2DA or
Wave2DBP by lipofectamine 2000 (Invitrogen) according to the
manufacturer’s recommendations. The cells were incubated at
37uC in a humidified incubator with 5% CO2 for 16 h, washed
twice in PBS before having their media replaced with DMEM as
described previously. Transfected cells were infected with the
appropriate strain as described above.
siRNA of Wave2
HeLa cells were seeded at a density of approximatetly 56106
cells per well 24 h prior to transfection of either Wave2 siRNA
pool or a non-targeting pool supplied by Dharmacon using
HiPerFect (Qiagen) according to the manufacturers instructions.
The media was changed 16 h after transfection and the cells were
allowed to recover for 12 h before being trypsinated and seeded at
a density of 56106 cells. The siRNA procedure was repeated for a
total of 3 rounds before the cells were used. Levels of Wave2 and
tubulin were then detected by western blotting using anti wave2
(Santa Cruz) and anti tubulin (Sigma) antibodies. Cells were then
infected with the appropriate strain and processed for immuno-
fluorescence microscopy as previously described.
Gentamycin protection assay
Cells seeded into the wells of a 24 well plate were infected as
described above for 6 h at 37uC in 5% CO2. The pre-
gentamycin plates were washed 5 times in PBS and then
permeabilzed for 15 minutes with 1% saponin in sterile water
before plating in triplicate on LB plates in dilutions ranging from
100 to 1027. The post gentamycin samples were washed 5 times
with PBS after the final wash the PBS was replaced with serum
free DMEM containing 200mg/ml of gentmaycin and the cells
incubated for 1 h at 37uC in 5% CO2. The plates were then
washed a further 5 times in PBS before permeabilization and
plating as described above. The pre and post gentamycin plates
were then incubated for 15 h in a static 37uC incubator and the
colony forming units (cfu) were counted. The percentage of
invasion was calculated based on the ratio of cfu on the pre and
post gentamycin plates.
Table 3. List of primers.
Primer Name Sequence
1 EspT-E110019-F 59-ttgaattcatgccaggaacagtaaactcc-39
2 EspT-E110019-R 59-ccaatgcattggttctgcattaaacatattttaaatttctc-39
3 EspTW63AF 59-gaaaaacgaaggaaaaatgaatgaggcgatgagggaagaatgtatttgcttt-39
4 EspTW63AR 59-aaagcaaatacattcttccctcatcgcctcattcatttttccttcgtttttc-39
5 EspTpCX340F 59-ttcatatgccgggaacaataagctccag-39
6 EspTpCX340R 59-tgaattcggggttctctgcgcctcctgaa-39
doi:10.1371/journal.ppat.1000683.t003
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Scanning electron microscopy
Glass coverslips were seeded and infected for 2 h with the
appropriate strains as described above. The cells were washed 3
times in phosphate buffer pH7.2 and then fixed with 2.5%
Gluteraldehyde (Agar) in phosphate buffer pH7.2 for 15 min. The
coverslips were then washed with phosphate buffer pH7.2 a
further 3 times before being post fixed in 1% Osmium Tetroxide
for 1 h. The cells were then washed 3 times in phosphate buffer
before being washed for 15 min in graded ethanol solutions from
50% to 100% to dehydrate the samples. The cells were then
transferred to an Emitech K850 Critical Point drier and processed
according to the manufacturer’s instructions. The coverslips were
coated in gold/palladium mix using a Emitech Sc7620 minisputter
to a thickness of approximately 370A˚. Samples for scanning
electron microscopy (SEM) were then examined blindly at an
accelerating voltage of 25 kV using a Jeol JSM-6390.
Transmission electron microscopy
6 well plates were seeded and infected for 2 h with the
appropriate strains. The cells were washed 3 times in phosphate
buffer pH7.2 and then fixed with 2.5% Gluteraldehyde in
phosphate buffer pH7.2 for 15 min. The plates were then washed
with phosphate buffer pH7.2 a further 3 times before being
removed from the plate using a Teflon scraper and subsequently
harvested into in eppendorf tube. The eppendorfs were then
centrifuged at 10,000 RPM to pellet the cells. The cell pellets were
post fixed in 1% Osmium Tetroxide for 1 h, followed by 1%
buffered tannic acid for 30 min and then a 1% aqueous sodium
sulfate rinse for 10 min. The sample was dehydrated using an
ethanol-propylene oxide series (with 2% uranyl acetate added at
the 30% step) and embedded in Epon-araldite for 24 h at 60uC.
Ultrathin sections (60 nm) were cut with a Leica EMUC6
ultramicrotome, contrasted with uranyl acetate and lead citrate,
and viewed with an FEI 120-kV Spirit Biotwin TEM. Images were
obtained with a Tietz F415 digital TemCam.
Supporting Information
Figure S1 EspT is translocated into host cells in a T3SS
dependent manner. HeLa cells were infected with EPEC E2348/
69 or E2348/69DescN containing the pCX340 b-lactamase fused
to EspT. b-lactamase cleaves the CCF2/AM substrate, which
fluoresces in green when uncleaved and in blue when cleaved,
indicating translocation of the fusion protein. The T3SS effector
NleD was used as a positive control.
Found at: doi:10.1371/journal.ppat.1000683.s001 (0.48 MB PDF)
Figure S2 IRSp53 is enriched in membrane ruffles induced by
EspT. HeLa and Swiss cells were transfected with the ectopic
expression vector pRK5 encoding EspT for 12 h. Actin was
labeled with Oregon Green phalloidin (Green), Wave2 was
detected with polyclonal rabbit antiserum (Red) and IRSp53 was
detected using a monoclonal mouse antibody (Yellow). Transfec-
tion of EspT resulted in formation of membrane ruffles and
lamellipodia in HeLa and Swiss cells respectively. Wave2 was
localized to membrane ruffles and lamellipodia induced by EspT.
IRSp53 was recruited to EspT dependent ruffles in HeLa cells but
was not present in lamellipodia induced on Swiss 3T3 cells.
Found at: doi:10.1371/journal.ppat.1000683.s002 (1.52 MB PDF)
Figure S3 Wave2 WHD and VCA domains are needed for
EspT-induced membrane remodeling. (A) Swiss cells were left
untransfected or transfected with pDSRed encoding wild type
Wave2 and Wave2DA (lacking the acidity Arp2/3 interacting
region) or Wave2DBP (lacking the WHD needed for Abi1
binding). Transfected cells were infected with JPN15 expressing
EspT for 2 h and processed for immuno-fluorescence microscopy.
Actin was stained with Oregon green phalloidin (Green), the Wave
constructs were detected with a polyclonal rabbit Wave2 antibody
(Red) and JPN15 expressing EspT were visualized by Dapi. Mock
transfected cells or cell transfected with wild type Wave2 displayed
lamellipodia in 80–90% of transfected cells. Cells transfected with
Wave2DA or Wave2DBP were severely attenuated in lamellipodia
formation compared to the mock or Wave2 wild type transfected
cells. (B) Quantification of lamellipodia and membrane ruffles on
Swiss and HeLa cells respectively after 2 h infection with JPN15
expressing EspT. 100 cells were counted in triplicate in three
independent experiments. Results are displayed as mean6SEM.
Found at: doi:10.1371/journal.ppat.1000683.s003 (2.59 MB PDF)
Figure S4 EspT mediated membrane remodeling and invasion
is dependent on the conserved WxxxE motif. HeLa cells infected
with JPN15, JPN15 expressing wild type EspT, or JPN15
expressing EspTW63A for 3 h were fixed and stained with
phalliodin (green) to detect actin and Dapi stain to label bacteria
(blue). In cells infected with JPN15 and JPN15 expressing
EspTW63A there was no significant induction of membrane
ruffling. Infection of HeLa cells with JPN15 expressing wild type
EspT resulted in the formation of characteristic membrane ruffles.
(B) Gentamycin protection assay of HeLa cells infected JPN15 and
JPN15 expressing EspT or EspTW63A. Results are representative
of 3 independent experiments carried out in duplicate and are
displayed as mean6SEM.
Found at: doi:10.1371/journal.ppat.1000683.s004 (0.92 MB PDF)
Figure S5 EspT is an essential mediator of C. rodentium invasion
of epithelial cells. HeLa cells infected with C. rodentium, C. rodentium
DespT or complemented C. rodentium DespT were fixed and stained
prior to permeabilization (extracellular labeling) (Red). The cells
were then washed, permeabilized, re-labeled (Total labeling)
(Green) along with Alexaflour 633 Phalloidin (Cyan) and Dapi
(Blue). In cells infected with C. rodentium DespT all bacterial cells
detected by the total stain were also labeled with the extracellular
stain indicating that this strain was not invasive (highlighted with
arrows). In cells infected with C. rodentium or C. rodentium DespT
expressing EspT a significant proportion of bacteria labeled with
the total probe were not strained with the extracellular probe
demonstrating cells invasion (highlighted with arrows).
Found at: doi:10.1371/journal.ppat.1000683.s005 (1.73 MB PDF)
Figure S6 Ectopic expression of EspT can facilitate invasion of
epithelial cells by a T3SS null mutant. HeLa cells were transfected
with pRK5 encoding EspT and subsequently infected with a DescN
T3SS mutant. The cells were then fixed and processed for
immuno-fluorescence microscopy. Actin was stained using Alexa-
fluor 633 phalloidin (Cyan), external and internal bacteria were
labeled in red and green respectively. Ectopic expression of EspT
led to the formation of actin rich membrane ruffles and a
significant proportion of DescN bacteria became internalized
(highlighted with arrows).
Found at: doi:10.1371/journal.ppat.1000683.s006 (0.90 MB PDF)
Figure S7 ECVs become Lamp1 positive at late time points of
infection. HeLa cells were infected with E110019 for 30 min before
the cells were washed with gentamycin to eliminate non invasive-
bacteria. The infected cells were then incubated for a further 16 h.
The cells were fixed and processed for immuno-fluorescence
microscopy Lamp1 was detected with a monoclonal antibody (Cyan),
actin was labelled with phalliodin (Red) and bacteria were detected
with Dapi. There was accumulation of Lamp1 staining on ECVs at
16 h post infection, which was not apparent at earlier time points.
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Found at: doi:10.1371/journal.ppat.1000683.s007 (0.75 MB PDF)
Figure S8 (A) Internalized EPEC survive and replicate in
epithelial cells. HeLa cells were infected with E110019 for
30 min before the cells were washed with gentamycin to eliminate
non invasive-bacteria. The cells were then incubated for 2, 8, 16
and 24 h in the presence of gentamycin. Cells were processed for
immuno-fluorescence microscopy, bacteria were detected with
Dapi (Dlue) and actin was labeled with phalliodin (Red). There
was a time dependent increase in the level of intracellular bacteria.
(B) Quantitative gentamycin protection assay of intracellular
growth. HeLa cells were infected for 3 h with C. rodentium, C.
rodentium Dtir and E110019 before extracellualr bacteria were
eliminated with gentamycin. Cells were then incubated in the
presence of gentamycin for 6, 12 or 24 h before the cells were
lysed and plated for CFU counting. Results are representative of 3
independent experiments and are presents as mean6SEM.
Found at: doi:10.1371/journal.ppat.1000683.s008 (1.92 MB PDF)
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A rare subset of enteropathogenic 
Escherichia coli (EPEC) isolates that 
can actively invade non-phagocytic 
host cells by inducing the forma-
tion of membrane ruffles has been 
characterized in detail in a recent 
publication in PLoS Pathogens.
EPEC is a member of the group of 
attaching and effacing (A/E) bacte-
rial pathogens, which attach tightly 
to host cells, efface the microvilli 
and subvert host cell actin to form 
characteristic pedestals beneath the 
attachment site. Although A/E patho-
gens are known to be extracellular, 
there have been isolated reports over 
the years that atypical EPEC isolates 
can invade non-phagocytic host cells.
Bulgin and colleagues were 
interested in following up their 
earlier work delineating the func-
tion of the type III secreted effector 
protein EspT, which belongs to the 
WXXXE family of effector proteins 
and which they had found could 
trigger the formation of membrane 
ruffles. Salmonella spp. and Shigella 
spp. induce membrane ruffles to 
facilitate entry into host cells in 
what is known as the trigger mech-
anism of entry. Using the EspT-
expressing EPEC str. E110019, 
Bulgin et al. demonstrated that 
EspT promotes EPEC invasion of 
non-phagocytic cells by the trigger 
mechanism and that invasion is 
dependent on the WXXXE motif. 
RAC1 and WAVE2 (also known 
as WASF2) were identified as 
downstream host proteins that 
are essential for EspT-mediated 
invasion. Analysis of the behaviour 
of EPEC str. E110019 within host 
cells showed that the bacterium can 
replicate intracellularly and is con-
tained in a vacuole. Intriguingly, 
transmission electron microscopy 
analysis showed that intracellular 
actin pedestals form around the cir-
cumference of the bacterium in the 
vacuole. The function of these ped-
estals remains to be investigated, 
but the authors speculate that they 
may form a physical barrier that 
prevents lysosomal fusion.
So, the expression of EspT allows 
EPEC isolates to actively invade 
non-phagocytic host cells. EspT is 
found in only a very small proportion 
of clinical isolates, but these rare 
isolates, such as EPEC str. E110019, 
can cause severe disease, and the 
authors conclude with the suggestion 
that this hypervirulence could be at 
least partly a result of the invasive 
phenotype.
Sheilagh Molloy
 b ac t e r i a l  pat h o g e n i c i t y
A closer look at intracellular EPEC
An EspT-induced ruffle (red) during enteropathogenic Escherichia coli (blue) invasion into Caco2 cells 
(green). Image courtesy of R. Bulgin, Imperial College, London, UK.
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The T3SS effector EspT defines a new category of 
invasive enteropathogenic E. coli (EPEC) which 
form intracellular actin pedestals. PLoS Pathog.  
5, e1000683 (2009)
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EspM2 is a RhoA guanine nucleotide exchange factor
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Summary
We investigated how the type III secretion system
WxxxE effectors EspM2 of enterohaemorrhagic
Escherichia coli, which triggers stress fibre forma-
tion, and SifA of Salmonella enterica serovar Typh-
imurium, which is involved in intracellular survival,
modulate Rho GTPases. We identified a direct
interaction between EspM2 or SifA and nucleotide-
free RhoA. Nuclear Magnetic Resonance Spectros-
copy revealed that EspM2 has a similar fold to
SifA and the guanine nucleotide exchange factor
(GEF) effector SopE. EspM2 induced nucleotide
exchange in RhoA but not in Rac1 or H-Ras, while
SifA induced nucleotide exchange in none of them.
Mutating W70 of the WxxxE motif or L118 and I127
residues, which surround the catalytic loop,
affected the stability of EspM2. Substitution of
Q124, located within the catalytic loop of EspM2,
with alanine, greatly attenuated the RhoA GEF
activity in vitro and the ability of EspM2 to induce
stress fibres upon ectopic expression. These
results suggest that binding of SifA to RhoA does
not trigger nucleotide exchange while EspM2 is a
unique Rho GTPase GEF.
Introduction
Pathogenic bacteria use a variety of strategies to subvert
cellular and immunological functions to facilitate coloniza-
tion, multiplication and survival within the host. Several
Gram-negative pathogens, e.g. Salmonella enterica, Shi-
gella spp. and enteropathogenic and enterohaemorragic
Escherichia coli (EPEC and EHEC), encode a type III
secretion system (T3SS) which is central for their infection
strategy. T3SS are molecular syringes that allow trans-
location of effector proteins directly from the bacteria to
the cytoplasm of the host cell. Once translocated the
effectors subvert cellular processes to facilitate the par-
ticular infection style of the pathogen (Mota and Cornelis,
2005). To this end bacterial T3SS effectors often display
sequence, structural or functional similarities to eukaryotic
proteins.cmi_1423 654..664
Rho GTPases react to a range of intrinsic and extrinsic
stimuli in order to regulate a plethora of host cell signalling
networks most notably those involved in remodelling the
eukaryotic actin cytoskeleton and, as such, are prominent
targets of T3SS effectors (Finlay, 2005). RhoA, Cdc42
and Rac1, the most studied Rho GTPases, induce forma-
tion of stress fibres, filopodia and lamellipodia respec-
tively (Jaffe and Hall, 2005). To exert their control on these
cellular processes Rho GTPases act as molecular
switches cycling between GTP-bound ‘on’ and GDP-
bound ‘off’ conformations. Rho GTPases have well-
defined nucleotide and magnesium binding pocket,
constituted mainly by two polypeptides called Switch I and
II and by the phosphate-binding loop or P-loop. Mg2+ ions
are required for high-affinity binding of guanine nucle-
otides to Rho GTPases. The Switch I and II regions define
the major conformational differences between the GDP
and GTP bound forms; only the GTP-bound conformation
allows interactions of the Rho GTPases with their down-
stream effectors. The activation state of Rho GTPases is
modulated by three main categories of regulatory pro-
teins: (i) guanine nucleotide dissociation inhibitors (GDI)
that sequester GTPases in the cytosol in a GDP-bound
state, (ii) guanine nucleotide exchange factors (GEFs)
that catalyse the GDP/GTP exchange, and (iii) GTPase
activating proteins (GAPs) that inactivate the Rho
GTPases by stimulating their intrinsic GTPase activity.
Type III secretion system effectors use different mecha-
nisms to subvert Rho GTPases. For example, EPEC and
EHEC EspG and EspG2 indirectly activate RhoA by dis-
rupting microtubules, which leads to liberation of a RhoA-
specific GEF, GEF-H1 (Matsuzawa et al., 2004). Other
T3SS effectors modulate Rho GTPase directly as they
function as either GEFs or GAPs. For example, the Sal-
monella effector SopE directly activates Rac1 and Cdc42
leading to lamellipodia formation and promoting bacterial
invasion into non-phagocytic cells (Hardt et al., 1998). In
contrast, Salmonella uses the GAP T3SS effector SptP to
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stimulate the intrinsic Rho GTPase activity to restore cell
architecture following bacterial internalization (Fu and
Galan, 1999). SopE and SptP homologues have been
identified in different species including Burkholderia pseu-
domallei (BopE), Yersinia pseudotuberculosis (YopE)
and Pseudomonas aeruginosa (ExoS) (Goehring et al.,
1999; Von Pawel-Rammingen et al., 2000; Stevens et al.,
2003). By modulating the actin cytoskeleton via Rho
GTPases, YopE and ExoS inhibit bacterial uptake by
macrophages (Black and Bliska, 2000; Deng and Barbieri,
2008).
Based on a conserved motif comprising an invariant
tryptophan (W) and a glutamic acid (E) separated by three
variable amino acids, Alto et al. (2006) grouped together a
number of known T3SS effectors from Shigella (IpgB1
and IpgB2), Salmonella (SifA and SifB) and EPEC and
EHEC (Map) and termed them WxxxE effectors. Recently,
we identified new WxxxE effectors encoded by EPEC and
EHEC, EspM (Tobe et al., 2006) and EspT (Bulgin et al.,
2009). Ectopic expression of Map leads to filopodia for-
mation (Alto et al., 2006), IpgB2 and EspM trigger stress
fibres (Alto et al., 2006; Arbeloa et al., 2008) and IpgB1
and EspT induce membrane ruffles and lamellipodia (Alto
et al., 2006; Bulgin et al., 2009). These phenotypes are
typically associated with activated Cdc42, RhoA and Rac1
(Hall et al., 1993) respectively.
Alto et al. suggested that the WxxxE effectors, which
play important roles in cell invasion (IpgB proteins) and
intracellular survival (SifA), mimic the function of Rho
GTPases. Handa et al. (2007) subsequently demon-
strated that IpgB1 stimulates formation of membrane
ruffles by activating Rac1 through recruitment of the
Rac1-specific ELMO–Dock180 GEF complex. Moreover,
the structure of SifA in complex with the PH domain of
SKIP has shown that its C-terminus domain, which
includes the WxxxE motif, adopts a fold similar to SopE
(Ohlson et al., 2008). However, neither direct binding to
the Rho GTPases nor GEF activity was detected in this
study. Furthermore, we have recently reported that Map
(Berger et al., 2009), EspM (Arbeloa et al., 2008) and
EspT (Bulgin et al., 2009) activate the Rho GTPases
Cdc42, RhoA and Rac1. The aim of this study was to
determine the mechanism through which EspM2 activates
RhoA.
Results
EspM2 binds RhoA
We used His-EspM2 to investigate if activation of RhoA
involves a direct interaction. Although highly soluble, His-
EspM2 was unstable and appeared in two distinct bands
corresponding to the full-length effector and a spontane-
ous degradation product; N-terminal sequencing revealed
that the latter corresponds to EspM2 lacking the first 28
amino acids (EspM229–196) (Appendix S1 and Fig. S1).
Ectopic expression of EspM229–196 in Swiss 3T3 cells
resulted in stress fibre formation at the same level as
full-length EspM2 (Fig. S2), confirming that it retained
full biological activity. Consequently we have used
EspM229–196 throughout this study.
Surface plasmon resonance was used to probe the
interaction between His-EspM229–196 and His-RhoA. This
technique allows binding to be observed in real time by
the change in mass over the derivatized surface of a
sensor chip. RhoA was flowed (sequential injections
ranging from 0.05 mM to 50 mM) over an EspM229–196-
bound surface and displayed an increased rate of binding
with concentration confirming a specific interaction
(Fig. 1A). Free GDP or GTP added to the running buffer
inhibited formation of an EspM229–196–RhoA complex in a
nucleotide concentration-dependent manner (Fig. 1B).
GDP and GTP have the same effect as one another
(within experimental error), reducing the binding affinity of
EspM229–196 to RhoA by up to 67% in the nucleotide con-
centration range 0.5–8 mM.
As a control, Rac1 was flowed over the same
EspM229–196 surface and for any given GTPase concen-
tration showed substantially less binding (Fig. 1C), con-
firming the specificity of EspM229–196 for RhoA over other
GTPases. As recent data suggested that SifA might bind
RhoA (Ohlson et al., 2008), their direct interaction was
also tested. We found that His-SifA and His–RhoA
bound in a concentration-dependent manner (Fig. 1D),
and was inhibited by free GDP or GTP (data not shown).
Although high RhoA concentrations (mM range) were
required to see an interaction, EspM229–196–RhoA binding
was found to be long-lived. The interaction response
was followed for 1000 s after each injection, by which
time the rate of dissociation appeared to have fallen to
zero in an incompletely dissociated state. Dissociation
of the pre-formed EspM229–196–RhoA, as well as SifA–
RhoA, complexes could not be brought about by addi-
tion of 500 mM free GDP in running buffer (in the
presence or absence of 5 mM MgCl2, data not shown)
in contrast to the rapid dissociation of SopE–Cdc42
reported by Rudolph et al. (1999). Dissociation of
EspM229–196–RhoA proved to be more difficult than that
of SifA–RhoA, requiring high pH conditions (25 mM
NaOH, pH 12.4), where high ionic strength (1 M NaCl)
would suffice for the latter to bring the response back to
the pre-experiment level.
EspM2 stimulates guanine nucleotide exchange
in RhoA
We next investigated the ability of EspM229–196 to stimulate
guanine nucleotide exchange in RhoA and other
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GTPases in vitro using a RhoGEF exchange assay. This
spectroscopic assay measures fluorescent emission upon
insertion of N-methylanthraniloyl(mant)-GTP into the
nucleotide binding pocket of the GTPases (Rossman
et al., 2002). As shown in Fig. 2 inclusion of 250 mM
EDTA (positive control) in the assay induced efficient
nucleotide exchange in RhoA, Cdc42, Rac1 and H-Ras,
indicating that these proteins were biologically functional,
while a slow intrinsic nucleotide exchange activity was
detected in the presence of buffer alone (negative
control). The fluorescence intensity rose dramatically and
in a concentration-dependent manner when increasing
amounts of purified EspM229–196 were added to RhoA
(Fig. 2A). In contrast, EspM229–196 showed a weak
exchange activity in Cdc42 (Fig. 2B), whereas it had no
effect on Rac-1 and H-Ras (Fig. 2C and data not shown).
No change in fluorescence emission was detected when
EspM2 was incubated in the absence of any of the small
GTPases (Fig. 2D). Testing the GEF activity of SifA
revealed that it did not stimulate nucleotide exchange in
any of the tested Rho GTPases or H-Ras (Fig. 2E). These
results demonstrate that EspM229–196 is a specific RhoA
GEF, and that although SifA can bind RhoA it cannot
induce nucleotide exchange.
A B
C D
Fig. 1. RhoA binds directly to EspM2 and SifA.
A. Surface plasmon resonance showing concentration-dependent binding of RhoA to EspM229–196. Concentrations of RhoA varying from
0.05 mM to 50 mM were flowed at 50 ml min-1 (duration indicated by black bar) over a CM5 sensor chip with EspM229–196 covalently bound to
the surface. Control substituted signals are shown.
B. Inhibition of EspM229–196–RhoA interaction by GDP or GTP. For RhoA (4 mM) flowing over an EspM229–196-bound surface in buffer containing
GDP/GTP, the response maxima relative to response maxima in the absence of nucleotide are plotted with respect to GDP/GTP
concentration.
C. Binding of EspM229–196 to RhoA and Rac1. Averaged response maxima for three representative concentrations compare the strength of
EspM2 binding with the two GTPases.
D. Surface plasmon resonance demonstrates RhoA concentration dependence for binding SifA. Concentrations of SifA varying from
0.5 mM to 6 mM were flowed at 50 ml min-1 over a CM5 sensor chip with RhoA covalently bound to the surface.
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Fig. 2. EspM2 is a RhoA GEF.
A. EspM229–196 mediates loading of mant-GTP into RhoA. mant-GTP (0.5 mM) was incubated with 2 mM RhoA in presence of 250 mM EDTA
(squares), or 0.05–50 mM EspM229–196 (circles) or in presence of buffer only (triangles). The insertion of the mant-GTP into the nucleotide
binding pocket of RhoA in presence of EspM229–196 detected by an increase in the fluorescent emission was found to be concentration
dependent.
B. EspM229–196 weakly induces loading of mant-GTP into Cdc42. mant-GTP (0.5 mM) was incubated with 2 mM Cdc42 in presence of 250 mM
EDTA (squares), or 0.05–50 mM EspM229–196 (circles) or in presence of buffer only (triangles). Slow loading of mant-GTP into Cdc42 was only
detected when high concentrations of EspM229–196 were added.
C. EspM229–196 does not induce nucleotide exchange for Rac1. mant-GTP (0.5 mM) was incubated with 2 mM Rac1 in presence of 250 mM
EDTA (squares), or 0.05–50 mM EspM229–196 (circles) or in presence of buffer only (triangles). No efficient loading of man-GTP into Rac1 was
observed after incubation with up to 50 mM EspM229–196.
D. Incubation of 50 mM EspM229–196 in the exchange buffer alone did not change the fluorescence intensity.
E. SifA does not induce nucleotide exchange in RhoA, Cdc42, Rac1 or H-Ras. mant-GTP (0.5 mM) was incubated with 2 mM RhoA (blue
circles), Cdc42 (pink circles), Rac1 (green circles) or H-Ras (orange circles) in presence of 5 mM SifA. No loading of man-GTP into any of the
small GTPases tested was observed in these conditions. Results shown are the average of three independent experiments.
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Mapping the EspM2 interface of the
EspM2–RhoA complex
Although EspM229–196 is significantly more stable than full
length, it has a proposenity to aggregate that can only be
alleviated by high salt concentrations and pH values.
These factors make EspM2 particularly unsuitable for
structural study by either NMR or crystallography. Indeed,
despite exhaustive attempts EspM229–196 and full-length
EspM2 proved refractory to crystallization (see Appen-
dix S1). Although deuteration of EspM2 was not possible,
~70% of the backbone resonances could be confidently
assigned using standard triple resonance NMR method-
ology on a 15N 13C-labelled sample. NMR was then used
to monitor the interaction of RhoA with EspM229–196 at a
residue-specific level. At 1:1 molar ratio significant
changes in 1H 15N TROSY-HSQC spectra of EspM2 were
detectable; and it was possible to determine which
assigned EspM2 residues were within intimate proximity
of RhoA upon complex formation (Fig. 3A). After the addi-
tion of sevenfold molar excess RhoA, peaks correspond-
ing to structured regions of EspM229–196 had broadened to
such an extent that many were no longer visible and
furthermore, addition of 5 mM GTP to the sample did not
result in dissociation of the complex.
The chemical shift index based on NMR data for 13Ca,
13Cb and 13C′ resonances (Wishart et al., 1993) reveals
that EspM2 is primarily helical (albeit for an unstructured
~30 residue region at the N-terminus), which is consistent
with secondary structure prediction with PSIPRED
(Jones, 1999) (Fig. S1). The helical content and locations
are similar to that of the C-terminal domain of SifA whose
crystal structure has been recently determined (Fig. S3)
(pdb:3cxb; Ohlson et al., 2008). Based on these data we
created a sequence alignment between EspM229–196 and
SifA, and together with the crystal structure we computed
a homology model of EspM229–196 using SWISS-MODEL
(Arnold et al., 2006). NMR chemical shift data from RhoA
titration was then mapped onto the model of EspM229–196
(Fig. 3B). Furthermore, a model of the complex with RhoA
was created by superposing the EspM229–196 homology
model and the crystal structure of RhoA (pdb:1xcg; Dere-
wenda et al., 2004) onto the crystal structures of SopE
and Cdc42, respectively, within the SopE–Cdc42 complex
(pdb:1gzs; Buchwald et al., 2002) (Fig. 3C). In this model
of the EspM2–RhoA complex, almost all of the perturbed
Fig. 3. Model of EspM229–196 and the EspM229–196–RhoA complex.
A. 1H 15N TROSY-HSQC titration of RhoA against EspM229–196.
Black peaks show no addition of RhoA while red peaks show
fourfold molar excess of RhoA. Chemical shift changes were
deemed significant if the peak intensity was reduced by more than
80% (i.e. D145).
B. Homology model of EspM229–196 created with SWISS-MODEL
(Arnold et al., 2006). Data from the RhoA NMR titration (red) and
alanine mutations (blue) have been mapped onto the model. Those
residues with chemical shift changes in the NMR titrations and
which have also been mutated to alanines are coloured cyan.
C. Model of the EspM229–196–RhoA complex created by
superimposing the EspM229–196 model and the crystal structure of
RhoA (pdb:1xcg; Derewenda et al., 2004) onto the crystal structure
of the SopE–Cdc42 complex (pdb:1gzs; Buchwald et al., 2002). All
residues identified by the RhoA titration appear at the interface
except for those within the C-terminal helix. In this model the
intimate contacts with EspM2 are through the switch regions I and
II of RhoA.
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residues identify from NMR titration experiments lie within
the interface and are situated at both of the switch sites of
RhoA.
Site-directed mutagenesis of interface EspM2 residues
We introduced alanine substations in EspM2 residues
L118A, Q124A and I127A, which are located within the
EspM2 loop equivalent to the catalytic domain of SopE,
D73, which located within the WxxxE motif and N154,
which based on our RhoA-EspM2 model makes a hydro-
gen bond with the RhoA backbone. EspM2 W70A was
used as a control. The EspM229–196 derivatives were
expressed ectopically in Swiss 3T3 cells and formation of
stress fibres was assessed microscopically (Fig. 4). While
the W70A substitution completely abolished function,
Q124A substitution attenuated stress fibre formation
(seen in 35% of transfected cells compared with cells
transfected with wild-type EspM2) while L118A and I127A
reduced stress fibre formation by 56% and 65% respec-
tively (Fig. 4). N154A only had a minor effect on stress
fibres formation by EspM2 while no effect was detected
for D73A (Fig. 4). We tested representative EspM2
mutants delivered form E2348/69 by infection. Consistent
with the transfection data W70A and I127A did not trigger
stress fibres while D73A, N154A and Q124A triggered
stress fibres at levels comparable to the wild-type EspM2
(data not shown).
We next cloned espM2 W70A, L118A, Q124A and
I127A into pET28a for expression as 6His-tagged
EspM229–196. Despite repeated attempts we were unable
to purified EspM2 W70A and I127A, while the yield of
EspM2 L118A was very low. These results suggest that
these amino acids play an important structural role, which
is consistent with the 3D model (Fig. 3). The Q124A
mutant, purified at the same efficiency as the wild-type
EspM2, was used in SPR and GEF assays. No significant
difference in binding to RhoA was observed between wild-
type EspM2 and EspM2 Q124A (Fig. 4). Importantly,
EspM2 Q124A was attenuated in its ability to induce
loading of GTP into RhoA as 50 mM protein was needed to
achieve GTP loading equivalent to that induced by 1 mM
wild-type EspM2 (Fig. 4).
Discussion
When first described the WxxxE effectors were thought to
be molecular mimics of Rho GTPases (Alto et al., 2006).
Recent data have shown that IpgB1 activates the Rac1
GEF complex ELMO/Dock180 (Handa et al., 2007), and
Map, EspT and EspM activate Rho GTPases (Arbeloa
et al., 2008; Berger et al., 2009; Bulgin et al., 2009) by an
unknown mechanism. In this study we have investigated
the mechanism by which EspM2 activates RhoA.
Using surface plasmon resonance we found that
EspM229–196 forms a stable complex with nucleotide-free
RhoA. The dissociation of the EspM2–RhoA complex was
very slow and as a consequence we were unable to
measure the dissociation rate constant. We found that the
affinity of EspM229–196 to RhoA in presence of GDP or GTP
was lower than in absence of nucleotide, which is similar
to eukaryotic GEFs that also exhibit higher affinity and
form stable complexes with the nucleotide-free Rho
GTPases.
The initial step in nucleotide exchange is the formation
of a low-affinity complex between the GEF and the GDP-
bound Rho GTPase via recognition of the Switch I and II
regions (Klebe et al., 1995), which favours GDP and Mg2+
release. This is then rapidly converted into a high-affinity
GEF–GTPase binary complex (Lai et al., 1993); loading
with free GTP leads to dissociation of the GEF and for-
mation of a high-affinity Rho GTPase–GTP complex,
which binds subsequently downstream effectors (Milburn
et al., 1990). To test if EspM2 has a GEF activity we
incubated RhoA with mant-GTP and increasing concen-
trations of EspM229–196. We found that EspM229–196
induced loading of GTP into RhoA in a concentration-
dependent manner. This activity was specific for RhoA as
EspM229–196 induced weak nucleotide exchange in Cdc42,
while no nucleotide exchange was seen for Rac1 and the
distant GTPase H-Ras. Interestingly, the Salmonella
WxxxE effector SifA, which also binds RhoA, did not
exhibit a detectable GEF activity. It is not currently known
why binding to RhoA does not lead to nucleotide
exchange or if SifA can induce nucleotide exchange in
other small GTPases (e.g. Rab).
SopE from Salmonella was the first T3SS effector
described as a GEF (Hardt et al., 1998). SopE activates
Cdc42 and Rac1 leading to formation of membrane ruffles
and bacterial invasion. The crystal structure of the SopE–
Cdc42 complex illuminated the mechanism by which
SopE functions as GEF. SopE is composed of six
a-helices arranged in two three-helix bundles forming a
V-shape. The junction connecting the two arms consists
on small b sheet followed by a loop consisting of the
GAGA motif, which is proposed to be the catalytic loop of
SopE. Insertion of the GAGA motif between the switch
regions of Cdc42 induces a push and pull type movement
and release of GDP. Although SopE does not share
sequence or structural similarity with eukaryotic GEFs,
they induce similar conformational changes in the Rho
GTPases. Recently, the crystal structure of SifA in
complex with SKIP was solved (Ohlson et al., 2008).
While the N-terminal SifA domain binds SKIP, the
C-terminal domain, which shares no sequence similarity
with SopE and harbours the WxxxE motif, adopts a SopE-
like fold. NMR analysis of EspM229–196 combined with
homology modelling revealed that it likely contains six to
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Fig. 4. Activity of EspM229–196 mutants.
A. Multiple sequence alignment of the putative catalytic loop and flanking regions of the WxxxE proteins: EspM2 of EHEC O157:H7 Sakai,
IpgB1 and IpgB2 of Shigella flexneri, EspT of Citrobacter rodentium, Map of EPEC E2348/69 and SifA and SifB of S. Typhimurium. The loop
region of SopE was added for comparison, with the catalytic region highlighted. Similar residues are highlighted in grey. A stretch of residues
in the putative catalytic loop of SifA that is different from the other WxxxE effectors is highlighted. EspM2 residues selected for mutagenesis
are indicated by a star.
B. Swiss 3T3 cells were transfected with pRK5 encoding myc-tagged EspM229–196, EspM229–196 W70A and EspM229–196 I127A. Actin was stained
with Oregon green phalloidin and the myc tag was detected with monoclonal antibody.
C. Quantification of stress fibres formation in cell transfected with different EspM229–196 mutants. Results are displayed as mean  SEM.
D. SPR comparison of RhoA binding to wild-type EspM2 and EspM2 Q124A. No significant difference in binding was detected over a range of
RhoA concentrations. Shown is the averaged response of three repeats.
E. EspM229–196 Q124A is impaired in loading mant-GTP into RhoA. mant-GTP (0.5 mM) was incubated with 2 mM RhoA in presence of 1 mM
EspM229–196 (blue circles) or 1 mM (green triangles), 5 mM (orange triangles) and 50 mM (red triangles) EspM229–196 Q124A.
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seven a-helices arranged in a V-shape structure similar to
SopE and SifA and a loop connecting the two arms
(Fig. S3). Interestingly, the sequence of this putative cata-
lytic loop is conserved between EspM229–196 and the other
WxxxE effectors, but not SifA (Fig. 4A), which might
provide an explanation as for why SifA cannot induce
nucleotide exchange in RhoA.
The tryptophan and glutamic acid of the WxxxE motif
have been shown to be essential as replacement of W or
E by alanine completely abolished the effectors’ function
(Alto et al., 2006; Arbeloa et al., 2008). However, we
recently found that conservative substitutions of the W
and E residues in EspM2 had little effect on stress fibre
formation, suggesting that they have a structural role. In
our model the W70 and E74 residues in EspM2 are posi-
tioned around the junction of the two three-helix bundles.
Consistently, the role proposed for these residues in SifA
was to maintain the conformation of the putative catalytic
loop through hydrophobic contacts with surrounding resi-
dues. Among these residues I258, the equivalent of I127
in EspM2, forms hydrophobic contacts with the tryp-
tophan and hydrophobic contacts and a hydrogen bond
with the glutamic acid (Ohlson et al., 2008). We observed
that alanine substitutions of W70 and I127 of EspM2
abolished almost completely its ability to induce forma-
tion of stress fibres. Despite repeated attempts we were
unable to purify His-tagged EspM2 W70 and I127 sug-
gesting that these residues play a role in maintaining the
global structure, which is consistent with the 3D model of
EspM2.
We use NMR to investigate how formation of a complex
with RhoA affects the conformation of EspM229–196. Titrat-
ing RhoA into 15N 13C-labelled EspM229–196 revealed spe-
cific protein interaction with most of the shifted peaks
being located either in the penultimate helix or in the
putative catalytic loop. Other than I127, substituting the
putative EspM catalytic loop residue L118 by alanine also
had a substantial effect on stress fibres formation;
however, the recombinant protein was highly unstable.
While this project was reaching conclusion, Huang et al.
(2009) published the crystal structure of the Map–Cdc42
complex and showed that Map induces guanine nucleotide
exchange in Cdc42 while IpgB2 and IpgB1 induce nucle-
otide exchange in RhoA and Rac1 respectively. In this
study it was shown that Map Q128, located within the
catalytic loop, makes a hydrogen bond with Cdc42 Phe37,
which fortifies the interaction between these two proteins.
Moreover Map Q128Y does not bind to, or induce nucle-
otide exchange in, Cdc42. Interestingly, while not affecting
the interaction of EspM2 with RhoA, EspM2 Q124A
(equivalent to Map Q128) was attenuated in stress fibre
formation by transfection and RhoA GEF activity; 50 mM
EspM2 Q124A was needed to achieve the same GEF
activity as 1 mM wild-type EspM2. Importantly, while muta-
tions affecting protein stability were inactive when deliv-
ered either by transfection or by infection, we did not detect
a significant effect on stress fibre formation when EspM2
Q124A (or D73A and N154A) were delivered by infection.
This suggests that upon translocation the local effector
concentration is high enough to induce nucleotide
exchange, compared with ectopic expression which leads
to global cytosolic distribution, low effector concentration
and hence an attenuated stress fibre formation.
The high-affinity complexes formed between GEFs and
their cognate Rho GTPases are quickly dissociated upon
addition of GTP or GDP. Unexpectedly we found that the
EspM229–196–RhoA and SifA–RhoA complexes did not
dissociate in the presence of exogenous nucleotides.
This result suggests that EspM2 could activate RhoA by
a unique mechanism, involving constitutive activation,
which allows recruitment of ROCK to the EspM2–RhoA
complex. Supporting this hypothesis is our finding that
upon infection of Swiss 3T3 cells with EPEC overexpress-
ing EspM2 the induced stress fibres were stable for at
least 5 h after the adherent bacteria were killed by gen-
tamicin (not shown). Moreover, Alto et al. (2006) have
shown that IpgB2 is co-immunoprecipitated with ROCK,
possibly via mutual interaction with RhoA.
In conclusion, our work shows that EspM2 is a RhoA
GEF. Importantly, a large screen of over 900 clinical EPEC
and EHEC isolates revealed that espM is found in c. 50%
of the strains (Arbeloa et al., 2009). It is now well docu-
mented that while 21 core effector genes are conserved in
all EPEC and EHEC strains, the distribution of the non-
conserved, accessory, effector genes varies from strain to
strains (Iguchi et al., 2009). This suggests that EPEC and
EHEC strains can employ different infection strategies.
Although the role of EspM2 during infection is not yet
known, a recent study by Simovitch et al. (2009) showed
that it is involved in delocalization of the thigh junctions
(TJ). Importantly, the TJ alterations induced by EspM2 did
not interfere with their functionality; on the contrary,
increased TER values were observed upon EspM2
expression. These results suggest that EspM2 might play
a role in maintaining TJ during infection. Moreover, EspM2
might modulate additional cellular pathways, as IpgB2
was recently implicated in activation of NF-kB in a RhoA-
ROCK-dependent manner (Fukazawa et al., 2008).
Further studies are needed in order to determine the role
played by EspM in vivo.
Experimental procedures
Bacterial strains and cell culture
Bacteria were grown from single colonies in Luria–Bertani (LB)
broth in a shaking incubator at 37°C or maintained on LB plates.
Culture medium was supplemented with ampicillin (100 mg ml-1)
or kanamycin (25 mg ml-1) as appropriate.
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Swiss 3T3 cells were maintained in DMEM with 4500 mg ml-1
glucose and supplemented with 10% fetal calf serum (Gibco) and
4 mM Glutamax (Gibco).
Plasmids and molecular techniques
Plasmids used in this study are listed in Table S1 in Support-
ing information; primers are listed in Table S2. espM2 and
espM229–196 were amplified by PCR using genomic EHEC
O157:H7 strain Sakai DNA as template and cloned into pET28
with non-cleavable N-terminal 6His tag or into the mammalian
expression vector pRK5 with an N-terminal myc tag. sifA was
amplified by PCR using genomic S. Typhimurium SL1344 DNA
as template and cloned into pET28 with an N-terminal 6His tag.
All constructs were verified by DNA sequencing.
The vector pMW172-His expressing RhoA or Rac1 fused to a
6His Tag was a gift from Michael Way.
Site-directed mutagenesis
Site-directed mutagenesis was carried out using a Quickchange
II kit (Stratagene) according to the manufacturer’s instructions.
Primers were designed using the Quickchange mutagenic primer
design program (Stratagene). Plasmids pRK5:espM229–196,
pET28:espM229–196 and pSA10:espM2 were used as template for
the mutagenic reactions. All constructs were verified by DNA
sequencing.
Preparation of recombinant proteins
Escherichia coli B834 containing pET28a (NdeI/BamHI inserted
espM229–196 or SifA) were grown at 310 K in LB broth containing
25 mg ml-1 kanamycin until an A600 of 0.6 was reached. Protein
overexpression was induced by the addition of 1.0 mM IPTG.
Cells were harvested after incubation at 293 K overnight (4500 g,
20 min, 277 K). Cell pellets were re-suspended in lysis buffer
(20 mM Tris pH 8, 500 mM NaCl, 1 mM DTT), complete EDTA-
free protease inhibitor cocktail (Roche) and homogenized. After
centrifugation (14 000 g, 30 min, 277 K), the soluble fraction was
applied to a 5 ml His trap FF Column (GE Healthcare) in a
gradient of 0–300 mM imidazole. EspM2 fractions were pooled
and purified using a Superdex 75 26/60 equilibrated in 20 mM
Tris pH 8, 500 mM NaCl, 10 mM DTT, high salt due to the insta-
bility of the protein. Protein was Liquid Nitrogen flash cooled and
frozen at 193 K on the same day, after experiencing protein
precipitation in samples kept at 277 K over 2–3 days.
Preparation of His-RhoA and His-Rac-1 was identical with the
following exceptions: expression was constitutive; cells were har-
vested after incubation at 310 K overnight. Lysis buffer was
20 mM Tris, 500 mM NaCl, 20 mM imidazole, 5 mM MgCl2. Size
exclusion buffer was 20 mM Tris, 200 mM NaCl, 3 mM MgCl2,
1 mM DTT.
Surface plasmon resonance
Experiments were carried out using a BIAcore™ 2000 System
(Biacore AB, Sweden) at 20°C. EspM229–196 was coupled to a
CM5 sensor chip leading to a rise of 2000 Response Units using
standard amine coupling protocols (BIAcore Amine Coupling Kit
BR-1000-50). Hepes-buffered saline containing 5 mM MgCl2 was
flowed throughout the experiment at 50 ml min-1. Samples of
RhoA/Rac-1 were injected (in the same buffer) for 180 s duration
over the EspM229–196 channel and over a RhoA control channel.
Dissociation was followed for 1000 s from the end of injection
after which regeneration of the surface was carried out with
25 mM NaOH. No loss of activity was seen after regeneration.
Experiments (repeated three times) were carried out with (i)
varying concentrations of RhoA (e = 18 825 M-1 cm-1) and Rac-1
(e = 23 295 M-1 cm-1) (concentration determined by Nanodrop
Spectrophotometer, 0.005–50 mM), and with (ii) fixed 4 mM RhoA
but varying concentrations of GDP/GTP (0.5–8 mM) added to the
buffer. RhoA control channel subtracted signals are presented
(BIAEvaluation software). The same conditions were used to
analyse the SifA–RhoA interaction.
Guanine nucleotide exchange analysis
In vitro GEF activity assay was carried out using RhoGEF
exchange assay biochem kit (Cytoskeleton Denver) according to
the manufacturer’s instructions. Briefly, exchange reaction assay
mixtures contained 20 mM Tris pH 7.5, 50 mM NaCl, 10 mM
MgCl2, 50 mg ml-1 bovine serum albumin (BSA), 0.75 mM
N-methylanthraniloyl(mant)-GTP, and 2 mM Rac1-His, Cdc42-
His, H-Ras-His or RhoA-His GTPase. Fluorescence spectro-
scopic analysis of mant-GTP was carried out using Fluostar
Optima spectrometer. The fluorescence measurements were
taken every 30 s with excitation and emission wavelengths of
360 nm and 440 nm respectively. After five readings (150 s),
purified EspM229–196 was added and the relative mant fluores-
cence was monitored every 30 s for a total time of 30 min. Experi-
ments were performed in triplicate.
NMR sample preparation and backbone assignment
of EspM229–196
Uniformly 15N 13C-labelled EspM229–196 was expressed in 15N 13C-
labelled rich media (Cambridge isotopes). After purification as
described above the sample was dialysed against NMR buffer
[50 mM NaPO4 pH 7.5, 150 mM NaCl, 5 mM DTT, 10% (v/v) D2O]
and concentrated to 0.9 mM. Backbone assignment for ~65% of
EspM229–196 was achieved using standard double- and triple-
resonance assignment experiments (Sattler et al., 1999) at
295 K.
NMR titration of RhoA against EspM229–196
15N 13C-labelled EspM229–196 was mixed with unlabelled His-RhoA
(dialysed in NMR buffer) ranging from 0x to 7x molar excess and
1H 15N TROSY-HSQC experiments were performed at each incre-
ment at 298 K. GTP (5 mM) was added to the sample of
EspM229–196 saturated with RhoA and a final 1H 15N TROSY-
HSQC was carried out.
Transfection
Swiss 3T3 cells were transfected with pRK5 encoding EspM2,
EspM229–196 and derivatives fused to a myc tag by lipofectamine
2000 (Invitrogen), according to the manufacturer’s recommenda-
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tions. The cells were incubated at 37°C in a humidified incubator
with 5% CO2 for 19 h, washed twice in PBS before having their
media replaced with DMEM as described previously (Arbeloa
et al., 2008).
Infection of Swiss 3T3
Forty-eight hours prior to infection cells were seeded onto glass
coverslips at a density of 5 ¥ 105 cells per well and maintained in
DMEM supplemented with 10% FCS at 37°C in 5% CO2. Three
hours before infection the cells were washed three times with
PBS, the media replaced with fresh DMEM without FCS and
500 ml of primed bacteria were added to each well and infections
were carried out for 90 min at 37°C in 5% CO2.
Immunofluorescence staining and microscopy
Swiss 3T3 cells on coverslips were washed three times in PBS
and fixed with 3% paraformaldehyde for 20 min before washing
three more times with PBS. For immunostaining, the cells were
permeabilized for 4 min in PBS 0.5% Triton X-100, washed three
times with PBS and quenched for 30 min with 50 mM NH4Cl. The
coverslips were then blocked for 1 h with 10% donkey serum
(Jackson laboratories) before incubation with primary and sec-
ondary antibodies. The primary antibody mouse anti-myc (Milli-
pore) was used at a dilution of 1:500. Coverslips were incubated
with the primary antibody for 1 h, washed three times in PBS and
incubated with the secondary antibody for 1 h. Donkey anti-
mouse IgG conjugated to a Cy3 fluorophore (Jackson laborato-
ries) was used at a 1:200. Actin was stained using Oregon Green
phalloidin (Invitrogen) at a 1:100 dilution. All dilutions were in 10%
donkey serum. Coverslips were mounted on slides using
ProLong Gold antifade reagent (Invitrogen) and visualized by
Zeiss Axioimager immunofluorescence microscope using the fol-
lowing excitation wavelengths: Cy3 – 550 nm, Cy5 – 650 nm and
Oregon Green – 488 nm. All images were analysed using the
Axiovision Rel 4.5 software.
Acknowledgements
We thank Michael Way for pMW172 derivatives expressing RhoA
or Rac1. We thank Clare Harding for cloning pET28:sifA and
Leah Ensell for technical assistance. This work was supported by
grants from the Wellcome Trust and the MRC.
References
Alto, N.M., Shao, F., Lazar, C.S., Brost, R.L., Chua, G.,
Mattoo, S., et al. (2006) Identification of a bacterial type III
effector family with G protein mimicry functions. Cell 124:
133–145.
Arbeloa, A., Bulgin, R.R., MacKenzie, G., Shaw, R.K., Pallen,
M.J., Crepin, V.F., et al. (2008) Subversion of actin dynam-
ics by EspM effectors of attaching and effacing bacterial
pathogens. Cell Microbiol 10: 1429–1441.
Arbeloa, A., Blanco, M., Moreira, F.C., Bulgin, R., Lopez, C.,
Dahbi, G., et al. (2009) Distribution of espM and espT
among enteropathogenic and enterohaemorrhagic
Escherichia coli. J Med Microbiol 58: 988–995.
Arnold, K., Bordoli, L., Kopp, J., and Schwede, T. (2006) The
SWISS-MODEL workspace: a web-based environment for
protein structure homology modelling. Bioinformatics 22:
195–201.
Berger, C.N., Crepin, V.F., Jepson, M.A., Arbeloa, A., and
Frankel, G. (2009) The mechanisms used by enteropatho-
genic Escherichia coli to control filopodia dynamics. Cell
Microbiol 11: 309–322.
Black, D.S., and Bliska, J.B. (2000) The RhoGAP activity of
the Yersinia pseudotuberculosis cytotoxin YopE is required
for antiphagocytic function and virulence. Mol Microbiol 37:
515–527.
Buchwald, G., Friebel, A., Galan, J.E., Hardt, W.D., Witting-
hofer, A., and Scheffzek, K. (2002) Structural basis for the
reversible activation of a Rho protein by the bacterial toxin
SopE. EMBO J 21: 3286–3295.
Bulgin, R.R., Arbeloa, A., Chung, J.C., and Frankel, G. (2009)
EspT triggers formation of lamellipodia and membrane
ruffles through activation of Rac-1 and Cdc42. Cell Micro-
biol 11: 217–229.
Deng, Q., and Barbieri, J.T. (2008) Modulation of host cell
endocytosis by the type III cytotoxin, Pseudomonas ExoS.
Traffic 9: 1948–1957.
Derewenda, U., Oleksy, A., Stevenson, A.S., Korczynska,
J., Dauter, Z., Somlyo, A.P., et al. (2004) The crystal
structure of RhoA in complex with the DH/PH fragment
of PDZRhoGEF, an activator of the Ca(2+) sensitiza-
tion pathway in smooth muscle. Structure 12: 1955–1965.
Finlay, B.B. (2005) Bacterial virulence strategies that
utilize Rho GTPases. Curr Top Microbiol Immunol 291:
1–10.
Fu, Y., and Galan, J.E. (1999) A Salmonella protein antago-
nizes Rac-1 and Cdc42 to mediate host-cell recovery after
bacterial invasion. Nature 401: 293–297.
Fukazawa, A., Alonso, C., Kurachi, K., Gupta, S., Lesser,
C.F., McCormick, B.A., and Reinecker, H.C. (2008)
GEF-H1 mediated control of NOD1 dependent
NF-kappaB activation by Shigella effectors. PLoS Pathog
4: e1000228.
Goehring, U.M., Schmidt, G., Pederson, K.J., Aktories, K.,
and Barbieri, J.T. (1999) The N-terminal domain of
Pseudomonas aeruginosa exoenzyme S is a GTPase-
activating protein for Rho GTPases. J Biol Chem 274:
36369–36372.
Hall, A., Paterson, H.F., Adamson, P., and Ridley, A.J. (1993)
Cellular responses regulated by rho-related small GTP-
binding proteins. Philos Trans R Soc Lond B Biol Sci 340:
267–271.
Handa, Y., Suzuki, M., Ohya, K., Iwai, H., Ishijima, N.,
Koleske, A.J., et al. (2007) Shigella IpgB1 promotes bac-
terial entry through the ELMO–Dock180 machinery. Nat
Cell Biol 9: 121–128.
Hardt, W.D., Chen, L.M., Schuebel, K.E., Bustelo, X.R., and
Galan, J.E. (1998) S. typhimurium encodes an activator of
Rho GTPases that induces membrane ruffling and nuclear
responses in host cells. Cell 93: 815–826.
Huang, Z., Sutton, S.E., Wallenfang, A.J., Orchard, R.C., Wu,
X., Feng, Y., et al. (2009) Structural insights into host
GTPase isoform selection by a family of bacterial GEF
mimics. Nat Struct Mol Biol 16: 853–860.
Iguchi, A., Thomson, N.R., Ogura, Y., Saunders, D., Ooka, T.,
EspM2 is a RhoA GEF 663
© 2010 Blackwell Publishing Ltd, Cellular Microbiology, 12, 654–664
Henderson, I.R., et al. (2009) Complete genome sequence
and comparative genome analysis of enteropathogenic
Escherichia coli O127:H6 strain E2348/69. J Bacteriol 191:
347–354.
Jaffe, A.B., and Hall, A. (2005) Rho GTPases: biochemistry
and biology. Annu Rev Cell Dev Biol 21: 247–269.
Jones, D.T. (1999) Protein secondary structure prediction
based on position-specific scoring matrices. J Mol Biol 292:
195–202.
Klebe, C., Prinz, H., Wittinghofer, A., and Goody, R.S. (1995)
The kinetic mechanism of Ran-nucleotide exchange cata-
lyzed by RCC1. Biochemistry 34: 12543–12552.
Lai, C.C., Boguski, M., Broek, D., and Powers, S. (1993)
Influence of guanine nucleotides on complex formation
between Ras and CDC25 proteins. Mol Cell Biol 13: 1345–
1352.
Matsuzawa, T., Kuwae, A., Yoshida, S., Sasakawa, C., and
Abe, A. (2004) Enteropathogenic Escherichia coli activates
the RhoA signaling pathway via the stimulation of GEF-H1.
EMBO J 23: 3570–3582.
Milburn, M.V., Tong, L., Vos, A.M., Brunger, A., Yamaizumi,
Z., Nishimura, S., and Kim, S.H. (1990) Molecular switch
for signal transduction: structural differences between
active and inactive forms of protooncogenic ras proteins.
Science 247: 939–945.
Mota, L.J., and Cornelis, G.R. (2005) The bacterial injection
kit: type III secretion systems. Ann Med 37: 234–249.
Ohlson, M.B., Huang, Z., Alto, N.M., Blanc, M.P., Dixon, J.E.,
Chai, J., and Miller, S.I. (2008) Structure and function of
Salmonella SifA indicate that its interactions with SKIP,
SseJ, and RhoA family GTPases induce endosomal tubu-
lation. Cell Host Microbe 4: 434–446.
Rossman, K.L., Worthylake, D.K., Snyder, J.T., Siderovski,
D.P., Campbell, S.L., and Sondek, J. (2002) A crystallo-
graphic view of interactions between Dbs and Cdc42: PH
domain-assisted guanine nucleotide exchange. EMBO J
21: 1315–1326.
Rudolph, M.G., Weise, C., Mirold, S., Hillenbrand, B., Bader,
B., Wittinghofer, A., and Hardt, W.D. (1999) Biochemical
analysis of SopE from Salmonella typhimurium, a highly
efficient guanosine nucleotide exchange factor for RhoGT-
Pases. J Biol Chem 274: 30501–30509.
Sattler, M., Schleucher, J., and Griesinger, C. (1999) Hetero-
nuclear multidimensional NMR experiments for the struc-
ture determination of proteins in solution employing pulsed
field gradients. Prog NMR Spectrosc 34: 93–158.
Simovitch, M., Sason, H., Cohen, S., Zahavi, E.E., Melamed-
Book, N., Weiss, A., et al. (2009) EspM inhibits pedestal
formation by EHEC and EPEC and disrupts the architec-
ture of a polarized epithelial monolayer. Cell Microbiol
Doi: 10.1111/j.1462-5822.2009.01410.x.
Stevens, M.P., Friebel, A., Taylor, L.A., Wood, M.W., Brown,
P.J., Hardt, W.D., and Galyov, E.E. (2003) A Burkholderia
pseudomallei type III secreted protein, BopE, facilitates
bacterial invasion of epithelial cells and exhibits guanine
nucleotide exchange factor activity. J Bacteriol 185: 4992–
4996.
Tobe, T., Beatson, S.A., Taniguchi, H., Abe, H., Bailey, C.M.,
Fivian, A., et al. (2006) An extensive repertoire of type III
secretion effectors in Escherichia coli O157 and the role of
lambdoid phages in their dissemination. Proc Natl Acad Sci
USA 103: 14941–14946.
Von Pawel-Rammingen, U., Telepnev, M.V., Schmidt, G.,
Aktories, K., Wolf-Watz, H., and Rosqvist, R. (2000) GAP
activity of the Yersinia YopE cytotoxin specifically targets
the Rho pathway: a mechanism for disruption of actin
microfilament structure. Mol Microbiol 36: 737–748.
Wishart, D.S., Sykes, B.D., and Richards, F.M. (1993)
Improved synthetic methods for the selective deuteration of
aromatic amino acids: applications of selective protonation
towards the identification of protein folding intermediates
through nuclear magnetic resonance. Biochim Biophys
Acta 1164: 36–46.
Supporting information
Additional Supporting Information may be found in the online
version of this article:
Appendix S1. Supplementary results.
Fig. S1. 1H 15N HSQC spectra of EspM2 constructs at 295 K.
A. Full-length EspM2 where the overlapping peaks within the
centre of the spectra are due to resonances from highly flexible
regions of the protein.
B. The much increased resolution of the spectra of EspM229–196
shows that this truncated form is a compact structure with an
appropriate number of amide peaks.
Fig. S2. Activity of EspM229–196.
A. Serum-starved Swiss 3T3 cells were mock transfected or
transfected with the mammalian expression vector pRK5 encod-
ing myc-tagged EspM2 and EspM229–196 for 19 h. Actin was
stained with Oregon green phalloidin and the myc tag was
detected with monoclonal antibody. Transfection of EspM2 and
EspM229–196 induces the formation of parallel stress fibres to the
same extent.
B. Quantification of stress fibres on Swiss 3T3 after 19 h trans-
fection with EspM2 and EspM229–196. Fifty cells were counted in
duplicate in three independent experiments. Results are dis-
played as mean  SEM.
Fig. S3. Secondary structure of EspM229–196. From the NMR
chemical shift index (CSI) (Wishart et al., 1993), predictions with
PSIPRED (Jones, 1999) and a model based on the crystal struc-
ture of the C-terminal domain of SifA (pdb:3cxb; Ohlson et al.,
2008) EspM229–196 most likely contains between six and seven
helices and two short N-terminal helices. Helices are shown as
red rectangles, sheets as blue arrows, coils and loops are grey
lines while regions in the CSI which have not been assigned are
left blank.
Table S1. List of plasmids.
Table S2. List of primers.
Please note: Wiley-Blackwell are not responsible for the content
or functionality of any supporting materials supplied by the
authors. Any queries (other than missing material) should be
directed to the corresponding author for the article.
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Abstract 
Subversion of Rho family small GTPases, which control actin dynamics, is a common 
infection strategy used by bacterial pathogens. In particular, Salmonella, Shigella, 
enteropathogenic (EPEC) and enterohemorrhagic (EHEC) Escherichia coli translocate type 
III secretion system (T3SS) effector proteins to modulate the Rho GTPases RhoA, Cdc42 and 
Rac1 that trigger formation of stress fibers, filopodia and lamellipodia/ruffles, respectively. 
The Salmonella effector SopE is a guanine nucleotide exchange factor (GEF) that activates 
Rac1 and Cdc42, which induce ‘the trigger mechanism of cell entry’. Based on a conserved 
Trp-xxx-Glu motif the T3SS effector proteins IpgB1 and IpgB2 of Shigella, SifA and SifB of 
Salmonella and Map of EPEC and EHEC were grouped together into a WxxxE family; recent 
studies identified the T3SS EPEC and EHEC effectors EspM and EspT as new family 
members. Recent structural and functional studies have shown that representatives of the 
WxxxE effectors share with SopE a 3D fold and a GEF activity. In this minireview we 
summarize contemporary findings related to the SopE and WxxxE GEFs in the context of 
their role in subverting general host cell signaling pathways and infection. 
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Introduction 
Colonization, multiplication and dissemination are the key steps of an infectious cycle. To 
persist within the hostile in vivo environments bacterial pathogens utilize sophisticated 
virulence strategies to subvert and hijack cellular and systemic functions. A common 
infection strategy used by Gram-negative pathogens involves injection of virulence factors, 
known as effectors, by the type III secretion system (T3SS), from the bacterial cell directly 
into the eukaryotic cell (reviewed in (26)). The injected effectors target different cellular 
compartments and subvert numerous signalling pathways for the benefit of the invaded or 
attached bacteria. Due to their essential role in regulating key cellular functions Rho-family 
small G proteins are common targets of T3SS bacterial effectors (reviewed in (23)). 
To date, 22 members of the Rho GTPase family, belonging to the small GTPase protein 
superfamily, have been identified (54). Cdc42, Rac1 and RhoA, which trigger formation of 
filopodia, lamellipodia/ruffles and stress fibers, respectively, are the best characterized (29). 
The Rho GTPases share a conserved structure consisting of two flexible domains called 
Switch I and Switch II and a phosphate binding loop (P-loop) which together form a Mg
2+
 
and nucleotide-binding pocket (reviewed in (22)). The small GTPases are modified post-
transcriptionally by the addition of a lipid moiety to the C-terminus (farnesyl, geranyl, 
palmitoyl or methyl), signalled by the carboxyl-terminal CAAX motif (55), which targets 
them to different membranous compartments.  
The function of the small GTPases is strictly regulated. By binding the two switch domains 
and the lipid moiety, the Guanine nucleotide Dissociation Inhibitors (GDIs) prevent 
membrane localization and maintain the GTPases in an inactive state in the cytosol (35, 59). 
Small GTPases act as molecular switches cycling between GTP bound (active) and GDP 
bound (inactive) conformations. Switching a GTPase on is mediated by Guanine nucleotide 
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Exchange Factors (GEFs) that facilitate exchange of GDP for GTP. The intrinsically low  
GTP hydrolysis activity of Rho GTPases is greatly increased by interaction with GTPase-
Activating Proteins (GAPs), leading to recycling of the G protein to its GDP-bound, inactive 
form. The Rho GTPases transmit signals in a GTP-dependent manner by activating and/or 
recruiting downstream effector proteins to their sites of action (reviewed in (38)). 
Rho GTPases GEFs belong mainly to the Dbl family and contain a catalytic Dbl homology 
domain (DH) and a pleckstrin homology domain (PH), which mediates membrane 
association, modulates the activity of the DH domain and probably determines substrate 
specificity (39). The DH domain is involved in the exchange of the GDP to GTP by a 
mechanism called “push and pull”. It interacts specifically with the Rho GTPases Switch I 
and Switch II regions leading to a conformational change and ejection of GDP and Mg
2+
. 
This in turn leads to loading with GTP, which is present in the cytosol at a high concentration 
(72). Loading of Rho GTPase with GTP-Mg
2+
 triggers the dissociation of the GEF Rho 
GTPase complex and allows interaction of the latter with its effectors.  
In order to subvert the Rho GTPase pathways, pathogenic bacteria inject into eukaryotic cells 
effector proteins that mimic GEF, GAP, or RhoGDI. For example Salmonella inject 
equivalent amounts of the T3SS effector proteins SopE and SptP that control the activity of 
Cdc42 and Rac1. Although sharing no sequence or structural similarities with eukaryotic 
GEFs (56), SopE triggers nucleotide exchange, which induces ‘the trigger mechanism of cell 
entry’ (32). SopE is then poly-ubiquitinated and targeted to the proteosome before SptP, 
which has a GAP activity and exhibits much slower degradation kinetics, helps the cell to 
recover from the SopE-induced membrane ruffling (42). 
Recently, Alto et al. (1) assembled several known T3SS effectors into a single family that 
share the common motif Trp-xxx-Glu (WxxxE). This family originally included the 
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Salmonella SifA and SifB, the Shigella IpgB2 and IpgB1 and the enteropathogenic 
Escherichia coli (EPEC) and enterohemorrhagic E. coli (EHEC) Map. Since the original 
classification new family members, EspM (3) and EspT (16), were discovered in EPEC, 
EHEC and Citrobacter rodentium (Fig. 1). Although initially thought to be Rho GTPase 
mimics (1), recent structural, biochemical and functional data show that the WxxxE effectors, 
like SopE, are Rho GTPases GEFs, which are the focus of this review. 
The WxxxE effectors: from Rho GTPase mimics to Rho GTPase GEFs  
The Rho GTPase mimicking hypothesis 
In 2006 Alto et al. have shown that when expressed ectopically several of the WxxxE 
effectors subvert actin dynamics (1). IpgB2 induced formation of stress fibers, Map induced 
filopodia and IpgB1 induced formation of membrane ruffles, phenotypes which correspond to 
those induced by the activated forms of RhoA, Cdc42 and Rac1 respectively (Fig. 2). In order 
to determine if formation of stress fibers induced by IpgB2 was epistatic to RhoA, the activity 
of endogenous RhoA was inhibited either by dominant negative or by the bacterial toxins 
YopT and C3. In these conditions, IpgB2-induced stress fiber formation was not affected, 
suggesting that IpgB2 was acting independently of the small GTPase. Concordantly, IpgB2 
was shown to interact with the Rho coiled coil p160 (ROCK) serine/threonine kinase and the 
RhoA binding motif of the formin mDia, the two canonical RhoA effectors involved in stress 
fiber formation (1). In vitro ROCK kinase assays showed that IpgB2 directly stimulated the 
activity of ROCK. Furthermore, inhibition of ROCK by the chemical inhibitor Y-27632 
abolished IpgB2-induced stress fiber formation (1). Together these findings led Alto and 
colleagues to conclude that IpgB2 acts as a RhoA mimic, triggering the RhoA pathway by 
directly activating the RhoA effectors ROCK and mDia. This mechanism was extended to 
other WxxxE family members and in the absence of sequence similarities and structural data 
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 6 
the results from the seminal paper of Alto et al (1) supported the hypothesis that the WxxxE 
effectors function as small GTPases mimics.  
Before the WxxxE effectors were grouped together, Ohya et al. showed that IpgB1 induces 
formation of membrane ruffles which was dependent on Rac1 and to a lesser extent on Cdc42 
(52). A follow-up study by Handa et al. has shown that IpgB1 binds the N-terminal region of 
the engulfment and motility protein (ELMO) in a similar manner to RhoG (30). Formation of 
membrane ruffles by IpgB1 was dependent on the ability of ELMO to bind the atypical Rac1 
GEF Dock180. Cells transfected with truncated ELMO, which cannot bind Dock180, or 
Dock180, which cannot bind Rac1, failed to induce formation of IpgB1-dependent membrane 
ruffles upon Shigella infection (30). Translocation of ELMO-Dock 180 complex to the 
membrane is mediated by activated RhoG. Likewise, expression of IpgB1 induces 
translocation of the ELMO-Dock180 complex to the membrane where it induces membrane 
ruffles (30). Together these results led the authors to conclude that IpgB1 activates Rac1 by 
binding the ELMO-Dock180 bipartite GEF (30). These results extended the mimicking 
paradigm as Handa et al. have shown that IpgB1 was mimicking RhoG (30).  
The ability of Map to induce formation of filopodia at the EPEC attachment sites during the 
early stages of infection was originally described by Kenny and co-workers in 2002 (41). 
Using dominant negative constructs Kenny et al. showed that Map induces filopodia in a 
Cdc42-dependent but Rac1-independent manner. These results were confirmed by Berger et 
al. that furthermore demonstrated that Map induces activation of Cdc42 (7). Similarly to 
IpgB2, transfection or translocation of the EspM effectors resulted in formation of stress 
fibers in a ROCK-dependent manner (3) (Fig. 2). Production of stress fibers by EspM 
required active RhoA, since inhibition of this GTPase by dominant negative constructs 
abolished stress fiber formation (3). Moreover, pull-down experiments have shown that 
expression of EspM induced activation of RhoA (3). EspT induces formation of membrane 
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 7 
ruffles, similar in morphology to those induced by IpgB1, and lamellipodia  (Fig. 2) (16), that 
facilitate EPEC invasion (15). The function of EspT was dependent on cellular GTPases as 
EspT enriches the GTP bound cellular fractions of Rac1 and Cdc42 in in vitro pull-down 
assays, while inhibition of Rac1, and to a lesser extent Cdc42, blocked EspT-induced 
formation of membrane ruffle and lamellipodia (16) and invasion (15). Despite the similarity 
between the phenotypes induced by EspT and IpgB1 the mechanism by which membrane 
ruffles and lamellipodia are formed by these two WxxxE effectors is distinct as EspT induces 
cytoskeletal re-arrangements independently of ELMO or Dock180 (16, 30); these results are 
consistent with the low sequence similarity between IpgB1 and EspT (Fig. 1). Moreover, 
siRNA and dominant negatives showed that formation of membrane ruffles by EspT is 
dependent on the Rac1 effector Wave2 (15).  
WxxxE structure and function 
The publication of the crystal structure of SifA in complex with the PH domain of its effector 
SKIP (SifA and kinesin–interacting protein) (51), represents a turning point in our 
understanding of the WxxxE effectors. SifA and SifB, which contrary to the other WxxxE 
effectors do not appear to affect actin dynamics, are particular in that they consist of two 
domains (51). Ohlson et al. have shown that while the N-terminal domain of SifA binds SKIP, 
the C-terminal domain, harbouring the WxxxE motif, contains two three helix bundles that 
form a V shape structure (51). This structure is surprisingly highly similar to that of SopE 
(14). The crystal structure of Cdc42 in complex with the biologically active catalytic 
fragment of SopE (residues 78-240) highlighted the mechanism by which SopE mediates 
guanine nucleotide exchange (32, 14) and as a result formation of membrane ruffles (Fig. 2). 
Although SopE does not share sequence or structural similarity with known eukaryotic GEFs, 
it locks the Switch I and II regions of Cdc42 in the same conformation as that observed in the 
equivalent regions of Rac1 or Cdc42 bound to the eukaryotic GEFs Tiam or Dbs, respectively.  
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 8 
SopE is composed of six -helices forming two three-helix bundles arranged in a V-shaped 
fashion. Connecting the two arms of the V is a small two-stranded -sheet followed by a 
peptide segment harbouring a GAGA motif. Binding of SopE induces conformational 
changes in the Switch regions of Cdc42, which are mostly due to insertion of the catalytic 
GAGA motif between Switch I and Switch II. This leads to exertion of a push and pull type 
movement, which induces the release of the guanine nucleotide. Consistently, replacement of 
the first glycine of the GAGA motif by alanine abolishes SopE activity in vitro (14). The two 
GEF homologues of SopE, SopE2 (Salmonella) and BopE2 (Burkholderia pseudomallei) 
share with SopE a similar catalytic loop sequence and structure, suggesting a common 
nucleotide exchange mechanism (5, 65, 66, 70). Interestingly, several of the Cdc42-
interacting residues of SopE are conserved in SifA. Moreover, although not similar in 
sequence, the chemical properties of the residues within the putative catalytic loop of SifA 
are comparable to those found in SopE (51). Nonetheless, despite the similarities with SopE 
and the ability to bind RhoA no GEF activity has yet demonstrated for SifA (4, 51).  
Two recent independent reports have shown that several WxxxE effectors are RhoGTPase 
GEFs (4, 36). First, Huang et al. demonstrated that Map specifically binds nucleotide free 
Cdc42 and is able to induce release of GDP and incorporation of GTP (36). Moreover, the 
crystal structure of Map in complex with Cdc42 showed a similar structure to that of SopE 
and SifA, which is composed of seven -helices arranged into one three-helix bundle and one 
four-helix bundle forming a V shaped structure; a putative catalytic loop connects the two V 
shaped arms. Furthermore, comparing the complexes of Cdc42 with Map, SopE, and the 
human GEF ITSN1 revealed that despite lacking sequence homology these three GEFs 
induce similar conformational changes in Cdc42, suggesting a common mechanism of 
nucleotide exchange. Importantly, although the sequences of the catalytic loops are somewhat 
different between SopE and Map, it was shown that an alanine and a glutamine residues 
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 9 
cement the interaction of Map with the Switch I region of Cdc42 by making a hydrophobic 
contact and a hydrogen bond, respectively (36). Concordantly, deletion of the catalytic loop 
or substitution of either of these two residues inhibited the GEF activity of Map in vitro and 
compromised host signalling functions of Map during infection (36). Furthermore, GEF 
activity assays using recombinant IpgB1 and IpgB2 have shown that the former triggers 
nucleotide exchange in Rac1 and to a lower extent in Cdc42 (but not in RhoA) while the 
latter induces strong activation of RhoA and weak activation of Cdc42 and Rac1 (36). This 
Rho GTPase specificity of the WxxxE effectors appears to be governed by a complementary 
paring between residues at the 4-6 “selective epitope” of the effectors and the 2-3 
intersiwtch strand of the GTPases.  
In a parallel study, EspM2 has been shown to bind tightly and irreversibly to RhoA in vitro 
and to specifically facilitate loading of GTP into purified RhoA (4). Moreover, modelling the 
structure of EspM2 aided by NMR, showed that it also adopts a SopE-like conformation (4). 
As it was shown for Map, mutagenesis of the equivalent glutamine within the catalytic loop 
impaired the ability of EspM2 to induce loading of GTP into RhoA and formation of stress 
fibers during ectopic expression (4).  
Alto et al. have shown that substituting the tryptophan or glutamic acid residues within the 
WxxxE motif with alanine was detrimental for function (1). As conservative substitutions 
(replacing the tryptophan and glutamic acid residues with tyrosine and aspartic acid 
respectively) in EspM2 did not result in any significant loss of function (3), the conserved W 
and E residues were hypothesized to have mainly a structural role. Indeed, the 3D structures 
of SifA and Map and the EspM2 model have shown that the W and E residues are positioned 
around the junction of the two three-helix bundles, maintaining the conformation of the 
putative catalytic loop through hydrophobic contacts with surrounding residues (36, 51). 
Consistently, an EspM2 W70A was highly unstable (4). Interestingly, although sharing 
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 10 
similar 3D structures with the WxxxE effectors, SopE has neither a W nor an E equivalent 
(Fig. 3). Nonetheless, taken together these results show that the WxxxE effectors belong to a 
large family of bacterial Rho GTPase GEFs, which also includes SopE, SopE2 and BopE2. 
Regulation of the WxxxE effector activities 
As it is now apparent that the WxxxE effectors, as is SopE, are Rho GTPase GEFs, there is a 
need to discuss this activity in the context of previously published data. For example Alto et 
al. (1) have shown that IpgB2 interacts with the RhoA effectors ROCK and mDia. It is 
possible that by binding simultaneously the Rho GTPase and its effectors IpgB2 amplify the 
transmitted signal, as was shown for eukaryotic GEFs (37). This might suggest a mechanism 
of nucleotide exchange by the WxxxE effectors involving formation of a tripartite complex 
consisting of GEF-Rho GTPase-effector as was suggested for EspM2 (4). Handa et al. have 
shown that IpgB1 forms a complex with ELMO-Dock180, which is essential for activation of 
Rac1 in vivo (30). Furthermore, Map contains a carboxy terminal PSD-95/Disk-large/ZO-1 
(PDZ)-binding motif (DTRL), which mediates interaction between Map and PDZ1 of the 
scaffold protein sodium/hydrogen exchanger regulatory factor-1 (NHERF1) (1, 63). Alto et 
al. have shown that depleting cells of NHERF1 abolished Map-induced filopodia formation 
(1) while Simpson et al. (63) have shown that cells infected with EPEC expressing Map

TRL 
exhibited no filopodia at 30 min post infection. Recently, Berger et al. have shown that 
maintenance of filopodia on the cell surface is dependent on the Map PDZ-binding motif, 
ezrin and the RhoA/ROCK pathway (7). These results suggest that the intrinsic GEF activity 
of these effectors is regulated by formation of large signalling complexes, as was also 
described for few eukaryotic GEFs, which were linked to activation of Rho GTPases in 
distinct cellular localizations and pathways (6, 60, 71).  
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 11 
Role of SopE and the WxxxE effector GEFs in pathogenesis 
SopE and the WxxxE effectors are central to the EPEC, EHEC, Shigella and Salmonella 
infection as they control cell invasion, intracellular survival and modulation of the host 
immune responses (Summarized in Fig. 4). Most of these activities are dependent on the GEF 
activity of these effectors.  
SopE and the WxxxE effectors - invasion and intracellular survival 
The virulence strategy used by Shigella and Salmonella involves invasion of enterocytes and 
macrophages. To invade non-phagocytyic cells Shigella and Salmonella use their T3SS to 
deliver effectors, which subvert actin dynamics leading to formation of membrane ruffles and 
macropinocytic pockets.
 
Shigella invasion is dependent on T3SS effectors IpgB1, IpaC, IpaA, 
VirA and IpgD (49, 68, 69, 73), while Salmonella invasion requires several SPI-1 effectors 
including SopE, SopE2 and SopB (5, 32, 50). Cell invasion by B. pseudomallei is mediated 
by BopE (66).  
In addition to playing a role in invasion, SopE has been suggested to affect intracellular 
bacterial survival by promoting fusion between the Salmonella containing vacuole (SCV) and 
early endosomes via recruitment and activation of the GTPase Rab5 (45). The SPI-2 effector 
SifA plays an important role in intracellular survival and virulence (8); while little is 
currently know of the function of SifB (9, 24). SifA contains a carboxyl-terminal CAAX 
motif, commonly found in the small GTPases, which when prenylated, facilitate membrane 
localization and activity (9, 53). SifA is involved in formation of the Salmonella-induced 
filaments (Sifs), which play a role in maintaining the integrity of the SCV (8, 58, 64). To 
achieve this SifA controls membrane dynamics and finely coordinates the equilibrium 
between the molecular motors kinesin and dynein. Indeed, by binding the host protein SKIP 
SifA inhibits recruitment of kinesin to the SCV (10), while by interacting with activated Rab7 
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 12 
it inhibits recruitment of dynein (33). The role played by the WxxxE domain of SifA in these 
activities is not currently known.  
In contrast with the other bacteria encoding SopE or the WxxxE effectors, the attaching and 
effacing pathogens (A/E) EPEC, EHEC and C. rodentium were considered to be exclusively 
extracellular, although sporadic reports have shown that atypical EPEC strains can invade 
non-phagocytic cells (21, 34). This invasive ability has been linked to the adherence pattern 
and tight association of EPEC with the host cell membrane, which was hypothesized to 
produce a passive push effect leading to internalization. Recently EspT has been shown to 
play an analogous role during EPEC and C. rodentium infections to that of IpgB1, SopE, 
SopE2 and BopE by promoting invasion into non-phagocytic cells via the triggered 
mechanism. EPEC and C. rodentium invasion requires Rac1 and Wave2 and to a lesser extent 
Cdc42 (15). Invaded EPEC resides in an E. coli containing vacuole (ECV) and induces 
formation of intracellular actin comets which appear to promote intracellular 
replication/survival (15).  Screening for the presence of espT among clinical EPEC and 
EHEC strains has shown that it is a rare effector present only in 1.8 % of the EPEC strains 
and missing from all the O157 and non-O157 EHEC isolates (2). EspT defines a new rare 
category of invasive EPEC (15).  
SopE and the WxxxE effectors - modulation of host responses 
S. Typhimurium is able to modulate innate immune responses in cultured epithelial cell 
models independently of the classical TLRs (Toll-like) or NLRs (NOD-like) receptors but via 
mechanisms involving SopE, SopE2, and SopB (13). By stimulating the Rho GTPases these 
effectors activate the MAP kinase and NF-kB signalling pathways (13). Moreover, in a 
Cdc42 and Rac1 dependent manner, SopE stimulates Caspase-1 activation in vitro which is 
needed for induction of mucosal inflammation in vivo (46). As similarly to SopE the WxxxE 
effectors are Rho GTPase GEFs they might also modulate innate immune response. Indeed, 
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activation of Rac1 by IpgB1-ELMO-Dock180 complex increases the cellular level of 
phosphorylated JNK, a MAP kinase involved in host responses (30). Moreover, a recent 
study by Fukazawa et al. (25) suggested that IpgB2, and to a minor extent IpgB1, activate 
NF-kB. IpgB2 was shown to activate NF-kB via a unique pathway involving GEF-H1, RhoA 
and NOD1.  
SopE and the WxxxE effectors – subversion of intestinal barrier functions and diarrhea 
Shigella, Salmonella, EPEC and EHEC diarrheal pathogens. Although other T3SS effectors 
are involved in disruption of the intestinal barrier functions and alteration of tight junctions 
(TJ), SopE and the WxxxE family members play an important role in this process.  
SopE and SopE2 disrupt TJ structure and function (11). In contrast to wild type S. 
Typhimurium, the double sopE/sopE2 mutant did not increase the permeability of polarized 
epithelial cell monolayers and was unable to cause redistribution of ZO-1 and occludin, or to 
alter cell polarity. As these phenotypes are dependent on host protein prenylation 
(geranylgeranylation) it was suggested that SopE and SopE2 utilize their ability to stimulate 
Rho family GTPases to disrupt TJ (11). 
Recently, EspM2 has been shown to play a role in the disruption of the architecture of the 
polarized epithelial monolayer (62). Translocation or ectopic expression of EspM2 affected 
localization of ZO-1 that migrated towards the basal side of the polarized epithelial 
monolayer. This in turn led to cell rounding and extrusion form the monolayer. However the 
TJ alterations induced by EspM2 did not interfere with their functionality, in fact increased 
TER values were observed upon EspM2 expression suggesting that this effector might play a 
role in maintaining TJ during infection (62).   
Map has been shown to play a role in reducing transepithelial electrical resistance (TER) in 
polarized Caco-2 cells (17, 43), although this was not reproduced in a subsequent study (63). 
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Furthermore, in 2006 Dean et al. reported a role for Map, together with the T3SS effectors 
EspF and Tir and intimin in the effacement of absorptive microvilli and inactivation of the 
sodium-D-glucose cotransporter (SGLT-1), EPEC phenotypes which are directly correlated 
with watery diarrhea (18). 
In vivo functions of SopE and the WxxxE effectors 
Despite major advances in our understanding of SopE and the WxxxE effectors in vitro, a 
complete picture of the function of these effectors in pathogenesis is yet to be obtained. 
However, several in vivo studies provided some information about the role played by these 
effectors during infection.  
The most dramatic in vivo phenotype associated with a WxxxE family member was observed 
with a sifA mutant. Consistent with the fact that SifA is required for Salmonella replication in 
macrophages in vitro, a Salmonella sifA mutant was severely attenuated during single or 
mixed mouse infections (8, 12, 24, 57). In contrast, a sifB mutant had little effect on virulence 
(24, 57). Using murine models of intestinal inflammation it was shown that SopE, and to a 
lesser extent SopE2, contribute to colitis (31) and virulence (40); SopE2 also induces 
diarrhoea in calves (74). It is worth noting that while SopE is absent from most of the S. 
Typhimurium isolates, SopE2 is conserved in all pathogenic strains (5, 65). Similarly to SopE, 
BopE has also been shown to play a role in B. speudomallei virulence as bopE mutants were 
attenuated when tested in a mouse model (67).  
The role of IpgB2 and IpgB1 in Shigella virulence was investigated using both the Sereny 
test (61) and the murine pulmonary model (44). An ipgB1/ipgB2 double mutant was highly 
attenuated as it did not induce any keratoconjunctivitis and was associated with reduced 
mortality (28). However, no particular phenotype was associated with a single ipgB2 mutant 
(28), and the ability of Shigella to induce keratoconjunctivitis using the Sereny test was 
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strongly enhanced in an ipgB1 mutant (28). The precise role of IpgB1 and IpgB2 in 
pathogenesis in vivo needs to be clarified.  
The role played in pathogenesis by Map, and more recently by EspM2 and EspT, has been 
investigated using the mouse-specific pathogen C. rodentium, the etiological agent of 
transmissible colonic hyperplasia, commonly used as a model for human EPEC and EHEC 
infections (reviewed in (47)). Single infection studies reported a subtle role for Map in 
colonization of the mouse colon (19, 48), while a mixed infection of wild type and map 
mutant revealed that the latter is extensively out competed (48). In addition, intestinal 
mitochondrial structure disruption and impaired mitochondrial cellular metabolism observed 
following C. rodentium infection were shown to be Map-dependent (43). Map was reported 
to have a role in TER disruption in vivo (43), although it had no role in maintaining colon 
water content at day 7 post infection (27). However, an independent study which compared 
stools water content in mice colonized at similar levels by wild type C. rodentium and a map 
mutant showed higher water content in the former group over a 12 days infection course, 
suggesting a possible role of Map in diarrhoea (63). This phenotype is consistent with 
binding of Map to NHERFs (63), which regulate ion channels activities. Recently, mouse 
infections have shown that while a C. rodentium espT mutant did not exhibit a significant 
difference in terms of bacterial shedding compared to wild type C. rodentium, an espM2 
mutant was shed at significantly lower levels, and caused less mortality in the highly 
susceptible CH3/HeJ mouse strain (20).  
Conclusions and perspectives 
SopE and the WxxxE effectors constitute an example of convergent evolution in bacterial 
virulence. Although exhibiting little sequence homology the WxxxE effectors and SopE share 
similar structure and function. Their mechanism of nucleotide exchanges appear to be similar 
to that employed by eukaryotic GEFS. While WxxxE effectors can trigger nucleotide 
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exchange in vitro, once translocated it appears that they function in the context of large 
signalling complexes, which are likely to regulate their activity. Importantly, while sharing 
3D structure with the other family members and capable of binding RhoA (4, 51), no GEF 
activity was thus far associated with SifA. Extensive research over many years has shown 
that SopE and the WxxxE effectors are involved in divers aspects of infection, including cell 
invasion, intracellular survival and replication, modulation of host responses and subversion 
of the intestinal barrier function (Fig. 4). Contrasting the rapid characterization of the in vitro 
phenotypes of SopE and the WxxxE effectors, our understanding of their role in virulence is 
lagging. Translating the fascinating cell biology surrounding these effectors to pathogenesis 
is the challenge of future studies. 
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Figures legends 
Figure 1. SopE and the WxxxE effectors. Multiple sequence alignment with hierarchical 
clustering of IpgB1 and IpgB2 from S. flexneri 2a, EspM2 from EHEC O157:H7, EspT from 
C. rodentium, Map from EPEC E2348/69, the C-terminal, WxxxE-containing motif of SifA 
and SifB, and SopE and SopE2 from S. Typhimurium and BopE from B. pseudomallei. 
Similar and identical residues are highlighted in grey. The WxxxE motif and the catalytic 
loops are boxed.  
 
Figure 2. SopE and WxxxE effectors subvert actin dynamics. Serum-starved Swiss 3T3 
cells were mock transfected or transfected with the mammalian expression vector pRK5 
encoding myc-tagged IpgB2, EspM2 (not shown), Map, IpgB1, EspT or the catalytic domain 
of SopE (residues 78-240) for 16 h. Ectopic expression of IpgB2 and EspM2 induced 
formation of stress fibers, Map induced filopodia formation, IpgB1 induced formation of 
membrane ruffle while EspT and SopE induce membrane ruffles and lamelipodia. Actin was 
stained with Oregon Green phalloidin, the myc tag was detected with monoclonal antibody. 
 
Figure 3: Structure of SopE and the WxxxE effectors. A. Overlay of the crystal structure 
of Map (yellow; pdb:3gcg; (36)), the crystal structure of the WxxxE-containing domain of 
SifA (green; pdb:3cxb; (51)), the model of EspM2 (purple; (4)) and the crystal structure of 
the GEF domain of SopE (cyan; pdb:1gzs; (14)). Although these structures generally 
superimpose well, there are differences between the helical arrangements within the 
corresponding WxxxE region of SopE (red box). Moreover differences in the orientation of 
the catalytic loop between SopE and Map and SifA and EspM2 could be accounted to the fact 
that crystal structures of SopE and Map are solved in complex with Cdc42, while the SifA 
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structure is of Rho GTPase free effector. EspM2 was modelled on the SifA structure. B. 
Within the WxxxE motif of Map E78 makes 2 hydrogen bonds via the carboxyl oxygen to the 
backbone nitrogen of S130 (in helix 4), whilst the ring nitrogen of W74 makes a single 
hydrogen bond to the hydroxyl group of S130. The side chain of W74 is also buried away 
from the solvent in a hydrophobic pocket containing L58 and V62. The combination of these 
interactions orientates the catalytic loop (N-terminal to helix 4) correctly with respect to 
forming a complex with Cdc42. In SopE, Y106 and T110 are in equivalent positions to W74 
and E78 in Map; however, they are not involved in inter-helical contacts. 
 
Figure 4. SopE and the WxxxE bacterial effectors subvert host-cell pathways. Using the 
T3SS Shigella (A), EPEC/EHEC (B), and Salmonella (C) inject the effectors IpgB1/IpgB2, 
EspT/Map/EspM and SopE/SopE2/SifA/SifB, respectively. Except for SifA and SifB, these 
effectors activate a cascade of signal transduction pathways starting with activation of Rho 
GTPases (either Rac1, RhoA or Cdc42), which lead to actin polymerization. Membrane 
ruffles induced by IpgB1, EspT, SopE and SopE2 allow bacterial engulfment and subsequent 
internalization into a bacterial containing vacuole (BCV). Invasive EPEC and Salmonella 
remain in the BCV and induce the formation of intracellular actin comets, and Salmonella-
induced filaments (Sifs), respectively, while Shigella escapes to the cytosol where it forms 
actin tails. In parallel to subversion of actin dynamics IpgB1, IpgB2, SopE and SopE2 induce 
inflammatory response; EspM, Map, SopE and SopE2 induce tight junction alteration and 
Map induces mitochondrial dysfunction. SopE and SifA, which is translocated across the 
SCV via the Spi2 T3SS, play a role in maintaining the SCV. The activity of SifB remains 
unknown.  
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Citrobacter rodentium (formally Citrobacter freundii biotype 4280) is a highly infectious pathogen that causes
colitis and transmissible colonic hyperplasia in mice. In common with enteropathogenic and enterohemor-
rhagic Escherichia coli (EPEC and EHEC, respectively), C. rodentium exploits a type III secretion system (T3SS)
to induce attaching and effacing (A/E) lesions that are essential for virulence. Here, we report the fully
annotated genome sequence of the 5.3-Mb chromosome and four plasmids harbored by C. rodentium strain
ICC168. The genome sequence revealed key information about the phylogeny of C. rodentium and identified
1,585 C. rodentium-specific (without orthologues in EPEC or EHEC) coding sequences, 10 prophage-like
regions, and 17 genomic islands, including the locus for enterocyte effacement (LEE) region, which encodes a
T3SS and effector proteins. Among the 29 T3SS effectors found in C. rodentium are all 22 of the core effectors
of EPEC strain E2348/69. In addition, we identified a novel C. rodentium effector, named EspS. C. rodentium
harbors two type VI secretion systems (T6SS) (CTS1 and CTS2), while EHEC contains only one T6SS (EHS).
Our analysis suggests that C. rodentium and EPEC/EHEC have converged on a common host infection strategy
through access to a common pool of mobile DNA and that C. rodentium has lost gene functions associated with
a previous pathogenic niche.
The mouse has been utilized extensively as a model for
studies of infection and immunity (11, 25, 41, 44). Mice can be
housed in relatively simple facilities and can be maintained
under controlled pathogen- or germ-free conditions. Further,
the availability of inbred or genetically manipulated mice
greatly enhances the potential of any studies (35, 80). Although
murine infection systems are used extensively, relatively few
pathogens have been exploited that are naturally virulent for
the species.
Spontaneous disease outbreaks in mouse colonies in the
United States and Japan in the 1960s and 1970s were associ-
ated with infections by the Gram-negative pathogens Esche-
richia coli (Ex30, also known as murine pathogenic E. coli
[MPEC]), Citrobacter freundii ANL, and C. freundii biotype
4280 (3, 9, 25, 43, 64). On the basis of DNA relatedness, these
pathogenic strains were subsequently assigned to a separate
species, Citrobacter rodentium (54, 84). C. rodentium is highly
infectious, causing colitis and transmissible colonic hyperplasia
(61). Following ingestion, C. rodentium colonizes the intestines
of mice, residing predominantly in the cecum and colon (91),
where in some inbred strains it can drive hyperplasia or over-
growth of the epithelium. C. rodentium-mediated colonic hy-
perplasia is highly infectious in poorly managed mouse facili-
ties, spreading between mice via contaminated feces and
environments (93). Some mouse strains are relatively resistant
to clinical disease, but in such strains, C. rodentium lives in the
intestine as a component of the microbiota; younger mice are
generally more susceptible to infection (89).
C. rodentium is genetically related to Escherichia coli and is
a member of the Enterobacteriacae. An extracellular pathogen,
C. rodentium colonizes the lumen of the mouse gut mucosa by
formation of so-called attaching/effacing (A/E) lesions on the
apical surfaces of the enterocytes (82; reviewed in references
30 and 61). A/E lesions, which are characterized by effacement
of the brush border microvilli and intimate bacterial attach-
ment to pedestal-like structures, are also classically associated
with the pathogenesis of enteropathogenic E. coli (EPEC), a
leading cause of pediatric diarrhea, and enterohemorrhagic E.
coli (EHEC), which causes diarrhea, hemorrhagic colitis, and
hemolytic uremic syndrome (HUS) (reviewed in reference 45).
In this respect, C. rodentium, EPEC, and EHEC share a com-
mon virulence strategy.
A/E lesion formation is dependent on the expression of
intimin, a type III secretion system (T3SS) (reviewed in refer-
ence 31) and effector proteins encoded on a specific pathoge-
nicity island (PI) known as the locus for enterocyte effacement
(LEE) (57). The LEE of C. rodentium, and those of EPEC and
EHEC, are horizontally acquired sections of DNA, and al-
though not identical, they are highly related in terms of overall
* Corresponding author. Mailing address: Pathogen Genomics, The
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Hinxton, Cambridge, CB10 1SA, United Kingdom. Phone: 44 (0)1223
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genetic organization and gene function (19, 26, 75). The fact
that mice are resistant to EPEC and EHEC infection (60)
makes C. rodentium an ideal animal model to study the roles of
conserved genes in pathogenesis in vivo.
Aside from the role of the LEE in pathogenesis, a number of
other genes have been shown to contribute to C. rodentium
disease, including type IV pili (63) and various T3SS effector
proteins (33, 39, 46, 55, 62, 86). However, direct comparisons
between the virulence gene repertoires of C. rodentium and
other enteric pathogens have been limited. Whole-genome
sequencing has proved to be a powerful approach to defining
the genetic structure of bacteria, providing a genomewide
blueprint to guide genetic analysis. A fully annotated genome
sequence can guide targeted mutagenesis and transcriptomic
or proteomic studies. Here, we report the fully annotated ge-
nome sequence of a murine virulent strain of C. rodentium,
ICC168, and make comparisons with the genomes of EPEC,
EHEC, and other enteric bacteria.
MATERIALS AND METHODS
Bacterial strains and sequencing. The strain of C. rodentium sequenced, strain
ICC168, was obtained in 1993 from S. W. Barthold’s original stocks, previously
known as Citrobacter freundii biotype 4280 (ATCC 51459) (3, 4), and subjected
to minimal passages. The bacterial strains, plasmids, and primers used in the
biological studies are shown in Table 1. Ten g genomic DNA was fragmented
by multiple passages through a 30-gauge needle and end repaired with a mixture
of Klenow polymerase, T4 DNA polymerase, and polynucleotide kinase before
size selection by preparative electrophoresis through a 0.8% agarose gel. The
recovered sized fractions were subjected to a second round of end repair and size
selection. Two- to 2.2-kb and 2.2- to 4-kb fractions were ligated into
pUC19_smaI, and 4- to 5-, 5- to 6-, 6- to 9-, and 9- to 10-kb fractions were ligated
into the low-copy-number vector pMAQ1b_smaI. Two bacterial artificial chro-
mosome (BAC) libraries containing 15- to 25- and 25- to 40-kb inserts were
constructed as previously described (69). End sequences obtained from 672
clones from each library were used to scaffold the assembly. The whole-genome
shotgun was sequenced to approximately 9 coverage on ABI3730 automated
sequencers using BigDye terminator chemistry.
The sequence was assembled, finished, and annotated as previously described
(72). The program Artemis (81) was used to collate data and facilitate annota-
tion. Base 1 of the C. rodentium genome matched that of E. coli K-12 MG1655
to aid whole-genome alignments, making the first gene thrL. The origin of
replication is located between positions 4232946 and 4233181.
Pseudogenes were defined as coding sequences (CDS)s that had one or more
possible inactivating mutations based on similarity with intact CDSs in related
bacteria. Each single frameshift mutation or premature stop codon within a CDS
was confirmed by checking the original sequencing data.
In addition, in order to provide a robust whole-genome phylogenetic species
tree for Citrobacter, we sequenced the whole genome of Citrobacter freundii
ballerup 7851 using 454 FLX pyrosequencing, assembled using the 454/Roche
Newbler assembly program into 357 contigs (N50 contig size, 60,237 bp) from
410,057 sequence reads with an average read length of 177 bp to give a total
sequence length of 4,904,659 bp.
Bioinformatics analyses. The following genome sequences were used in ge-
nome comparisons with C. rodentium ICC168: E. coli K-12 MG1655 (K-12;
accession number U00096), E. coli E2348/69 (EPEC; accession number
FM180568), E. coli O157:H7 Sakai (EHEC; accession number BA000007), Sal-
monella enterica subspecies enterica serovar Typhi CT18 (accession number
AL513382), S. enterica subspecies enterica serovar Typhimurium LT2 (accession
number AE006468), S. enterica subspecies enterica serovar Enteritidis P125109
(accession number AM933172), Citrobacter koseri ATCC BAA-895 (accession
number CP000822), Yersinia enterocolitica 8081 (accession number AM286415),
Pectobacterium atrosepticum SCRI1043 (accession number BX950851), Klebsiella
pneumoniae 342 (accession number CP000964), Enterobacter sakazakii ATCC
BAA-894 (accession number CP000783), and Serratia marcescens Db11 (http:
//www.sanger.ac.uk/Projects/S_marcescens/).
Pairwise whole-genome comparisons of C. rodentium with a range of enteric
bacteria were performed using TBLASTX and visualized using the Artemis
Comparison Tool (13). Circular diagrams were made using DNAplotter (12).
Average nucleotide identities (ANI) were calculated from BLASTN matches
over the entire lengths of the bacterial chromosomes. Orthologues in C. roden-
tium ICC168 and the three E. coli genomes (K-12, EPEC, and EHEC) were
identified using an all-against-all reciprocal FASTA comparison of translated
DNA with at least 40% identity over 80% of the length.
Phylogenetic analyses. The sequences for each of seven housekeeping genes
(adk, fumC, gyrB, icd, mdh, purA, and recA) were extracted from the whole-
genome sequences of several enteric bacteria, individually aligned using MUSCLE
(24), and then concatenated. FindModel (77) was used to identify the best
phylogenetic model to fit the data. Phylogenetic trees were constructed by the
TABLE 1. Bacterial strains, plasmids and primers used in this study
Strain, plasmid,
or primer Description Reference
Strains
ICC169 Spontaneous Nalr derivative of ICC168 92
ICC304 espA::AphT in ICC169 This study
E2348/69 Wild-type EPEC O127:H6 50
Plasmids
pCX340 Expression vector for TEM fusion protein 14
pICC453 pCX340-EspS, expressing C. rodentium EspS fused to TEM This study
pICC454 pCX340-EspH, expressing E2348/69 EspH fused to TEM This study
pACYC184 Bacterial expression vector New England Biolabs
pICC490 pACYC184 expressing espA from the tet promoter This study
Primers
NdeI-EspS-Fw 5-AAACTCGAGCATATGTTTAGTATAAAAGGATACCTACC-3
EcoRI-EspS-Rv 5-CCGGAATTCTCGTCAATATCTGTTGGTTGTGTCC-3
NdeI-EspH-Fw 5-CCCGAGCATATGCGTTATATAGGGAGGTGTATG-3
EcoRI-EspH-Rv 5-CGGAATTCCCAACTGTCACACCTGATAAAGAG 3
EspA-Fw 5-TTATTAGGTGAGGATGATTGGG-3
BamHI-EspA-Rv 5-CGGGATCCCTGATGTCATAGTTGATGTATCC-3
BamHI-EspA-Fw 5-CGGGATCCAACTGTTTCAGCAATACCCATTG-3
EspA-Rv 5-ATCATTATTAAGCACAGTTGTACC-3
EcoRV-rbsEspA-Fw 5-TTTGATATCAAGAAGGAGATATACCATGGATACATCAACTATGACAT
CAGTTGC-3
BamHI-EspA-Rv 5-CGCGGATCCTTATTTGCCAATGGGTATTGCTGAAACAG-3
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maximum-likelihood method using the General Time Reversible (GTR) plus
Gamma model with PhyML (34) and Bayesian likelihood using GTR plus
Gamma with 100,000 generations, sampling every 1,000, and a burn-in of 1,000
using MrBayes, and gave consistent results.
Strain and plasmid construction. C. rodentium strain ICC169 espA (ICC304)
was constructed using a modified version of the lambda red-based mutagenesis
system (18). The espA gene and flanking regions were PCR amplified from
wild-type C. rodentium ICC169 genomic DNA using the primers EspA-Fw/
BamHI-EspA-Rv and BamHI-EspA-Fw/EspA-Rv (Table 1). The two fragments
were digested with BamHI, ligated to each other, and cloned into pGEMT, and
the nonpolar aphT cassette was then inserted into the BamHI site between the
two fragments. After verification for correct orientation of the kanamycin resis-
tance gene cassette, the insert was PCR amplified using the EspA-Fw and
EspA-Rv primers (Table 1). The PCR product was electroporated into ICC169
containing pKD46 encoding the lambda red recombinase (18). Transformants
were selected on kanamycin plates, and the correct insertion of the kanamycin
resistance gene cassette was confirmed by PCR.
Full-length espA was amplified using C. rodentium ICC169 genomic DNA as a
template and the primer pair EcoRV-rbsEspA-Fw and BamHI-EspA-Rv (Table
1). The PCR product was digested and ligated into the EcoRV/BamHI sites of
pACYC184 to produce plasmid pICC490, which constitutively expresses espA
from the tetracycline promoter (Table 1). The construction was confirmed by
DNA sequencing.
Genes encoding EspS and EspH fusions to TEM-1 -lactamase were con-
structed by PCR amplification using ICC169 or E2348/69 genomic DNA and the
primer sets NdeI-EspS-Fw/EcoRI-EspS-Rv and Nde-EspH-Fw/EcoRI-EspH-
Rv, respectively (Table 1). The plasmids resulting from the ligation of the
digested PCR products into pCX340 were called pICC453 and pICC454, respec-
tively.
The Role of EspA in vivo. Pathogen-free male C3H/Hej mice, 6 to 8 weeks old,
were purchased from Harlan Olac (Bichester, United Kingdom). All animals
were housed in individually HEPA-filtered cages with sterile bedding and free
access to sterilized food and water. All animal experiments were performed in
accordance with the Animals Scientific Procedures (Act 1986) and were ap-
proved by the local ethical review committee. Independent single-infection ex-
periments were performed twice using four mice per group. The mice were
inoculated by oral gavage with 200 ml of overnight LB-grown C. rodentium
suspension in phosphate-buffered saline (PBS) (5  109 CFU). The number of
viable bacteria used as an inoculum was determined by retrospective plating on
LB agar containing antibiotics. Stool samples were recovered aseptically at var-
ious time points after inoculation, and the number of viable bacteria per gram of
stool was determined by plating them on LB agar (93). The experiment was
terminated at day 8 postinoculation by sacrificing the mice.
T3SS translocation assay. The translocation assay is an adaptation of the assay
described previously (14). The Swiss 3T3 cell line was grown in Dulbecco’s
modified Eagle’s medium (DMEM) containing 4,500 mg liter glucose1 supple-
mented with 10% fetal calf serum and 2 mM glutamine at 37°C in 5% CO2. Two
hundred l of cells was seeded in black-wall/clear-bottom 96-well plates at a
density of 2  104 cells per well to obtain 100% confluence on the day of
infection. C. rodentium strains were grown for 8 h in LB broth and then trans-
ferred into fresh, sterile DMEM containing 1,000 mg liter glucose1 and incu-
bated statically at 37°C in 5% CO2 overnight prior to infection. Each well was
infected with 40 l of the static overnight culture of either C. rodentium ICC169
or ICC304 carrying either pICC453 or pICC454. This was then centrifuged at
1,000 rpm for 5 min at room temperature. The infection was carried out at 37°C
in 5% CO2 for 2 h, followed by induction of the TEM-1 -lactamase fusion
protein for 1 h 30 min in the presence of 1 mM IPTG (isopropyl--D-thiogalac-
topyranoside). The cells were washed three times with Hanks’ buffered salt
solution (HBSS) and incubated for a minimum of 1 h 30 min in the dark at room
temperature in 100 l of 6 mM probenecid in HBSS-20 mM HEPES buffer
supplemented with 20 l of 6 CCF2/AM solution freshly prepared with the
CCF2/AM loading kit (Invitrogen). The cells were washed in HBSS, and the
fluorescence was quantified on a Fluostar Optima reader with excitation at 410
nm (10-nm band-pass), and emission was detected via 450-nm (blue fluores-
cence) and 520-nm (green fluorescence) filters. The translocation rate was ex-
pressed as the 450/520-nm emission ratio. Experiments were performed in trip-
licate.
Nucleotide sequence accession numbers. The annotated genome sequence of
C. rodentium ICC168 has been deposited in the public databases under accession
numbers FN543502 (chromosome), FN543503 (pCROD1), FN543504 (pCROD2),
and FN543505 (pCROD3). The sequence of the fourth plasmid was identical to
that of the previously sequenced plasmid pCRP3 (accession number AF311902).
The raw sequence data generated for Citrobacter freundii ballerup 7851 has been
deposited in the trace archive under accession number ERA000106 (ftp://ftp
.era.ebi.ac.uk/vol1/ERA000/).
RESULTS
Genome structure and general features. The genome of C.
rodentium ICC168 consists of a 5.3-Mb circular chromosome
and four plasmids (pCROD1 to -3 and pCRP3) that range in
size from 54 to 3 kb (Table 2; see Table S1 in the supplemental
material). The genome of C. rodentium ICC168 shares signif-
icant synteny with those of E. coli K-12 and other members of
the Enterobacteriaceae; however, there is evidence of repeated
mediated recombination events (see below and data not
shown). The chromosome is predicted to contain 4,984 CDSs,
including 182 pseudogenes, 86 tRNAs, and 7 rRNA operons.
We identified a total of 10 prophage-like regions, including five
complete prophages, which were mainly Mu- or P2-like, and
four putative lambdoid prophage remnants (Table 3). Seven-
teen genomic islands (GIs) were also identified within the
chromosome (GI1 to GI16 and the LEE) as regions of aber-
rant GC content carrying mobility functions or showing evi-
dence of integration, such as being flanked by direct repeats or
insertion sequence (IS) elements. The exceptions are GI2,
GI6, and GI13, which were identified on the basis of similarity
to Salmonella pathogenicity islands 4 and 9. Many of the
known and putative virulence factors of C. rodentium are en-
coded on the GIs (Table 3).
TABLE 2. Genome features of C. rodentium ICC168
Parameter
Value
Chromosome pCROD1 pCROD2 pCROD3 pCRP3
Genome size (bp) 5,346,659 54,449 39,265 3,910 3,172
GC content (%) 54.7 47.2 41.8 51.0 46.8
No. of CDSsa 4,984 (182) 60 (5) 56 (1) 3 8
CDS density (%) 88.5 82.5 86.2 79.6 72.6
No. of tRNAs 86 0 0 0 0
No. of rRNA operons 7 0 0 0 0
No. of miscellaneous RNAs 56 1 0 0 1
No. of prophage regions 10 0 0 0 0
No. of genomic islands 17 0 0 0 0
No. of IS elementsb 109 (31) 3 (2) 1 0 0
a The numbers in parentheses indicate the numbers of pseudogenes.
b The numbers in parentheses indicate partial/disrupted IS elements.
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A total of 113 IS elements comprising 29 different types were
found within the genome of C. rodentium ICC168, six of which
(ISCro1 to -6) were newly identified in this study. The most
abundant element, ISCro1, which had 22 intact copies in the
genome sequence, was previously referred to as IS679 (19) but is
actually a novel IS element. ISCro1 was found to be very similar
to the single IS679 element in C. rodentium (59%, 97%, and 98%
amino acid identity to transposases A, B, and C, respectively), and
it is possible, therefore, that one is a derivative of the other. It has
been suggested that IS679-like elements may be involved in the
horizontal transfer of virulence determinants (32), and it is nota-
ble that both GI7, which encodes the virulence factor LifA (47),
and the LEE are flanked by intact copies of ISEc14 at one end
and ISCro1 at the other end.
TABLE 3. Prophages and genomic islands of C. rodentium ICC168
Name Startposition
End
position
Length
(bp) Insertion site
Flanking repeat
(bp)a Type
Virulence-related and other
notable factors encoded
Prophages
CRP28 285,573 325,997 40,425 lfiG-lfiI ND Mu-like prophage; intact Dam
CRP99 990,424 1,027,608 37,185 ROD_08971 ND Mu-like prophage; intact Dam
CRPr11 1,143,137 1,151,111 7,975 ROD_t18 (tRNASer) 70 DR Putative lambdoid
prophage; remnant
CRPr13 1,304,879 1,315,433 10,555 potC-potB 12 DR Putative lambdoid
prophage; remnant
Three T3SS effectors (EspX7,
EspN1c, EspK)
CRPr17 1,762,632 1,769,107 6,476 uspF-ttcA 25 DR (2 MM) putative lambdoid
prophage; remnant
Three T3SS effectors (NleC,
NleB2c, NleG1)
CRPr20 2,096,166 2,115,165 19,000 fliC 8 DR P2-like prophage;
remnant
Dam
phiNP 2,730,430 2,775,336 44,907 ssrA (tmRNA) 25 DR Untypeable prophage;
intact
Five DNA methyltransferases
(3 Dam, 1 Dcm, 1
unknown), DinI
CRPr33 1,304,879 1,315,433 3,912 ROD_31701-ROD_31781 ND Putative lambdoid
prophage; remnant
Three T3SS effectors
(NleG2c, NleGc, EspM3)
CRP38 3,838,308 3,875,066 36,759 ROD_36451 ND P2-like prophage; intact HokA
CRP49 4,945,776 4,986,231 40,460 gatD 28 IR (8 MM) 4
DR
Mu-like prophage; intact tRNAArg
Genomic
islands
GI1 363,963 378,377 14,415 ROD_t04(tRNAThr)-ROD_03491 40 IR (2 MM) Genomic island; no
integrase; previously
IS flanked
Two T3SS effectors (EspS,
NleA/EspI), Aap-like
protein, tRNAThr
GI2 981,787 1,036,635 17,664 ROD_t17(tRNASer) ND Putative genomic island;
no integrase
T1SS and large repetitive
proteinc
GI3 1,151,112 1,154,180 3,069 ROD_t18(tRNASer) 70 DR (1 D, 3
MM)
Genomic island;
integrasec
GI4 1,185,005 1,194,883 9,879 ROD_t19(tRNASer) 18 DR (1 MM) Genomic island;
integrasec
Three T3SS effectors (EspL2,
NleB1 and NleE)
GI5 2,147,048 2,164,244 17,197 ROD_t28(tRNASer) 19 DR (1 MM) Genomic island;
integrase
Two H-NS
GI6 2,712,024 2,730,042 18,019 smpB_ssrA ND Putative genomic island;
no integrase
T1SS and large repetitive
protein
GI7 2,775,891 2,794,475 18,585 ROD_26351-ROD_26491 ND Genomic island; no
integrase; IS flanked
LifA
GI8 3,124,334 3,142,596 18,263 ROD_29461-ROD_29651 ND Genomic island; no
integrase; IS flanked
CroR/I, T1SS, and large
repetitive protein
LEE 3,142,637 3,183,242 40,606 ROD_29641-ROD_30191 ND Genomic island; no
integrase; IS flanked
T3SS, intimin, seven T3SS
effectors (EspG, EspF,
EspB, Tir, Map, EspH,
EspZ)
GI9 3,340,622 3,370,076 29,455 ROD_t53(tRNAPhe) ND Genomic island;
integrasec
LifA-like protein, one T3SS
effector (EspN2-1c)
GI10 3,517,032 3,557,418 40,387 ROD_t56(tRNALeu) 51 DR (1MM) Degenerate ICE
element (ICECr1);
integrasec
T1 RM system (M,S,R)
GI11 4,316,630 4,333,192 16,563 ROD_40761-ROD_41011 ND Genomic island; no
integrase; IS flanked
Intimin-like proteinc, five
T3SS effectors (EspM1c,
EspO, EspT, NleG8. and
EspM2)
GI12 5,017,131 5,037,202 20,072 ROD_47721-ROD_47851 ND Genomic island; no
integrase; IS flanked
LifA-like protein, one T3SS
effector (EspN2-2)
GI13 5,064,524 5,087,409 22,886 ROD_48131-ROD_48201 ND Putative genomic island,
no integrase
T1SS and large repetitive
proteinc
GI14 5,146,469 5,158,968 12,500 yjjG-prfC 22 DR (4 MM) Genomic island;
integrasec
Four T3SS effectors (NleH,
NleF, NleG7, and EspJ)
GI15 5,207,322 5,212,668 5,347 ROD_t85(tRNA-gly) 21 DR Genomic island;
integrase
GI16 5,218,554 5,271,734 53,181 ROD_t86(tRNAPhe) 17 DR Genomic islandb;
integrase
AIDA-like protein,
hemolysin, PagC-like
protein
a ND, none detected; DR, direct repeat; IR, inverted repeat; MM, mismatch; D, deletion.
b Also known as GIpheV-CRICC168 (32).
c Pseudogene.
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Relationship between C. rodentium and other Enterobacteri-
aceae. To determine the relationship between C. rodentium, E.
coli, and other enteric bacteria, a phylogenetic tree was con-
structed, based on the DNA sequences of seven conserved
backbone genes located in core regions of the genome (Fig. 1).
Figure 1 shows that C. rodentium clusters within the tree be-
tween other members of the Enterobacteriaceae. However,
even though C. rodentium and C. koseri appear to cluster, the
branch lengths separating them are almost as long as those
separating E. coli and Salmonella, and C. freundii is more
distantly related. These data indicate that Citrobacter as a ge-
nus is polyphyletic. This is consistent with the whole-genome
ANI shared between C. rodentium and C. koseri (92.2%), E.
coli K-12 (90.7%), Salmonella Typhi CT18 (90.7%), and C.
freundii (88.9%).
Genome comparison with EPEC E2348/69 and EHEC Sakai.
Reciprocal FASTA comparisons showed that the number of
genes shared between C. rodentium, EPEC O127:H6 E2348/69
(referred to here as EPEC) (42), and EHEC O157:H7 Sakai
(referred to here as EHEC) (37) is 2,940 (Fig. 2). This com-
pares to 3,305 shared between E. coli strains K-12 MG1655
(referred to here as K-12) (6), EPEC, and EHEC.
The numbers of CDSs unique to C. rodentium and those
shared exclusively between C. rodentium and either EPEC or
EHEC were also high: 1,585, 230, and 229 CDSs, respectively
FIG. 1. Phylogeny of C. rodentium showing the phylogenetic relationship of C. rodentium to various enteric bacteria based on the nucleotide
sequences of seven housekeeping genes (adk, fumC, gyrB, icd, mdh, purA, and recA). The tree shows bootstrap values (percentages of 1,000
replicates) below the branches and was rooted using an outgroup comprising Yersinia, Serratia, and Pectobacterium. The posterior probability for
each node was 1 in every case and thus is not shown on the tree. The scale bar represents the number of substitutions per site.
FIG. 2. Orthologous CDSs in C. rodentium ICC168, E. coli
E2348/69 (EPEC), and E. coli O157:H7 Sakai (EHEC). The Venn
diagram shows the number of genes that are unique to one strain, or
shared between two or three of the strains, based on the results of
reciprocal FASTA analysis with a minimum similarity of 40% identity
over 80% of the CDSs. The numbers in parentheses indicate the
numbers of C. rodentium genes in that category that have no ortho-
logue in E. coli K-12 strain MG1655.
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(Fig. 2). We analyzed these three CDS groups in more detail.
We subtracted from the groups those genes that were also
shared with K-12 (Fig. 2). This comparison has been used
previously to differentiate core E. coli genes from pathotype-
specific functions (42). Almost half of the CDSs C. rodentium
shares with either EPEC (75/117 CDSs) or EHEC (67/146
CDSs), but without an orthologue in K-12, were found to be
clustered and located on GIs or prophages (Fig. 3). Of the
genes shared with either EPEC or EHEC that were in the
“backbone” of C. rodentium, many had putative functions as-
sociated with metabolism and sugar transport and utilization.
Of particular note, C. rodentium carries all of the genes in the
propanediol utilization operon, which are also found in EPEC
but are absent in many other E. coli strains, including EHEC
and K-12 (42). This supports the suggestion that the cob-pdu
locus originated in a common ancestor of the Enterobacteria-
ceae and has been lost repeatedly by different lineages (42, 79).
Also, among the genes shared only with EHEC was a urease gene
cluster. The lack of urease production in EHEC has been linked
to a premature stop codon in ureD (38, 65); however, C. roden-
tium encodes the full-length UreD and can produce urease (84).
Interestingly, also among the EHEC and C. rodentium shared
genes were those encoding the clustered regularly interspaced
short palindromic repeats (CRISPR)-associated proteins, which
were absent from EPEC and divergent from those found in K-12.
The C. rodentium genome sequence also contains two CRISPRs,
located in genomic locations equivalent to those in EHEC but
which contain different numbers of repeats and spacers. No
CRISPRs were apparent within the genome of EPEC. Figure 3
shows that C. rodentium-specific genes were located throughout
the chromosome, although 414 of the 1,578 unique genes (genes
not shared with EPEC, EHEC, or K-12) were located on genomic
islands or prophages and are likely to have been acquired by
recent horizontal gene transfer.
FIG. 3. Circular map of the C. rodentium ICC168 chromosome. From the outside in, the first circle shows the positions of genomic islands and
prophages (detailed in Table 3). The second circle shows the genomic positions in Mbp. The third and fourth circles show the CDSs transcribed
clockwise and counterclockwise, respectively (color coded according to the predicted functions of their gene products: black, pathogenicity or
adaptation; gray, energy metabolism; red, information transfer; green, membrane or surface structure; yellow, central or intermediary metabolism;
cyan, degradation of macromolecules; cerise, degradation of small molecules; pale blue, regulator; pink, prophage or IS element; orange, conserved
hypothetical; pale green, unknown; and brown, pseudogene). The fifth circle shows C. rodentium CDSs (dark blue) that lack orthologues (by
reciprocal FASTA analysis) in EPEC E2348/69, EHEC Sakai, or K-12 MG1655. The sixth circle shows C. rodentium CDSs (black) that have
orthologues (by reciprocal FASTA analysis) in both EPEC and EHEC but not K-12. Circles 7, 8, and 9 show the positions of C. rodentium CDSs
that have orthologues (by reciprocal FASTA analysis) in EPEC (red), EHEC (green), or K-12 (orange) (excluding those CDSs that also had
orthologues in one or both of the other E. coli strains). The innermost circle shows a plot of GC content.
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Of the 2,940 core genes present in C. rodentium, EPEC, and
EHEC, only 99 had no orthologues in K-12 (see Table S2 in
the supplemental material), and of these 76 were located on
GIs and prophages. Over half (49) of these 76 genes were
associated with virulence and included those found on the
LEE, as well as other non-LEE-encoded T3SS effectors. Of
note, among the remaining shared genes was a cluster with a
putative role in the production of 4-hydroxybenzoate decar-
boxylase, which is found sporadically in other members of the
Enterobacteriaceae, as well as elsewhere, and may be involved
in metabolism of aromatic compounds under anaerobic con-
ditions (20, 53, 56).
Patterns of functional gene loss. The genome of C. roden-
tium ICC168 has 188 pseudogenes, 43% of which are found in
prophages, GIs, or plasmids (summarized in Table S3 in the
supplemental material). Almost a quarter of the pseudogenes
(42/188 CDSs) have been caused by prophage- or IS-mediated
insertional inactivation, including disruption of flagellum bio-
genesis genes and other core and accessory functions (see
Table S3 in the supplemental material). The remainder of the
pseudogenes are truncated by frameshift mutations or prema-
ture stop codons or are gene remnants identified by similarity
to full-length genes in other bacteria. Fifty-six of 188 pseudo-
genes had only a single frameshift mutation or premature stop
codon, indicating that these inactivating mutations were rela-
tively recent events. There are a number of sugar uptake and
energy generation pseudogenes (see Table S3 in the supple-
mental material), which may be indicative of metabolic stream-
lining. Also, a number of pseudogenes are associated with
virulence factors, including several T3SS effector proteins and
essential functions within three distinct fimbrial operons (Ta-
ble 4; see Tables S3 and S4 in the supplemental material).
Virulence determinants. Through targeted investigations
and comparison with EPEC and EHEC, a number of factors
have previously been shown to be important for C. rodentium
virulence. Here, we describe the full repertoire of the known
and potential virulence-associated determinants that were
identified in the genome sequence of ICC168 (summarized in
Table S4 in the supplemental material).
T2SS. C. rodentium has a type II secretion system (T2SS)
encoded in a single locus (ROD_44871 to ROD_45001). Nine
putative substrates for this secretion system were also identi-
fied, including four likely polysaccharide-degrading enzymes
with similarity to chitinases encoded adjacent to the T2SS itself
and four additional similar enzymes (including one encoded by
a pseudogene) encoded elsewhere in the C. rodentium genome.
C. rodentium also carries an orthologue of yodA, the product of
which has been shown to be secreted by the pO157-encoded
T2SS and to promote virulence in EHEC (40).
LEE-encoded T3SS. The LEE pathogenicity island, along
with its associated T3SS, is conserved among the genomes of
EPEC, EHEC, and C. rodentium, but with some notable dif-
ferences. While the LEEs of EPEC and EHEC are inserted
into the SelC tRNA locus, the C. rodentium LEE is in a non-
synonymous location flanked by IS elements, adjacent to an-
other genomic island (GI8). Moreover, in relation to EPEC
and EHEC, the rorf1 and espG genes of C. rodentium are
located at the opposite end of the LEE (19).
The C. rodentium T3SS translocated-protein repertoire. C.
rodentium possesses a repertoire of 35 genes (including six
pseudogenes) (Table 4) encoding proteins that show significant
sequence homology to known T3SS effector proteins in other
systems or that we have shown to be translocated by the
Citrobacter T3SS. In comparison, EPEC E2348/69 encodes 27
T3SS effectors (42), EPEC B171 has 40 (42), and EHEC Sakai
has 62 effector proteins (88) (Table 4). All of the C. rodentium
effectors are encoded in regions thought to have been laterally
acquired. Of the 29 intact C. rodentium effectors, seven are
encoded on the LEE; five are present on the prophage rem-
nants denoted CPRr13, CPRr17, and CPRr33; and 14 effector
proteins are encoded on five GIs (GI1, GI2, GI4, GI11, and
GI14) (Table 3). The three remaining effectors are located
within regions with low GC content. The three prophage-like
elements, CRPr13, CRPr17, and CRPr33, each consist of two
genes encoding putative phage-related functions, along with
three different T3SS effectors each. It is notable that these
regions share similarity with and are integrated at the same
sites as lambdoid prophages identified within the genomes of
EPEC and EHEC (Table 3) (37, 42). CRPr13 encodes the
effectors EspX7, EspN1, and EspK, which are homologues of
effectors encoded on EHEC prophage Sp6. CRPr17 encodes
an Sp10-like integrase and homologues of the effectors NleC,
NleB, and NleG, which are found encoded on different lamb-
doid prophages in EPEC and EHEC, and CRPr33 shares sim-
TABLE 4. C. rodentium T3SS effectors and their homologues in
EPEC and EHEC
Effector
No. ina:
C. rodentium
ICC168
O127:H6
E2348/69
O111:NM
B171
O157:H7
Sakai
Cif 0 1 (1) 1 0
EspB 1 1 1 1
EspF 1 1 1 1
EspG 1 2 1 1
EspH 1 1 1 1
EspJ 1 1 0 1
EspK 1 0 0 1
EspL 1 3 (2) 3 (2) 4 (1)
EspM 3 (1) 0 3 (1) 2
EspN 3 (2) 0 1 1
EspO 1 1 (1) 0 2
EspR 0 0 0 4 (1)
EspS 1 0 0 0
EspT 1 0 0 0
EspV 1 0 1 (1) 1 (1)
EspW 0 0 1 1
EspX 1 0 0 6 (1)
EspY 0 0 0 5 (1)
EspZ 1 1 1 1
Map 1 1 1 1
NleA 1 1 1 1
NleB 2 (1) 3 (1) 3 (2) 3 (1)
NleC 1 1 2 (2) 1
NleD 2 1 0 1
NleE 1 2 1 1
NleF 1 1 1 1
NleG 5 (2) 1 6 14 (5)
NleH 1 3 (1) 2 (1) 2
Ibe 0 0 2 (1) 0
TccP 0 0 1 2 (1)
Tir 1 1 1 1
Total 35 (6) 27 (6) 40 (12) 62 (12)
a The numbers in parentheses indicate pseudogenes.
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ilarities with prophage Sp17 and encodes homologues of three
of the four effectors found on this prophage. It therefore seems
likely that these three regions are remnants of lambdoid
prophages and that the nine associated effector proteins have
been carried into the C. rodentium genome on these phages by
specialized transduction.
T3SS effector families. C. rodentium genes encode at least
one intact member of each of the core set of effector families,
consisting of the seven LEE-encoded effectors plus the non-
LEE-encoded NleA/EspI, NleB, NleE, NleF, NleG, NleH, and
EspL, previously suggested to represent the minimum set re-
quired to facilitate infection (42), as they are common to all
LEE-encoding species sequenced to date. All the effector fam-
ilies that are not represented in the C. rodentium genome are
also absent from at least one of the other sequenced A/E
pathogens, E2348/69, B171, and Sakai (Table 4).
In addition to homologues of EPEC and EHEC effectors, we
identified a new T3SS translocated protein in C. rodentium,
named EspS, which has some similarity to OspB of Shigella.
Using a -lactamase fusion, we showed that EspS is translo-
cated in an EspA-dependent manner (Fig. 4). Mouse inocula-
tion showed that a espA mutant was severely attenuated in
virulence (Fig. 5). C. rodentium also encodes the effector EspT,
found only rarely in EPEC (1), which subverts the eukaryotic
cytoskeleton by activating the small Rho GTPases Rac1 and
Cdc42 (10), and an intact copy of EspV, which is considered to
be a pseudogene in EHEC Sakai due to an N-terminal trun-
cation (88). Interestingly, two identical copies of NleD are
encoded within the genome of C. rodentium adjacent to iden-
tical transposases, and three EspN family members are present
(though two of these are encoded by pseudogenes), whereas
E2348/69, B171, and Sakai have only one or no representatives
from these four families (Table 4). This indicates that there has
been an expansion of the NleD-like gene repertoire in C.
rodentium.
T6SS. A new class of secretion system, the type VI secretion
system (T6SS), has recently been described in a variety of
bacterial species. T6SS gene clusters commonly consist of be-
tween 15 and 25 genes and were initially identified based on
the presence of a gene encoding a homologue of the Legionella
pneumophila type IV secretion system (T4SS) protein IcmF
(17). A contribution to virulence was shown for T6SSs of sev-
eral pathogenic bacteria (28). The T6SS apparatus is not well
characterized yet, but recent studies indicate that several core
components resemble bacteriophage tail proteins (49). The
Hcp and VgrG proteins have been demonstrated to be se-
creted in several organisms; however, a possible dual role of
these proteins as a structural part of the T6SS and secreted
effector molecules is becoming evident (78).
There are two distinct T6SS gene clusters in the genome of
C. rodentium, which we have designated Citrobacter rodentium
type six secretion system cluster 1 (CTS1) and 2 (CTS2). CTS1
is composed of 39 genes, 18 of which are conserved compo-
nents of the T6SS (Fig. 6). CTS1 is almost identical to a T6SS
gene cluster carried by Enterobacter cancerogenus and also
shows limited similarity to components of SPI-6 (also known as
Salmonella enterica centisome 7 genomic island [sci]) (29). Like
the T6SS cluster encoded by E. cancerogenus and the sci locus,
CTS1 also carries a chaperone-usher fimbrial biogenesis
operon (29). CTS1 contains all of the components that have
been determined to be necessary for a functional T6SS in other
bacteria (95). Interestingly, the icmF homologue in CTS1 has
a frameshift at a region containing a polyadenosine tract,
which may allow regulation of the gene via transcriptional
slippage in an manner analogous to that of mixE of Shigella or
the pyrBI locus in E. coli (52, 74).
CTS2 consists of 16 genes, 13 of which are conserved within
other T6SS clusters (Fig. 6). Although CTS2 encodes all the
components required for assembly of a functional T6SS, the
icmF homologue in this cluster has a bona fide frameshift,
which makes it unlikely that CTS2 is sufficient to produce a
functional T6SS. CTS2 is highly similar to a putative T6SS in C.
freundii, which has conserved gene order and an intact icmF
homologue in a single frame (data not shown). CTS2 also
FIG. 4. EspS is a T3SS translocated protein. Translocation of
EspS–TEM-1 and the control EspH–TEM-1 from wild-type (ICC169)
and espA (ICC304) C. rodentium was quantified using a Fluostar
Optima reader with excitation at 410 nm (10-nm band-pass). Emission
was detected via 450-nm (blue fluorescence) and 520-nm (green fluo-
rescence) filters. The translocation rate was expressed as the 450/
520-nm emission ratio. EspS and EspH were translocated from wild-
type C. rodentium, but not from the espA mutant. The error bars
represent mean standard deviations (SD).
FIG. 5. Colonization dynamic of wild-type, espA (ICC304), and
espA(pACYC-espA) C. rodentium strains after oral inoculation of
C3H/Hej mice. Mice inoculated with wild-type (WT) and espA
(pACYC-espA) C. rodentium exhibited similar colonization dynamics,
whereas espA C. rodentium was unable to colonize. The inoculum
count is the number of viable bacteria in 200 ml used to inoculate mice
by oral gavage. The data are represented as means 	 SD.
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shares limited similarity with components of the T6SS clusters
in Pseudomonas species (59, 85).
The differing architectures and lack of homology between
CTS1 and CTS2 suggest that these two T6SS clusters have
distinct evolutionary histories. In addition to CTS1 and CTS2,
which each encode one Hcp family protein, there are four
other Hcp homologues encoded in the C. rodentium chromo-
some, which share little homology to each other and thus may
also have been acquired independently.
EHEC also encodes a T6SS, which we have designated the
enterohemorrhagic E. coli type six secretion system cluster
(EHS), which is encoded in O island 7 and has high homology
to the Shigella sonnei T6SS (85). EHS is distinct from both C.
rodentium T6SSs and consists of 33 genes, 18 of which are
conserved components of the T6SS (Fig. 6). Unlike in CTS1
and CTS2, the icmF gene in the EHS operon is not interrupted
by a frameshift. Additionally, downstream of ehsG there is a
region including genes that are associated with Rhs proteins
(51, 90). EHEC encodes only two Hcp homologues, EhsH1
and EhsH2, which are both encoded in the EHS cluster and
have very limited similarity to each other. In contrast to the
T3SS, which is conserved in all A/E pathogens and is essential
for virulence, the overall lack of homology between EHS,
CTS1, and CTS2 suggests that the T6SS may facilitate more
subtle strain-specific adaptations to divergent host or environ-
mental niches.
Other secretion systems. Type I secretion systems (T1SS)
are involved in the transport of a wide range of substrates, and
in common with many other enteric bacteria, C. rodentium
encodes multiple T1SSs. Of particular note are four genomic
islands (GI2, GI6, GI8, and GI13) (Table 3) that are predicted
to each encode T1SS apparatus, as well as a presumptive se-
creted substrate, a large (1,637- to 5,979-amino-acid [aa])
repetitive protein (Table 3). The gene products forming the
T1SSs share 50% amino acid identity with each other. The
associated repetitive proteins show higher variation in protein
length and lower overall sequence conservation, with 25%
amino acid identity between ROD_08971, ROD_25701,
ROD_29581, and ROD_48171.
The arrangement, nature, and proposed functions of CDSs
seen in the four C. rodentium T1SS genomic islands appear to
suggest that they are functional modules that have been later-
ally acquired. Wider comparisons also showed that these GIs
are similar in gene content, arrangement, and, in some in-
stances, sequence to GIs previously seen in other enteric bac-
teria. Comparisons with these other loci showed that the large
repetitive protein encoded by GI6 shares 47% identity over
3,790 aa with the large repetitive protein of S. Typhi encoded
on SPI-9. Both GIs are inserted in the same intergenic region
between ssrA and smpB.
GI2, GI8, and GI13 also have some similarity to SPI-9 and
the related SPI-4; however, GI13 has a high degree of similar-
ity to O island 28 in EHEC EDL933 (51% identity over 5,392
aa to the large repetitive protein), and the large repetitive
protein of GI2 is similar to a putative hemagglutinin/hemoly-
sin-related protein in Ralstonia solanacearum. SPI-9 has been
FIG. 6. T6SSs in C. rodentium and EHEC. Shown is a schematic representation of the C. rodentium ICC168 T6SS gene clusters CTS1 and CTS2
and the EHEC O157:H7 Sakai T6SS cluster EHS. Conserved T6SS components are highlighted. The differing architectures and lack of homology
between CTS1, CTS2, and EHS suggest that these T6SS clusters have distinct evolutionary histories.
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shown to be required for intestinal colonization in mice and in
vitro biofilm formation in S. Enteritidis (48); therefore, GI2,
GI6, and GI13 may encode factors that play roles in the viru-
lence of C. rodentium. However, transcription of the large
repetitive protein of GI2 is unlikely to be due to the insertion
of prophage CRP99 in the middle of the CDS. In addition, the
CDS for the large repetitive protein on GI13 has been trun-
cated by a premature stop codon; however, as it is located close
to the C terminus, it is possible that a 5,884-aa protein may be
expressed as opposed to the 5,979-aa full-length protein.
There are 20 putative type V secretion systems, or autotrans-
porters, encoded in the C. rodentium genome. Fourteen of
these, including one encoded by a pseudogene, were identified
as putative autotransporter adhesins and were related to
AIDA-I, TibA, or pertactin, which are involved in virulence in
EPEC, enterotoxigenic E. coli (ETEC), and Bordetella pertus-
sis, respectively (5, 8, 27). Two other autotransporters were
predicted to belong to the serine protease autotransporter of
the Enterobacteriaceae (SPATE) family of proteins, members
of which have been shown to contribute to virulence in other
pathogens (7, 23, 70). The majority of the autotransporters are
located in the chromosomal backbone; however, one, AdcA,
which was shown to function as an adhesin but had no obvious
role in colonization of mice (36), is encoded on a genomic
island. In addition, the two SPATE autotransporters are en-
coded by genes on the large plasmid pCROD1, along with a
TibA-like autotransporter adhesin and its associated glycosyl-
transferase.
Adhesins. C. rodentium carries a total of 19 fimbrial biogen-
esis operons, including four incomplete operons (Table 5). Of
the intact operons, the product of the Kfc chaperone-usher
fimbrial operon and CFC type IV fimbriae were previously
determined to be involved in gastrointestinal colonization (36,
63), whereas long polar fimbriae had no discernible role in the
virulence of C. rodentium (87).
Of the nonfimbrial adhesins encoded by C. rodentium genes,
LifA (47) and intimin (83) are essential for colonization. We
also found two LifA homologues that are divergent from LifA
at the N terminus but almost identical at the C terminus and
that had 97% amino acid identity to each other. In addition,
two intact genes and one pseudogene encoding intimin-like
proteins were identified outside of the LEE (see Table S4 in
the supplemental material).
Other potential virulence factors. Other predicted proteins
encoded by C. rodentium genes that are potentially involved in
virulence include homologues of the dispersin Aap of entero-
aggrative E. coli (EAEC) (58) and virulence factor CexE of
ETEC (76), the virulence-related outer membrane protein
PagC (66), and the Yersinia enterocolitica porin required for
colonization, SpfA (36).
Other factors previously reported to be important for the
virulence of C. rodentium include the transcription factors Ler,
TABLE 5. Fimbrial biosythesis operons identified in C. rodentium
Operon CDS ID Genes Descriptionc EPEC orthologue Sakai orthologue
1 ROD_01101–01121 hofCB-ppdD Type IV fimbriae E2348_C_0109–0111 ECs0110–0112
2 ROD_03641–03671 Chaperone-usher 
4 fimbriae
3 ROD_03351,
10951–11021
crl csgGFEDBAC Curli fimbriae E2348_C_0233,
1129–1136
ECs0267,
1414–1412
4 ROD_11771–11781 Chaperone-usher  fimbriaee
5 ROD_18141–18181 lpfEDCBA Long polar fimbriae (chaperone-usher

1 fimbriae)
6 ROD_19341–19381 Chaperone-usher  fimbriae
7 ROD_22311–22341 Chaperone-usher 
4 fimbriae
8 ROD_27771–27801 Chaperone-usher 
4 fimbriae
9 ROD_29101–29191 fimBEAICDFGHK Chaperone-usher 
1 fimbriae E2348_C_4619–4627a ECs5271–5279a
10 ROD_29201–29241 Alternate chaperone-usher ()
fimbriae
E2348_C_0247–0249b ECs0321–0323b
11 ROD_29351–29391 Chaperone-usher 
4 fimbriaed
12 ROD_34961–35021 Chaperone-usher  fimbriae
13 ROD_41241–41291 kfcHGFEDC Kfc (K99-like factor involved in
Citrobacter colonization)
chaperone-usher  fimbriae
14 ROD_41381–41551 flp1 rcpCA tadZABCD
tadVEFG
Tight adherance (tad) locus (type IV
fimbriae)
15 ROD_44281–44321 hofMNOPQ Type IV fimbriae E2348_C_3635–3639 ECs4233–4237
16 ROD_46461–46571 cfcABCDEFGHIJPV CFC (colonization factor Citrobacter)
type IV fimbriae
17 ROD_50611–50651 Chaperone-usher 
4 fimbriaed
18 ROD_p1161–p1201 Chaperone-usher  fimbriae
19 ROD_p1291–p1301 Chaperone-usher 
1 fimbriaed,e
a fimK is missing in EPEC and EHEC.
b No orthologues of ROD_29231 or ROD_29241.
c Chaperone-usher fimbrial operons have been grouped into clades and subclades according to the fimbrial usher protein classification scheme (68).
d Contains pseudogenes.
e Part of operon is missing.
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GrlA, GrlR, RegA, and RpoS (2, 19, 21, 36); the quorum-
sensing locus (CroIR); and the Pho regulon (15, 16). In addi-
tion, C. rodentium genes encode three putative hemolysin ex-
pression regulatory proteins, two on the chromosome and the
third on pCROD2, and the putative hemolysin activator
HlyBC, which is presumably involved in the regulation of the
putative hemolysin/hemagglutinin encoded by the downstream
ROD_49941.
Plasmids. C. rodentium carries four plasmids (Table 2), the
largest of which, pCROD1, is nonconjugative; encodes two
toxin/antitoxin (TA) addiction systems, PemIK and CcdAB;
and has a replication locus similar to those of plasmids belong-
ing to the incompatibility group IncFII, such as the E. coli
plasmid R100 (NR1) (94). In addition to functions associated
with plasmid replication and maintenance, pCROD1 genes,
including a colicin S4-like biosynthesis operon and one intact
and one degenerate chaperone-usher fimbrial operon, encode
proteins associated with virulence, including three putative
autotransporters (Table 5).
The backbone of the 39-kb plasmid, pCROD2, is syntenic
with those of plasmids R6K (IncX1) and pOLA52 (IncX2)
(67), sharing 22 CDSs (average 47% amino acid identity) with
the former and 31 CDSs (average 59% amino acid identity)
with the latter out of the 51 pCROD2 CDSs. Included in
the shared regions is the plasmid replication locus, suggesting
that pCROD2 also belongs to incompatibility group IncX.
pCROD2 carries a 16-kb conjugative plasmid transfer locus
(ROD_p2371-ROD_p2531); however, transfer of this plasmid
might be impaired due to the disruption of triD (ROD_p2461)
by IS102. Two addiction systems are likely to be involved in the
stability of this plasmid, the TA system stbDE and the putative
TA locus hicAB. pCROD2 also encodes a putative H-NS
DNA-binding protein (ROD_p2271) that has been linked to
mitigating the impact of low-GC DNA acquired by lateral
gene transfer in other systems (22).
Plasmids pCROD3 and pCROD4 are small (3.9 and 3.2 kb,
respectively) and nonconjugative. The sequence of the smallest
plasmid is identical to that of the previously sequenced
3,172-bp pCRP3 from C. rodentium strain DBS100 (19).
DISCUSSION
The data that we have described here highlight several clear
messages. The phylogenetic analysis of C. rodentium showed
that although it clusters with members of the Enterobacteria-
ceae, C. rodentium is more distantly related to E. coli than E.
coli is to Salmonella. Moreover, the genomic evidence we have
presented also shows that the sequenced species currently
within the genus Citrobacter do not cluster, and our analysis
indicates that the genus is in fact polyphyletic.
It is apparent from the comparisons of the gene sets of C.
rodentium, EPEC, and EHEC that a large percentage (32%)
of the C. rodentium genome is unique. These distinguishing
functions include those known to be important for virulence in
other systems, including T6SSs and associated effectors and
multiple fimbrial operons, as well as other exported adhesins.
Also included in this group are some novel T3SS effector
proteins.
The majority of functions shared between C. rodentium,
EPEC, and EHEC are also found in the nonpathogenic K-12,
which suggests that these genes encode core enterobacterial
functions. However, there are a significant number of genes
found in C. rodentium, EPEC, and EHEC that are absent from
K-12. The majority of these are located on mobile genetic
elements and are also recognizable as key virulence determi-
nants, including lifA, LEE, and many of the C. rodentium T3SS
effector proteins. It is the acquisition of these factors that is
likely to have been responsible for their convergently evolved
common virulence strategy.
Specialized transduction by lambdoid phages has been shown
to be important for the acquisition of virulence determinants
by both EPEC and EHEC (88). It is clear from this analysis
that this is also the likely mechanism by which many of the C.
rodentium effectors have been acquired. It is important to note
that although the cargo genes are found at analogous sites in
the genome, comparisons of the phage genes thought to have
brought these shared effectors into the genome show that they
probably came from distinct phages and so are likely to be part
of a large pool of temperate phages disseminating a related set
of effector genes to a diverse set of hosts, underscoring their
importance in pathogen evolution. It is access to this gene pool
that has allowed C. rodentium, at least in part, to convergently
evolve with the pathogenic E. coli strains.
It is likely that the acquisition of the LEE and its associated
effector proteins had a dramatic effect on the pathogenic po-
tential of C. rodentium in the mouse and perhaps even the
niche it occupies within this host. Certainly the presence of
such a large number of pseudogenes and IS elements in other
bacteria, such as S. Typhi and Yersinia pestis, has been tightly
linked to a change in lifestyle associated with the occupation of
a new niche (71, 73). Although the numbers of pseudogenes in
C. rodentium and EPEC are comparable, 60% of EPEC pseu-
dogenes are in regions that are thought to have been laterally
acquired. The inverse is true of C. rodentium, where 57% of
pseudogenes fall in the core regions.
It is not just the relative number of pseudogenes lost by C.
rodentium that draws parallels with S. Typhi and Y. pestis; C.
rodentium has also lost metabolic, colonization, and virulence-
associated functions. If there had been a change of niche, it
would be expected that genes important for the previous life-
style would be lost. Certainly the observation that the majority
of pseudogenes lie in the C. rodentium backbone is consistent
with this. A specific example that illustrates this point is the
loss of function in the fimbrial genes that has occurred exclu-
sively in operons unique to C. rodentium compared to EPEC
and EHEC.
C. rodentium is the etiological agent of transmissible colonic
hyperplasia in mice. It colonizes the gut mucosa via A/E lesions
and may also reach deeper tissues (e.g., the liver and spleen).
We have recently shown that espT can mediate invasion of C.
rodentium into mammalian cells (10a); it is not yet known if
EspT plays a role in in vivo dissemination or in the hyperplastic
or immunological responses. C. rodentium is nontoxigenic, us-
ing an infection strategy that appear to rely mainly on its T3SS
effector repertoire. Although we have shown that C. rodentium
is genetically distinct from EPEC and EHEC and does not
share the same host, the three bacteria have similar infection
strategies and share virulence genes that are found on mobile
genetic elements. Accordingly, it is unlikely that C. rodentium
acquired the virulence loci directly from EPEC or EHEC, and
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the data point to the existence of a common ancestral source.
Nonetheless, the availability of the complete C. rodentium ge-
nome annotation will enhance future studies of virulence
mechanisms in A/E pathogens using a natural and unique
host-pathogen interaction model.
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